flucytosine has been researched along with amphotericin b in 1333 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 561 (42.09) | 18.7374 |
| 1990's | 338 (25.36) | 18.2507 |
| 2000's | 230 (17.25) | 29.6817 |
| 2010's | 160 (12.00) | 24.3611 |
| 2020's | 44 (3.30) | 2.80 |
| Authors | Studies |
|---|---|
| Gershon, H; Shanks, L | 1 |
| Dherbomez, M; El kihel, L; Fouace, S; Letourneux, Y | 1 |
| Chen, Y; Chilson, K; Harmody, DK; McCarthy, PJ; Pomponi, SA; Schimoler-O'Rourke, R; Selitrennikoff, C; Wright, AE | 1 |
| Clark, AM; ElSohly, HN; Jacob, MR; Li, XC; Nagle, DG; Smillie, TJ; Walker, LA | 1 |
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Dannaoui, E; Dromer, F; Janbon, G; Lortholary, O; Schwarz, P | 1 |
| Abonía, R; Delgado, P; Enriz, RD; Garibotto, FM; Insuasty, B; Juárez, S; Nogueras, M; Quiroga, J; Rodero, L; Sortino, M; Zacchino, SA | 1 |
| Aurbach, U; Cornely, O; Seifert, H; Stefanik, D | 1 |
| Alvarado-Ramírez, E; Torres-Rodríguez, JM | 1 |
| Almyroudis, NG; Fothergill, AW; Kusne, S; Rinaldi, MG; Sutton, DA | 1 |
| Guarro, J; Mariné, M; Pastor, FJ; Rodríguez, MM; Serena, C | 1 |
| Denning, DW; Drusano, GL; Hope, WW; Keevil, B; Louie, A; Reed, P; Sharp, A; Walsh, TJ; Warn, PA | 1 |
| Gesztelyi, R; Kardos, G; Kelentey, B; Majoros, L; Sóczó, G; Varga, I | 1 |
| Enriz, RD; Freile, M; Gupta, MP; Kouznetsov, VV; Sortino, M; Vargas Méndez, LY; Vásquez, Y; Zacchino, SA | 1 |
| Cano, J; Gené, J; Guarro, J; Marimon, R; Serena, C | 1 |
| Fritsche, TR; Jones, RN; Rhomberg, PR; Sader, HS | 1 |
| Buitrago, MJ; Cuenca-Estrella, M; Gomez-Lopez, A; Gutierrez, MO; Rodriguez-Tudela, JL | 1 |
| Boekhout, T; Curfs-Breuker, I; Fernández, CM; Illnait-Zaragozi, MT; Martínez, GF; Meis, JF | 1 |
| Alastruey-Izquierdo, A; Almirante, B; Cuenca-Estrella, M; Gomez-Lopez, A; Pahissa, A; Rodriguez, D; Rodriguez-Tudela, JL | 1 |
| Jin, LJ; Samaranayake, LP; Samaranayake, YH; Seneviratne, CJ | 1 |
| González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
| Fothergill, AW; Patterson, TF; Thompson, GR; Vallor, AC; Wickes, BL; Wiederhold, NP | 1 |
| Hata, M; Kitamura, A; Nakajima, R; Someya, K; Takemura, M | 1 |
| Cannon, RD; Holmes, AR; Lamping, E; Nakamura, K; Niimi, K; Niimi, M; Ranchod, A; Tyndall, JD | 1 |
| Dimopoulos, G; Falagas, ME; Velegraki, A | 1 |
| Buitrago, MJ; Cuenca-Estrella, M; Gomez-Lopez, A; Mellado, E; Monzon, A; Rodriguez-Tudela, JL | 3 |
| Chittick, P; Delashmitt, B; Evans, J; Palavecino, EL; Peacock, JE | 1 |
| Calvo, E; Guarro, J; Pastor, FJ; Rodríguez, MM; Salas, V; Sutton, DA | 1 |
| Gao, C; Pang, G; Sun, S; Wang, B; Xu, Y; Zhao, D; Zhou, L | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Chapeland-Leclerc, F; Girard, A; Hennequin, C; Lacroix, C; Noël, T; Papon, N; Ribaud, P; Socié, G | 1 |
| Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
| Andes, DR; Crawford, K; Marchillo, K; Nett, JE | 1 |
| Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
| Ekins, S; Williams, AJ; Xu, JJ | 1 |
| Afeltra, J; Moglioni, AG; Moltrasio, GY; Sarmiento, GP; Vitale, RG | 1 |
| Chothe, AS; Dudhe, PB; Gadhwe, S; Kathiravan, MK; Mukta, MS; Salake, AB; Watode, RP | 1 |
| Bowlin, TL; Ding, X; Kwasny, SM; Nguyen, ST; Opperman, TJ; Peet, NP; Williams, JD | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Ji, C; Li, J; Li, W; Liu, N; Sheng, C; Tu, J; Yang, W; Yun, Z | 1 |
| Cangir, A; Rivera, R | 1 |
| Ness, D; Thong, YH | 1 |
| Lilien, LD; Pildes, RS; Ramamurthy, RS | 1 |
| Ishak, B; Lim, EW; Tan, RJ | 1 |
| Hecht, R; Montgomerie, JZ | 1 |
| Bartmann, K | 1 |
| Wegmann, T | 7 |
| Jones, DB | 2 |
| Acers, TE; Mohr, JA; Newsom, DL; Rodriguez, J; Rowsey, JJ; Smith, DL | 1 |
| Arroyo, J; Kobayashi, GS; Medoff, G | 1 |
| Bennet, JE | 1 |
| Andrews, FA; Beggs, WH; Sarosi, GA | 2 |
| Chleboun, J; Nade, S | 1 |
| Bowman, CR; Calderone, RA; Sande, MA | 1 |
| Kobayashi, GS; Medoff, G | 5 |
| Hariri, A; Larsh, HW; Sneller, MR; Sorenson, WG | 1 |
| Chen, CY; Lai, YH; Tsai, JH | 1 |
| Glassford, GH; Lertratanakul, Y; Rubinstein, HM | 1 |
| Ata, H | 1 |
| Polak, A | 7 |
| Shadomy, S | 1 |
| Seeliger, HP | 1 |
| Beyt, BE; Waltman, SR | 1 |
| Hamra, LK; Pankiewicz, IJ | 1 |
| Hoeprich, PD | 2 |
| Drouhet, E | 1 |
| Ikemoto, H; Jimbow, T; Tejima, Y | 1 |
| Craven, PC; Drutz, DJ; Graybill, JR; Mitchell, LF | 1 |
| Codish, SD; Monaco, AP; Tobias, JS | 1 |
| Plempel, M | 3 |
| Eilard, T; Norrby, R | 1 |
| Holmberg, K | 1 |
| Codish, SD; Hannigan, M; Tobias, JS | 1 |
| Berendes, K; Dörstelmann, D; Engelke, W | 1 |
| Domula, M; Handrick, W; Lietz, T; Matzen, C; Schönborn, C | 1 |
| Akrabawi, P; Elliott, JH; Gutow, GS; O'Day, DM; Podgorski, SF | 1 |
| Livramento, JA; Machado, LR; Nobrega, JP; Spina-França, A | 1 |
| Bartlett, MS; Ellis, NS; Smith, JW | 1 |
| Haller, I | 1 |
| Merz, WG; Sandford, GR | 1 |
| Meade, RH | 1 |
| Janosko, EO; McRoberts, JW | 1 |
| Baum, GL | 1 |
| Odds, FC | 2 |
| Wilkinson, GT | 1 |
| Alvarenga, RJ; Lopes, CF; Moreira, YK; Resende, MA | 1 |
| Coodley, EL | 1 |
| Frey, U; Speiser, P; Wegmann, T | 1 |
| Castaldo, RA; Gump, DW; McCormack, JJ | 1 |
| Khermosh, O; Langer, L; Milbauer, B; Rubinstein, E; Svirsky-Fein, S | 1 |
| Fernald, GW; Poliner, JR; Wilkins, EB | 1 |
| Haegi, V; Huggler, AH; Monegat, J; Wegmann, T | 1 |
| Freund, U; Gimmon, Z; Katz, S | 1 |
| Kristensen, JE | 1 |
| Buergelt, CD; Schwartz, A; Weir, EC | 1 |
| Meinhof, W | 2 |
| Alling, DW; Bennett, JE; Bradshaw, M; Cate, TR; Cobbs, CG; Dismukes, WE; Duma, RJ; Fields, BT; Gallis, H; Haywood, H; Leonard, J; McGee, ZA; Medoff, G; Sande, MA; Warner, JF | 1 |
| Andrews, GP; Bartlett, RC; Mazens, MF | 1 |
| Argemi, J; Botet, F; Casanova-Bellido, M; Lechuga, JL; Valls, A | 1 |
| Beardmore, GL | 1 |
| Duma, R; Fisher, J; Mayhall, G; Shadomy, J; Shadomy, S; Watlington, C | 1 |
| Negroni, R | 1 |
| Graham, DR | 1 |
| Cross, CE; Last, JA | 1 |
| Martin, E; Neu, HC; Pancoast, SJ | 1 |
| Ahmed, M; Thompson, R; Wain, W; Yacoub, M | 1 |
| Hong, SS; Kim, WJ; Lee, S; Park, YK | 1 |
| Baliszewska, B; Wierzbicka, D | 1 |
| Bennett, WM; Muther, RS | 2 |
| Block, CS; Myers, RA; Young, CN | 1 |
| Hoeprich, PD; Saubolle, MA | 1 |
| Rubinstein, E | 1 |
| Drouhet, E; Dupont, B | 3 |
| Hermans, PE | 1 |
| Utz, JP | 4 |
| Aronson, IK; Chan, WC; Lorincz, AL; Matz, G; Rieger, CH; Soltani, K; Tkalcevic, V | 1 |
| Myers, GJ; Rao, HK | 1 |
| Male, O | 1 |
| Stewart, JD | 1 |
| Hoeprich, PD; Huston, AC | 2 |
| Bryan, CS; McFarland, JA | 1 |
| Brown, A; Mayrer, AR; Postic, B; Ragni, M; Weintraub, RA | 1 |
| Darrell, AH; Goolden, AW; Saunders, AM | 1 |
| Galgiant, JN; Stevens, DA | 1 |
| Bogdanowicz, WM; Chesney, PJ; Justman, RA | 1 |
| Bergan, T | 1 |
| Cartwright, RY | 2 |
| Lauer, BA; Reller, LB; Schröter, GP | 1 |
| Budak, A; Laskownicka, Z; Macura, A; Pawlik, B | 1 |
| Straus, SE | 1 |
| Kauffman, CA; Roselle, GA | 2 |
| Coltman, CA; Rossof, AH; Sinclair, AJ | 1 |
| Gross, PA; Patel, C; Spitler, LE | 1 |
| Andriole, VT; Downs, J; Hammond, GL; Marier, R; Wynne, B; Zakhireh, B | 1 |
| Egere, JU; Gugnani, HC; Okoro, AN; Onuigbo, WI; Suseelan, AV | 1 |
| Ferrada, L; Lazo, M; Retamal, C; Schütte, H | 1 |
| Ferrada, L; Lazo, M; Retamal, C; Schütte, H; Silva, M | 1 |
| Codish, SD; Monaco, AP | 1 |
| Hallberg, T; Jonsson, N; Mårdh, PA; Pedersen, NB | 1 |
| Husberg, BS; Schröter, GP; Starzl, TE; Temple, DR; Weil, R | 1 |
| Carleton, JA; Frame, PT; Kauffman, CA | 1 |
| Beggs, WH; Sarosi, GA; Steele, NM | 1 |
| Krick, JA; Remington, JS | 2 |
| Hanna, BA; Keusch, GT; Perloff, M; Ribner, B | 1 |
| Alestig, K; Beskow, D; Eilard, T; Norrby, R; Wåhlén, P | 1 |
| Michels, RG; Snip, RC | 1 |
| Piersantelli, N; Robert, L | 1 |
| Bopp, C | 1 |
| Michigan, S | 1 |
| Dupont, MC; Kayser, FH; Schär, G | 1 |
| Kitahara, M; Kobayashi, GS; Medoff, G; Seth, VK | 1 |
| Galgiani, JN; Stevens, DA | 1 |
| Herzog, H; Kobza, K; Kopp, C; Mihatsch, M; Perruchoud, A | 1 |
| Cairns, SA; Fakunle, F; Speller, DC; Stephens, M | 1 |
| Edwards, JE; Guze, LB; Nilsson-Ehle, I; Schotz, MC; Yoshikawa, TT | 1 |
| Magovern, GJ; Rotheram, EB | 1 |
| Arnon, RG; Ehrlich, R | 1 |
| Friedlander, M; Gelfand, M | 1 |
| Pien, FD | 1 |
| Gioannini, P | 1 |
| Ratzmann, GW | 1 |
| Condon, PI; Falconer, H; Terry, SI | 1 |
| Gordon, MA; Holzman, RS; Kupersmith, MJ; Lapa, EW; Senter, H | 1 |
| Cerruti, MM; Friedman, SA; Gladstone, JL; Jomain, SL | 1 |
| Björkstén, B; Quie, PG; Ray, C | 1 |
| Shaw, E; Tobias, JS; Wrigley, PF | 1 |
| Chand, K; Lall, KS | 1 |
| Iellin, A; Stavorovsky, M; Wientraub, S | 1 |
| Archer, G; Rohwedder, JJ | 1 |
| Galgiani, JN; Johnson, RH; Lutwick, LI; Stevens, DA | 1 |
| Ajello, L; Padhye, AA; Segal, E | 1 |
| Chesney, PJ; Marks, MI; Mulvihill, JJ; Salit, IE; Teets, KC | 1 |
| Aurich, G; Plenert, W | 1 |
| Goldberg, P; Kozinn, PJ; Wise, GJ | 2 |
| Diem, E; Male, O | 1 |
| Allwood, GK; Cornere, BM; Sharpe, DN; Singh, BN | 1 |
| Jose, DG | 1 |
| Horne, MJ; Taylor, RF; Williams, R; Zylstra, W | 1 |
| Elliott, DM; Hamilton, JD | 1 |
| Belcher, RW; Palazij, R; Wolinsky, E | 1 |
| Blaton, H; Laterre, EC; Lissoir, FG; Schouttens, E; Vandepitte, J; Yourassowsky, E | 1 |
| Irvine, AR; O'Connor, GR; Stone, RD | 1 |
| Drutz, DJ; Kaspar, RL | 1 |
| Edwards, JE; Guze, LB; Montgomerie, JZ | 1 |
| Barfuss, T; Plempel, M; Seeliger, HP | 1 |
| Bottone, EJ; Hammer, GS; Hirschman, SZ | 1 |
| Dismukes, WE; Snow, RM | 1 |
| Berman, RA; Cate, TR; Gallis, HA; Gunnells, JC; Hamilton, JD; Stickel, DL | 1 |
| Smith, JG; Stretcher, GS | 1 |
| Davis, BA; Espinel-Ingroff, E; Shadomy, S; Wagner, G | 1 |
| Kapila, R; Louria, DB; Premsingh, N; Smith, LG; Tecson, F | 1 |
| Gittes, RF; Keiller, D; Warshawsky, AB | 1 |
| Di Liberti, JH; Hughes, RA | 1 |
| Holt, RJ | 2 |
| Andreassi, L; Fimiani, M; Ottolenghi, F; Sbano, E | 1 |
| Darrell, JH | 1 |
| Hand, R; Salit, I | 1 |
| de Camargo, ZP; Fischman, O; Grinblat, M | 1 |
| Harder, EJ; Hermans, PE | 1 |
| Drevets, CC; Hummer, LM | 1 |
| Hargesheimer, E; Sekhon, AS | 1 |
| Holzman, R; Noriega, ER; Rahal, JJ; Rubinstein, E; Simberkoff, MS | 1 |
| Hermans, PE; Wilkowske, CJ | 1 |
| Duma, RJ; Garriques, IL; Mandell, GL; McGehee, RF; Sande, MA; Shadomy, S; Utz, JP; Warner, JF | 1 |
| Stone, DL | 1 |
| Lagios, MD; Lee, WS; Leonards, R | 1 |
| Sekhon, AS | 1 |
| Livramento, JA; Nobrega, JP; Spina-França, A | 1 |
| Würsten, D | 1 |
| Speller, DC; Warnock, DW | 1 |
| Conly, J; Farah, S; Hellman, L; Johnson, J; Rennie, R | 1 |
| Denning, DW; Hanson, LH; Perlman, AM; Stevens, DA | 1 |
| de Gans, J; Eeftinck Schattenkerk, JK; Portegies, P; Stam, J; Tiessens, G; van Boxtel, CJ; van Ketel, RJ | 1 |
| Cajot, MA; Gosselin, B; Goullard, L; Koussa, A; Marquette, F; Pol, A; Roux, JP; Soots, G; Warembourg, H | 1 |
| Van Cutsem, J | 1 |
| Carbon, C; Eloy, O; Ghnassia, JC; Joly, V; Yeni, P | 1 |
| Bava, AJ; Negroni, R | 1 |
| Büchner, T; Roos, N | 1 |
| Lode, H; Schaberg, T | 1 |
| al-Abedeen Jamjoom, Z; al-Hedaithy, S; Jamali, A; Jamjoom, A; Malabarey, T | 1 |
| Lozano, MC; Martín, E; Parras, P | 1 |
| Chotmongkol, V; Sookprasert, A | 1 |
| Kujala, P; Ruutu, P | 1 |
| Lyman, CA; Walsh, TJ | 2 |
| Galbraith, J; Garg, AK; Mielke, BW; Sekhon, AS; Sheehan, G | 1 |
| Hopfer, RL | 1 |
| Mocsny, N | 1 |
| Hernández Molina, JM; Llosá, J; Martinez Brocal, A; Ventosa, A | 1 |
| Lally, EV; Spiegel, M; Zimmermann, B | 1 |
| Crumbley, AJ; Farrar, WE; Sudduth, EJ | 1 |
| Kaminski, ZC; Kapila, R; Kaufman, L; Kloser, P; Sharer, LR | 1 |
| Kurata, H; Matsuoka, H; Oh, K; Sumita, O; Takatori, K | 1 |
| Berger, M; Boehm, KD; Kaplan, D; Sorensen, RU | 1 |
| Francis, P; Walsh, TJ | 1 |
| Lelarge, P; Mariot, J | 1 |
| Cheng, S | 1 |
| Branch, RA; Brune, KH; Heidemann, HT; Sabra, R | 1 |
| Kurita, N; Mikami, Y; Miyaji, M; Scalarone, GM; Yazawa, K | 1 |
| de Montclos, H; de Montclos, M; Flandrois, JP | 1 |
| Berciano, J; Casafont, F; Fábrega, E; Fariñas, MC; Polo, JM; Salesa, R; Vázquez, A | 1 |
| Karp, R; McCabe, R; Meldahl, R | 1 |
| Meunier, F | 1 |
| Eifrig, DE; Hester, DE; Kylstra, JA | 1 |
| Bernacer, B; Carrasco, R; Navarro, V; Nieto, A; Rodríguez, M; Roig, P; Salavert, M | 1 |
| Powderly, WG | 3 |
| Richardson, MD; Scott, G; Shankland, GS | 1 |
| Azón, A; Gatell, JM; González-Clemente, JM; Mallolas, J; Mensa, J; Miró, JM; Moreno, A; Pedrol, E; Soriano, E | 1 |
| Rohkamm, R | 1 |
| Ash, S; Cohen, J; Corbett, EL; Foster, O; Johnston, SR | 1 |
| Armstrong, D; Blevins, A; Cirrincione, C; White, M | 1 |
| Crump, JR; Elner, SG; Elner, VM; Kauffman, CA | 1 |
| Mitchell, DH; Sorrell, TC | 1 |
| Ishiyama, H; Kanno, H; Miyaji, M; Nishimura, K; Taguchi, H; Tanaka, R | 1 |
| Adrados de Llano, M; García Aguado, C; Gazapo Carretero, E; González Lahoz, JM; Martínez Blanco, ML; Verdejo Ortes, J | 1 |
| Amundson, DE | 1 |
| Larsen, RA | 2 |
| Allerberger, F; Dierich, MP; Reisinger, E; Roberts, G | 1 |
| Cobbs, CG; Dismukes, WE; Lank, KM; Smith, KR | 1 |
| Gerarden, T; Hollis, R; Isenberg, HD; Levenson, D; Pfaller, MA; Smith, MA; Tucci, CB | 1 |
| al-Fawaz, IM; al-Rasheed, SA | 1 |
| Hughes, CE; Terrell, CL | 1 |
| Goldenfeld, M; Kremer, I; Shmueli, D | 1 |
| Glück, T; Weber, P; Wiedmann, KH | 1 |
| Alkalay, AL; Blifeld, C; Komaiko, MS; Pomerance, JJ; Srugo, I | 1 |
| Bergerat, JP; Dufour, P; Herbrecht, R; Koenig, H; Liu, KL; Maloisel, F; Marcellin, L; Oberling, F; Waller, J; Weber, JC | 1 |
| Carrasco, R; Cervelló, A; Navarro, V; Nieto, A; Roig, P; Salavert, M | 1 |
| Chotmongkol, V; Siricharoensang, S | 1 |
| Brockmeyer, NH; Goos, M; Hantschke, D; Hengge, UA; Olbricht, T | 1 |
| de Pauw, BE; Fibbe, WE; Novakova, I; van der Meer, JW; van't Wout, JW; Verhagen, CA | 1 |
| Liang, R; Tsui, E | 1 |
| Halliday, H; McClure, G; Reid, M; Rollins, N | 1 |
| Bradley, SF; Kauffman, CA; Ross, SC; Weber, DR | 1 |
| Daum, RS; Rabalais, GP; Rosenberg, EM; Van Dyke, RB; Zenker, PN | 1 |
| Bruun, B; Nielsen, H; Stenderup, J | 1 |
| Buxton, MJ; Dubois, DJ; Robinson, PA; Sculpher, MJ; Searcy, C; Turner, RR | 1 |
| Sugar, AM | 1 |
| Charles, RW; Goga, IE; Govender, S; Rajoo, R | 1 |
| Benson, JD; Padhye, AA; Sides, EH | 1 |
| Shindo, K | 1 |
| Boltze, HJ; Naumann, GO; Rummelt, V; Ruprecht, KW | 1 |
| Dettori, G; Manzara, S; Morace, G | 1 |
| Chan, PC; Chau, SP; Cheng, IK; Lim, W | 1 |
| Aggarwal, R; Gibb, AP; Swainson, CP | 1 |
| Fishbein, J; Sánchez, PJ; Siegel, JD | 1 |
| Büchner, T; Essink, ME; Fegeler, W; Hiddemann, W; Sauerland, C; Zühlsdorf, M | 1 |
| Flynn, PM; Hughes, WT; Marina, NM; Rivera, GK | 1 |
| Allendoerfer, R; Graybill, JR; Marquis, AJ; Rinaldi, MG | 1 |
| Barriere, SL | 1 |
| Barrio Andrés, MC; de Alba Romero, C; Flores Antón, B; Orbe León, V | 1 |
| Ikemoto, H | 4 |
| Chatterjee, PK; Sharma, S; Singh, SM | 1 |
| Baklanova, OV; Padeĭskaia, EN; Skosyreva, AM | 1 |
| Carrillo, A; Gallach, C; Madrenys, N; Sabaté, M; Torres-Rodríguez, JM | 1 |
| Ruf, B | 1 |
| Kjaeldgaard, P; Nielsen, K; Schultz, KS; Stenderup, J | 1 |
| Berthe-Bonnet, S; Comhaire-Poutchinian, Y; Cremer, V; Grek, V | 1 |
| Aoki, S; Bacher, J; Lee, J; Mechinaud, F; Pizzo, PA; Rubin, M; Walsh, TJ | 1 |
| Andreassian, B; Bouttier, S; Branger, C; Elzaabi, M; Icard, P; Nussaume, O | 1 |
| Brod, RD; Clarkson, JG; Culbertson, WW; Flynn, HW; Miller, D; Pflugfelder, SC | 1 |
| Boubaker, S; Bouratbine, A; Chatti, S; Haouet, S; Jemel, H; Kchir, N; Khaldi, M; Zitouna, MM | 1 |
| Chan, LS; Larsen, RA; Leal, MA | 1 |
| Deppner, M; Dupont, B; Floch, JJ; Goasguen, J; Kadende, P; Laroche, R; Saunière, JF | 1 |
| Abe, M; Asahi, Y; Kasugai, H; Kawada, T; Murayama, M; Nakamura, T; Okada, T; Sotozono, K; Sugai, J; Watanabe, Y | 1 |
| Kuijper, EJ; ter Borg, F; van der Lelie, H | 1 |
| Cook, RA; Galgiani, JN; McIntyre, KA | 1 |
| Bower, M; Gazzard, B; Nelson, MR; Reed, C; Shanson, D; Smith, D | 1 |
| Crist, WM; Flynn, PM; Hughes, WT; Jenkins, JJ; Magill, HL; Pearson, T | 1 |
| Scheld, WM | 1 |
| Bogner, JR; Lüftl, S; Middeke, M; Spengel, F | 1 |
| Boongird, P; Gerstenbrand, F; Jitpimolmard, S; Ponglikitmongkol, S; Schmutzhard, E; Vejjajiva, A | 1 |
| Powell, G; Reents, SB | 1 |
| Watanabe, K | 2 |
| Bartlett, MS; Body, BA; Espinel-Ingroff, A; Fromtling, RA; Galgiani, JN; Hall, GS; Hughes, CE; Odds, FC; Pfaller, MA; Rinaldi, MG | 1 |
| Barth, KH; Dejter, SW; Gibbons, MD; Matsumoto, AH | 1 |
| Andrews, W; Cramer, BC; Ozere, R | 1 |
| Fujita, S; Hisazumi, H; Nishikawa, T; Ohkawa, M; Takashima, M; Tokunaga, S; Wheat, RW | 1 |
| Herrod, HG | 1 |
| Baley, JE; Blumer, JL; Jacobs, MR; Kliegman, RM; Meyers, C | 1 |
| Boogaerts, M; Marcelis, L; Surmont, I; Verbist, L; Vergauwen, B; Verhoef, G | 1 |
| Dan, K; Ito, T; Iwakiri, K; Nomura, T; Ogata, K; Tanabe, Y; Yamada, T | 1 |
| Carney, MD; Combs, JL; Waschler, W | 1 |
| Balletta, M; Cascioli, CF; Donadio, P; Liguori, M | 1 |
| Faix, RG; Feick, HJ; Frommelt, P; Snider, AR | 1 |
| Chida, Y; Hiruma, M; Ida, T; Makiguchi, K; Malumo, F; Matsuda, O; Tsutsui, H | 1 |
| Bruun, B; Ladefoged, J; Nielsen, H; Stenderup, J | 1 |
| Fitz-Henley, M; Horner-Bryce, J; Mitchell, DM | 1 |
| Loke, HL; Szymonowicz, W; Verber, I; Yu, VY | 1 |
| Burke, J; Johnson, EM; Pracharktam, R; Warnock, DW | 1 |
| Dupont, B | 3 |
| Burns, RJ; Cochius, JI; Willoughby, JO | 1 |
| Kikuchi, H; Komiyama, T; Mitamura, K; Nirasawa, M; Oikawa, T; Sugaya, N | 1 |
| Gupta, M; Kumari, S; Mehndiratta, MM; Rajendran, C; Sehgal, S | 1 |
| Hirano, M; Kamei, H; Numata, K; Oki, T; Tomatsu, K | 1 |
| Abdul-Samad, S; Arumugham, G; Yasin, MS | 1 |
| Fritsch, P; Kofler, H | 1 |
| Anastassiades, E; Gokal, R; Kaczmarski, EB; Manos, J; Tooth, JA | 1 |
| Radentz, WH | 1 |
| Ray, TL | 1 |
| Hernandez, AD | 1 |
| Chuck, SL; Sande, MA | 1 |
| Ayela, P; Camuzard, JF; Santini, J; Thyss, A | 1 |
| Cheong, YM; Chin, CS; Wong, YH | 1 |
| Bradley, SF; Bulo, AN; Kauffman, CA | 2 |
| Bass, JW; Blaney, SM; Cook, BA; White, CB | 1 |
| Adler, S; Deutsch, D; Savir, H; Teller, J | 1 |
| Beattie, TJ; McAllister, TA; Mocan, H; Murphy, AV | 1 |
| Hashimoto, Y; Ito, A; Matsumoto, Y; Matsumura, M; Mizuno, T; Shindo, K; Shionoiri, H | 1 |
| Longman, LP; Martin, MV | 1 |
| Walsh, TJ | 1 |
| Pizzo, A; Walsh, TJ | 1 |
| Buchanan, CR; Cooke, RW; Damjanovic, V; Hart, CA; Murphy, N; Whitaker, R | 1 |
| Lavandier, M; Lemaire, B; Lemarié, E; Renoux, G; Renoux, M; Saudeau, D | 1 |
| Arisz, L; Boeschoten, EW; Krediet, RT; Rietra, PJ; Struijk, DG | 2 |
| de Matos-Marques, B; Pohle, HD; Rögler, G; Seibold, M; Sixt, C; Staib, F; Weinke, T | 1 |
| Oelz, O; Stahel, RA; Vogt, P; Zimmermann-Hölsi, MB | 1 |
| Bradsher, RW; Nowack, WJ | 1 |
| Bouchez, MC; Dubos, JP; Duquennoy, C; Kacet, N; Lequien, P; Pierrat, V; Thieuleux, M; Zaoui, C | 1 |
| Ackerbauer, H; Meingassner, JG; Mieth, H | 1 |
| Abbott, AB; Cockayne, A; Hayward, J; Odds, FC | 1 |
| Dietemann-Molard, A; Pauli, G; Pujol, JL; Roegel, E | 1 |
| Abruzzo, GK; Bulmer, GS; Fromtling, RA | 1 |
| Borgers, M; Cauwenbergh, G; Vanden Bossche, H | 1 |
| Gallin, JI; Kwon-Chung, KJ; White, CJ | 1 |
| Barki, Y; Carmi, R; Golan, A; Gradus Ben-Ezer, D; Sober, I; Yadin, O | 1 |
| Hoagland, M; Hood, AF; Jett-Goheen, M; Junkins, JM; Karp, JE; Merz, WG | 1 |
| Nóbrega, JP | 1 |
| Fasoli, M; Kerridge, D; Wayman, FJ | 1 |
| Gray, CA; Richardson, MD | 1 |
| Heidemann, H | 2 |
| Bangel, C; Bennhold, I; Blisse, A; Staib, F; Voigt, HW | 1 |
| Davies, SP; Denning, DW; Murray, WK; Patou, G; Webb, WJ | 1 |
| Green, AD; Masterton, RG; Rainford, DJ; Stevens, PE | 1 |
| Hasegawa, H; Horiuchi, A; Itagaki, N; Shimotuma, N; Sugishima, H | 1 |
| Cavanna, C; Garavelli, PL; Maccabruni, A; Michelone, G | 1 |
| Burch, PA; Karp, JE; Merz, WG | 1 |
| Chen, TJ; Cheng, SY; Ryu, SJ; Tang, LM | 1 |
| Schmutzhard, E; Vejajjiva, A | 1 |
| Monsour, H; Pfeiffer, R; Smith, P; Wszolek, Z | 1 |
| Hopkins, SJ; Mina, FA; Richelo, B | 1 |
| Bernuzzi, AM; Cevini, C; Chichino, G; Gatti, S; Rondanelli, EG; Scaglia, M | 1 |
| Gerarden, T; Pfaller, MA; Wenzel, RP; Yu, M | 1 |
| Beal, MF | 1 |
| Sagraves, R; Santeiro, ML; Thompson, DF | 1 |
| Carrieri, PB; Chirianni, A; Orefice, G; Striano, S; Tullio-Cataldo, P; Vecchione, V | 1 |
| Aris, L; Castillo, J; Chea, R; James, E; Mocarquer, A; Morales, J; Moyano, C; Segovia, L | 1 |
| Bottone, EJ; Cronin, DC; Poon, M; Wormser, GP | 1 |
| Buffard, Y; Gabriel, B; Goudard, M; Regli, P | 1 |
| Bodey, GP | 1 |
| Petrou, MA; Rogers, TR | 1 |
| Blackwelder, WC; Bowles, CA; Cloud, G; Craven, PC; Diasio, RB; Dismukes, WE; Fisher, JF; Gallis, HA; Gregg, CR; Kaplowitz, LG; Kaufman, L; Kerkering, TM; Medoff, G; Shadomy, S; Soong, S; Stamm, AM | 1 |
| Bowles, CA; Cloud, GA; Diasio, RB; Dismukes, WE; Espinel-Ingroff, A; Karam, GH; Shadomy, S; Stamm, AM | 1 |
| Davis, CP; Gudewicz, TM; Mader, JT | 1 |
| Denning, DW; Williams, AH | 1 |
| Cooper, BH; Sanchez, PJ | 1 |
| Marichal, P; Vanden Bossche, H; Willemsens, G | 1 |
| Cabrita, J; Cachão, P; Rocha, MM; Rodrigo, JG | 1 |
| Crowley, JL; Donald, FE; Firth, JL; Ispahani, P; Sharp, JF | 1 |
| Barber, JC; Coats, M; Lawrence, L; Leveque, C; Schulman, JA | 1 |
| Baldwin, S; Kelly, DR; Odrezin, GT; Stagno, S; Whitley, RJ | 1 |
| van 't Wout, JW; van Furth, R | 1 |
| Fernex, M; Keller, P; Kissling, M | 1 |
| Kauffman, CA; Leavitt, AD | 1 |
| Bacher, J; O'Leary, T; Pizzo, PA; Thaler, M | 1 |
| Bartone, FF; Franceschini, R; Hurwitz, RS; Rojas, EL; Steinberg, E | 1 |
| Baley, JE; Silverman, RA | 1 |
| Muramoto, T; Nishimura, K; Ohi, T | 1 |
| Seibold, M; Staib, F | 1 |
| Aubert, D; Burguet, A; Costaz, R; Fromentin, C; Lemouel, A; Menget, A | 1 |
| Araviĭskiĭ, RA; Potyl'chanskaia, OL | 1 |
| Boongird, P; Jitpimolmard, S; Schmutzhard, E; Vejjajiva, A | 1 |
| Bhansali, S; Crane, L; Karanes, C; Kiel, R; Palutke, W; Ratanatharathorn, V | 1 |
| Feld, R; Haron, E; Hasselback, R; Matlow, A; Patterson, B; Tuffnell, P | 1 |
| Head, WS; O'Day, DM; Robinson, RD | 1 |
| Barrie, T | 1 |
| Del Prado, C; Lucentini, MO; Mattera, RS; Tiraboschi, NI | 1 |
| Bennett, JE; Calhoun, DL; Feingold, DS; Galgiani, JN; Jorgensen, J; Kobayashi, GS; Roberts, GD; Shadomy, S | 1 |
| Carrico, CJ; Helton, WS; Schaller, R; Zaveruha, PA | 1 |
| Beggs, WH | 1 |
| Inoue, Y; Matsumoto, Y; Matsuoka, T; Mikami, J; Morinaga, K; Ohmiya, N; Sato, H; Takahashi, Y; Takeda, S; Ueda, M | 1 |
| Meyer, RD | 1 |
| Brenciaglia, MI; Cipriani, P; Ghezzi, MC; Mancini, C; Trancassini, M | 1 |
| Bennett, JE; Klym, DM; Kroll, MH; Washburn, RG | 1 |
| Bishburg, E; Eng, RH; Kapila, R; Smith, SM | 1 |
| Chapin, K; Doern, GV; Rinaldi, MG; Tubert, TA | 1 |
| Guinet, R | 1 |
| Clarke, SW; McCall, J; Spiteri, MA | 1 |
| Chau, RY; Dismukes, WE; Shadomy, HJ; Shadomy, S; Wood-Helie, S | 1 |
| Burch, PA; Fishman, EK; Karp, JE; Kuhlman, JE; Siegelman, SS; Zerhouni, EA | 1 |
| Aubert, G; Bertrand, AM; Brunon, J; Delorme, C; Duthel, R; Hajjar, J; Jaubert, J | 1 |
| Abu Aisha, H; Chagla, AH; Laajam, M; Yaqoub, B | 1 |
| Freeman, R; Mansy, H; Tapson, JS; Wilkinson, R | 1 |
| Alameda, F; Alvarez, E; Carbonell, X; Dolcet, M; Esque Ruiz, MT; Lavilla, H | 1 |
| Gilligan, BS; Waterston, JA | 1 |
| Chan, FL; Huang, CY; Kwong, YL; Lam, KS; Woo, E; Yu, YL | 1 |
| Abston, S; Desai, MH; Herndon, DN | 1 |
| Guérin, JM; Lebiez, PE; Segrestaa, JM | 1 |
| Brass, C; Espinel-Ingroff, A; Galgiani, JN; Gordon, MA; Kerkering, TM; Reiser, J | 1 |
| Hermans, PE; Terrell, CL | 1 |
| Bevier, D; Panciera, DL | 1 |
| Abruzzo, GK; Capizzi, TP; Fromtling, RA; Giltinan, DM | 1 |
| Eichenlaub, D; Pohle, HD; Prüfer-Krämer, L; Rögler, G; Seibold, M; Staib, F | 1 |
| Boiardi, A; Bussone, G; Frediani, F; La Mantia, L; Lamperti, E; Parati, EA; Peccarisi, C; Tortorano, AM; Viviani, MA | 1 |
| Alvarez, J; Anhalt, E; Berg, R | 1 |
| Ceuppens, AM; Heymans, C; Meunier, F; Van der Auwera, P | 1 |
| Brish, M; Graif, M; Laufer, J; Reichman, B | 1 |
| Hatakeyama, M; Kano, S; Kimura, K; Miyagi, J; Sumiya, M; Takaku, F; Takeda, A; Yamamoto, K | 1 |
| Heilesen, AM | 1 |
| George, RH; Thobani, SU | 1 |
| Ito, A | 1 |
| Radetsky, M; Roe, MH; Todd, JK; Wheeler, RC | 1 |
| Flournoy, DJ; Hussain Qadri, SM; Qadri, SG; Ramirez, EG | 1 |
| Merz, WG | 1 |
| Etcubanas, E; Feldman, S; Flynn, P; Johnson, FL; Lenoir, A; Pearson, T | 1 |
| Birrell, LN; Edwards, R; Finch, RG | 1 |
| Sandstrom, PA | 1 |
| Hino, Y; Kojima, T; Matsuzaki, M; Nagura, E; Saito, H; Sano, M; Suzuki, H | 1 |
| Billson, F; Clifton-Bligh, P; Gallo, J; Gregory-Roberts, J; Grunstein, H; Playfair, J | 1 |
| Fanconi, S; Gmür, J; Hitzig, WH; Otto, R; Schaer, G; Seger, R; Spiess, H; Willi, U | 1 |
| Scholer, HJ | 2 |
| Braverman, R; Cabreja, RF; Russell, RP; Watson, AJ; Whelton, A | 1 |
| Rankin, GO; Yang, DJ | 1 |
| Gelmann, EP; Gill, VJ; Kovacs, AA; Kovacs, JA; Lane, HC; Longfield, R; Overturf, G; Polis, M; Tuazon, CU; Wright, WC | 1 |
| Ferris, B; Jones, C | 1 |
| Bernard, E; Chichmanian, RM; Dellamonica, P; Fournier, JP; Garraffo, R; Lapalus, P; Le Fichoux, Y; Marty, P | 1 |
| Bonchek, LI; Rytel, MW; Shimshak, T; Wagner, DK; Werner, PH | 1 |
| Holzman, RS; Louie, E; Rahal, JJ; Simberkoff, MS; Zuger, A | 1 |
| Brennan, M; Morgan, HJ | 1 |
| Bohle, C; Sinn, M; Staib, F; Werner, E | 1 |
| Biniek, R; Hilgenstock, F; Schuchardt, V | 1 |
| Calvin, S; Luis, ES; McDaid, T; Potter, D; Powell, D | 1 |
| Martenet, AC; Marugg, D; Morell, B; Oelz, O | 1 |
| Donowitz, LG; Hendley, JO; Turner, RB | 1 |
| Freeman, JM; Head, WS; O'Day, DM; Robinson, RD; Stern, WH | 1 |
| Fouillit, M; Guinet, R; Leclercq, M; Panteix, G | 1 |
| Andriole, VT; Sabetta, JR | 1 |
| Matsushita, T; Suzuki, K | 1 |
| Congdon, P; Smith, H | 1 |
| Ahmad, S; Gallagher, N; Johnson, RJ; Ramsey, PG | 1 |
| Baudraz-Rosselet, F; Calandra, T; Francioli, P; Glauser, MP; Grigoriu, D; Ruffieux, C | 1 |
| Bodet, CA; Drutz, DJ; Jorgensen, JH | 1 |
| Tan, CB; Tjia, TL; Yeow, YK | 1 |
| Benevent, D; Lagarde, C; Leroux-Robert, C; Peyronnet, P | 1 |
| Flood, LM; Graham, MD; Maslan, MJ | 1 |
| Helgerson, RB; Maki, DG; Strinden, WD | 1 |
| Barnwell, PA; Jelsma, LF; Raff, MJ | 1 |
| McCluskey, PJ; Wakefield, D | 1 |
| Ho, NK | 1 |
| Katzenstein, D | 1 |
| Wise, GJ | 1 |
| Irvine, AR; Jacobs, RA; O'Day, DM; Pons, VG; Stern, WH; Stone, RD; Tamura, E | 1 |
| Harvey, JH; Sekhon, AS; Willans, DJ | 1 |
| Cotter, DA | 1 |
| Melnick, S; Smith, DE | 1 |
| Acar, J; Bastin, R; Cabrol, C; Duron, F; Frottier, J; Jallut, H | 1 |
| Bodey, GP; Luna, M | 1 |
| Aitken, G; Barge, J; Boussougant, Y; Carbon, C; Docquir, C; Lamotte-Barrillon, S; Maillard, JN | 1 |
| Pastakia, LF; Singhal, BS; Veer, AS | 1 |
| Greene, WH; Wiernik, PH | 1 |
| Zylstra, W | 1 |
| Hill, HR; Matsen, JM; Mitchell, TG; Quie, PG | 1 |
| O'Grady, F | 1 |
| Hamilton-Miller, JM | 1 |
| Blaker, RG; Doutt, BJ | 1 |
| Bennett, JE; Block, ER | 1 |
| Kozinn, PJ; Toni, E; Wise, GJ | 1 |
| Lindholm, T; Lindström, FD | 1 |
| Lo, D; Philpot, CR | 1 |
| Daloviso, JR; Pankey, GA | 1 |
| Grunberg, E; Titsworth, E | 1 |
| Clayton, YM | 1 |
| Anderson, DC; Eisen, S; Feigin, RD; Pickering, LK; Shackelford, PG; Spitler, LE | 1 |
| Riley, HD | 2 |
| Agarunova, IuS; Reznikova, MM | 1 |
| Harford, CG | 1 |
| Bryant, T; Donta, ST; Rabinovich, S; Shaw, BD | 1 |
| Bahu, RM; Barney, PL; Briggs, DR | 1 |
| Halkin, H; Ravid, M; Reichert, N; Zulman, J | 1 |
| Firkin, FC | 1 |
| Newberry, WM | 1 |
| Mundy, HB; Sales, JL | 1 |
| Smith, JW | 1 |
| Fishman, LS; Foos, RY; Griffin, JR; Pettit, TH | 1 |
| Abernathy, RS | 1 |
| Bennett, JE | 1 |
| Finegold, SM; Fishbach, RS; White, ML | 1 |
| Carrizosa, J; Kaye, D; Lawrence, T; Levison, ME | 1 |
| Alexander, RL; Sheldon, GM | 1 |
| Amoils, RL; Hammond, JA; van den Ende, EW | 1 |
| Bennett, JE; Block, ER; Henderson, L; Klein, WJ; Livoti, LG; MacGregor, RR | 1 |
| Hoeprich, PD; Ingraham, JL; Kleker, E; Winship, MJ | 1 |
| Buchwald, R; Farmer, RG; Haselby, R; Lefton, HB | 1 |
| Breault, J; Harris, PD; Katz, S; Meltzer, J; Yeoh, CB | 1 |
| Barkve, H; Langberg, CW; Tjørstad, K | 1 |
| Kostiala, AA; Kostiala, I | 1 |
| Lefrock, JL; Smith, BR | 1 |
| Arai, Y; Ikeda, T; Konami, T; Takeuchi, H; Tatewaki, K; Tomoyoshi, T | 1 |
| Kinyoun, JL | 1 |
| Hamilton, JD; Kwon-Chung, KJ; Perfect, JR; Seaworth, BJ | 1 |
| Anagnostopoulos, C; Lerner, SA; Resnekov, L; Samelson, LE | 1 |
| Foster, CS; Giovanoni, R; Lass, JH; Moran-Wallace, K | 1 |
| Högl, F; Raab, W | 1 |
| Roberts, DT | 1 |
| Jones, HE | 1 |
| Durack, DT; Perfect, JR | 1 |
| Corrado, ML; Cummings, M; Eng, RH; Kramer, M | 1 |
| Höffken, G; Lode, H | 1 |
| Hironaga, M; Mochizuki, T; Watanabe, S | 1 |
| Polak, A; Scholer, HJ; Wall, M | 1 |
| Craven, PC; Graybill, JR | 2 |
| Brabender, W; Hodges, GR | 1 |
| Dismukes, WE; Stamm, AM | 1 |
| Bolard, J; Brajtburg, J; Kobayashi, GS; Medoff, G | 1 |
| Pohjola-Sintonen, S; Ruutu, P; Tallroth, K | 1 |
| Head, WS; O'Day, DM; Ray, WA; Robinson, R | 1 |
| Ahearn, DG; McGlohn, MS | 1 |
| Okafor, JI; TeStrake, D; Yangco, BG | 1 |
| Gerding, DN; Harris, C; Hughes, CE; Moody, JA; Peterson, LR | 1 |
| Head, WS; O'Day, DM; Ray, WA; Robinson, RD | 1 |
| Feld, R; Rusthoven, JJ; Tuffnell, PG | 1 |
| Durack, DT; Gallis, HA; Perfect, JR | 1 |
| Koldin, MH; Medoff, G | 1 |
| Hermans, PE; Keys, TF | 1 |
| Markowitz, SM; Sagar, KB; Vishniavsky, N | 1 |
| Bräuninger, W; Dippold, W; Hütteroth, T; Knuth, A; Krämer, G; Mauerer, K; Meyer zum Büschenfelde, KH | 1 |
| Arai, T; Uno, H | 1 |
| Clemente González, C | 1 |
| Bennett, JE; Collen, MJ; Gallin, JI; Handler, R; Jacobs, DH; Macher, AM | 1 |
| Kitagawa, S; Miura, Y; Miyazono, K; Sakamoto, S; Shina, A; Tsuboyama, A; Yoshida, M | 1 |
| Kambayashi, J; Kosaki, G; Ogawa, Y | 1 |
| Catanzaro, A | 1 |
| Bradford, BF; Levkoff, AH; Pappu, LD; Purohit, DM; Turner, WR | 1 |
| Faix, RG | 1 |
| Collignon, PJ; Dunlop, C; Harding, JA; Sorrell, TC | 1 |
| Drukker, A; Farkas, A; Pomeranz, A; Prat, O; Schurr, D | 1 |
| Bolivar, R; Guarda, LA; Korinek, JK; Stroehlein, JR | 1 |
| Frick, P; Oelz, O; Schaer, G; Schaffner, A | 1 |
| Gross, M | 1 |
| Bohigian, G; Boucher, C; Grand, MG; Hanish, SJ; Perlmutter, JC | 1 |
| Drukker, A; Mor, J; Pomeranz, A; Reichenberg, Y | 1 |
| Handrick, W; Hückel, D; Ockert, C; Schönborn, C; Spencker, FB | 1 |
| Odegaard, A; Stavem, P; Steinbakk, M | 1 |
| Azanza Perea, JR; Cuena Boy, R; Honorato Pérez, J | 1 |
| Boudon, A; Guélain, J; Ogrizek, M; Ricossé, PJ | 1 |
| Takeuchi, H; Tomoyoshi, T | 1 |
| Evarts, CM; Steigbigel, RT; Younkin, S | 1 |
| Bass, JL; Foker, JE; Johnson, DE; Thompson, T; Tilleli, JA | 1 |
| Ferrieri, P; Green, TP; Johnson, DE; Thompson, TR | 1 |
| Baley, JE; Fanaroff, AA; Kliegman, RM | 1 |
| Beaumont, F; Kauffman, HF; Rodenhuis, S; Sluiter, HJ | 1 |
| Piaserico, PL | 1 |
| Gabal, MA | 1 |
| Gilbert, CM; Novak, MA | 1 |
| Buckley, RH; Devoe, PW; Perfect, JR; Sampson, HA; Smego, RA; Wilfert, CM | 1 |
| Aldenhoff, P; Grosse, G; Henze, G; Kazner, E; Staib, F; Stephani, U | 1 |
| Beggs, WH; Sarosi, GA | 1 |
| Daschner, F | 1 |
| Shelley, WB; Sica, PA | 1 |
| Buchs, S; Pfister, P | 1 |
| Duffty, P; Lloyd, DJ | 1 |
| Dalton, AS; Sattler, FR; Ward, RM | 1 |
| Fournier, E; Lahoute, C; Ramon, P; Tonnel, AB; Voisin, C | 1 |
| Bhaduri, S; Heimpel, H; Krieger, D; Kurrle, E; Pflieger, H | 1 |
| Esmann, V; Schønheyder, H; Stenderup, A; Thestrup-Pedersen, K | 3 |
| Buchanan, N; van Dellen, JR | 1 |
| Yoshikawa, TT | 1 |
| Crist, MY; Johnson, MG; McGinnis, MR; Schell, WA; Weitzman, I | 1 |
| Chapman-Smith, JS; Parr, DH; Say, PJ | 1 |
| Aber, RC; Appelbaum, PC; Shaikh, BS | 1 |
| Allen, R; Barter, CE; Chachoua, LL; Cleeve, L; Daniel, FJ; O'Connell, JM | 1 |
| Palmer, EA | 1 |
| Jeker, J; Leuenberger, AE | 1 |
| Brookner, A; Rosenthal, S; Stenson, S | 1 |
| Bayer, AS; Choi, C; Guze, LB; Tillman, DB | 1 |
| Clarkson, JG; Doft, BH; Forster, RK; Rebell, G | 1 |
| Moellering, RC; Murray, BE | 1 |
| Pennington, JE | 1 |
| Chaves, E; Da Silva, EB; Da Silva, JA | 1 |
| Geraci, JE; Giuliani, ER; Nichols, DR; Thompson, RL; Wilson, WR | 1 |
| Bell, WE | 1 |
| Astorga, E; Bonilla, E; Martínez, C; Mura, W | 1 |
| Thianprasit, M | 1 |
| De Wytt, CN; Dickson, PL; Holt, GW | 1 |
| Wilson, E | 1 |
| Chen, HH; Hsieh, WC; Liushih, RN | 1 |
| Blaschke-Hellmessen, R; Hermann, V; Morgner, J; Sachs, B | 1 |
| Domingo, J; Haller, JO; Hammerschlag, MR; Papayanopulos, D | 1 |
| Watanakunakorn, C | 1 |
| Adams, SB; Long, GG; Rebar, AH; Steckel, RR | 1 |
| Johnson, TS; Schiffman, RL; Schwartz, A; Weinberger, SE; Weiss, ST | 1 |
| Traube, J; White, CA | 1 |
| Thron, A; Wiethölter, H | 1 |
| Bayardelle, P; Brazeau, M; Delorme, J; Giard, N; Maltais, R | 1 |
| Palmieri, B | 1 |
| Daish, P; Fleming, PJ; McDougall, PN; Speidel, BD; Speller, DC | 1 |
| Richardson, MD; Turner, A; Warnock, DW | 1 |
| Hirayama, K; Ito, N; Kojima, S; Tokumaru, Y; Yamada, T | 1 |
| Cassuto, JP; Chichmanian, RM; Dujardin, P; Fuzibet, JG; Gratecos, N; Lapalus, P; Squara, P; Verdier, JM | 1 |
| Campbell, CK; Hay, RJ; Mackenzie, DW; Philpot, CM | 1 |
| Annable, WL; Baley, JE; Kliegman, RM | 1 |
| Pizzo, PA | 1 |
| Elfervig, JL; Everett, ED; Sprouse, R; Weis, RF | 1 |
| Jordan, RM; Ramos-Gabatin, A | 1 |
| Fujii, Y; Hara, H; Hara, Y; Matsushima, T; Nakashima, T; Soejima, R; Yagi, S | 1 |
| Ferreira Lopes, C | 1 |
| Curole, DN | 1 |
| Deutsch, E; Laggner, A; Maida, E; Pointner, H; Schnaberth, G | 1 |
| Götz, M; Groh, C; Haschke, F; Kristoferitsch, W; Maida, E; Popow, C; Schilling, R | 1 |
| Sakellarides, E | 1 |
| Riyat, MS | 1 |
| Vazzana, A | 1 |
| Friis, H; Vejlsgaard, R | 1 |
| Sandven, P | 1 |
| Edwards, JE; Feldman, RA; Fujita, N; Grinnell, V | 1 |
| Rohner, TJ; Tuliszewski, RM | 1 |
| Cazaux, M; Lepargneur, JP; Linas, MD; Riser, A; Saveres, C; Seguela, JP | 1 |
| Agyare, E; Corrado, ML; Goetz, R; Stanek, A; Weitzman, I | 1 |
| Chu, AC; Hay, RJ; MacDonald, DM | 1 |
| Desruelles, J; Durocher, A | 1 |
| Busch, M; Frühmorgen, P; Roos, W; Rühl, U; Weiler, H | 1 |
| Chang, JY; Chao, TY; Tsao, TY; Yu, CY | 1 |
| al-Rasheed, SA | 1 |
| Grünewald, T; Pohle, HD; Reichart, PA; Schmidt-Westhausen, A | 1 |
| Martinez-Suárez, JV; Rodriguez-Tudela, JL | 2 |
| Blatter, DD; Burgert, SJ; Burke, JP; Classen, DC | 1 |
| Atkinson, BA; Bocanegra, R; Bouthet, C; Correa, A; Graybill, JR; Luther, MF | 1 |
| Conrad, PD; Kamitsuka, MD; Nugent, NA; Swanson, TN | 1 |
| Kitamura, S; Saitoh, K; Shibuya, Y; Sohara, Y | 1 |
| Chiang, SS; Hseih, SJ; Lee, SH; Shen, HM | 2 |
| Bale, M; Buschelman, B; Cooper, CR; Espinel-Ingroff, A; Lancaster, M; McGinnis, MR; Pfaller, MA; Rex, JH; Rinaldi, MG | 1 |
| Gehrt, A; Peter, J; Pizzo, PA; Walsh, TJ | 1 |
| Berenguer, J; Bouza, E; Fernández-Baca, V; Sánchez, R | 1 |
| Hall, MA; Hitchcock, RJ; Malone, PS; Pallett, A | 1 |
| Barry, AL; Pfaller, MA | 2 |
| Brown, N; Trevett, A | 1 |
| Freedman, AR; Rowe-Jones, JM | 1 |
| Denning, DW; Ganguli, LA; Keaney, MG; Law, D; Moore, CB; Wardle, HM | 1 |
| Dupont, B; Improvisi, L; Kerridge, D; Marichal, P; Odds, FC; Provost, F; Ronin, O; Sen Gupta, S; Vanden Bossche, H; Warnock, DW | 1 |
| Kreis, H; Legendre, C; Page, B; Thervet, E | 1 |
| Fisher, JF; Newman, CL; Sobel, JD | 1 |
| Baltch, AL; Franke, MA; Gordon, MA; Louie, A; Smith, RP | 1 |
| Becker, G; Bogdahn, U; Lindner, A; Schalke, BC; Toyka, KV; Warmuth-Metz, M | 1 |
| Hamada, T; Nikawa, H; Samaranayake, LP; Tenovuo, J | 1 |
| Dismukes, WE | 1 |
| Avet-Loiseau, H; Cohen, JY; Harousseau, JL; Mechinaud-Lacroix, F | 1 |
| Rowley, AH; Stamos, JK | 1 |
| Allworth, AM; Gottlieb, T; Heath, CH; McGregor, AR; Mitchell, DH; Papanaoum, K; Richards, MJ; Sorrell, TC | 1 |
| Viviani, MA | 1 |
| Hay, RJ | 1 |
| Hollis, RJ; Messer, SA; Pfaller, MA | 1 |
| Belcher, KE; Law, EJ; Spencer, SA; Still, JM | 1 |
| Boudon, P; Hilpert, F; Lepennec, MP; Malbec, D; Pinès, E | 1 |
| Marichal, P; Odds, FC; Vanden Bossche, H | 1 |
| Clini, E; Pogliani, E | 1 |
| Joly, V | 1 |
| Chakraborty, A; Goenka, MK; Malik, AK; Mehta, S; Nagi, B; Yachha, SK | 1 |
| Solomkin, JS | 1 |
| Bale, M; Buschelman, B; Espinel-Ingroff, A; Lancaster, M; Pfaller, MA; Rex, JH; Rinaldi, MG | 1 |
| Anandi, V; Date, A; Jacob, CK; John, GT; Mathew, M; Shastry, JC; Snehalatha, E | 1 |
| Bradley, SF; Kauffman, CA; Sangeorzan, JA; Voice, RA | 1 |
| Bale, MJ; Buschelman, B; Espinel-Ingroff, A; Lancaster, M; Pfaller, MA; Rex, JH; Rinaldi, MG | 1 |
| Craig, WA; Gudmundsson, S; Turnidge, JD; Vogelman, B | 1 |
| Cortet, B; Delcambre, B; Deprez, X; Duquesnoy, B; Flipo, RM; Le Loët, X; Lucet, L; Richard, R | 1 |
| Ancarani, F; Arzeni, D; Barchiesi, F; Del Poeta, M; Marinucci, G; Morbiducci, V; Scalise, G | 1 |
| Lynch, ME; Sobel, JD | 1 |
| Block, C; Farfel, Z; Goldschmied-Reuven, A; Gurevitz, O; Hassin, D; Kopolovic, J | 1 |
| Agrawal, JP; Kawabata, K; Matsuda, T; Okuda, B; Sugita, M; Tachibana, H; Tomino, Y | 1 |
| Anaissie, EJ; Dignani, MC; Hachem, R; Karyotakis, NC; Paetznick, V; Rex, JH | 1 |
| Fisher, D; Lalloo, D; Laurenson, I; Mavo, B; Naraqi, S; Saweri, A; Sinha, A; Temu, P | 1 |
| Dubé, MP; Evans, S; Heseltine, PN; Rinaldi, MG; Zawacki, B | 1 |
| Cook, RA; Crane, LR; Galgiani, JN; Gallis, HA; Pappas, PG; Pottage, JC; Villareal, KM; Wenzel, RP | 1 |
| Bickers, DR | 1 |
| Denning, DW | 1 |
| Appleyard, MN; Hartley, JP; Leake, HA | 1 |
| Chen, JY | 1 |
| Bhakdi, S; Maier, F; Martin, E | 1 |
| Aznar, C; Boccon-Gibod, L; Landman, J; Lasfargues, G; Leverger, G; Tabone, MD | 1 |
| Uchida, K; Yamaguchi, H | 1 |
| Karp, JE; Merz, WG; Miller, CB; Rinaldi, MG; Saral, R; Wingard, JR | 1 |
| Cortet, B; Delcambre, B; Deprez, X; Duquesnoy, B; Flipo, RM; Savage, C; Triki, R | 1 |
| Donnet, A; Durand, JM; Graziani, N; Grisoli, F; Harlé, JR; Touta, A | 1 |
| Lisch, S; Steudel, WI | 1 |
| Bollinger, M; Kühnert, M; Loewenich, V; Schlösser, RL; Zubcov, A | 1 |
| Breslin, BJ; Cooper, CR; Kamwan, C; Merz, WG; Nelson, KE; Sirisanthana, T; Supparatpinyo, K | 1 |
| Christensson, B; Dahlberg, L; Lohmander, S; Ryd, L | 1 |
| Garg, AK; Hamir, Z; Padhye, AA; Sekhon, AS | 1 |
| Badoual, J; Boccara, JF; Houmeau, L; Monfort-Gouraud, M | 1 |
| Menon, T; Ponnuvel, KM; Rama, CP | 1 |
| St Georgiev, V | 1 |
| Chotmongkol, V; Jitpimolmard, S | 2 |
| Bolzonella, R; Contestabile, A; Fabris, A; Gardin, C; Pellanda, MV | 1 |
| Cohen, M; Montgomerie, JZ | 1 |
| Bonnin, A; Bonnotte, B; Caillot, D; Casasnovas, O; Chavanet, P; Entezam, F; Guy, H; Lopez, J; Reny, G; Solary, E | 1 |
| Kaku, M; Koga, H; Kohno, S; Maesaki, S; Yamada, H | 1 |
| Danziger, LH; Gubbins, PO; Piscitelli, SC | 1 |
| Catalin, J; Durand, A; Lacarelle, B; Rajaonarison, JF; Sampol, E | 1 |
| Araj, GF; Diab, SM; Nazzal, M; Sa'adah, MA | 1 |
| Fung, J; Jabbour, N; Kusne, S; Martin, M; Reyes, J | 1 |
| Nguyen, MH; Yu, VL | 1 |
| Hunt, SJ; Mathews, WC; Reed, SL; Torian, B | 1 |
| Fothergill, AW; Rinaldi, MG; To, WK | 1 |
| Criddle, RS; Edwards, JE; Fu, Y; Ghannoum, MA; Ibrahim, AS; Mortara, LA; Shafiq, MC | 1 |
| Chen, CP; Wang, KG | 1 |
| Craig, AJ; Love, DN; Malik, R; Martin, P; Wigney, DI | 1 |
| Okazawa, Y; Tosaka, M; Yamane, N | 1 |
| Gupta, M; Weinberger, B; Whitley-Williams, PN | 1 |
| Feldman, C; Goolam Mahomed, A; Mahida, P; Morar, R; Song, E; Tissandie, JP | 1 |
| Capasso, G; Cernuschi, M; Erembourg, L; Finazzi, R; Gesu, G; Guffanti, M; Ossi, C | 1 |
| Benard, G; Duarte, AJ; Gryschek, RC; Shikanai-Yasuda, MA | 1 |
| Kume, H; Murase, S | 1 |
| Han, MH; Kang, MK; Kim, HS; Lee, KS; Min, YG | 1 |
| Blaschke-Hellmessen, R; Kabus, M; Kaulen, F; Schwarze, R; Wendisch, J | 1 |
| Bolmström, A; Messer, SA; Odds, FC; Pfaller, MA; Rex, JH | 1 |
| Berrouane, YF; Hollis, RJ; Pfaller, MA | 1 |
| Hennessy, MJ | 1 |
| Fujita, S | 1 |
| Bedos, JP; Darras-Joly, C; Gachot, B; Regnier, B; Veber, B; Wolff, M | 1 |
| Bryant, KK; Lewis, JJ; Rabalais, GP; Samiec, TD | 1 |
| Boyvat, A; Geilen, CC; Orfanos, CE; Seibold, M; Tebbe, B; Wölfer, LU | 1 |
| Berenguer, J; Martínez-Suárez, JV; Rodríguez-Tudela, JL; Sanchez, R | 1 |
| Aberg, JA; Powderly, WG | 1 |
| Anaissie, EJ; Rex, JH; Rodriguez, LJ | 1 |
| Anaissie, EJ; Ensign, LG; Espinel-Ingroff, A; Galgiani, JN; Hitchcock, CA; LaRocco, M; Paetznick, VL; Patterson, T; Pfaller, MA; Rex, JH; Rinaldi, MG | 1 |
| Love, DN; Malik, R; Medeiros, C; Wigney, DI | 1 |
| Chanock, SJ; Walsh, TJ | 1 |
| Dix, S; Falconer, DJ; Geller, R; Gilmore, C; Nolte, FS; Parkinson, T; Williams, J; Wingard, JR | 1 |
| Goto, Y; Hashimoto, A; Nagai, H; Nasu, M; Perparim, K; Tashiro, T | 1 |
| Alonso, J; Iglesias, L; Rodriguez-Peralto, JL; Romero, G; Sanchez-Albisua, B; Vanaclocha, F | 1 |
| Callister, SM; Kirk, SM; Lim, LC; Schell, RF | 1 |
| Jones, RN; Messer, S; Pfaller, MA | 1 |
| Hiramitsu, S; Kubo, N; Morimoto, S | 1 |
| Fujihara, M; Kyo, T; Mikami, Y; Myoken, Y; Sugata, T | 3 |
| Igari, J; Yamane, N | 1 |
| Cuenca, M; Gadea, I; Gegúndez, MI; Soriano, F; Valero, ML; Zapardiel, J | 1 |
| Hollis, RJ; Pfaller, MA; Zhang, J | 1 |
| Digranes, A; Lassen, J; Nilsen, K; Sandven, P; Tjade, T | 1 |
| Adeyemi-Doro, FA; Chan, RC; Cheng, AF; Cheung, SW; Ng, TK | 1 |
| Cloud, GA; Dismukes, WE; Graybill, JR; Hamill, RJ; Johnson, PC; Kerkering, T; Moskovitz, BL; Powderly, WG; Saag, MS; Sobel, JD; Tuazon, CU; van der Horst, CM | 1 |
| Jaruratanasirikul, S | 1 |
| Chotmongkol, V; Sukeepaisarncharoen, W; Thavornpitak, Y | 1 |
| Rodríguez Tudela, JL | 1 |
| Casado, JL; Cobo, J; Corral, I; Moreno, A; Navas, E; Oliva, J; Pintado, V; Quereda, C | 1 |
| Lee, K; Scherer, WJ | 1 |
| Batura-Gabryel, H; Mlynarczyk, W; Wieczorek, U | 1 |
| Yamaguchi, H | 2 |
| Dugel, PU; Kolahdouz-Isfahani, A; Rao, NA; Rostomian, K; Smith, RE; Thach, AB | 1 |
| Kauffman, CA; Spiegel, JE; Tiballi, RN; Zarins, LT | 1 |
| Espinel-Ingroff, A | 1 |
| Aihara, M; Asakura, S; Fujio, A; Kitano, M; Matsui, T; Takeuchi, Y | 1 |
| Graybill, JR | 1 |
| Berenguer Berenguer, J | 1 |
| Jones, RN; Marco, F; Messer, S; Pfaller, MA | 1 |
| Barnes, RA; Flanagan, PG | 1 |
| Gore, SJ; Graybill, JR; Hardin, TC; Summers, KK | 1 |
| Bruno, R; Calderon, W; Filice, G; Malfitano, A; Parisi, A; Patruno, SF; Sacchi, P | 1 |
| Doi, SA; Liam, CK; Naganathan, K; Tan, CT | 1 |
| Glasmacher, A; Just-Nübling, G; Molitor, E | 1 |
| Anaissie, EJ; Rex, JH; Walsh, TJ | 1 |
| Bauer, M; Daniel, BE; Diamond, DM; Ding, JC; Graybill, JR; Johnson, D; Larsen, RA; Leal, MA; Najvar, L; Thomas, AM; Williams, BK | 1 |
| Seaton, RA | 1 |
| Gould, IM; Kunova, A; Milne, K; Wood, W | 1 |
| Colbridge, M; Keenan, F; Melzer, M; Ong, EL; Stainsby, D | 1 |
| Ghannoum, MA; Hawser, SP; Jessup, CJ; Norris, H | 1 |
| Kerridge, D; Siau, H | 1 |
| Cordonnier, C; De Bacquer, D; De Pauw, B; Engelhard, D; Ljungman, P; Meunier, F; Offner, F; Prentice, HG | 1 |
| Tang, D; Wang, W | 1 |
| Blaschke-Hellmessen, R; Schwarze, R; Seebacher, C | 1 |
| Ellepola, AN; Samaranayake, LP | 4 |
| Aiyar, S; Haq, JA; Menon, BS; Noh, LM; Shuaib, IL; Zamari, M | 1 |
| Arikan, S; Chen, Y; Coffman, S; Heffner, T; Lozano-Chiu, M; Messer, SA; Pfaller, MA; Rennie, R; Rex, JH; Sand, C; Wang, J; Yamane, N | 1 |
| Jones, RN; Marco, F; Messer, SA; Pfaller, MA | 3 |
| Chaine, G; Fajnkuchen, F; Le Thien, L | 1 |
| Cambon, M; Condat, P; Fouassier, M; Joly, D; Peigue-Lafeuille, H | 1 |
| Andriole, VT | 1 |
| Furuta, I; Kuroda, T; Obana, Y; Ohata, T; Yamazumi, T | 1 |
| Johnson, EM; Rogers, TR; Warnock, DW | 1 |
| Blétry, O; Cassoux, N; Kemali, Z; Le Hoang, P; Le Thi Huong, D; Piette, JC; Wechsler, B | 1 |
| Casal, M; Linares, MJ; Muñoz, JF; Rodríguez, FC; Solís, F; Valero, A | 1 |
| Daza, RM; Martín, JE; Martín, P; Martínez, MM; Mendaza, P; Portero, F; Sánchez, G | 1 |
| Patel, R | 1 |
| Araj, GF; Daher, NK; Tabbarah, ZA | 1 |
| Espinel-Ingroff, A; Ghannoum, MA; Killian, S; Knapp, CC; Messer, SA; Norris, HA; Pfaller, M | 1 |
| Coleman, DC; Gee, S; Joly, S; Messer, SA; Pfaller, MA; Pujol, C; Soll, DR; Sullivan, DJ | 1 |
| Bauer, M; Diamond, DA; Evans, SG; Holtom, PD; Larsen, RA; Leal, MA; Leedom, JM; Robinson, PA | 1 |
| Boschini, A; Calista, D; Coccia, L | 1 |
| Avlami, A; Georgakopoulos, G; Kordossis, T; Legakis, NJ; Papalambrou, C; Stefanou, I; Velegraki, A | 1 |
| Bennett, JE; Hospenthal, DR; Park, MK | 1 |
| Guarro, J; Mayayo, E; Pujol, I | 1 |
| Alonso, M; García, F; Gatell, JM; Mallolas, J; Miró, JM; Ortega, M; Soriano, A; Soriano, E | 1 |
| Berg, G; Darwazah, A; Faris, B | 1 |
| Cordero Matía, E; López-Cortés, LF; Martínez Fernández, EM; Regordan, C | 1 |
| de Pauw, BE; Meunier, F | 1 |
| Brownstein, S; Deschênes, J; Jackson, WB; Kirsch, LS; Sorgini, C | 1 |
| Hashiguchi, K; Higashiyama, Y; Hossain, MA; Kohno, S; Maesaki, S; Sasaki, E; Tashiro, T; Tomono, K; Yoshitsugu, Y | 1 |
| Desmet, P; Raes-Wuytack, C; Swinne, D; Van Looveren, K | 1 |
| Cuenca-Estrella, M; Rodríguez-Tudela, JL | 1 |
| Chang, HW; Chang, WN; Chuang, YC; Lu, CH | 1 |
| Martín Dávila, P; Muñoz Labián, V; Pintado García, V; Quereda Rodríguez-Navarro, C | 1 |
| de Pauw, BE; Kullberg, BJ | 1 |
| Ghannoum, MA; Rice, LB | 1 |
| Liam, CK; Lim, KH; Wong, CM | 1 |
| de Vries, HG; Eikelboom, MC; Kuipers, ME; Meijer, DK; Swart, PJ | 1 |
| Cantón, E; Gobernado, M; Pemán, J; Ubeda, P; Viudes, A | 1 |
| Bejarano Palma, A; Carrasco Sánchez, P; Castillo Montero, ML; Durán de Vargas, L; González-Meneses, A; López Sanz, A; Sáenz Reguera, C; Santano Gallinato, M | 1 |
| Drusano, GL; Liu, QF; Liu, W; Louie, A; Mayers, M; Miller, DA; Miller, MH; Sucke, AC | 1 |
| Bash, E; Giladi, M; Izkhakov, E; Orni-Wasserlauf, R; Polacheck, I; Siegman-Igra, Y | 1 |
| Cloud, G; Dismukes, W; Graybill, JR; Hamill, R; Powderly, W; Riser, L; Saag, M; Sobel, J; van Der Horst, C | 1 |
| Cahn, P; Canteros, C; Córdoba, S; Davel, G; Guelfand, L; Hochenfellner, F; Kaufman, S; Rodero, L | 1 |
| Chang, HC; Chang, JJ; Chang, TC; Huang, AH | 1 |
| Chaiprasert, A; Prariyachatigul, C; Rungsipanuratn, W; Srimuang, S; Tanphaichitra, D | 1 |
| Chang, SC; Chen, YC; Hsieh, WC; Hung, CC; Luhbd, KT; Pan, YS; Shih, CC | 1 |
| Maheshwari, A; Marwaha, RK | 1 |
| Braxton, GR; Cawley, MJ; Guilday, RE; Haith, LR; Patton, ML; Reilly, KJ | 1 |
| Clancy, CJ; Hong Nguyen, M; Wingard, JR | 1 |
| Ciblak, MA; Clayton, GE; Elie, CM; Li, RK | 1 |
| Schmidt, A; Schmidt, DI | 1 |
| Hartmann, M; Kappe, R; Prariyachatigul, C; Rimek, D; Zimmermann, T | 1 |
| Büchner, T; Essink, M; Fegeler, W; Roos, N; Silling, G | 1 |
| Govender, S; Mutasa, E; Parbhoo, AH | 1 |
| Anndo, T | 1 |
| Akgün, Y; Anğ, O; Erturan, Z; Kiraz, N | 1 |
| Denning, DW; Eden, OB; Gadong, N; Kelsey, A; Leggate, J; Ng, A | 1 |
| Apfalter, P; Hirschl, AM; Makristathis, A; Rotter, M; Seibold, M; Willinger, B | 1 |
| Abu Jawdeh, L; Akel, S; Bitar, F; Dbaibo, GS; Haidar, R; Mroueh, S; Nuwayri-Salti, N | 1 |
| Aoun, M | 1 |
| Guarro, J; Llop, C; Riba, MD; Sala, J | 1 |
| Amariglio, N; Bielorai, B; Golan, H; Kaplinisky, C; Keller, N; Mandel, M; Neumann, Y; Paswell, J; Rechavi, G; Toren, A; Weintraub, M; Wolach, B | 1 |
| Aller, AI; Bernal, S; Chávez, M; Gutiérrez, MJ; Martín-Mazuelos, E; Recio, FJ | 1 |
| Haapasalo, MP; Meurman, JH; Samaranayake, LP; Waltimo, TM; Ørstavik, D | 1 |
| Li, Z; Liao, W; Xu, H; Yao, Z | 1 |
| García, MT; Llorente, MT; Mínguez, F; Prieto, J | 1 |
| Amerongen, AV; Helmerhorst, EJ; Reijnders, IM; Simoons-Smit, IM; van't Hof, W; Veerman, EC; Walgreen-Weterings, E | 1 |
| Bourgault, AM; Laverdière, M; Lemieux, C; Libman, M; Noël, G; Pelletier, R; St-Germain, G | 1 |
| Butcher, I; Grigoris, P; Ramamohan, N; Zeineh, N | 1 |
| Barchiesi, F; Cogliati, M; Di Francesco, LF; Scalise, G; Tortorano, AM; Viviani, MA | 1 |
| Milheiro, A; Pacheco, FA; Vieira, MR | 1 |
| Denning, DW; Moore, CB; Oakley, KL | 1 |
| Kämmerer, R; Klempien, I; Kujath, P; Muhl, E | 1 |
| Czaika, V; Schmalreck, A; Schultze, W; Sterry, W; Tietz, HJ | 1 |
| Kox, WJ; Tietz, HJ; Wauer, HJ; West, C | 1 |
| Jurga, L; Krcmery, V; Mateicka, F; Sulcová, M | 1 |
| Cantón, E; Gobernado, M; López-Ribot, J; Pemán, J; Viudes, A | 1 |
| Dromer, F | 1 |
| André, MH; Lortholary, O | 1 |
| Dupont, H | 1 |
| Habib, AR; Langford, S; Symonds, M; Vanthuyne, A; White, DJ | 1 |
| Huang, YC; Kao, HT; Kuo, AJ; Lin, TY | 1 |
| Laxmi, V; Murthy, JM; Prasad, VS; Purohit, AK; Rammurti, S; Sundaram, C | 1 |
| Bossi, P; Bricaire, F; Caumes, E; Katlama, C; Rollot, F; Tubiana, R; Zeller, V | 1 |
| Izumi, Y; Kameyama, M; Sakoda, H; Udaka, F | 1 |
| Anil, S; Ellepola, AN; Samaranayake, LP | 1 |
| Discher, T; Friese, G; Füssle, R; Lohmeyer, J; Schmalreck, A | 1 |
| Torres-Rodríguez, JM; Vivas, JR | 1 |
| Cuenca-Estrella, M; Gómez-López, A; Monzón, A; Rodriguez-Tudela, JL | 1 |
| DeLallo, VC; Ernst, EJ; Keele, DJ; Klepser, ME; Lewis, RE | 1 |
| Liao, W; Wen, H; Yao, Z | 1 |
| Ernst, EJ; Klepser, ME; Roling, EE; Yodoi, K | 1 |
| Aller, AI; Bernal, S; Chávez, M; Gutiérrez, MJ; Martín Mazuelos, E; Quindós, G; Serrano, C; Valverde, A | 1 |
| Odds, FC; Sanglard, D | 1 |
| Nakanishi, T; Sekimizu, K | 1 |
| Bonacci, W; Mezzano, P; Serra, G | 1 |
| Batisse, D; Karmochkine, M; Kazatchkine, MD; Mikol, J; Mrejen, S; Piketty, C; Rambeloarisoa, J; Thiebaut, JB; Weiss, L | 1 |
| Clarke, MA; Hedderwick, SA; Jones, JM; Sarsam, MA | 1 |
| Denning, DW; Moore, CB; Mosquera, J; Sharp, A; Warn, PA | 1 |
| Bergervoet, M; Meis, JF; Meletiadis, J; Mouton, JW; Punt, NC; Te Dorsthorst, DT; Verweij, PE | 1 |
| Paterson, DL; Singh, N | 1 |
| Ammar, H; Bouraoui, H; Ernez-Hajri, S; Jeridi, G; Mahdhaoui, A; Mejdoub, M; Zaaraoui, J | 1 |
| Pfaller, MA; Rex, JH | 1 |
| Acus, R; Askew, M; Dipersio, J; Kodali, P; Silverberg, D | 1 |
| Berrouschot, J; Günther, P; Hermann, W; Kühn, HJ; Wagner, A | 1 |
| Edlind, TD; Smith, WL | 1 |
| Patterson, TF; Perea, S | 1 |
| Ariagno, RL; Brindle, ME; Colby, CE; Drohan, L; Sanislo, S | 1 |
| Ghannoum, MA; Hossain, MA; Long, L; Mukherjee, PK; Reyes, G | 1 |
| Li, T; Liu, Z; Qin, S; Sheng, R; Wang, A | 1 |
| Gibson, LE; Kist, JM; Mehrany, K | 1 |
| Kantarcioglu, AS; Yücel, A | 1 |
| Boswell, TC; Galloway, A; James, SA; Lennard, A; Olver, WJ; Roberts, IN; Russell, NH | 1 |
| Cartelle, M; Cuenca-Estrella, M; Durán, MT; Gil, E; Guerrero, A; Molina, F; Rodríguez-Tudela, JL | 1 |
| Arosio, M; Farina, C; Goglio, A; Moioli, F; Vailati, F | 1 |
| Afeltra, J; de Hoog, GS; Rijs, AJ; Verweij, PE; Vitale, RG | 1 |
| Kakkar, M; Kaur, R; Monga, R; Rawat, D; Sharma, VK | 1 |
| Abu-Elmagd, K; Fung, J; Kormos, R; Kusne, S; McCurry, K; Shapiro, R; Vilchez, R | 1 |
| Shann, S; Wilson, J | 1 |
| Cogliati, M; Esposto, MC; Tortorano, AM; Viviani, MA | 1 |
| Hamdan, JS; Moraes, EM; Prímola, NS | 1 |
| Kretzer, V; Lawrenz, K; Pollak, A; Pumberger, W; Wald, M; Weninger, M; Zaknun, D | 1 |
| Aureli, P; Ceddia, T; Ferrini, AM; Oliva, B; Piccirilli, E; Pontieri, E | 1 |
| Khambadkone, S; Tsang, VT; Vricella, LA; Yates, R | 1 |
| Fehér, J; Lengyel, G | 1 |
| Maroon, M; Suranyi, E; Tyler, WB | 1 |
| Alfonso, EC; Culbertson, WW; Kurstin, J; Marangon, FB; Miller, D; Muallem, MS; Romano, AC; Yoo, SH | 1 |
| Bliss, JM; Gigliotti, F; Wellington, M | 1 |
| Gangneux, JP; Guiguen, C; Preney, L; Théraud, M | 1 |
| Fujihara, N; Ichiyama, S; Iinuma, Y; Kudo, T; Saito, T; Takakura, S | 1 |
| Ahuja, SR; Karande, S; Kulkarni, MV; Tendolkar, U | 1 |
| Boyken, L; Diekema, DJ; Hollis, RJ; Jones, RN; Messer, SA; Pfaller, MA | 1 |
| Bauer, M; Graybill, JR; Larsen, RA; Thomas, AM | 1 |
| Pretzlaff, RK; Wertz, KK | 1 |
| Abe, N; Aihara, M; Fukuda, S; Iwasaki, M; Komatsu, M; Matsuo, S; Nagasaka, Y; Shimakawa, K | 1 |
| Schwartz, S; Thiel, E | 1 |
| Al Hedaithy, SS; Fotedar, R | 1 |
| Aranda, JV; Frattarelli, DA; Giacoia, GP; Reed, MD | 1 |
| Meis, JF; Mouton, JW; Punt, NC; Te Dorsthorst, DT; Verweij, PE | 1 |
| Brouwer, AE; Chierakul, W; Griffin, GE; Harrison, TS; Larsen, RA; Rajanuwong, A; White, NJ | 1 |
| Akpinar, I; Alpay, H; Biyikli, NK; Ozek, E; Tugtepe, H | 1 |
| Cantón, E; Gobernado, M; Pemán, J; Romero, M | 1 |
| Meis, JF; Mouton, JW; Te Dorsthorst, DT; van den Beukel, CJ; van der Lee, HA; Verweij, PE | 1 |
| Abbasoğlu, U; Cesur, S; Citak, S; Içli, F; Ozçelik, B | 1 |
| Horstkotte, D; Piper, C | 1 |
| Archer, J; Lane, M; McBride, J | 1 |
| Al-Fattani, MA; Douglas, LJ | 1 |
| Baldassarri, I; Barchiesi, F; Fothergill, AW; Maracci, M; Rinaldi, MG; Scalise, G; Spreghini, E | 1 |
| Booton, GC; Dunnebacke, TH; Schuster, FL; Yagi, S | 1 |
| Cuenca-Estrella, M | 1 |
| Cheung, BP; Samaranayake, LP; Samaranayake, YH; Yau, JY; Ye, J | 1 |
| Alfaro, B; Avila-Aguero, ML; Canas-Coto, A; Caro, MA; Paris, MM; Ulloa-Gutierrez, R | 1 |
| Azran, MS; Biousse, V; Frankel, M; Newman, NJ; Waljee, A | 1 |
| Chung, KY; Lee, KH; Oh, SH; Park, SG; Suh, SB | 1 |
| Cuadrado, JM; Jover, F; Martínez-Baltanás, A; Roig, P | 1 |
| Block, ER; Pennington, JE; Reynolds, HY | 1 |
| Bicanic, T; Harrison, TS | 1 |
| Feiszt, P; Kardos, G; Majoros, L; Szabó, B | 1 |
| Barker, KS; Homayouni, R; Lee, RE; Liu, TT; Rogers, PD; Wei, L | 1 |
| Steinbach, WJ | 1 |
| McGirt, MJ; Rigamonti, D; Williams, MA; Woodworth, GF | 1 |
| Thompson, HJ | 1 |
| Chen, R; Liao, W; Yao, Z | 1 |
| Denning, DW; Drusano, GL; Hope, WW; Keevil, B; Louie, A; Reed, P; Sharp, A; Warn, PA | 1 |
| Meis, JF; Mouton, JW; te Dorsthorst, DT; Verweij, PE | 1 |
| Benjamin, DK; Steinbach, WJ; Zaoutis, TE | 1 |
| Fohrer, C; Herbrecht, R; Letscher-Bru, V; Natarajan-Amé, S; Nivoix, Y | 1 |
| Bekker, LG; Bicanic, T; Darder, M; Harrison, TS; Meintjes, G; Wood, R | 1 |
| Bedard, M; Lulic-Botica, M; Natarajan, G; Pappas, A; Rongkavilit, C | 1 |
| Nachega, JB; Rombaux, P; Thomas, G; Weynand, B; Zech, F | 1 |
| Burnie, J; Hassan, I; Kirby, A | 1 |
| Esposito, P; Kehrli, P; Maitrot, D; Pain, L; Zerr, N | 1 |
| Fernández-Torres, B; Guarro, J; Mariné, M; Pastor, FJ; Serena, C | 1 |
| Bicanic, T; Brouwer, AE; Harrison, TS; Macallan, DC; Macsween, KF; Marsh, H | 1 |
| Burkert, M; Fuhr, HG; Mertelsmann, R | 1 |
| Dannaoui, E; Dromer, F; Lortholary, O; Schwarz, P | 1 |
| Brouwer, N; Jamie, J; Kohen, J; Vemulpad, S | 1 |
| Goldstein, BP; Hoban, DJ; Karlowsky, JA; Zhanel, GG | 1 |
| Beytout, J; Corbain, V; Ferrier, A; Gibold, X; Gourdon, F; Husson, A; Irthum, P; Laurichesse, H; Lesens, O; Vidal, M | 1 |
| Bretaudeau, K; Bruneel, F; Eloy, O; Lortholary, O; Pico, F; Richer, A; Scott-Algara, D | 1 |
| Nakamura, K; Nakasone, I; Ohta, C; Onaga, S; Yamane, N | 1 |
| Ciftçi, E; Dalgiç, N; Dogru, U; Güriz, H; Ince, E; Kendirli, T; Oncel, S; Unal, E | 1 |
| Hamimah, H; Ng, KP; Rohani, MY; Tanty Haryanty, T; Tay, ST | 1 |
| Abdul, M; Arpin, M; Dannaoui, E; Dromer, F; Favel, A; Lortholary, O; Michel-Nguyen, A; Piens, MA | 1 |
| Fukushima, K; Hyon, SH; Park, BJ; Park, JC; Taguchi, H; Takatori, K | 1 |
| Candido, RC; Ferreira, JC; Pedroso, RS | 1 |
| Borowska-Rybus, B; Grzegorczyk, W; Kupś, J; Woźniakowska-Gesicka, T | 1 |
| Bakir, M; Barton, R; Cerikcioglu, N; Yagci, A | 1 |
| Guarro, J; Mariné, M; Pastor, FJ; Serena, C | 1 |
| Cano, J; Gené, J; Gilgado, F; Guarro, J; Serena, C | 1 |
| de Souza, JA | 1 |
| Denning, DW; Drusano, GL; Hope, WW; Louie, A; Moore, CB; Sharp, A; Walsh, TJ; Warn, PA | 1 |
| Decembrino, L; Stronati, M | 1 |
| Guarro, J; Marimon, R; Mariné, M; Pastor, FJ; Serena, C | 1 |
| Chaturvedi, AK; Duggineni, S; Kumar, M; Kundu, B; Shukla, PK; Srivastava, G | 1 |
| Krutikova, YV; Linthicum, FH | 1 |
| Danko, JR; Roberts, A | 1 |
| Amar, JN; Enns, RA; Kirby, SD; Law, JK; Zetler, PJ | 1 |
| Dromer, F; Launay, O; Lortholary, O; Mathoulin-Pélissier, S | 1 |
| Altas, K; Boekhout, T; De Hoog, GS; Ekmekci, TR; Fries, BC; Ikeda, R; Kantarcioğlu, AS; Koslu, A; Theelen, B; Yücel, A | 1 |
| Boerma, EC; van der Voort, PH; Yska, JP | 1 |
| Makimura, K | 1 |
| Reed, E; Ribaud, P; Ruhnke, M; Schwartz, S; Thiel, E; Troke, P | 1 |
| Akioka, T; Hanafusa, T; Hara, S; Hirata, Y; Kobayashi, K; Miyoshi, T; Oka, S; Tsuji, M; Yokote, T | 1 |
| Agarwal, S; Rani, L; Singh, G; Thakur, K | 1 |
| Creutzig, U; Groll, AH; Kaiser, J; Klingebiel, T; Lehrnbecher, T; Ritter, J; Schwabe, D; Varwig, D | 1 |
| Andes, D; Kethireddy, S | 1 |
| Diekema, DJ; Pfaller, MA; Procop, GW; Rinaldi, MG | 1 |
| Khakoo, RA; Khan, FA; Slain, D | 1 |
| Auler, ME; Dias, AL; Gandra, RF; Gonçalves da Silva, E; Matsumoto, FE; Melhem, MS; Paula, CR; Ruiz, LS; Szeszs, MW | 1 |
| Murakami, C; Nakano, N; Wada, R; Wakasaya, Y; Yagihashi, S; Yajima, N; Yamato, K; Yoneyama, T | 1 |
| Carrillo-Muñoz, AJ; Eraso, E; Espinel-Ingroff, A; Quindós, G; Ruesga, M; Villar-Vidal, M | 1 |
| Hogan, F; Pettit, GR; Pettit, RK; Repp, KK | 1 |
| Ichikawa, M; Kaneda, M; Kobayashi, R; Nakagawa, A; Sato, T; Suzuki, D | 1 |
| Cancelli, I; Gigli, GL; Merlino, G; Serafini, A; Valente, M | 1 |
| Choi, JD; Friedman, AH; Powers, CJ; Sampson, JH; Vredenburgh, JJ | 1 |
| Andes, D; Knilans, K; Kwon, GS; Vakil, R | 1 |
| Campbell-Bright, S; Johnson, RE; Raasch, RH; Rodgers, JE; Rosenberg, BS | 1 |
| Bekker, LG; Bicanic, T; Brouwer, A; Harrison, T; Jaffar, S; Loyse, A; Meintjes, G; Rebe, K; Wood, R | 1 |
| Geramishoar, M; Hedayat, T; Kheirkhah, M; Khotael, G; Mahjoub, F; Rezai, MS | 1 |
| Cuenca-Estrella, M; Dos Anjos Martins, M; Gomez-Lopez, A; Melhem, MC; Rodriguez-Tudela, JL; Zaragoza, O | 1 |
| Altas, K; Boekhout, T; Kantarcioğlu, AS; Yücel, A | 1 |
| Bernede-Bauduin, C; Dromer, F; Guillemot, D; Lortholary, O | 1 |
| Ikehara, M; Komase, Y; Shinagawa, T; Yamaguchi, H; Yamamoto, T | 1 |
| Fong, NC; Leung, CW; Ma, AL | 1 |
| Balasubramaniam, B; Dick, A; Johnson, E; Mayer, E; Narendran, N | 1 |
| Pasqualotto, AC | 1 |
| Abraham, OC; George, IA; John, L; Joseph, V; Karthik, R; Mathews, MS; Sundar, A | 1 |
| Dedicoat, M; Dlamini, S; Paul, N; Sloan, D | 1 |
| Dromer, F; Harrison, TS; Jarvis, JN; Lortholary, O | 1 |
| Maesaki, S; Tarumoto, N | 1 |
| Alastruey-Izquierdo, A; Araujo Ribeiro, M; Cuenca-Estrella, M; Gomez-Lopez, A; Rodriguez-Tudela, JL | 1 |
| Cisalpino, PS; da Costa César, G; de Carvalho, IR; dos Anjos Martins, M; Kohler, LM; Santos, DA; Soares, BM | 1 |
| Guarro, J; Mariné, M; Pastor, FJ | 1 |
| Gerlach, U; Guckelberger, O; Jörres, D; Kohler, S; Neuhaus, P; Pascher, A; Pratschke, J; Sauer, IM | 1 |
| Huang, J; Liu, H; Wu, B; Zhang, T; Zhang, W | 1 |
| Bing, Z; Blumberg, EA; Furth, EE; Lu, S | 1 |
| Asari, S; Iwatani, Y; Nishi, I; Sunada, A; Toyokawa, M | 1 |
| Pai, MP | 1 |
| Greenhow, TL; Pahud, BA; Piecuch, B; Weintrub, PS | 1 |
| Danzi, M; Marino, A; Mungiguerra, M; Pisano, L; Ricciardi, AM; Ricciardi, R | 1 |
| Bosshard, PP; Calligaris-Maibach, RC; Georgi, A; Meyer, S; Schneemann, M; Tintelnot, K; Weber, R | 1 |
| Gupta, AK; Kapilamoorthy, TR; Kesavadas, C; Patro, SN; Thomas, B | 1 |
| Albini, TA; Couvillion, SS; Davis, JL; Dubovy, SR; Wykoff, CC | 1 |
| Avolio, M; Bruschetta, G; Camporese, A; De Rosa, R; Grosso, S | 1 |
| Ewanowski, C; Hogan, KP; Kupiec-Banasikowska, A; Patel, NC | 1 |
| Bonnal, C; Bouges-Michel, C; Bretagne, S; Chochillon, C; Dannaoui, E; Datry, A; Develoux, M; Dromer, F; Matheron, J; Paugam, A | 1 |
| Gao, F; Jiang, PF; Shen, SX; Shui, QX; Xia, ZZ; Yu, HM; Zhou, BL | 1 |
| Bagheri, F; Cervellione, KL; Marino, W; Maruf, M; Santucci, T | 1 |
| Jayatilake, JA; Samaranayake, LP; Samaranayake, YH; Thein, ZM; Yau, JY; Yeung, KW | 1 |
| Aquino, VR; Bay, MB; Falci, DR; Goldani, LZ; Lunardi, LW; Ramos, CG | 1 |
| Ashbee, HR; Hettiarachchi, N; Hetticarachchi, N; Wilson, JD | 1 |
| Huang, YX; Jiang, WM; Jin, JL; Ou, XT; Weng, XH; Wu, JQ; Xie, Y; Xu, B; Zhu, LP | 1 |
| Borman, AM; Houbraken, J; Rijs, AJ; Samson, RA; Verweij, PE | 1 |
| Liggett, J; Ozog, D | 1 |
| Baker, S; Campbell, JI; Chau, TT; Chuong, LV; Day, JN; Diep, PT; Duong, VA; Farrar, JJ; Hien, TT; Lalloo, DG; Mai, NH; Nghia, HD; Phu, NH; Sinh, DX | 1 |
| Krzyściak, P; Macura, AB | 1 |
| Bartlett, KH; Boekhout, T; Geertsen, E; Hagen, F; Illnait-Zaragozi, MT; Klaassen, CH; Meis, JF; Swinne, D | 1 |
| Assie, C; Cheriet, S; Etienne, M; Favennec, L; Marie, I | 1 |
| Ainoda, Y; Fujita, T; Hirai, Y; Mori, N; Motoji, T; Shiseki, M; Shoji, T; Teramura, M; Totsuka, K; Yoshinaga, K | 1 |
| Fisher, JF; Kauffman, CA; Newman, CA; Sobel, JD | 1 |
| Nweze, EI; Ogbonnaya, UL | 1 |
| Jullien, V | 1 |
| Abele-Horn, M; Beer, M; Hebestreit, H; Kunzmann, S; Radike, K | 1 |
| Boekhout, T; Hagen, F; Liao, W; Meis, JF; Pan, W; Shi, W; Theelen, B | 1 |
| Meurman, JH; Pärnänen, P; Samaranayake, LP; Seneviratne, CJ; Vaara, M; Wong, SS; Yuen, KY | 1 |
| Hai, W; Jianghan, C; Julin, G; Nan, X; Wanqing, L; Xiaojun, W; Yuanjie, Z | 1 |
| Allada, G; Garrett, L; Marr, K; West, S | 1 |
| Celebi, S; Hacimustafaoglu, M | 1 |
| Hamoud, S; Hayek, T; Keidar, Z | 1 |
| Arenas, C; García-Lázaro, M; Rivero, A; Salido, R | 1 |
| Han, I; Jung, MH; Kim, KS; Kim, MH; Kim, YS; Park, HK | 2 |
| Becker, K; Blum, G; Fegeler, W; Haase, G; Lass-Flörl, C; Schmalreck, AF; Willinger, B | 1 |
| Bauer, M; Larsen, RA; Thomas, AM | 1 |
| Huang, JR; Li, LJ; Lian, JS; Yan, D | 1 |
| Chowdhary, A; Cuenca-Estrella, M; Espinel-Ingroff, A; Fothergill, A; Fuller, J; Govender, N; Guarro, J; Hagen, F; Johnson, E; Kidd, S; Lass-Flörl, C; Lockhart, SR; Martins, MA; Meis, JF; Melhem, MS; Ostrosky-Zeichner, L; Pelaez, T; Pfaller, MA; Schell, WA; Trilles, L; Turnidge, J | 1 |
| Bekker, LG; Bicanic, T; Harrison, TS; Jarvis, JN; Meintjes, G; Rebe, K; Schutz, C; Williams, A; Williams, GN; Wood, R | 1 |
| Tang, ZH; Yu, YS; Zang, GQ; Zhang, Y | 1 |
| Espinosa-Heidmann, D; Harper, T; Jamie Miller, G; Kresch, ZA | 1 |
| Canton, E; Castanheira, M; Cuenca-Estrella, M; Diekema, DJ; Espinel-Ingroff, A; Fothergill, A; Fuller, J; Ghannoum, M; Jones, RN; Lockhart, SR; Martin-Mazuelos, E; Melhem, MS; Ostrosky-Zeichner, L; Pappas, P; Pelaez, T; Peman, J; Pfaller, MA; Rex, J; Szeszs, MW | 1 |
| Ford, N; Milani, B | 1 |
| Bedin, M; D'Angelo, M; Gion, M; Grandesso, S; Mazzuccato, S; Sapino, B; Solinas, M | 1 |
| Chikasema, M; Harrison, TS; Hosseinipour, MC; Jackson, AT; Jaffar, S; Jarvis, JN; Kanyemba, C; Namarika, D; Nussbaum, JC; Phulusa, J; van der Horst, C | 1 |
| Caggiano, G; Carone, A; Corbo, F; Franchini, C; Montagna, MT; Muraglia, M; Piarulli, M; Rosato, A; Schiavone, BI | 1 |
| Kim, HR; Lee, MK; Yu, N | 1 |
| Chi, CY; Chou, CH; Ho, CM; Ho, MW; Liao, CH; Lin, PC; Tseng, SW; Wang, JH; Wang, YJ | 1 |
| Challenor, R; Ekanayaka, R; Pinsent, S | 1 |
| Clerihew, L; McGuire, W | 1 |
| Debandt, M; Djaha, JM; Kaci, R; Nankeu, S; Saint Marcoux, B | 1 |
| Bicmen, C; Doluca, M; Gulat, S; Gunduz, AT; Tuksavul, F | 1 |
| Chevrier, S; Houot, R; Lamy, T; Marchand, T; Poullot, E; Revest, M; Tattevin, P | 1 |
| Su, J; Sun, W; Xu, S; Yan, D | 1 |
| Ayats, J; Bratos, A; Buendía, B; Cantón, E; Echeverría, J; Fernández-Natal, I; Fontanals, D; Gomila-Sard, B; Hervás, D; Iñiguez, C; Martínez-Alarcón, J; Navarro, D; Pemán, J; Sánchez-Reus, F; Torroba, L | 1 |
| Birkenkamp, KE; Boulware, DR; Meya, DB; Rajasingham, R; Rolfes, MA | 1 |
| Munson, E; Olson, R | 1 |
| Choi, HJ; Ju, MY; Jung, SI; Kim, SH; Lee, K; Lee, WG; Park, YJ; Shin, JH | 1 |
| Furuya, N; Mano, Y; Morishige, H; Oguri, T | 1 |
| Datta, S; Goel, N; Oberoi, JK; Prasad, K; Raveendran, R; Wattal, C | 1 |
| Akhaddar, A; Baallal, H; Boucetta, M; El Asri, AC; El Mostarchid, B; Eljebbouri, B; Gazzaz, M | 1 |
| Bratton, EW; Chastain, CA; El Husseini, N; Juliano, JJ; Lee, MS; Perfect, JR; Poole, C; Stürmer, T; Weber, DJ | 1 |
| Arsić Arsenijević, V; Barać, A; Crnčević Radović, L; Pekmezović, M; Trpković, A | 1 |
| Bouchara, JP; Chabasse, D; Chiron, LM; de Gentile, L; Pihet, M; Rouleau, F | 1 |
| Baker, SG; Campbell, JI; Chau, NVV; Chau, TTH; Chuong, LV; Day, JN; Diep, PT; Dung, NT; Duong, VA; Farrar, JJ; Hien, TT; Hoang, TN; Lalloo, DG; Mai, NH; Mai, PP; Nghia, HD; Phong, ND; Phu, NH; Sieu, TPM; Sinh, DX; Thai, CQ; Thai, LH; Wolbers, M | 1 |
| Perfect, JR | 2 |
| Felton, TW; Goodwin, J; Gregson, L; Harrison, TS; Hope, WW; Howard, SJ; Livermore, J; Neely, MN; O'Connor, L; Perfect, JR; Schwartz, JA; Sharp, AD | 1 |
| DeSimone, JA; Fennelly, AM; Moussouttas, M; Murphy, LC; Slenker, AK | 1 |
| Bak, N; Byth, K; Chen, SC; Currie, BJ; Hajkowicz, K; Heath, CH; Kidd, S; Korman, TM; Marriott, D; McBride, WJ; Meyer, W; Murray, R; Playford, EG; Slavin, MA; Sorrell, TC | 1 |
| Day, J; Dromer, F; Harrison, TS; Lortholary, O; Loyse, A | 1 |
| Chau, TT; Day, JN; Lalloo, DG | 1 |
| Bicanic, T; Jarvis, JN; Loyse, A | 1 |
| Bachmann, A; Bonkat, G; Braissant, O; Gasser, TC; Wernli, L | 1 |
| Bethlendy, G; Kravets, A; Rustchenko, E; Welle, S; Yang, F | 1 |
| Deng, L; Hu, DD; Hu, GH; Jiang, YY; Li, DD; Wang, Y; Zhao, LX | 1 |
| Ju, HZ; Wang, J; Yang, MF | 1 |
| Bastide, C; Bruyère, F; Chandenier, J; Desoubeaux, G; Fourcade, C; Guy, L; Karsenty, G; Lachaud, L; Lavigne, JP; Malavaud, S; Sotto, A | 1 |
| Li, M; Liu, J; Peng, FH; Tan, F; Wang, X; Yuan, Y; Zhong, XF; Zhong, YH | 1 |
| Banerjee, D; Burkard, L; Panepinto, JC | 1 |
| Lin, DF; Lu, X; Shen, C; Yao, ZW | 1 |
| Fujisaki, J; Hamada, T; Hirabayashi, D; Kamikawa, Y; Mori, Y; Nagayama, T; Sakamoto, R; Sugihara, K | 1 |
| Emonet, S; Gariani, K; Hibbs, J; Renzi, G; Rougemont, M; Schrenzel, J | 1 |
| Deng, S; Wan, C; Wen, Y; Zhu, Y | 1 |
| Horiuchi, C; Ikeda, T; Iwanaga, N; Kamiya, C; Katsuragi, S; Kobayashi, Y; Miyoshi, T; Neki, R; Sata, M; Tanaka, H; Yamanaka, K; Yamashita, Y; Yoshimatsu, J | 1 |
| Matsumoto, K; Shiga, M; Suenaga, H; Tsukatani, T | 1 |
| Assi, M; Chaaban, S; Wheat, LJ | 1 |
| Brillowska-Dabrowska, A; Dzierzanowska-Fangrat, K; Gucwa, K; Milewski, S; Naumiuk, L; Romanowska, E; Szweda, P; Wojciechowska-Koszko, I | 1 |
| Chen, J; Du, L; Liao, W; Pan, W; Sang, J; Yang, Y; Zhu, Y | 1 |
| Chang, CC; Coovadia, Y; Dorasamy, A; French, M; Lewin, S; Mahabeer, Y; Mlisana, K; Moosa, MY; Naidu, D; Ndung'u, T | 1 |
| Espino Barros Palau, A; Foroozan, R; Lee, AG; Morgan, ML | 1 |
| Ishiguro, T; Odashima, K; Shimizu, Y; Sugita, Y; Takayanagi, N | 1 |
| Li, J; Liu, B; Pan, A; Zhang, L; Zhou, S | 1 |
| Jiang, G; Liu, X; Qi, Q; Sun, J | 1 |
| Rughwani, N; Sangarlangkarn, A | 1 |
| Castanheira, M; Jones, RN; Messer, SA; Pfaller, MA | 1 |
| He, C; Kang, M; Lei, Y; Xiao, YL; Xie, Y; Zhang, CY | 1 |
| Aliredjo, RP; de Jong, PY; de Sévaux, RG; Nooijen, S; van Spil, WE; Verhave, JC | 1 |
| Bulanda, M; Jagielski, T; Skóra, M | 1 |
| Sharifzadeh, A; Shokri, H; Soltani, M | 1 |
| Adeyemi, BO; Ross, A | 1 |
| Bicanic, T; Bottomley, C; Brouwer, AE; Harrison, TS; Hosseinipour, MC; Jackson, A; Jarvis, JN; Limmathurotsakul, D; Loyse, A; Meintjes, G; Muzoora, C; Phulusa, J; Taseera, K; van der Horst, C; White, NJ; Wilson, D; Wood, R | 1 |
| Chen, D; Chen, M; Dai, C; Huang, X; Li, Y; Wang, L; Wang, X; Xu, X; Yang, L; Yao, D; Yu, C; Yu, X | 1 |
| Argüelles, JC; González-Párraga, P; Guirao-Abad, JP | 1 |
| Bouchrik, M; Boumhil, L; Iken, M; Lemkhente, Z; Lmimouni, B; Naoui, H; Uwingabiye, J; Zohoun, AG | 1 |
| Al-Hayek, S; Aliyu, SH; Dev, H; Lawrentschuk, N; Papa, N; Toner, L | 1 |
| Hadid, H; Nona, P; Paje, D; Usman, M | 1 |
| Delarze, E; Sanglard, D | 1 |
| de Hoog, GS; Deng, S; Gerrits van den Ende, AH; Ilkit, M; Liao, W; Pan, W; Rafati, H; Rijs, AJ; Seyedmousavi, S; Van der Lee, AH; Verweij, PE; Vitale, RG | 1 |
| Altamirano, R; Córdoba, S; Davel, G; Isla, MG; Szusz, W; Vivot, W | 1 |
| Ardelean, A; Balta, C; Boldura, OM; Cotoraci, C; Dinescu, S; Folk, A; Herman, H; Hermenean, A; Paiusan, L; Suciu, M | 1 |
| Boulware, DR; Merry, M | 1 |
| Lau, KH; Peaper, DR; Villanueva, M; Yamahiro, A | 1 |
| Busso-Lopes, AF; Kamei, K; Lyra, L; Mikami, Y; Moretti, ML; Peron, IH; Reichert-Lima, F; Schreiber, AZ; Taguchi, H | 1 |
| Behan, JW; Declerck, B; Kim, GH; Rodriguez, PG; Zhu, TH | 1 |
| Furue, M; Matsuda, T; Shigyo, A; Tsuji, G | 1 |
| Cen, W; Feng, W; Lv, Y; Ma, Y; Qiao, Z; Wang, Y; Xi, Z; Yang, J | 1 |
| Bartolomé, J; Candel, FJ; Lozano, MA; Lucena, R | 1 |
| Castillo-Ojeda, E; Genebat, M; Jiménez-Mejías, ME; Márquez-Rivas, FJ; Mayorga-Buiza, MJ; Rivero-Garvía, M | 1 |
| Ali, I; Babik, JM; Brondfield, MN; Cope, JR; DeMarco, T; Doernberg, SB; Hilts-Horeczko, A; Klein, L; Matanock, A; Reid, MJ; Ritter, JM; Rutishauser, RL; Tang, J | 1 |
| Ma, P; Qian, J; Qu, L; Yin, Z | 1 |
| Alvarez, C; Andes, DR; Kang, JY; Krug, C; Kwon, GS | 1 |
| Guo, L; Huang, Z; Ling, L; Wang, J; Zhang, L; Zhu, J | 1 |
| Chastain, DB; Franco-Paredes, C; Guarner, J | 1 |
| Cendejas-Bueno, E; Falces-Romero, I; García-Rodríguez, J; Romero-Gómez, MP | 1 |
| Hatlen, TJ; Murphy, RA; Persichino, JG | 1 |
| Aquino, VR; de Azevedo, MI; Goldani, LZ; Neto, GW; Pilla, C; Wirth, F | 1 |
| Aboubakar, T; Bellet, V; Bertout, S; Delaporte, E; Doumbia, A; Drakulovski, P; Kassi, FK; Kouakou, GA; Krasteva, D; Menan, HIE; Reynes, J; Roger, F; Valérie, BA; Yavo, W | 1 |
| Abbas, H; Abbas, N; CiFuentes Kottkamp, A; Cindrich, R; Singh, M | 1 |
| Adams, J; Bicanic, T; Bradley, J; Bright, P; Chan, AK; Chanda, D; Chawinga, C; Chen, T; Ellis, J; Gaskell, K; Harrison, TS; Heyderman, RS; Hosseinipour, MC; Jaffar, S; Kalata, N; Kanyama, C; Karunaharan, N; Kouanfack, C; Lakhi, S; Lalloo, DG; Lesikari, S; Lontsi, S; Lortholary, O; Loyse, A; Lupiya, D; Mapoure, YN; Mfinanga, S; Molloy, SF; Mwaba, P; Ndong, JG; Peirse, M; Sini, V; Stone, N; Temfack, E; van der Horst, C; van Oosterhout, JJ; Wang, D | 1 |
| Kuang, W; Li, M; Liao, J; Liu, J; Peng, F; Xu, L; Yi, H; Zhang, Q; Zhu, C | 1 |
| Blice, JP; Johnson, WJ; Lee, KK | 1 |
| Guragai, N; Patel, H; Pullatt, R; Rampal, U; Salamera, J; Shah, D; Shamoon, F; Vasudev, R | 1 |
| Chang, JH; Chen, CW; Chi, H; Hsu, CH; Lin, CC; Sheu, JC; Tsai, JD | 1 |
| Eshun-Wilson, I; Ford, N; Jarvis, JN; Li, T; Rouse, B; Shapiro, AE; Tenforde, MW | 1 |
| Das, SU; Liu, X; White, A | 1 |
| Chiovaro, J; Haraga, J; LeBlanc, M | 1 |
| Aliyu, SH; Andrieux-Meyer, I; Bicanic, T; Boulware, DR; Burry, J; Chan, A; Chanda, D; Chiller, T; Cohn, J; Day, J; Denning, D; Doherty, M; Dromer, F; Ford, N; Gondwe-Chunda, L; Govender, N; Harrison, TS; Heyderman, R; Hosseinipour, M; Jaffar, S; Jarvis, JN; Kalata, N; Kanyama, C; Klausner, JD; Kouanfack, C; Koulla-Shiro, S; Lakhi, S; Lalloo, D; Le, T; Lesikari, S; Lortholary, O; Loyse, A; Mapoure, Y; Mfinanga, S; Mghamba, J; Migone, C; Molloy, SF; Muzoora, C; Mwaba, P; Ngoma, J; Nyirenda, R; Oladele, R; Perfect, C; Ramadhani, A; Ribeiro, I; Rodrigues, M; Schutz, C; Shimwela, M; Shroufi, A; Sini, V; Stack, M; Temfack, E; Van der Horst, C; van Oosterhout, J; Wilson, D | 1 |
| Alanio, A; Alufandika, M; Boulware, DR; Boyer-Chammard, T; Chen, T; Dromer, F; Harrison, TS; Hlupeni, A; Hope, W; Hosseinipour, MC; Jaffar, S; Jarvis, JN; Kanyama, C; Lalloo, DG; Lawrence, DS; Lortholary, O; Loyse, A; Meintjes, G; Meya, DB; Molloy, SF; Mosepele, M; Muzoora, C; Mwandumba, HC; Ndhlovu, CE; Niessen, L; Schutz, C; Stott, KE; Wang, D; Youssouf, N | 1 |
| Kim, S; Lee, DG; Woo, ER | 1 |
| Eshun-Wilson, I; Ford, N; Garner, P; Migone, C | 1 |
| Cheng, JH; Harrison, TS; Huang, LP; Jiang, YK; Wang, RY; Wang, X; Zhao, HZ; Zhou, LH; Zhu, LP | 1 |
| Almeida-Paes, R; Brito-Santos, F; Cardarelli-Leite, P; da Silva, SA; Fialho, MM; Fortes, ST; Lázera, MDS; Morales, BP; Nascimento, CR; Nishikawa, MM; Santos, LO; Santos, W; Trilles, L | 1 |
| Al-Hatmi, AMS; Alves, SH; de Azevedo, MI; Loreto, ES; Rossato, L; Santurio, JM; Venturini, TP | 1 |
| Li, L; Yang, M; Yang, X; Yi, P; Zhang, Y | 1 |
| Ataollahy, N; Hammarström, H; Kondori, N; Lindberg, E | 1 |
| Jandhyala, D; Sohail, MR; Stahr, DC; Tan, EM | 1 |
| Gupta, KL; Pattanashetti, N; Ramachandran, R; Sood, V | 1 |
| Kimbrough, T; Peng, TJ; Tolchin, BD | 1 |
| El-Hajjar, M; Fahad, F; Roddy, K; Schulman-Marcus, J | 1 |
| Chong, Y; Jie, Y; Li, X; Li, Z; Liu, Y; Yan, Y; Zheng, X | 1 |
| Alanio, A; Boyer-Chammard, T; Harrison, TS; Jarvis, JN; Lortholary, O; Temfack, E | 1 |
| Cai, H; Chang, YC; Garraffo, HM; Khanal Lamichhane, A; Kwon-Chung, KJ; Walter, PJ | 1 |
| Alanio, A; Boyer-Chammard, T; Delliere, S; Lanternier, F; Lawrence, D; Lortholary, O; Loyse, A; Temfack, E | 1 |
| Bellet, V; Bertout, S; Chabrol, A; Delaporte, E; Doumbia, A; Drakulovski, P; Kakou, A; Kassi, FK; Krasteva, D; Landman, R; Menan, HEI; Reynes, J; Roger, F | 1 |
| Applen Clancey, S; Billmyre, RB; Doering, TL; Heitman, J; Li, LX | 1 |
| Agreda-Mellon, D; de Oliveira, HC; García-Cambero, JP; Lucio, J; Mendes-Giannini, MJS; Rossi, SA; Zaragoza, O | 1 |
| Borman, AM; Fraser, M; Johnson, EM; Muller, J; Palmer, MD; Patterson, Z; Szekely, A; Walsh-Quantick, J | 1 |
| Jeng, A; Kalinoski, T; Malenfant, J; Yim, C | 1 |
| Pea, F | 1 |
| Lacy, AJ; Murphy, LS; Shah, KS; Smith, AT | 1 |
| Fujimoto, S; Fujioka, Y; Mitani, R; Oda, N; Takata, I | 1 |
| Cunha Pereira, T; Domingues, N; Félix Soares, R; Mariz, J; Rb-Silva, R | 1 |
| Larson, L; Mejia-Chew, C; Powderly, WG; Spec, A; Sung, A | 1 |
| Deng, X; Gan, Q; Jiang, Y; Li, M; Liu, J; Peng, F; Wang, Y; Xu, X | 1 |
| Boulware, DR; de Albuquerque Moraes, C; de Oliveira, ACP; de Siqueira, REB; Marcusso, R; Miranda, NFB; Vidal, JE | 1 |
| Baptiste, S; Boulware, DR; Chiller, T; Denning, DW; Govender, NP; Harrison, TS; Jarvis, JN; Jordan, A; Loyse, A; Rajasingham, R; Ribeiro, I; Shroufi, A; Van Cutsem, G | 1 |
| Asuquo, IP; Deng, H; Gao, J; Ma, X; Meng, M; Meng, Y; Pan, L; Qin, C; Wu, C; Xue, X; Zang, X; Zhao, L | 1 |
| Dong, J; Huang, D; Liang, Z; Tang, Y; Wang, K; Wang, Y; Wen, L; Yu, H; Zhang, Y | 1 |
| Alufandika, M; Bicanic, T; Day, JN; Harrison, TS; Hope, W; Jarvis, JN; Lalloo, DG; Loyse, A; Mwandumba, HC; Perfect, JR; Stott, KE | 1 |
| Khan, A; Li, K; Mishra, S; Zhabokritsky, A | 1 |
| Chang, YJ; Chen, CH; Chen, HM; Chen, YM; Hsu, CW; Li, H; Lin, KH; Lin, PY; Tseng, PT; Tu, YK | 1 |
| Fatahinia, M; Kiasat, N; Mahmoudabadi, AZ; Moslem, M | 1 |
| Agarwal, T; Ahmed, NH; Chawla, R; Hussain, T; Satpathy, G; Sharma, N; Singh, G; Tandon, R; Xess, I | 1 |
| Berman, J; Gao, L; Gritsenko, V; Jiang, YY; Lu, H; Yang, F; Zhen, C | 1 |
| Chen, W; Dai, H; Hu, X; Li, H; Liu, H; Qiao, S; Sun, L; Sun, S; Wang, K; Zhang, S; Zhao, X | 1 |
| Barrett, K; Gilbert, A; McGinity, M; Tavakoli, S | 1 |
| Boulware, DR; Boyer-Chammard, T; Chawinga, C; Chen, T; Comins, K; Harrison, TS; Hlupeni, A; Hope, W; Hosseinipour, MC; Jaffar, S; Jarvis, JN; Jjunju, S; Kagimu, E; Kanyama, C; Kasibante, J; Lalloo, DG; Lawrence, DS; Leeme, T; Lortholary, O; Loyse, A; Meintjes, G; Meya, DB; Molloy, SF; Mosepele, M; Moyo, M; Mpoza, E; Mutata, C; Muzoora, C; Mwandumba, HC; Mzinganjira, H; Ndhlovu, CE; Nuwagira, E; Rhein, J; Rutakingirwa, MK; Schutz, C; Siamisang, K; Singh, A; Ssebambulidde, K; Tugume, L; van Widenfelt, E; Wang, D; Youssouf, N | 1 |
| Lu, F; Wang, B; Wang, Y; Xu, Y; Zhang, L; Zhang, M | 1 |
| Ashizawa, N; Fushimi, K; Hidaka, Y; Hirayama, T; Hosogaya, N; Iwanaga, N; Izumikawa, K; Morimoto, S; Mukae, H; Takazono, T; Takeda, K; Tashiro, M; Yamamoto, K; Yanagihara, K | 1 |
| Jiang, Y; Li, M; Liu, J; Peng, F; Su, X; Wang, A; Wang, Y; Xu, X; Yang, L | 1 |
| Falci, DR; Pasqualotto, AC | 1 |
| Harrison, TS; Jarvis, JN; Lawrence, DS | 1 |
| Chen, Y; Harypursat, V; Lan, K; Lu, Y; Wu, Y; Xu, X; Yang, T; Yu, J; Zeng, Q; Zhang, W; Zhao, T; Zhou, G | 1 |
| Day, JN; Flower, B; Ngan, NTT | 1 |
| Chiller, TM; Ford, N; Rajasingham, R; Shapiro, AE; Tenforde, MW | 1 |
| Boulware, DR; Harrison, TS; Hosseinipour, MC; Jarvis, JN; Lawrence, DS; Lortholary, O; Meintjes, G; Mosepele, M; Mwandumba, HC | 1 |
| Golubykh, K; Holleran, L; Kovalenko, I; Qurashi, S; Saleem, T | 1 |
| Harrison, TS; Jarvis, JN; Lawrence, DS; Maphane, L; Meya, DB; Moshashane, N; Nabaggala, G; Seeley, J; Ssali, A | 1 |
| Bermann, CDS; Botton, SA; Braga, CQ; Ianiski, LB; Pereira, DIB | 1 |
| Aberg, JA; Badal-Faesen, S; Bukuru, A; Clifford, DB; Hogg, E; Komarow, L; Lagat, D; Lalloo, UG; Langat, D; Larsen, RA; Mave, V; McKhann, A; Pillay, S; Samaneka, W; Supparatpinyo, K; Ticona, E | 1 |
| Du, L; Liu, J; Ma, H; Wang, X; Wang, Y | 1 |
| Cai, W; Fang, J; Huang, J; Li, J; Lin, L; Lu, S; Zhang, J | 1 |
| Ding, Y; Gu, C; Li, Y; Liu, J; Tang, M; Yang, Y; Ye, C; Zeng, Z | 1 |
| Almeida, JDR; Frickmann, H; Lacerda, MVG; Sousa, NSO; Souza, JVB | 1 |
| Bive, BZ; Bontems, S; Hayette, MP; Lelo, GM; Mudogo, CN; Sacheli, R; Zakayi, PK | 1 |
| Alviña, K; Charles-Niño, CL; Dores, MR; Enriquez, V; Hamed, MF; Martinez, LR; Munzen, ME; Reguera Gomez, M | 1 |
| de Menezes, RT; de Oliveira, HC; de Oliveira, LD; do Carmo, PHF; Junqueira, JC; Pereira, TC; Scorzoni, L | 1 |
193 review(s) available for flucytosine and amphotericin b
| Article | Year |
|---|---|
The biology and chemistry of antifungal agents: a review.
Topics: Animals; Antifungal Agents; Azoles; Fungi; Humans; Imidazoles; Mycoses | 2012 |
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Flucytosine.
Topics: Amphotericin B; Candidiasis; Chromoblastomycosis; Cryptococcosis; Cytosine; Drug Therapy, Combination; Flucytosine; Mycoses | 1977 |
Skeletal cryptococcosis.
Topics: Adolescent; Adult; Aged; Amphotericin B; Bone Diseases; Cryptococcosis; Diagnosis, Differential; Female; Flucytosine; Humans; Immunologic Deficiency Syndromes; Male; Sarcoidosis | 1977 |
Antifungal agents: recent developments.
Topics: Amphotericin B; Antifungal Agents; Cell Membrane; Chemical Phenomena; Chemistry; Clotrimazole; Drug Resistance, Microbial; Drug Therapy, Combination; Flucytosine; Fungi; Griseofulvin; Miconazole; Microtubules; Mitosis; Mycoses; Nystatin; Phenyl Ethers; Structure-Activity Relationship; Tolnaftate | 1977 |
Chemotherapy of systemic fungal diseases.
Topics: Amphotericin B; Animals; Eukaryota; Flucytosine; Helminths; Humans; Miconazole; Mycoplasma; Mycoses; Viruses | 1978 |
Antifungal agents.
Topics: Amphotericin B; Antifungal Agents; Clotrimazole; Econazole; Flucytosine; Griseofulvin; Humans; Imidazoles; Intestinal Absorption; Miconazole; Nystatin; Peptides; Polyenes | 1978 |
[Progress in the therapy of systemic mycoses].
Topics: Amphotericin B; Aspergillus; Candida; Clotrimazole; Cryptococcus; Drug Therapy, Combination; Flucytosine; Miconazole; Mucor; Mycoses | 1978 |
Treatment of opportunistic systemic mycoses.
Topics: Amphotericin B; Cytosine; Drug Evaluation; Drug Resistance, Microbial; Drug Therapy, Combination; Flucytosine; Humans; Mycoses | 1978 |
Drug therapy reviews: clinical pharmacology and therapeutic use of antimycotic drugs.
Topics: Amphotericin B; Antifungal Agents; Clotrimazole; Flucytosine; Griseofulvin; Humans; Miconazole; Nystatin | 1979 |
Evaluation and treatment of urinary candidiasis.
Topics: Amphotericin B; Bezoars; Candidiasis; Flucytosine; Humans; Kidney Diseases; Urologic Diseases | 1979 |
Feline cryptococcosis: a review and seven case reports.
Topics: Amphotericin B; Animals; Cat Diseases; Cats; Cryptococcosis; Diagnosis, Differential; Female; Flucytosine; Male | 1979 |
Cutaneous alternariosis.
Topics: Adolescent; Adult; Alternaria; Amphotericin B; Child, Preschool; Chlorquinaldol; Dermatomycoses; Female; Flucytosine; Gentian Violet; Griseofulvin; Humans; Male; Middle Aged; Mitosporic Fungi; Nystatin; Potassium Permanganate; Skin Ulcer | 1976 |
Opportunistic invasive fungal infections in patients with leukaemia lymphoma.
Topics: Acute Disease; Adrenal Cortex Hormones; Amphotericin B; Aspergillosis; Blood Transfusion; Candidiasis; Cryptococcosis; Drug Therapy, Combination; Flucytosine; Hodgkin Disease; Humans; Iron; Leukemia; Leukemia, Lymphoid; Lymphoma; Mucor; Multiple Myeloma; Mycoses; Neutropenia; Rhizopus | 1976 |
[Special therapeutic aspects of cryptococcal meningoencephalitis].
Topics: Amphotericin B; Antifungal Agents; Child; Clotrimazole; Cryptococcosis; Cryptococcus neoformans; Drug Therapy, Combination; Estrogens; Female; Flucytosine; Humans; Immunologic Techniques; Male; Meningoencephalitis; Miconazole; Middle Aged; Phagocytosis; Rifampin; Transfer Factor | 1976 |
Genitourinary fungal infections.
Topics: Amphotericin B; Animals; Candida; Candidiasis; Female; Flucytosine; Genital Diseases, Female; Genital Diseases, Male; Humans; Male; Mice; Mycoses; Urinary Tract Infections | 1976 |
Antifungal drugs.
Topics: Amphotericin B; Animals; Antifungal Agents; Aspergillosis; Blastomycosis; Candicidin; Candidiasis; Coccidioidomycosis; Colistin; Cryptococcosis; Dermatomycoses; Drug Resistance, Microbial; Emetine; Flucytosine; Griseofulvin; Histoplasmosis; Humans; Imidazoles; Minocycline; Natamycin; Nystatin; Polyenes; Tolnaftate | 1975 |
Candida endocarditis in two patients.
Topics: Adolescent; Amphotericin B; Aortic Valve; Candidiasis; Drug Therapy, Combination; Endocarditis; Flucytosine; Heart Valve Diseases; Heart Valve Prosthesis; Humans; Male; Middle Aged; Nystatin; Tricuspid Valve | 1976 |
[Primary Aspergillus endocarditis. Apropos of a case and review of the international literature].
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Combined Modality Therapy; Drug Therapy, Combination; Endocarditis; Flucytosine; Humans; Itraconazole; Ketoconazole; Male; Middle Aged; Recurrence; Reoperation | 1992 |
[Choice and monitoring of the treatment of systemic mycoses. Value and limitations of in vitro tests].
Topics: Acquired Immunodeficiency Syndrome; Amphotericin B; Antifungal Agents; Candida; Candidiasis; Drug Therapy, Combination; Fluconazole; Flucytosine; Humans; In Vitro Techniques; Itraconazole; Ketoconazole; Opportunistic Infections | 1992 |
Antifungal treatment strategy in leukemia patients.
Topics: Amphotericin B; Antifungal Agents; Drug Therapy, Combination; Fluconazole; Flucytosine; Humans; Itraconazole; Ketoconazole; Leukemia; Mycoses; Tomography, X-Ray Computed | 1992 |
[Therapy of pulmonary mycoses].
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillosis, Allergic Bronchopulmonary; Blastomycosis; Coccidioidomycosis; Cryptococcosis; Fluconazole; Flucytosine; Histoplasmosis; Humans; Itraconazole; Ketoconazole; Lung Diseases, Fungal | 1992 |
[Systemic antifungal drugs].
Topics: Amphotericin B; Animals; Antifungal Agents; Flucytosine; Humans; In Vitro Techniques; Itraconazole; Ketoconazole; Miconazole; Mycoses; Rabbits | 1991 |
Systemically administered antifungal agents. A review of their clinical pharmacology and therapeutic applications.
Topics: Amphotericin B; Antifungal Agents; Azoles; Drug Resistance, Microbial; Drugs, Investigational; Flucytosine; Fungi; Humans; Mycoses | 1992 |
Cerebral phaeohyphomycosis caused by Xylohypha bantiana, with a review of the literature.
Topics: Adolescent; Adult; Aged; Amphotericin B; Antibodies, Fungal; Brain Abscess; Child; Cladosporium; Female; Flucytosine; Humans; Male; Middle Aged; Mycoses; Tomography, X-Ray Computed | 1992 |
Cryptococcal meningitis in patients with AIDS.
Topics: AIDS-Related Opportunistic Infections; Amphotericin B; Drug Therapy, Combination; Fluconazole; Flucytosine; Humans; Meningitis, Cryptococcal; Neurologic Examination; Nursing Assessment; Patient Education as Topic | 1992 |
Phaeohyphomycosis due to Exophiala species: clinical spectrum of disease in humans.
Topics: Adult; Amphotericin B; Combined Modality Therapy; Drug Administration Schedule; Drug Therapy, Combination; Exophiala; Flucytosine; Heart Transplantation; Humans; Immunosuppression Therapy; Male; Mycoses; Opportunistic Infections | 1992 |
Evolving role of flucytosine in immunocompromised patients: new insights into safety, pharmacokinetics, and antifungal therapy.
Topics: Adolescent; Adult; Amphotericin B; Child, Preschool; Drug Therapy, Combination; Female; Flucytosine; Humans; Immunocompromised Host; Male; Middle Aged; Mycoses | 1992 |
[Systemic candidiasis].
Topics: Amphotericin B; Candida; Candidiasis; Decontamination; Drug Therapy, Combination; Female; Flucytosine; Humans; Ketoconazole; Male; Miconazole | 1992 |
Therapy for cryptococcal meningitis in patients with AIDS.
Topics: Acquired Immunodeficiency Syndrome; Amphotericin B; Animals; Fluconazole; Flucytosine; Humans; Meningitis, Cryptococcal | 1992 |
Cryptococcal endophthalmitis: case report and review.
Topics: Aged; Amphotericin B; Cryptococcosis; Cryptococcus neoformans; Endophthalmitis; Eye Infections, Fungal; Female; Flucytosine; Humans; Treatment Outcome | 1992 |
Laboratory monitoring of antifungal chemotherapy. British Society for Antimicrobial Chemotherapy Working Party.
Topics: Adult; Amphotericin B; Antifungal Agents; Chromatography, High Pressure Liquid; Drug Resistance; Drug Therapy, Combination; Fluconazole; Flucytosine; Humans; Immunodiffusion; Itraconazole; Ketoconazole; Microbial Sensitivity Tests; Mycoses | 1991 |
Antifungal agents used for deep-seated mycotic infections.
Topics: Amphotericin B; Antifungal Agents; Flucytosine; Humans; Imidazoles; Mycoses; Thromboxane-A Synthase; Triazoles | 1992 |
Cunninghamella bertholletiae: an uncommon agent of opportunistic fungal infection. Case report and review.
Topics: Adult; Amphotericin B; Anemia, Aplastic; Flucytosine; Humans; Immunocompromised Host; Lung Diseases, Fungal; Male; Mucorales; Mucormycosis; Opportunistic Infections | 1991 |
Cryptococcal meningitis in pregnancy: a case report.
Topics: Adult; Amphotericin B; Cerebrospinal Fluid Shunts; Combined Modality Therapy; Female; Flucytosine; Humans; Meningitis, Cryptococcal; Pregnancy; Pregnancy Complications, Infectious | 1991 |
Fungemia in a university hospital 1984-1988. Clinical and mycological characteristics.
Topics: Adolescent; Adult; Aged; Amphotericin B; Antifungal Agents; Candida albicans; Candidiasis; Child; Child, Preschool; Female; Flucytosine; Hospitals, University; Humans; Infant; Infant, Newborn; Male; Middle Aged; Mycoses; Retrospective Studies; Risk Factors | 1991 |
Overview: cryptococcosis in the patient with AIDS.
Topics: Acquired Immunodeficiency Syndrome; Amphotericin B; Cryptococcosis; Fluconazole; Flucytosine; Humans | 1991 |
Candida endocarditis: successful medical management in three preterm infants and review of the literature.
Topics: Amphotericin B; Candidiasis; Drug Therapy, Combination; Endocarditis; Female; Flucytosine; Humans; Infant, Newborn; Infant, Premature, Diseases; Male | 1991 |
Pharmacology and pharmacokinetics of traditional systemic antifungal agents.
Topics: Amphotericin B; Flucytosine; Humans; Ketoconazole; Miconazole | 1990 |
[Neonatal systemic candidiasis].
Topics: Amphotericin B; Anti-Bacterial Agents; Candidiasis; Female; Flucytosine; Humans; Infant, Newborn; Male | 1990 |
[Cryptococcosis in AIDS: therapeutic concepts].
Topics: Acquired Immunodeficiency Syndrome; Amphotericin B; Cryptococcosis; Drug Therapy, Combination; Fluconazole; Flucytosine; Humans | 1990 |
[Cerebral aspergillotic granuloma. Apropos of a case and a review of the literature].
Topics: Adult; Aged; Amphotericin B; Aspergillosis; Brain Diseases; Brain Neoplasms; Child; Diagnosis, Differential; Female; Flucytosine; Granuloma; Humans; Male; Meningioma; Middle Aged; Olfaction Disorders; Tomography, X-Ray Computed | 1990 |
Combination therapy in systemic mycosis.
Topics: Amphotericin B; Aspergillosis; Candidiasis; Cryptococcosis; Drug Synergism; Drug Therapy, Combination; Flucytosine; Humans; Mycoses; Prospective Studies; Rifampin | 1990 |
[The antimycotic drugs].
Topics: Amphotericin B; Antifungal Agents; Flucytosine; Humans; Imidazoles; Mycoses | 1989 |
Cryptococcosis in the immunocompromised host.
Topics: Amphotericin B; Cryptococcosis; Flucytosine; Humans; Immunologic Deficiency Syndromes; Male; Middle Aged; Opportunistic Infections | 1989 |
Opportunistic fungal infections in immunocompromised hosts.
Topics: Amphotericin B; Dermatomycoses; Flucytosine; Humans; Immunosuppression Therapy; Ketoconazole; Opportunistic Infections | 1989 |
Systemic candidiasis.
Topics: Amphotericin B; Candidiasis; Flucytosine; Humans; Immune Tolerance; Ketoconazole; Neoplasms; Opportunistic Infections; Risk Factors | 1989 |
Cutaneous cryptococcosis.
Topics: Acquired Immunodeficiency Syndrome; Amphotericin B; Biopsy; Cryptococcosis; Cryptococcus neoformans; Dermatomycoses; Drug Therapy, Combination; Flucytosine; Humans; Immune Tolerance | 1989 |
[Mycotic osteitis of the facial bones. A review of the literature apropos of a case].
Topics: Amphotericin B; Candidiasis; Diagnosis, Differential; Facial Bones; Female; Flucytosine; Granuloma, Lethal Midline; Humans; Immunologic Deficiency Syndromes; Middle Aged; Osteitis | 1989 |
Recent advances in the treatment of systemic fungal infections.
Topics: Acquired Immunodeficiency Syndrome; Amphotericin B; Antifungal Agents; Drug Resistance, Microbial; Drug Therapy, Combination; Fluconazole; Flucytosine; Humans; Itraconazole; Ketoconazole; Miconazole; Mycoses; Triazoles | 1987 |
Treatment of systemic fungal infections: recent progress and current problems.
Topics: Amphotericin B; Antifungal Agents; Chemical Phenomena; Chemistry; Fluconazole; Flucytosine; Humans; Itraconazole; Ketoconazole; Miconazole; Mycoses; Triazoles | 1988 |
The pharmacology of agents used in the treatment of pulmonary mycoses.
Topics: Amphotericin B; Antifungal Agents; Drug Interactions; Flucytosine; Humans; Itraconazole; Ketoconazole; Lung Diseases, Fungal; Miconazole | 1986 |
Diagnosis and successful treatment of fusariosis in the compromised host.
Topics: Adult; Amphotericin B; Female; Flucytosine; Fusarium; Humans; Immune Tolerance; Leukemia; Leukemia, Megakaryoblastic, Acute; Leukemia, Monocytic, Acute; Leukemia, Myeloid, Acute; Leukemia, Prolymphocytic; Male; Middle Aged; Mycoses; Opportunistic Infections | 1988 |
Prevention of amphotericin B nephrotoxicity: the effect of salt loading and flucytosine.
Topics: Amphotericin B; Animals; Flucytosine; Humans; Kidney; Sodium Chloride | 1988 |
Prevention of amphotericin B nephrotoxicity: the effect of salt loading and flucytosine.
Topics: Amphotericin B; Animals; Flucytosine; Humans; Kidney; Kidney Diseases; Sodium | 1988 |
Topical and systemic antifungal agents.
Topics: Administration, Topical; Amphotericin B; Antifungal Agents; Dermatomycoses; Flucytosine; Humans; Ketoconazole; Miconazole; Mycoses | 1988 |
Candida lusitaniae: sepsis and meningitis in a neonate.
Topics: Amphotericin B; Candida; Candidiasis; Catheters, Indwelling; Flucytosine; Humans; Infant, Newborn; Infant, Premature, Diseases; Male; Meningitis | 1987 |
Anti-Candida drugs--the biochemical basis for their activity.
Topics: Amphotericin B; Antifungal Agents; Candida; Flucytosine; Nystatin | 1987 |
Cutaneous and mucosal manifestations of the deep mycotic infections.
Topics: Amphotericin B; Aspergillosis; Blastomycosis; Candidiasis; Candidiasis, Cutaneous; Coccidioidomycosis; Cryptococcosis; Dermatomycoses; Flucytosine; Histoplasmosis; Humans; Immunosuppression Therapy; Ketoconazole; Miconazole; Mouth Diseases; Mouth Mucosa; Mucormycosis; Mycoses; Paracoccidioidomycosis; Sporotrichosis; Travel | 1986 |
Diagnosis of cryptococcosis and monitoring of chemotherapy.
Topics: Adolescent; Adult; Africa; Amphotericin B; Asia, Southeastern; Australia; Central Nervous System Diseases; Cryptococcosis; Cytosine; Drug Therapy, Combination; Europe; Female; Flucytosine; Humans; Japan; Male; United States | 1985 |
Nephrotoxicity of antifungal agents.
Topics: Amphotericin B; Antifungal Agents; Chemical Phenomena; Chemistry; Dermatomycoses; Flucytosine; Griseofulvin; Humans; Imidazoles; Kidney Diseases; Mycoses | 1985 |
Pharmacokinetics of the treatment of fungal infections.
Topics: Alkenes; Amphotericin B; Animals; Antifungal Agents; Aspergillus; Benzene Derivatives; Candida; Dermatomycoses; Flucytosine; Griseofulvin; Humans; Imidazoles; Kinetics; Mice; Microsporum; Mycoses; Natamycin; Nystatin; Trichophyton | 1972 |
Therapy of fungal infections.
Topics: Administration, Topical; Amphotericin B; Candidiasis; Coccidioides; Flucytosine; Fusarium; Griseofulvin; Histoplasma; Humans; Mycoses; Natamycin; Nystatin; Streptomyces | 1973 |
Therapy with amphotericin B and other new antifungal agents.
Topics: Alkenes; Amphotericin B; Animals; Antifungal Agents; Flucytosine; Humans; Injections, Intravenous; Mice; Mycoses; Peptides; Stilbamidines; Streptomyces | 1974 |
[Chemotherapy of deep mycoses (a review of the literature)].
Topics: Amphotericin B; Antifungal Agents; Chronic Disease; Flucytosine; Humans; Imidazoles; Mycoses; Natamycin; Nystatin; Peptides; Polyenes; Trityl Compounds | 1973 |
Drug treatment of the systemic mycoses.
Topics: Actinomycosis; Amphotericin B; Antifungal Agents; Aspergillosis; Blastomycosis; Candidiasis; Coccidioidomycosis; Cryptococcosis; Flucytosine; Histoplasmosis; Humans; Mucormycosis; Mycoses; Nocardia Infections; Sporotrichosis | 1972 |
The current status of systemic antifungal agents.
Topics: Amphotericin B; Antifungal Agents; Flucytosine; Griseofulvin; Humans; Imidazoles; Ketoconazole; Miconazole; Mycoses; Piperazines | 1982 |
[Systemic antimycotic treatment].
Topics: Amphotericin B; Drug Therapy, Combination; Flucytosine; Griseofulvin; Humans; Imidazoles; Iodides; Ketoconazole; Miconazole; Mycoses; Piperazines; Transfer Factor | 1982 |
Antifungal agents used in systemic mycoses. Activity and therapeutic use.
Topics: Amphotericin B; Antifungal Agents; Central Nervous System; Flucytosine; Humans; Imidazoles; Ketoconazole; Kidney; Kidney Diseases; Kinetics; Miconazole; Mycoses; Piperazines | 1983 |
Current therapy of pulmonary and disseminated fungal diseases.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Blastomycosis; Candidiasis; Chromoblastomycosis; Coccidioidomycosis; Cryptococcosis; Flucytosine; Histoplasmosis; Humans; Imidazoles; Ketoconazole; Lung Diseases, Fungal; Miconazole; Mycoses; Nausea; Piperazines; Vomiting | 1983 |
[Chemotherapy of aspergillus lung disease].
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Drug Therapy, Combination; Flucytosine; Humans; Imidazoles; Ketoconazole; Lung Diseases, Fungal; Miconazole; Piperazines | 1983 |
Antifungal agents useful in therapy of systemic fungal infections.
Topics: Amphotericin B; Animals; Antifungal Agents; Binding, Competitive; Cholesterol; Ergosterol; Flucytosine; Fungi; Humans; Imidazoles; Ketoconazole; Membranes, Artificial; Miconazole; Mycoses; Phospholipids; Piperazines; Sterols | 1983 |
Antifungal chemotherapy.
Topics: Amphotericin B; Antifungal Agents; Child; Child, Preschool; Drug Combinations; Flucytosine; Humans; Imidazoles; Infant; Mycoses; Potassium Iodide; Structure-Activity Relationship | 1983 |
Antifungal agents used for deep-seated mycotic infections.
Topics: Amphotericin B; Antifungal Agents; Candidiasis; Cryptococcosis; Flucytosine; Humans; Imidazoles; Mycoses; Stilbamidines | 1983 |
[Basis of antifungal chemotherapy].
Topics: Amphotericin B; Animals; Antifungal Agents; Drug Interactions; Drug Resistance, Microbial; Drug Therapy, Combination; Flucytosine; Fungi; Humans; Imidazoles; Mice; Molecular Conformation; Mycoses; Time Factors | 1983 |
[Current treatment of systematic mycoses].
Topics: Amphotericin B; Aspergillosis; Candidiasis; Cryptococcosis; Drug Therapy, Combination; Flucytosine; Humans; Imidazoles; Mucormycosis; Mycoses; Prognosis | 1983 |
Strategies in the treatment of systemic fungal infections.
Topics: Amphotericin B; Animals; Antifungal Agents; Clotrimazole; Drug Resistance, Microbial; Drug Therapy, Combination; Flucytosine; Fungi; Humans; Imidazoles; Iodides; Miconazole; Mycoses; Piperazines; Structure-Activity Relationship | 1980 |
Fungal arthritis. V. Cryptococcal and histoplasmal arthritis.
Topics: Adult; Aged; Amphotericin B; Arthritis, Infectious; Cryptococcosis; Female; Flucytosine; Histoplasmosis; Humans; Male; Middle Aged | 1980 |
Antimicrobial agents in pulmonary infections.
Topics: Aminoglycosides; Amphotericin B; Anti-Infective Agents; Cephalosporins; Cephamycins; Chloramphenicol; Clindamycin; Erythromycin; Flucytosine; Humans; Miconazole; Penicillins; Respiratory Tract Infections; Tetracycline; Vancomycin | 1980 |
Aspergillus lung disease.
Topics: Alveolitis, Extrinsic Allergic; Amphotericin B; Aspergillosis, Allergic Bronchopulmonary; Asthma; Flucytosine; Humans | 1980 |
Progress in antimycotic chemotherapy 1945-1980.
Topics: Amphotericin B; Antifungal Agents; Blastomycosis; Candidiasis; Flucytosine; Humans; Imidazoles; Mycoses; Natamycin; Nystatin; Polyenes | 1980 |
Infective endocarditis: therapeutic considerations.
Topics: Amphotericin B; Ampicillin; Aspergillus; Blood; Candida; Culture Media; Drug Resistance; Endocarditis, Bacterial; Flucytosine; Haemophilus; Heart Valve Prosthesis; Humans; Microbial Sensitivity Tests; Penicillin G; Staphylococcus; Streptococcus | 1980 |
Treatment of fungal infections of the central nervous system.
Topics: Amphotericin B; Antifungal Agents; Central Nervous System Diseases; Chemical Phenomena; Chemistry; Flucytosine; Humans; Kidney Diseases; Miconazole; Mycoses | 1981 |
Chemotherapy of the systemic mycoses.
Topics: Amphotericin B; Flucytosine; Humans; Imidazoles; Mycoses; Potassium Iodide; Stilbamidines | 1982 |
The management of fungal obstructive uropathy in neonates and infants.
Topics: Amphotericin B; Candidiasis; Drug Therapy, Combination; Flucytosine; Humans; Hydronephrosis; Infant; Infant, Newborn; Kidney Diseases; Kidney Pelvis; Male; Ureteral Obstruction | 1994 |
Antifungal chemotherapy.
Topics: Amphotericin B; Antifungal Agents; Fluconazole; Flucytosine; Itraconazole; Ketoconazole; Morpholines; Naphthalenes; Terbinafine | 1995 |
Adjuvant itraconazole in the treatment of destructive sphenoid aspergillosis.
Topics: Adult; Aged; Amphotericin B; Aspergillosis; Aspergillus flavus; Aspergillus fumigatus; Combined Modality Therapy; Drug Therapy, Combination; Female; Flucytosine; Humans; Itraconazole; Male; Paranasal Sinus Diseases; Sphenoid Sinus | 1994 |
Mechanisms and clinical impact of antifungal drug resistance.
Topics: Amphotericin B; Azoles; Drug Resistance, Microbial; Flucytosine; Fungi; Humans; Mycoses; Treatment Failure | 1994 |
Yeast in the urine: solutions for a budding problem.
Topics: Algorithms; Amphotericin B; Animals; Azoles; Candidiasis; Flucytosine; Humans | 1995 |
Management of cryptococcosis.
Topics: AIDS-Related Opportunistic Infections; Amphotericin B; Cryptococcosis; Flucytosine; Humans; Lung Diseases, Fungal; Meningitis; Triazoles | 1993 |
Candidemia in a pediatric population.
Topics: Adolescent; Age Distribution; Amphotericin B; Candidiasis; Child; Child, Preschool; Drug Therapy, Combination; Female; Flucytosine; Fungemia; Humans; Infant; Infant, Newborn; Male; Treatment Outcome | 1995 |
Cryptococcal disease of the CNS in immunocompetent hosts: influence of cryptococcal variety on clinical manifestations and outcome.
Topics: Adult; Aged; AIDS-Related Opportunistic Infections; Amphotericin B; Antigens, Fungal; Cryptococcus neoformans; Female; Flucytosine; Humans; Immunocompetence; Male; Meningitis, Cryptococcal; Middle Aged; Retrospective Studies; Species Specificity; Treatment Outcome | 1995 |
Flucytosine--what is its future?
Topics: Amphotericin B; Drug Resistance, Microbial; Drug Therapy, Combination; Flucytosine; Forecasting; Humans; Mycoses | 1995 |
Molecular mechanisms of drug resistance in fungi.
Topics: Amphotericin B; Azoles; Candida; Drug Resistance, Microbial; Flucytosine | 1994 |
[Curative treatment of invasive aspergillosis].
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Drug Therapy, Combination; Flucytosine; Humans; Itraconazole; Lung Diseases, Fungal; Rifampin | 1994 |
[Role of chemoprophylaxis in the prevention of invasive aspergillosis].
Topics: Aerosols; Amphotericin B; Aspergillosis; Drug Therapy, Combination; Female; Fluconazole; Flucytosine; Humans; Itraconazole; Lung Diseases, Fungal; Male | 1994 |
Pathogenesis and management of Candida infection syndromes in non-neutropenic patients.
Topics: Amphotericin B; Candidiasis; Clinical Trials as Topic; Cross Infection; Fluconazole; Flucytosine; Fungemia; Gastrointestinal Diseases; Humans; Intensive Care Units; Risk Factors | 1993 |
Chronic candidal meningitis: an uncommon manifestation of candidiasis.
Topics: Aged; Amphotericin B; Candida albicans; Candidiasis; Cerebrospinal Fluid Proteins; Female; Flucytosine; Glucose; Humans; Leukocyte Count; Meningitis, Fungal; Neutrophils | 1994 |
Antifungal therapy: potential interactions with other classes of drugs.
Topics: Amphotericin B; Antifungal Agents; Drug Interactions; Drug Synergism; Drug Therapy, Combination; Fluconazole; Flucytosine; Griseofulvin; Humans; Itraconazole; Ketoconazole; Mycoses | 1994 |
Treatment of invasive aspergillosis.
Topics: AIDS-Related Opportunistic Infections; Amphotericin B; Aspergillosis; Cholesterol Esters; Drug Carriers; Drug Therapy, Combination; Flucytosine; Humans; Immunocompromised Host; Infusions, Intravenous; Itraconazole; Liposomes; Opportunistic Infections; Rifampin | 1994 |
[Aspergillus spondylodiscitis. Apropos of 5 cases].
Topics: Adult; Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Discitis; Flucytosine; Humans; Immunocompromised Host; Itraconazole; Magnetic Resonance Imaging; Male; Middle Aged; Tomography, X-Ray Computed | 1993 |
[Neurological form of cryptococcosis. Apropos of 2 atypical cases in non HIV-infected patients].
Topics: Adolescent; Adult; Agammaglobulinemia; Amphotericin B; Brain Abscess; Brain Diseases; Cryptococcosis; Female; Flucytosine; HIV Seronegativity; Humans; Hydrocephalus; Magnetic Resonance Imaging; Male; Opportunistic Infections | 1993 |
Opportunistic/nosocomial infections. Treatment and developmental therapeutics. I. Cryptococcosis.
Topics: Amphotericin B; Animals; Cross Infection; Cryptococcosis; Cryptococcus neoformans; Drug Therapy, Combination; Flucytosine; Humans; Opportunistic Infections | 1993 |
Hematogenous endophthalmitis due to Candida tropicalis: report of two cases and review.
Topics: Adult; Amphotericin B; Blood; Candida; Candidiasis; Drug Therapy, Combination; Endophthalmitis; Eye Infections, Fungal; Female; Flucytosine; Humans; Male; Middle Aged | 1993 |
Cryptococcal meningitis and confusional psychosis. A case report and literature review.
Topics: Adult; Amphotericin B; Confusion; Flucytosine; Humans; Male; Meningitis, Cryptococcal; Neurocognitive Disorders | 1995 |
Meningitis caused by Candida species: an emerging problem in neurosurgical patients.
Topics: Adult; Aged; Amphotericin B; Anti-Infective Agents; Antifungal Agents; Brain; Candidiasis; Drug Therapy, Combination; Female; Flucytosine; Humans; Male; Meningitis, Bacterial; Meningitis, Fungal; Middle Aged; Postoperative Complications | 1995 |
New antifungal compounds and strategies for treatment of invasive fungal infections in patients with neoplastic diseases.
Topics: Amphotericin B; Antifungal Agents; Azoles; Flucytosine; Humans; Immunocompromised Host; Mycoses; Neoplasms; Neutropenia | 1995 |
[Antifungal drugs].
Topics: Amphotericin B; Antifungal Agents; Fluconazole; Flucytosine; Humans; Itraconazole; Miconazole | 1995 |
Infection of a total knee arthroplasty by Candida parapsilosis. A case report of successful treatment by joint reimplantation with a literature review.
Topics: Amphotericin B; Antifungal Agents; Candidiasis; Combined Modality Therapy; External Fixators; Female; Flucytosine; Humans; Knee Prosthesis; Middle Aged; Prosthesis Design; Prosthesis-Related Infections; Reoperation | 1996 |
Nosocomial cerebral aspergillosis: a report of 3 cases.
Topics: Adolescent; Adult; Aged; Amphotericin B; Antifungal Agents; Aspergillosis; Brain; Cross Infection; Drug Carriers; Drug Therapy, Combination; Female; Flucytosine; Humans; Immunocompromised Host; Itraconazole; Liposomes; Male; Neurosurgery | 1996 |
Cryptococcosis.
Topics: AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Azoles; Clinical Trials as Topic; Cryptococcosis; Drug Interactions; Flucytosine; Humans | 1997 |
Update on invasive candidiasis.
Topics: Amphotericin B; Animals; Antifungal Agents; Azoles; Candidiasis; Drug Interactions; Flucytosine; Humans | 1997 |
Evolving concepts of prevention and treatment of invasive fungal infections in pediatric bone marrow transplant recipients.
Topics: Amphotericin B; Antifungal Agents; Bone Marrow Transplantation; Child; Clinical Trials as Topic; Fluconazole; Flucytosine; Humans; Imidazoles; Immunocompromised Host; Itraconazole; Mycoses; Neutropenia; Transplantation Conditioning; Triazoles | 1996 |
[Fungal myocarditis].
Topics: Amphotericin B; Antifungal Agents; Candidiasis; Flucytosine; Humans; Mycoses; Myocarditis; Prognosis | 1996 |
[The resistance of opportunistic fungi to antifungals].
Topics: Amphotericin B; Antifungal Agents; Azoles; Dose-Response Relationship, Drug; Drug Resistance, Microbial; Flucytosine; Fungi; Microbial Sensitivity Tests | 1997 |
Candidal meningitis in HIV-infected patients: analysis of 14 cases.
Topics: Adult; AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Candidiasis; Female; Fluconazole; Flucytosine; Humans; Male; Meningitis, Fungal; Middle Aged; Risk Factors | 1997 |
[Antimicrobial drug therapy and microbial sensitivity tests--antifungal agents and microbial sensitivity tests].
Topics: Amphotericin B; Antifungal Agents; Candida; Drug Resistance, Microbial; Fluconazole; Flucytosine; Itraconazole; Miconazole; Microbial Sensitivity Tests; Quality Control; Saccharomyces cerevisiae | 1997 |
Clinical relevance of antifungal resistance.
Topics: Amphotericin B; Animals; Antifungal Agents; Candidiasis; Cryptococcosis; Drug Resistance, Microbial; Fluconazole; Flucytosine; Humans; Itraconazole; Mycoses | 1997 |
[Treatment of cryptococcosis in patients with acquired immunodeficiency syndrome].
Topics: Adult; AIDS-Related Opportunistic Infections; Amphotericin B; Animals; Antifungal Agents; Clinical Trials as Topic; Cryptococcosis; Fluconazole; Flucytosine; Humans; Immunotherapy; Itraconazole; Meningitis, Cryptococcal; Mice; Multicenter Studies as Topic; Vaccination | 1995 |
[Commonly used antifungal agents in the treatment of systemic mycoses].
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Blastomycosis; Candidiasis; Clinical Trials as Topic; Coccidioidomycosis; Cryptococcosis; Fluconazole; Flucytosine; Hematologic Diseases; Histoplasmosis; Humans; Itraconazole; Ketoconazole; Kidney; Mycoses; Thrombophlebitis | 1995 |
Therapeutic drug monitoring of systemic antifungal therapy.
Topics: Amphotericin B; Antifungal Agents; Drug Monitoring; Flucytosine; Humans; Itraconazole; Mycoses | 1997 |
[Therapy of invasive mycoses in neutropenic patients with hematologic system diseases].
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Candidiasis; Chemistry, Pharmaceutical; Fluconazole; Flucytosine; Hematologic Diseases; Humans; Itraconazole; Mycoses | 1998 |
Fungal infections in iatrogenically compromised hosts.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Azoles; Candidiasis; Catheters, Indwelling; Diagnosis, Differential; Flucytosine; Fusarium; Humans; Iatrogenic Disease; Immunocompromised Host; Mycoses; Opportunistic Infections; Syndrome; Trichosporon | 1998 |
The management of cryptococcal meningitis in Papua New Guinea.
Topics: Amphotericin B; Anti-Inflammatory Agents; Antifungal Agents; Cause of Death; Drug Combinations; Drug Monitoring; Fluconazole; Flucytosine; Humans; Hydrocortisone; Immunocompetence; Intracranial Hypertension; Intracranial Pressure; Itraconazole; Meningitis, Cryptococcal; Multicenter Studies as Topic; Papua New Guinea | 1996 |
[Candida infections in infancy and early childhood].
Topics: Amphotericin B; Antifungal Agents; Candidiasis; Child, Preschool; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Fluconazole; Flucytosine; Humans; Infant; Infant, Newborn; Male; Risk Factors | 1998 |
[Geotrichum capitatum infection in a neutropenic patient. Apropos of a case and review of the literature].
Topics: Acute Disease; Amphotericin B; Antifungal Agents; Antineoplastic Agents; Drug Combinations; Fatal Outcome; Flucytosine; Geotrichosis; Humans; Immunocompromised Host; Itraconazole; Leukemia; Male; Middle Aged; Neutropenia; Opportunistic Infections | 1998 |
Current and future therapy of invasive fungal infections.
Topics: Amphotericin B; Antifungal Agents; Drug Carriers; Flucytosine; Humans; Liposomes; Mycoses; Triazoles | 1998 |
Antifungal agents. Part I. Amphotericin B preparations and flucytosine.
Topics: Amphotericin B; Antifungal Agents; Drug Carriers; Flucytosine; Humans; Liposomes | 1998 |
[Advances in the treatment of severe refractory infections. 4) Deep fungal infection].
Topics: Amphotericin B; Antifungal Agents; Fluconazole; Flucytosine; Humans; Itraconazole; Miconazole; Mycoses | 1998 |
The challenge of invasive fungal infection.
Topics: AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Aspergillosis; Candidiasis; Cryptococcosis; Deoxycholic Acid; Drug Combinations; Fluconazole; Flucytosine; Fungemia; Histoplasmosis; Humans; Immunocompromised Host; Mycoses; Zygomycosis | 1999 |
[The future of antifungal agents. Non azole antifungal agents].
Topics: Amphotericin B; Animals; Antifungal Agents; Drug Carriers; Echinocandins; Flucytosine; Fungi; Glucosyltransferases; Lipopeptides; Lipoproteins; Liposomes; Membrane Proteins; Micafungin; Mice; Mycoses; Peptides, Cyclic; Rats; Schizosaccharomyces pombe Proteins | 1999 |
[The efficacy of sequential treatment with amphotericin B-fluorocytosine and fluconazole in cryptococcal meningitis not associated with AIDS].
Topics: Aged; AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Drug Therapy, Combination; Fatal Outcome; Fluconazole; Flucytosine; Humans; Male; Meningitis, Cryptococcal | 1999 |
Therapy of invasive fungal infections.
Topics: Amphotericin B; Antifungal Agents; Catheterization, Central Venous; Contraindications; Drug Therapy, Combination; Flucytosine; Fungemia; Granulocyte Colony-Stimulating Factor; Humans; Immunotherapy; Mycoses; Neutropenia; Triazoles | 1999 |
Antifungal agents: mode of action, mechanisms of resistance, and correlation of these mechanisms with bacterial resistance.
Topics: Amphotericin B; Animals; Antifungal Agents; Bacteria; Cell Wall; Drug Resistance, Microbial; Flucytosine; Humans; Miconazole; Naphthalenes; Terbinafine | 1999 |
Molecular and biochemical mechanisms of drug resistance in fungi.
Topics: Amphotericin B; Antifungal Agents; Drug Resistance, Microbial; Fluconazole; Flucytosine; Fungi | 1999 |
[Update on the pharmacological interactions of systemic antifungal agents].
Topics: Amphotericin B; Antifungal Agents; Azoles; Drug Interactions; Flucytosine; Humans | 1999 |
Systemic antifungal therapy in pediatric practice.
Topics: Amphotericin B; Antifungal Agents; Azoles; Candidiasis; Child; Flucytosine; Griseofulvin; Humans; India; Mycoses | 1999 |
Trichosporon beigelii infection: experience in a regional burn center.
Topics: Adult; Amphotericin B; Antifungal Agents; Burns; Catheters, Indwelling; Drug Resistance, Microbial; Fatal Outcome; Female; Fluconazole; Flucytosine; Fungemia; Humans; Immunocompromised Host; Male; Mycoses; Opportunistic Infections; Sputum; Trichosporon; Wound Infection | 2000 |
Subcutaneous phaeohyphomycosis in transplant recipients: review of the literature and demonstration of in vitro synergy between antifungal agents.
Topics: Amphotericin B; Antifungal Agents; Biopsy; Bone Marrow Transplantation; Combined Modality Therapy; Dermatomycoses; Drug Resistance, Microbial; Drug Therapy, Combination; Flucytosine; Fungi; Humans; Itraconazole; Male; Middle Aged; Skin | 2000 |
Current approach to the acute management of cryptococcal infections.
Topics: AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; CD4 Lymphocyte Count; Cryptococcosis; Cryptococcus neoformans; Drug Therapy, Combination; Fluconazole; Flucytosine; HIV; HIV Infections; Humans; Itraconazole; Lung Diseases, Fungal; Meningitis, Cryptococcal; Randomized Controlled Trials as Topic | 2000 |
Standard antifungal therapy in neutropenic patients.
Topics: Amphotericin B; Antifungal Agents; Fever; Flucytosine; Humans; Mycoses; Neutropenia | 2000 |
[The activity of systemic antimycotic drug combinations].
Topics: Amphotericin B; Antifungal Agents; Azoles; Drug Interactions; Drug Therapy, Combination; Flucytosine; Fungi; Humans | 2001 |
[Cryptococcosis].
Topics: Adult; AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Child; Cryptococcosis; Female; Flucytosine; Humans; Male; Meningitis, Cryptococcal; Mycology; Prognosis; Risk Factors; Time Factors | 2001 |
[Choice and use of antifungal drugs].
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Candidiasis; Fluconazole; Flucytosine; Humans; Itraconazole; Lung Diseases, Fungal; Mycoses; Time Factors | 2001 |
Resistance of Candida species to antifungal agents: molecular mechanisms and clinical consequences.
Topics: Amphotericin B; Antifungal Agents; Azoles; Candida; Candidiasis; Cytochrome P-450 Enzyme System; Drug Resistance, Fungal; Flucytosine; Fungemia; Humans; Microbial Sensitivity Tests; Oxidoreductases; Sterol 14-Demethylase; Triazoles | 2002 |
Oral candidal infections and antimycotics.
Topics: AIDS-Related Opportunistic Infections; Amphotericin B; Anti-Infective Agents, Local; Antifungal Agents; Candida; Candidiasis, Oral; Chlorhexidine; Clotrimazole; Drug Resistance, Fungal; Fluconazole; Flucytosine; Humans; Immunocompromised Host; Itraconazole; Ketoconazole; Miconazole; Mouth; Nystatin; Opportunistic Infections; Saliva; Treatment Failure; Triazoles | 2000 |
[Flucytosine - a classical partner for combination therapy].
Topics: Amphotericin B; Antifungal Agents; Drug Therapy, Combination; Flucytosine; Humans; Mitosporic Fungi; Mycoses; Opportunistic Infections | 2002 |
[Therapeutic safety of antimycotics in the treatment of systemic fungal infections].
Topics: Amphotericin B; Antifungal Agents; Drug Interactions; Fluconazole; Flucytosine; Humans; Itraconazole; Ketoconazole; Liver; Mycoses | 2003 |
Antifungal pharmacotherapy for neonatal candidiasis.
Topics: Amphotericin B; Antifungal Agents; Candidiasis; Caspofungin; Cross Infection; Echinocandins; Fluconazole; Flucytosine; Fungal Proteins; Fungemia; Humans; Infant, Newborn; Infant, Premature; Intensive Care Units, Neonatal; Ketoconazole; Lipopeptides; Peptides; Peptides, Cyclic; Pyrimidines; Triazoles; Voriconazole | 2003 |
CNS-aspergillosis: are there new treatment options?
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Blood-Brain Barrier; Caspofungin; Central Nervous System Fungal Infections; Echinocandins; Female; Flucytosine; Humans; Immunocompromised Host; Itraconazole; Lipopeptides; Male; Peptides; Peptides, Cyclic; Pyrimidines; Triazoles; Voriconazole | 2003 |
Antifungals in systemic neonatal candidiasis.
Topics: Amphotericin B; Antifungal Agents; Candidiasis; Clinical Trials as Topic; Drug Therapy, Combination; Echinocandins; Fluconazole; Flucytosine; Fungal Proteins; Humans; Infant, Newborn; Peptides; Peptides, Cyclic | 2004 |
The longest use of liposomal amphotericin B and 5-fluorocytosine in neonatal renal candidiasis.
Topics: Acute Kidney Injury; Amphotericin B; Antifungal Agents; Candidiasis; Female; Flucytosine; Humans; Infant; Kidney Diseases; Liposomes; Time Factors | 2004 |
New aspects of infective endocarditis.
Topics: Aminoglycosides; Amphotericin B; Antifungal Agents; Drug Combinations; Drug Therapy, Combination; Echocardiography, Transesophageal; Endocarditis, Bacterial; Flucytosine; Humans; Penicillins; Prognosis; Vancomycin | 2004 |
Combinations of antifungal agents in therapy--what value are they?
Topics: Amphotericin B; Animals; Antifungal Agents; Azoles; Caspofungin; Drug Therapy, Combination; Echinocandins; Flucytosine; Humans; Lipopeptides; Microbial Sensitivity Tests; Mycoses; Naphthalenes; Peptides, Cyclic; Terbinafine | 2004 |
Cryptococcal meningitis.
Topics: AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Drug Therapy, Combination; Fluconazole; Flucytosine; Humans; Immunotherapy; Intracranial Pressure; Meningitis, Cryptococcal; Prognosis; Treatment Outcome | 2004 |
Antifungal agents in children.
Topics: Age Factors; Amphotericin B; Anidulafungin; Antifungal Agents; Caspofungin; Chemistry, Pharmaceutical; Child; Clinical Trials as Topic; Drug Approval; Drug Resistance, Fungal; Echinocandins; Fluconazole; Flucytosine; Humans; Itraconazole; Lipopeptides; Lipoproteins; Micafungin; Mycoses; Patient Selection; Pediatrics; Peptides, Cyclic; Pyrimidines; Safety; Thiazoles; Triazoles; United States; Voriconazole | 2005 |
Not your "typical patient": cryptococcal meningitis in an immunocompetent patient.
Topics: Amphotericin B; Antifungal Agents; Biopsy, Needle; Consciousness Disorders; Fatigue; Flucytosine; Headache; HIV Seronegativity; Humans; Immunocompetence; Male; Medical History Taking; Meningitis, Cryptococcal; Middle Aged; Nausea; Nurse's Role; Nursing Assessment; Patient Care Planning; Physical Examination; Recurrence; Tomography, X-Ray Computed; Ventriculoperitoneal Shunt | 2005 |
Antifungal treatment in pediatric patients.
Topics: Adolescent; Amphotericin B; Antifungal Agents; Azoles; Caspofungin; Child; Child, Preschool; Drug Resistance, Fungal; Echinocandins; Flucytosine; Fungal Proteins; Humans; Infant; Lipopeptides; Lipoproteins; Micafungin; Mycoses; Peptides, Cyclic; Triazoles | 2005 |
Management of systemic fungal infections: alternatives to itraconazole.
Topics: Amphotericin B; Antifungal Agents; Flucytosine; Humans; Mycoses; Randomized Controlled Trials as Topic; Triazoles | 2005 |
Recommendations for managing Aspergillus osteomyelitis and joint infections based on a review of the literature.
Topics: Amphotericin B; Antifungal Agents; Arthritis, Infectious; Aspergillosis; Aspergillus; Disease Management; Drug Resistance, Fungal; Drug Therapy, Combination; Flucytosine; Humans; Microbial Sensitivity Tests; Osteomyelitis; Treatment Failure | 2006 |
Lumbar drainage for control of raised cerebrospinal fluid pressure in cryptococcal meningitis: case report and review.
Topics: Adult; AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Cerebrospinal Fluid Pressure; Cryptococcus neoformans; Deoxycholic Acid; Drainage; Drug Combinations; Female; Fluconazole; Flucytosine; HIV-1; Humans; Meningitis, Cryptococcal; Spinal Puncture; Treatment Outcome | 2005 |
Neonatal invasive candidiasis.
Topics: Age Factors; Amphotericin B; Antifungal Agents; Candidiasis; Drug Therapy, Combination; Fluconazole; Flucytosine; Humans; Incidence; Infant, Newborn; Infant, Very Low Birth Weight; Prognosis; Risk Factors; Sensitivity and Specificity | 2006 |
[Mechanisms of resistance to antifungal agents].
Topics: Amphotericin B; Antifungal Agents; Azoles; Drug Resistance, Fungal; Flucytosine; Fungi; Humans; Mycoses | 2007 |
CNS pharmacokinetics of antifungal agents.
Topics: Amphotericin B; Animals; Antifungal Agents; Central Nervous System; Flucytosine; Humans; Triazoles | 2007 |
Candida endophthalmitis: focus on current and future antifungal treatment options.
Topics: Amphotericin B; Antifungal Agents; Candidiasis; Echinocandins; Endophthalmitis; Fluconazole; Flucytosine; Humans; Pyrimidines; Risk Factors; Triazoles; Voriconazole | 2007 |
Treatment of acute cryptococcal meningitis in HIV infected adults, with an emphasis on resource-limited settings.
Topics: Acetazolamide; Acute Disease; Adult; Amphotericin B; Antifungal Agents; Antihypertensive Agents; Developing Countries; Fluconazole; Flucytosine; Health Resources; HIV Infections; Humans; Intracranial Hypertension; Meningitis, Cryptococcal | 2008 |
Managing cryptococcosis in the immunocompromised host.
Topics: Amphotericin B; Antifungal Agents; Case Management; Cryptococcosis; Drug Therapy, Combination; Flucytosine; Humans; Immunocompromised Host | 2008 |
[Oral antifungal agents].
Topics: Administration, Oral; Amphotericin B; Antifungal Agents; Diabetes Complications; Fluconazole; Flucytosine; Humans; Itraconazole; Japan; Mycoses; Practice Guidelines as Topic; Pyrimidines; Triazoles; Voriconazole | 2008 |
[Pharmacokinetics and pharmacodynamics of antifungal drugs in children].
Topics: Amphotericin B; Antifungal Agents; Child; Echinocandins; Evidence-Based Medicine; Flucytosine; Humans; Mycoses; Triazoles | 2011 |
Meningitis caused by Filobasidium uniguttulatum: case report and overview of the literature.
Topics: Adult; Aged; Amphotericin B; Antifungal Agents; Basidiomycota; Drug Resistance, Fungal; Female; Flucytosine; Humans; Male; Meningitis, Cryptococcal; Microbial Sensitivity Tests; Mycological Typing Techniques | 2012 |
Candida infections in non-neutropenic children after the neonatal period.
Topics: Amphotericin B; Antifungal Agents; Candida; Candidemia; Catheter-Related Infections; Child; Cross Infection; Deoxycholic Acid; Drug Combinations; Echinocandins; Fluconazole; Flucytosine; Humans; Infant, Newborn; Intensive Care Units; Leukocyte Count; Mycological Typing Techniques; Neutrophils; Survival Rate; United States | 2011 |
Antifungal therapy for newborn infants with invasive fungal infection.
Topics: Amphotericin B; Antifungal Agents; Fluconazole; Flucytosine; Humans; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Mycoses; Randomized Controlled Trials as Topic | 2012 |
Candida cerebral abscesses: a case report and review of the literature.
Topics: Administration, Intravenous; Administration, Oral; Adolescent; Adult; Amphotericin B; Brain Abscess; Candida; Candidiasis; Child, Preschool; Diabetes Complications; Female; Fluconazole; Flucytosine; Humans; Infant; Male; Middle Aged; Substance Abuse, Intravenous; Young Adult | 2013 |
Flucytosine and cryptococcosis: time to urgently address the worldwide accessibility of a 50-year-old antifungal.
Topics: Africa; AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Asia; Fluconazole; Flucytosine; HIV Infections; Humans; Meningitis, Cryptococcal | 2013 |
[Non-antibiotic anti-infectious treatments in urology].
Topics: Acyclovir; Albendazole; Amphotericin B; Anti-Infective Agents; Caspofungin; Cidofovir; Cytosine; Echinocandins; Fluconazole; Flucytosine; Foscarnet; Ganciclovir; Humans; Ivermectin; Lipopeptides; Organophosphonates; Praziquantel; Urologic Diseases; Valganciclovir | 2013 |
Comparison of flucytosine and fluconazole combined with amphotericin B for the treatment of HIV-associated cryptococcal meningitis: a systematic review and meta-analysis.
Topics: Amphotericin B; Antifungal Agents; Coinfection; Drug Therapy, Combination; Fluconazole; Flucytosine; HIV Infections; Humans; Immunocompromised Host; Meningitis, Cryptococcal; Treatment Outcome | 2014 |
[Cryptococcal meningitis].
Topics: Adult; Aged; Amphotericin B; Antifungal Agents; Cryptococcus neoformans; Female; Fluconazole; Flucytosine; HIV Infections; Humans; Immunocompromised Host; Kidney Transplantation; Male; Meningitis, Cryptococcal; Spinal Puncture; Treatment Outcome | 2015 |
Pleural effusion as the initial clinical presentation in disseminated cryptococcosis and fungaemia: an unusual manifestation and a literature review.
Topics: Amphotericin B; Antifungal Agents; Cryptococcosis; Cryptococcus neoformans; Fluconazole; Flucytosine; Fungemia; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Middle Aged; Pleural Effusion; Voriconazole | 2015 |
Defining the frontiers between antifungal resistance, tolerance and the concept of persistence.
Topics: Amphotericin B; Antifungal Agents; Dose-Response Relationship, Drug; Drug Resistance, Fungal; Drug Tolerance; Echinocandins; Flucytosine; Fungi; Host-Pathogen Interactions; Humans; Microbial Sensitivity Tests; Mycoses; Triazoles | 2015 |
Meningitis Caused by Candida Dubliniensis in a Patient with Cirrhosis: A Case Report and Review of the Literature.
Topics: Amphotericin B; Antifungal Agents; Brain; Candida; Candidiasis; Cerebrospinal Fluid; Fatal Outcome; Flucytosine; Hepatitis C, Chronic; Humans; Liver Cirrhosis; Magnetic Resonance Imaging; Male; Meningitis; Middle Aged; Substance-Related Disorders | 2016 |
Disseminated Acanthamoeba infection in a heart transplant recipient treated successfully with a miltefosine-containing regimen: Case report and review of the literature.
Topics: Acanthamoeba; Amebiasis; Amebicides; Amphotericin B; Anti-Bacterial Agents; Antilymphocyte Serum; Biopsy; Cardiomyopathies; Drugs, Investigational; Endoscopy; Female; Fluconazole; Flucytosine; Heart Transplantation; Humans; Immunocompromised Host; Immunosuppressive Agents; Magnetic Resonance Imaging; Metacarpal Bones; Metronidazole; Middle Aged; Phosphorylcholine; Polymerase Chain Reaction; Radiography; Sinusitis; Skin | 2017 |
Treatment for HIV-associated cryptococcal meningitis.
Topics: Acetazolamide; Acute Disease; Adult; Amphotericin B; Antifungal Agents; Developing Countries; Drug Administration Schedule; Drug Therapy, Combination; Fluconazole; Flucytosine; Health Resources; HIV Infections; Humans; Induction Chemotherapy; Intracranial Hypertension; Meningitis, Cryptococcal; Network Meta-Analysis | 2018 |
Leave no one behind: response to new evidence and guidelines for the management of cryptococcal meningitis in low-income and middle-income countries.
Topics: Africa; Amphotericin B; Antifungal Agents; Coinfection; Cryptococcus neoformans; Developing Countries; Disease Management; Drug Administration Schedule; Drug Therapy, Combination; Fluconazole; Flucytosine; Guidelines as Topic; HIV Infections; Humans; Income; Meningitis, Cryptococcal; Survival Analysis | 2019 |
Recent advances in managing HIV-associated cryptococcal meningitis.
Topics: Amphotericin B; Antifungal Agents; Fluconazole; Flucytosine; HIV Infections; Humans; Meningitis, Cryptococcal | 2019 |
New Insights Into Cryptococcus Spp. Biology and Cryptococcal Meningitis.
Topics: Amphotericin B; Antifungal Agents; Antiretroviral Therapy, Highly Active; Cryptococcus; Drug Therapy, Combination; Fluconazole; Flucytosine; HIV Infections; Humans; Immunologic Deficiency Syndromes; Intracranial Hypertension; Meningitis, Cryptococcal; Risk Factors | 2019 |
From bench to bedside: Perspectives on the utility of pharmacokinetics/pharmacodynamics in predicting the efficacy of antifungals in invasive candidiasis.
Topics: Amphotericin B; Animals; Antifungal Agents; Antimicrobial Stewardship; Candida; Candida albicans; Candida glabrata; Candida parapsilosis; Candida tropicalis; Candidiasis, Invasive; Echinocandins; Fluconazole; Flucytosine; Humans; Species Specificity; Triazoles; Voriconazole | 2020 |
Cryptococcosis caused by cryptococcus gattii: 2 case reports and literature review.
Topics: Administration, Intravenous; Adolescent; Adult; Aged; Amphotericin B; Antifungal Agents; Asian People; Central Nervous System Fungal Infections; Cryptococcosis; Cryptococcus gattii; Drug Therapy, Combination; Female; Flucytosine; Genotype; Geography; Humans; Immunocompromised Host; Male; Middle Aged; Prevalence; Recurrence; Spinal Puncture; Treatment Outcome; Treatment Refusal; Young Adult | 2020 |
Cryptococcal meningoencephalitis: time for action.
Topics: Amphotericin B; Antifungal Agents; Cryptococcosis; Databases, Factual; Deoxycholic Acid; Drug Combinations; Drug Therapy, Combination; Fluconazole; Flucytosine; Humans; Meningoencephalitis | 2021 |
Efficacy of induction regimens for cryptococcal meningitis in HIV-infected adults: a systematic review and network meta-analysis.
Topics: AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Deoxycholic Acid; Drug Combinations; Flucytosine; Humans; Induction Chemotherapy; Meningitis, Cryptococcal; Treatment Outcome | 2021 |
Treatment of Cryptococcal Meningitis: How Have We Got Here and Where are We Going?
Topics: Adult; Amphotericin B; Antifungal Agents; Fluconazole; Flucytosine; Glucocorticoids; HIV Infections; Humans; Meningitis, Cryptococcal; Sertraline; Tamoxifen | 2022 |
An updated systematic review of HIV-associated cryptococcal meningitis treatment strategies.
Topics: Amphotericin B; Antifungal Agents; Drug Therapy, Combination; Fluconazole; Flucytosine; HIV Infections; Humans; Meningitis, Cryptococcal; Randomized Controlled Trials as Topic | 2023 |
Cryptococcosis in domestic and wild animals: A review.
Topics: Amphotericin B; Animals; Cryptococcosis; Cryptococcus gattii; Cryptococcus neoformans; Ferrets; Flucytosine; Humans | 2023 |
Searching for new antifungals for the treatment of cryptococcosis.
Topics: Amphotericin B; Antifungal Agents; Cryptococcosis; Cryptococcus neoformans; Fluconazole; Flucytosine; Humans | 2023 |
39 trial(s) available for flucytosine and amphotericin b
| Article | Year |
|---|---|
Comparison between 5-fluorocytosine, amphotericin B and the combined administration of these agents in the therapeutic effectiveness for cryptococcal meningitis.
Topics: Adult; Aged; Amphotericin B; Clinical Trials as Topic; Cryptococcosis; Cytosine; Drug Administration Schedule; Drug Evaluation; Drug Therapy, Combination; Female; Flucytosine; Gastrointestinal Diseases; Hematologic Diseases; Humans; Injections, Intravenous; Male; Meningitis; Middle Aged; Time Factors | 1978 |
Antifungal therapy, 1978.
Topics: Amphotericin B; Antifungal Agents; Blastomycosis; Clinical Trials as Topic; Flucytosine; History, 18th Century; History, 19th Century; History, 20th Century; Humans; Mycoses; Nystatin; Stilbamidines; United States | 1979 |
A comparison of amphotericin B alone and combined with flucytosine in the treatment of cryptoccal meningitis.
Topics: Adolescent; Adult; Aged; Amphotericin B; Cryptococcosis; Cytosine; Drug Evaluation; Drug Therapy, Combination; Flucytosine; Humans; Meningitis; Middle Aged; Prospective Studies; Time Factors | 1979 |
[Therapy of chromoblastomycosis with a new method].
Topics: Adult; Amphotericin B; Chromoblastomycosis; Clinical Trials as Topic; Cytosine; Drug Evaluation; Drug Therapy, Combination; Female; Flucytosine; Humans; Injections, Intravenous; Male; Middle Aged; Tablets | 1976 |
Itraconazole compared with amphotericin B plus flucytosine in AIDS patients with cryptococcal meningitis.
Topics: Acquired Immunodeficiency Syndrome; Adult; Amphotericin B; Antifungal Agents; Drug Therapy, Combination; Flucytosine; Humans; Itraconazole; Ketoconazole; Male; Meningitis, Cryptococcal; Middle Aged; Opportunistic Infections; Prospective Studies; Survival Analysis | 1992 |
The efficacy of itraconazole against systemic fungal infections in neutropenic patients: a randomised comparative study with amphotericin B.
Topics: Amphotericin B; Aspergillosis; Aspergillus fumigatus; Candidiasis; Drug Therapy, Combination; Female; Flucytosine; Humans; Itraconazole; Ketoconazole; Male; Middle Aged; Neutropenia; Prospective Studies | 1991 |
Antifungal treatment by amphotericin B and 5-fluorocytosine delays the recovery of normal hematopoietic cells after intensive cytostatic therapy for acute myeloid leukemia.
Topics: Acute Disease; Adolescent; Adult; Aged; Amphotericin B; Antineoplastic Agents; Candidiasis; Drug Administration Schedule; Drug Therapy, Combination; Flucytosine; Hematopoiesis; Humans; Immune Tolerance; Leukemia, Myeloid; Middle Aged; Random Allocation | 1991 |
Fluconazole compared with amphotericin B plus flucytosine for cryptococcal meningitis in AIDS. A randomized trial.
Topics: Acquired Immunodeficiency Syndrome; Adult; Amphotericin B; Cryptococcosis; Cryptococcus neoformans; Drug Therapy, Combination; Fluconazole; Flucytosine; Humans; Male; Meningitis; Opportunistic Infections; Prospective Studies; Randomized Controlled Trials as Topic | 1990 |
Combination therapy in systemic mycosis.
Topics: Amphotericin B; Aspergillosis; Candidiasis; Cryptococcosis; Drug Synergism; Drug Therapy, Combination; Flucytosine; Humans; Mycoses; Prospective Studies; Rifampin | 1990 |
Collaborative investigation of variables in susceptibility testing of yeasts.
Topics: Amphotericin B; Candida; Cell Division; Culture Media; Evaluation Studies as Topic; Flucytosine; Ketoconazole; Microbial Sensitivity Tests; Microbiological Techniques; Temperature; Time Factors | 1990 |
Treatment of cryptococcal meningitis with combination amphotericin B and flucytosine for four as compared with six weeks.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amphotericin B; Antigens, Fungal; Child; Clinical Trials as Topic; Cryptococcosis; Drug Administration Schedule; Drug Therapy, Combination; Female; Flucytosine; Heart Transplantation; Humans; Kidney Transplantation; Male; Meningitis; Middle Aged; Prospective Studies; Random Allocation; Recurrence | 1987 |
Toxicity of amphotericin B plus flucytosine in 194 patients with cryptococcal meningitis.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amphotericin B; Child; Clinical Trials as Topic; Creatinine; Cryptococcosis; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Flucytosine; Humans; Male; Meningitis; Middle Aged; Prospective Studies; Random Allocation; Time Factors | 1987 |
Antimicrobial prophylaxis in acute leukaemia: prospective randomized study comparing two methods of selective decontamination.
Topics: Acute Disease; Adolescent; Adult; Aged; Aminoglycosides; Amphotericin B; Anti-Bacterial Agents; Bacterial Infections; Candidiasis; Cephalosporins; Enterobacteriaceae Infections; Female; Flucytosine; Humans; Leukemia; Male; Middle Aged; Oxacillin; Penicillins; Prospective Studies; Staphylococcal Infections; Streptococcal Infections | 1983 |
Candida albicans arthritis in a nonimmunocompromised patient. Complication of placebo intraarticular injections.
Topics: Adult; Amphotericin B; Arthritis, Infectious; Candida albicans; Candidiasis; Combined Modality Therapy; Double-Blind Method; Drug Therapy, Combination; Flucytosine; Humans; Hyaluronic Acid; Injections, Intra-Articular; Male; Synovectomy | 1993 |
Treatment of cryptococcal meningitis with triple combination of amphotericin B, flucytosine and itraconazole.
Topics: Adult; Aged; Amphotericin B; Antifungal Agents; Drug Therapy, Combination; Female; Flucytosine; Humans; Itraconazole; Male; Meningitis, Cryptococcal; Middle Aged; Thailand | 1995 |
Treatment of cryptococcal meningitis associated with the acquired immunodeficiency syndrome. National Institute of Allergy and Infectious Diseases Mycoses Study Group and AIDS Clinical Trials Group.
Topics: Adult; Aged; AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Double-Blind Method; Drug Therapy, Combination; Female; Fluconazole; Flucytosine; Humans; Itraconazole; Male; Meningitis, Cryptococcal; Middle Aged; Multivariate Analysis; Survival Analysis | 1997 |
Comparison of amphotericin B, flucytosine and itraconazole with amphotericin B and flucytosine in the treatment of cryptococcal meningitis in AIDS.
Topics: Adolescent; Adult; AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Chi-Square Distribution; Cryptococcus neoformans; Drug Therapy, Combination; Female; Flucytosine; Humans; Itraconazole; Male; Meningitis, Cryptococcal; Middle Aged | 1997 |
Efficacy of a short-term amphotericin B + flucytosine combination therapy followed by itraconazole monotherapy in acute and chronic AIDS-associated cryptococcosis.
Topics: Acute Disease; AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Antigens, Fungal; Chronic Disease; Cryptococcosis; Drug Therapy, Combination; Flucytosine; Follow-Up Studies; Humans; Itraconazole; Meningitis, Cryptococcal | 1997 |
Diagnosis and management of increased intracranial pressure in patients with AIDS and cryptococcal meningitis. The NIAID Mycoses Study Group and AIDS Cooperative Treatment Groups.
Topics: AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Cerebrospinal Fluid; Flucytosine; Humans; Intracranial Hypertension; Meningitis, Cryptococcal; Spinal Puncture; Treatment Outcome | 2000 |
Early empiric antifungal therapy of infections in neutropenic patients comparing fluconazole with amphotericin B/flucytosine.
Topics: Adolescent; Adult; Aged; Amphotericin B; Antifungal Agents; Drug Therapy, Combination; Female; Fluconazole; Flucytosine; Humans; Male; Middle Aged; Mycoses; Neutropenia | 1999 |
Discontinuation of secondary prophylaxis against cryptococcosis in patients with AIDS receiving highly active antiretroviral therapy.
Topics: Adult; AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Antiretroviral Therapy, Highly Active; Cryptococcosis; Fluconazole; Flucytosine; Humans; Male | 2001 |
Antifungal therapy for treatment of cryptococcal meningitis.
Topics: Adolescent; Adult; Amphotericin B; Antifungal Agents; Child; Child, Preschool; Cryptococcus neoformans; Drug Therapy, Combination; Female; Fluconazole; Flucytosine; Humans; Infant; Injections, Intravenous; Injections, Spinal; Male; Meningitis, Cryptococcal; Middle Aged; Treatment Outcome | 2000 |
Therapeutic treatment of systemic candidiasis in newborns.
Topics: Amphotericin B; Antifungal Agents; Candidiasis; Dose-Response Relationship, Drug; Drug Therapy, Combination; Flucytosine; Humans; Infant, Newborn; Infant, Premature; Infant, Very Low Birth Weight; Infusions, Intravenous; Treatment Outcome | 1991 |
Flucytosine and cryptococcosis: which in vitro test is the best predictor of outcome?
Topics: Adult; Amphotericin B; Anti-Bacterial Agents; Antifungal Agents; Cryptococcosis; Cryptococcus neoformans; Culture Media; Drug Therapy, Combination; Female; Flucytosine; Humans; Hydrogen-Ion Concentration; Male; Microbial Sensitivity Tests; Middle Aged; Predictive Value of Tests; Treatment Outcome | 2003 |
Combination antifungal therapies for HIV-associated cryptococcal meningitis: a randomised trial.
Topics: Adult; AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Antigens, Fungal; Cerebrospinal Fluid; Cerebrospinal Fluid Pressure; Colony Count, Microbial; Cryptococcus neoformans; Drug Therapy, Combination; Female; Fluconazole; Flucytosine; Humans; Male; Meningitis, Cryptococcal | 2004 |
Poor efficacy of amphotericin B-based therapy in CNS aspergillosis.
Topics: Adolescent; Adult; Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus flavus; Aspergillus fumigatus; Central Nervous System Fungal Infections; Child; Drug Therapy, Combination; Female; Flucytosine; Humans; Itraconazole; Male; Middle Aged; Neuroaspergillosis; Treatment Outcome | 2007 |
Antifungal usage in children undergoing intensive treatment for acute myeloid leukemia: analysis of the multicenter clinical trial AML-BFM 93.
Topics: Adolescent; Amphotericin B; Antifungal Agents; Aspergillosis; Candidiasis; Child; Female; Fluconazole; Flucytosine; Humans; Infant; Infant, Newborn; Itraconazole; Leukemia, Myelomonocytic, Acute; Male; Retrospective Studies | 2007 |
High-dose amphotericin B with flucytosine for the treatment of cryptococcal meningitis in HIV-infected patients: a randomized trial.
Topics: Adult; AIDS-Related Opportunistic Infections; Amphotericin B; Anemia; Antifungal Agents; Cerebrospinal Fluid; Creatinine; Cryptococcus neoformans; Female; Flucytosine; Follow-Up Studies; Hemoglobins; Humans; Male; Meningitis, Cryptococcal; Renal Insufficiency; Sex Factors; South Africa; Treatment Outcome | 2008 |
Amphotericin B: the higher the dose, the higher the toxicity.
Topics: Amphotericin B; Antifungal Agents; Dose-Response Relationship, Drug; Fluconazole; Flucytosine; HIV Infections; Humans; Meningitis, Cryptococcal | 2008 |
[Evaluation of low-dose amphotericin B and flucytosine in the treatment of cryptococcal meningitis].
Topics: Adolescent; Adult; Amphotericin B; Antifungal Agents; Child; Drug Evaluation; Drug Therapy, Combination; Female; Flucytosine; Humans; Male; Meningitis, Cryptococcal; Middle Aged; Retrospective Studies; Young Adult | 2010 |
Adjunctive interferon-γ immunotherapy for the treatment of HIV-associated cryptococcal meningitis: a randomized controlled trial.
Topics: Adult; AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Antiviral Agents; Cryptococcus neoformans; Deoxycholic Acid; Drug Combinations; Female; Flucytosine; HIV Infections; Humans; Interferon-gamma; Male; Meningitis, Cryptococcal; Treatment Outcome | 2012 |
A phase II randomized controlled trial adding oral flucytosine to high-dose fluconazole, with short-course amphotericin B, for cryptococcal meningitis.
Topics: Acquired Immunodeficiency Syndrome; Administration, Oral; Adult; Aged; AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Drug Therapy, Combination; Female; Fluconazole; Flucytosine; Humans; Malawi; Male; Meningitis, Cryptococcal; Middle Aged; Treatment Outcome; Young Adult | 2012 |
Combination antifungal therapy for cryptococcal meningitis.
Topics: Adult; Amphotericin B; Antifungal Agents; Drug Therapy, Combination; Female; Flucytosine; Humans; Induction Chemotherapy; Kaplan-Meier Estimate; Male; Meningitis, Cryptococcal | 2013 |
Toxicity of Amphotericin B Deoxycholate-Based Induction Therapy in Patients with HIV-Associated Cryptococcal Meningitis.
Topics: Adult; Amphotericin B; Anemia; Antifungal Agents; Blood Cell Count; Coinfection; Creatinine; Cryptococcus neoformans; Deoxycholic Acid; Drug Combinations; Female; Flucytosine; Hemoglobins; HIV; HIV Infections; Humans; Hypokalemia; Induction Chemotherapy; Kidney; Male; Meningitis, Cryptococcal; Neutropenia; Survival Analysis; Treatment Outcome | 2015 |
Antifungal Combinations for Treatment of Cryptococcal Meningitis in Africa.
Topics: Administration, Oral; Adult; Africa; AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Drug Administration Schedule; Drug Therapy, Combination; Female; Fluconazole; Flucytosine; HIV Seropositivity; Humans; Kaplan-Meier Estimate; Male; Meningitis, Cryptococcal; Proportional Hazards Models | 2018 |
AMBIsome Therapy Induction OptimisatioN (AMBITION): High Dose AmBisome for Cryptococcal Meningitis Induction Therapy in sub-Saharan Africa: Study Protocol for a Phase 3 Randomised Controlled Non-Inferiority Trial.
Topics: Africa South of the Sahara; Amphotericin B; Antifungal Agents; Clinical Trials, Phase III as Topic; Cost-Benefit Analysis; Cryptococcus neoformans; Drug Administration Schedule; Drug Costs; Drug Therapy, Combination; Equivalence Trials as Topic; Fluconazole; Flucytosine; Humans; Induction Chemotherapy; Meningitis, Cryptococcal; Multicenter Studies as Topic; Time Factors; Treatment Outcome | 2018 |
Single-Dose Liposomal Amphotericin B Treatment for Cryptococcal Meningitis.
Topics: Administration, Oral; Africa South of the Sahara; AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Drug Administration Schedule; Drug Therapy, Combination; Fluconazole; Flucytosine; HIV Infections; Meningitis, Cryptococcal | 2022 |
How Applicable Is the Single-Dose AMBITION Regimen for Human Immunodeficiency Virus-Associated Cryptococcal Meningitis to High-Income Settings?
Topics: Antifungal Agents; Drug Therapy, Combination; Fluconazole; Flucytosine; HIV; HIV Infections; Humans; Meningitis, Cryptococcal | 2023 |
Higher Dose Oral Fluconazole for the Treatment of AIDS-related Cryptococcal Meningitis (HIFLAC)-report of A5225, a multicentre, phase I/II, two-stage, dose-finding, safety, tolerability and efficacy randomised, amphotericin B-controlled trial of the AIDS
Topics: Acquired Immunodeficiency Syndrome; Adult; Amphotericin B; Antifungal Agents; Drug Therapy, Combination; Fluconazole; Flucytosine; HIV Infections; Humans; Meningitis, Cryptococcal; Treatment Outcome | 2023 |
1102 other study(ies) available for flucytosine and amphotericin b
| Article | Year |
|---|---|
Antifungal properties of 2-bromo-3-fluorosuccinic acid esters and related compounds.
Topics: Antifungal Agents; Aspergillus niger; Candida albicans; Methods; Mucor; Structure-Activity Relationship; Succinates; Trichophyton | 1977 |
Stereoselective synthesis of 7 alpha- and 7 beta-aminocholestanol as potent fungicidal drugs.
Topics: Amphotericin B; Antifungal Agents; Biochemistry; Candida; Cholestanols; Drug Evaluation, Preclinical; Flucytosine; Microbial Sensitivity Tests; Stereoisomerism | 2001 |
New bioactive peroxides from marine sponges of the family plakiniidae.
Topics: Animals; Aspergillus fumigatus; Candida albicans; Microbial Sensitivity Tests; Peroxides; Porifera; Spectrum Analysis | 2002 |
Acetylenic acids inhibiting azole-resistant Candida albicans from Pentagonia gigantifolia.
Topics: Amphotericin B; Antifungal Agents; Candida albicans; Drug Resistance, Microbial; Fatty Acids, Monounsaturated; Fluconazole; Gas Chromatography-Mass Spectrometry; Methylation; Microbial Sensitivity Tests; Molecular Structure; Peru; Plant Roots; Sphingolipids | 2003 |
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Combination of amphotericin B with flucytosine is active in vitro against flucytosine-resistant isolates of Cryptococcus neoformans.
Topics: Amphotericin B; Antifungal Agents; Cryptococcus neoformans; DNA, Fungal; Drug Resistance, Fungal; Drug Synergism; Flucytosine; Fungal Proteins; Microbial Sensitivity Tests; Molecular Sequence Data; Sequence Analysis, DNA | 2007 |
Synthesis and antifungal activity of (Z)-5-arylidenerhodanines.
Topics: Antifungal Agents; Computer Simulation; Drug Design; Microbial Sensitivity Tests; Microwaves; Mitosporic Fungi; Molecular Structure; Rhodanine; Sensitivity and Specificity; Stereoisomerism; Structure-Activity Relationship; Yeasts | 2007 |
In vitro activities of isavuconazole and other antifungal agents against Candida bloodstream isolates.
Topics: Antifungal Agents; Area Under Curve; Candida; Fungemia; Humans; Microbial Sensitivity Tests; Nitriles; Pyridines; Triazoles | 2007 |
In vitro susceptibility of Sporothrix schenckii to six antifungal agents determined using three different methods.
Topics: Amphotericin B; Antifungal Agents; Fluconazole; Flucytosine; Humans; In Vitro Techniques; Itraconazole; Ketoconazole; Microbial Sensitivity Tests; Pyrimidines; Quality Control; Sporothrix; Sporotrichosis; Triazoles; Voriconazole | 2007 |
In vitro susceptibilities of 217 clinical isolates of zygomycetes to conventional and new antifungal agents.
Topics: Amphotericin B; Antifungal Agents; Caspofungin; Echinocandins; Fluconazole; Flucytosine; Humans; In Vitro Techniques; Itraconazole; Ketoconazole; Lipopeptides; Microbial Sensitivity Tests; Mucormycosis; Peptides, Cyclic; Pyrimidines; Triazoles; Voriconazole | 2007 |
Combined therapies in a murine model of blastoschizomycosis.
Topics: Amphotericin B; Animals; Antifungal Agents; Colony Count, Microbial; Disease Models, Animal; Drug Synergism; Drug Therapy, Combination; Echinocandins; Flucytosine; Geotrichosis; Geotrichum; Humans; Immunocompromised Host; Lipopeptides; Lipoproteins; Male; Micafungin; Mice; Mice, Inbred Strains; Microbial Sensitivity Tests; Mycoses; Peptides, Cyclic; Pyrimidines; Survival Analysis; Triazoles; Trichosporon; Voriconazole | 2007 |
Optimization of the dosage of flucytosine in combination with amphotericin B for disseminated candidiasis: a pharmacodynamic rationale for reduced dosing.
Topics: Algorithms; Amphotericin B; Antifungal Agents; Area Under Curve; Candidiasis; Child; Drug Interactions; Flucytosine; Humans; Models, Statistical; Monte Carlo Method | 2007 |
In vitro study of Candida tropicalis isolates exhibiting paradoxical growth in the presence of high concentrations of caspofungin.
Topics: Antifungal Agents; Candida tropicalis; Caspofungin; Echinocandins; Lipopeptides; Microbial Sensitivity Tests; Time Factors | 2007 |
Antifungal and cytotoxic activities of some N-substituted aniline derivatives bearing a hetaryl fragment.
Topics: Aniline Compounds; Antifungal Agents; Antineoplastic Agents; Drug Screening Assays, Antitumor; Humans; Imines; Microbial Sensitivity Tests; Molecular Structure; National Cancer Institute (U.S.); United States | 2008 |
In vitro antifungal susceptibilities of five species of sporothrix.
Topics: Animals; Antifungal Agents; Drug Resistance, Fungal; Humans; Microbial Sensitivity Tests; Species Specificity; Sporothrix; Sporotrichosis | 2008 |
Antimicrobial activity of omiganan pentahydrochloride against contemporary fungal pathogens responsible for catheter-associated infections.
Topics: Antifungal Agents; Antimicrobial Cationic Peptides; Aspergillosis; Aspergillus; Candida; Candidiasis; Catheterization, Central Venous; Dose-Response Relationship, Drug; Drug Resistance, Fungal; Fungemia; Fungi; Humans; Microbial Sensitivity Tests | 2008 |
Reliability of the WIDERYST susceptibility testing system for detection of in vitro antifungal resistance in yeasts.
Topics: Amphotericin B; Antifungal Agents; Azoles; Candida; Culture Media; Drug Resistance, Fungal; Fungi; Humans; Microbial Sensitivity Tests; Mycoses; Reproducibility of Results; Yeasts | 2008 |
In Vitro activity of the new azole isavuconazole (BAL4815) compared with six other antifungal agents against 162 Cryptococcus neoformans isolates from Cuba.
Topics: Antifungal Agents; Azoles; Cryptococcosis; Cryptococcus neoformans; Cuba; Humans; Microbial Sensitivity Tests; Nitriles; Pyridines; Triazoles | 2008 |
Prevalence and susceptibility profile of Candida metapsilosis and Candida orthopsilosis: results from population-based surveillance of candidemia in Spain.
Topics: Antifungal Agents; Candida; Candidiasis; Fungemia; Humans; Microbial Sensitivity Tests; Population Surveillance; Prevalence; Spain; Species Specificity | 2008 |
Cell density and cell aging as factors modulating antifungal resistance of Candida albicans biofilms.
Topics: Antifungal Agents; Biofilms; Candida albicans; Cell Adhesion; Colony Count, Microbial; Culture Media; Drug Resistance, Fungal; Humans; Microbial Sensitivity Tests; Polystyrenes; Time Factors | 2008 |
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Antifungal susceptibilities among different serotypes of Cryptococcus gattii and Cryptococcus neoformans.
Topics: Antifungal Agents; Cryptococcus; Cryptococcus neoformans; Fluconazole; Microbial Sensitivity Tests; Nitriles; Pyridines; Pyrimidines; Serotyping; Triazoles; Voriconazole | 2009 |
Discovery of a small-molecule inhibitor of {beta}-1,6-glucan synthesis.
Topics: Acetic Acid; Anti-Bacterial Agents; Antifungal Agents; Antineoplastic Agents; Benzimidazoles; beta-Glucans; Blotting, Western; Cell Wall; Drug Resistance, Fungal; Fungi; Glucose; Leucine; Microbial Sensitivity Tests; Pyridines; Saccharomyces cerevisiae; Uridine | 2009 |
Abc1p is a multidrug efflux transporter that tips the balance in favor of innate azole resistance in Candida krusei.
Topics: Amino Acid Sequence; Animals; Antifungal Agents; ATP-Binding Cassette Transporters; Azoles; Blotting, Northern; Blotting, Southern; Candida; Candidiasis; Cell Membrane; Chromosomes, Fungal; Drug Resistance, Fungal; Endoplasmic Reticulum; Humans; Phenotype; Plasmids; Reverse Transcriptase Polymerase Chain Reaction; Saccharomyces cerevisiae | 2009 |
A 10-year survey of antifungal susceptibility of candidemia isolates from intensive care unit patients in Greece.
Topics: Antifungal Agents; Candida; Candidiasis; Data Collection; Disease Susceptibility; Greece; Humans; Intensive Care Units; Microbial Sensitivity Tests; Retrospective Studies | 2009 |
Activity profile in vitro of micafungin against Spanish clinical isolates of common and emerging species of yeasts and molds.
Topics: Acremonium; Antifungal Agents; Aspergillus; Candida; Drug Resistance, Fungal; Echinocandins; Fungi; Humans; Lipopeptides; Micafungin; Microbial Sensitivity Tests; Mycoses; Penicillium; Scedosporium; Spain | 2009 |
Case of fatal Blastoschizomyces capitatus infection occurring in a patient receiving empiric micafungin therapy.
Topics: Aged; Antifungal Agents; Echinocandins; Fatal Outcome; Geotrichosis; Geotrichum; Humans; Lipopeptides; Male; Micafungin; Microbial Sensitivity Tests; Neutropenia | 2009 |
Correlation of in vitro activity, serum levels, and in vivo efficacy of posaconazole against Rhizopus microsporus in a murine disseminated infection.
Topics: Amphotericin B; Animals; Antifungal Agents; Brain; Kidney; Male; Mice; Mucormycosis; Rhizopus; Triazoles | 2009 |
In vitro activity of thimerosal against ocular pathogenic fungi.
Topics: Alternaria; Amphotericin B; Antifungal Agents; Aspergillus; Eye Infections, Fungal; Fungi; Fusarium; Humans; Microbial Sensitivity Tests; Natamycin; Thimerosal | 2010 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Acquisition of flucytosine, azole, and caspofungin resistance in Candida glabrata bloodstream isolates serially obtained from a hematopoietic stem cell transplant recipient.
Topics: Antifungal Agents; Azoles; Candida glabrata; Candidiasis; Caspofungin; Child; Drug Resistance, Fungal; Echinocandins; Female; Flucytosine; Fungal Proteins; Fungemia; Hematopoietic Stem Cell Transplantation; Humans; Lipopeptides; Microbial Sensitivity Tests; Point Mutation | 2010 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
Role of Fks1p and matrix glucan in Candida albicans biofilm resistance to an echinocandin, pyrimidine, and polyene.
Topics: Amphotericin B; Anidulafungin; Antifungal Agents; Biofilms; Candida albicans; Drug Resistance, Fungal; Echinocandins; Flucytosine; Fungal Proteins; Glucans; Glucosyltransferases; Humans; Microbial Sensitivity Tests; Polyenes; Pyrimidines | 2010 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
Synthesis and antifungal activity of some substituted phenothiazines and related compounds.
Topics: Antifungal Agents; Drug Discovery; Fungi; Microbial Sensitivity Tests; Phenothiazines; Structure-Activity Relationship | 2011 |
Synthesis and antifungal evaluation of head-to-head and head-to-tail bisamidine compounds.
Topics: Antifungal Agents; Candida; Cryptococcus neoformans; DNA-Binding Proteins; Furans; Humans | 2015 |
Discovery of Novel Sertraline Derivatives as Potent Anti-
Topics: Antidepressive Agents; Antifungal Agents; Cryptococcus; Cryptococcus neoformans; Humans; Meningitis, Cryptococcal; Microbial Sensitivity Tests; Sertraline | 2022 |
Trichosporon sepsis and leukemia.
Topics: Amphotericin B; Anti-Bacterial Agents; Bleomycin; Child; Cytarabine; Enterobacteriaceae Infections; Flucytosine; Humans; Leukemia, Lymphoid; Male; Mycoses; Sepsis; Vincristine; Yeasts | 1975 |
Treatment of cryptococcosis.
Topics: Amphotericin B; Cryptococcosis; Cryptococcus neoformans; Drug Evaluation; Flucytosine; Humans; Meningitis; Miconazole | 1979 |
Antifungal drugs and neutrophil chemotaxis.
Topics: Amphotericin B; Candida; Chemotaxis, Leukocyte; Flucytosine; Humans; Miconazole; Neutrophils | 1977 |
Candida albicans meningitis in a premature neonate successfully treated with 5-fluorocytosine and amphotericin B: a case report and review of the literature.
Topics: Amphotericin B; Candidiasis; Drug Therapy, Combination; Female; Flucytosine; Humans; Infant; Infant, Newborn; Infant, Premature, Diseases; Male; Meningitis | 1978 |
Torulopsis glabrata--urinary tract infections in diabetic patients in Singapore.
Topics: Adult; Aged; Amphotericin B; Candida; Diabetes Complications; Female; Flucytosine; Humans; Middle Aged; Mycoses; Urinary Tract Infections | 1977 |
Maxillary sinus infection with Allescheria boydii (Petriellidium boydii).
Topics: Adult; Amphotericin B; Anti-Bacterial Agents; Face; Flucytosine; Humans; Leukemia, Lymphoid; Male; Maxillary Sinus; Mycoses; Paranasal Sinus Diseases; Pseudallescheria | 1978 |
Treatment of systemic mycoses. Panel discussion.
Topics: Amphotericin B; Cytosine; Drug Evaluation; Drug Resistance, Microbial; Flucytosine; Humans; Mycoses | 1978 |
[Pulmonary mycoses; laboratory diagnosis, antimycotic therapy].
Topics: Administration, Topical; Amphotericin B; Clinical Laboratory Techniques; Clotrimazole; Drug Resistance, Microbial; Drug Therapy, Combination; Flucytosine; Humans; Imidazoles; Lung Diseases, Fungal; Miconazole; Natamycin; Nystatin; Sputum; Yeasts | 1977 |
[Diagnosis and therapy of generalized mycoses].
Topics: Amphotericin B; Flucytosine; Humans; Mycoses; Natamycin; Nystatin; Serologic Tests; Skin Tests; Specimen Handling; Sputum | 1978 |
Therapy of postsurgical fungal endophthalmitis.
Topics: Aged; Amphotericin B; Animals; Antifungal Agents; Aspergillosis; Cataract Extraction; Eye Diseases; Female; Flucytosine; Humans; Methods; Miconazole; Mycoses; Natamycin; Postoperative Complications; Rabbits | 1978 |
Fusarium oxysporum endophthalmitis.
Topics: Adult; Amphotericin B; Drug Resistance, Microbial; Drug Therapy, Combination; Electroretinography; Endophthalmitis; Flucytosine; Fusarium; Humans; Male; Mycoses; Vitreous Body | 1979 |
Therapy of murine aspergillosis with amphotericin B in combination with rifampin of 5-fluorocytosine.
Topics: Amphotericin B; Animals; Aspergillosis; Aspergillus fumigatus; Cytosine; Drug Therapy, Combination; Female; Flucytosine; Mice; Mice, Inbred AKR; Rifampin | 1977 |
Evidence for sequential action of amphotericin B and 5-fluorocytosine on Canida albicans ATCC 11651.
Topics: Amphotericin B; Candida albicans; Cytosine; Drug Interactions; Flucytosine; Time Factors | 1977 |
Experimental Candida albicans endocarditis: characterization of the disease and response to therapy.
Topics: Agglutinins; Amphotericin B; Animals; Antibodies, Fungal; Aortic Valve; Candida albicans; Candidiasis; Cytosine; Disease Models, Animal; Endocarditis; Flucytosine; Kidney; Rabbits | 1977 |
Comparative study of trichothecin, amphotericin B, and 5-fluorocytosine against Cryptococcus neoformans in vitro and in vivo.
Topics: Amphotericin B; Animals; Cryptococcosis; Cryptococcus; Cryptococcus neoformans; Cytosine; Disease Models, Animal; Drug Evaluation, Preclinical; Drug Synergism; Drug Therapy, Combination; Female; Flucytosine; Male; Mice; Sesquiterpenes; Trichothecenes | 1977 |
[Amphotericin B and 5-fluorocytosine treatment in renal transplant recipient with cryptococcal meningitis (author's transl)].
Topics: Adult; Amphotericin B; Cryptococcosis; Cytosine; Flucytosine; Humans; Kidney Transplantation; Male; Meningitis; Postoperative Complications; Transplantation, Homologous | 1977 |
Arthritis and osteomyelitis due to Candida albicans: a case report.
Topics: Administration, Oral; Adult; Amphotericin B; Arthritis, Infectious; Candida albicans; Candidiasis; Female; Flucytosine; Humans; Osteomyelitis; Time Factors | 1977 |
[Fungal infections following renal transplantation].
Topics: Amphotericin B; Flucytosine; Humans; Immunosuppression Therapy; Kidney Transplantation; Miconazole; Mycoses; Postoperative Complications | 1977 |
Synergism of polyene antibiotics with 5-fluorocytosine.
Topics: Amino Acids; Amphotericin B; Animals; Antifungal Agents; Candicidin; Candida; Candida albicans; Candidiasis; Cryptococcus neoformans; Cytosine; Drug Resistance, Microbial; Drug Synergism; Female; Flucytosine; Mice; Nystatin; Pyrimidines; Rats; RNA; Yeasts | 1978 |
In vitro and in vivo studies on synergistic antifungal activity.
Topics: Amphotericin B; Animals; Antifungal Agents; Candida albicans; Candidiasis; Cryptococcosis; Cryptococcus neoformans; Drug Synergism; Drug Therapy, Combination; Flucytosine; Mice; Yeasts | 1977 |
Cryptococcosis: a diagnostic challenge.
Topics: Agglutination Tests; Amphotericin B; Antibodies, Fungal; Cryptococcosis; Cryptococcus neoformans; Diagnosis, Differential; Ecology; Flucytosine; Humans | 1977 |
Cryptococcal endophthalmitis after corneal transplantation.
Topics: Adult; Aged; Amphotericin B; Corneal Transplantation; Cryptococcosis; Endophthalmitis; Female; Flucytosine; Humans; Postoperative Complications; Tissue Donors; Transplantation, Homologous | 1978 |
The susceptibility of Candida albicans to amphotericin B, nystatin, and 5-fluorocytosine.
Topics: Amphotericin B; Candida albicans; Cytosine; Drug Resistance, Microbial; Flucytosine; Nystatin | 1977 |
Interaction of chemotherapy and immune defenses in experimental murine cryptococcosis.
Topics: Amphotericin B; Animals; Cryptococcosis; Cryptococcus neoformans; Female; Flucytosine; Immunity, Cellular; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Microbial Sensitivity Tests | 1978 |
Recent advances in the treatment of systemic mycotic infections.
Topics: Amphotericin B; Animals; Antifungal Agents; Cryptococcosis; Drug Therapy, Combination; Flucytosine; Humans; Immunity; Kidney Transplantation; Miconazole; Mycoses | 1979 |
Laboratory tests of antifungal drugs in treatment of systemic mycoses.
Topics: Amphotericin B; Antifungal Agents; Biological Assay; Body Fluids; Culture Media; Drug Resistance, Microbial; Flucytosine; Fungi; Humans; Miconazole; Microbial Sensitivity Tests; Microbiological Techniques; Solutions; Temperature | 1978 |
Combined amphotericin B-flucytosine therapy in Aspergillus pneumonia.
Topics: Amphotericin B; Aspergillosis; Aspergillus fumigatus; Cytosine; Drug Synergism; Drug Therapy, Combination; Flucytosine; Humans; Lung Diseases, Fungal; Male; Middle Aged; Pneumonia; Sputum | 1979 |
[Cryptococcal meningoencephalitis with extremely high C.S.F. gamma-globulin and immunoglobulin (author's transl)].
Topics: Aged; Amphotericin B; Chronic Disease; Cryptococcosis; Cryptococcus neoformans; Diagnosis, Differential; Female; Flucytosine; Humans; Immunoglobulin G; Meningoencephalitis | 1979 |
[Contribution to diagnosis and therapy of juvenile candidiasis].
Topics: Accidents, Traffic; Amphotericin B; Antibodies, Fungal; Blood; Brain Injuries; Candida albicans; Candidiasis; Child; Flucytosine; Humans; Male; Miconazole; Prednisolone | 1979 |
Mycotic endophthalmitis in drug abusers.
Topics: Administration, Oral; Administration, Topical; Adult; Amphetamines; Amphotericin B; Antifungal Agents; Aspergillosis; Candida; Candida albicans; Candidiasis; Clotrimazole; Endophthalmitis; Female; Flucytosine; Humans; Injections, Intravenous; Male; Microbial Sensitivity Tests; Middle Aged; Prednisolone; Prednisone; Substance-Related Disorders | 1979 |
[Cryptococcosis of the central nervous system: evaluation of amphotericin-B, 5-fluorocytosine and miconazole therapy in 18 cases].
Topics: Adolescent; Adult; Amphotericin B; Central Nervous System Diseases; Child, Preschool; Cryptococcosis; Cytosine; Drug Therapy, Combination; Female; Flucytosine; Humans; Imidazoles; Injections, Intraventricular; Injections, Spinal; Kidney Transplantation; Male; Miconazole; Middle Aged; Transplantation, Homologous | 1979 |
Assay for yeast susceptibility to 5-fluorocytosine and amphotericin B in a frozen microtiter system.
Topics: Amphotericin B; Candida; Candida albicans; Cryptococcus; Cryptococcus neoformans; Cytosine; Flucytosine; Freezing; Indicators and Reagents; Microbial Sensitivity Tests; Preservation, Biological | 1979 |
[Experimental aspergillosis in mice].
Topics: Amphotericin B; Animals; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Drug Evaluation, Preclinical; Flucytosine; Fluorenes; Imidazoles; Mice | 1979 |
Isolation and characterization of a polyene-resistant variant of Candida tropicalis.
Topics: Amphotericin B; Bone Marrow Transplantation; Candida; Drug Resistance, Microbial; Flucytosine; Genetic Variation; Humans; Nystatin; Urine | 1979 |
Problems in the laboratory assessment of antifungal activity.
Topics: Amphotericin B; Antifungal Agents; Candida albicans; Candidiasis, Vulvovaginal; Drug Evaluation, Preclinical; Female; Flucytosine; Humans; Miconazole; Microbial Sensitivity Tests; Models, Biological | 1979 |
[Combination of 5-fluorocytosine and amphotericin B in the treatment of chromomycosis].
Topics: Adult; Aged; Amphotericin B; Capsules; Chromobacterium; Chromoblastomycosis; Cytosine; Drug Evaluation; Drug Therapy, Combination; Flucytosine; Humans; Injections, Intravenous; Male; Middle Aged | 1979 |
Diagnosis and management of opportunistic infections. Part II. Diagnosis and therapy.
Topics: Amphotericin B; Anaerobiosis; Anti-Infective Agents; Bacterial Infections; Flucytosine; Humans; Infection Control; Infections; Mycoses; Parasitic Diseases; Virus Diseases | 1977 |
[Mycotic panuveitis (author's transl)].
Topics: Amphotericin B; Candidiasis; Flucytosine; Humans; Male; Middle Aged; Uveitis | 1979 |
Activity of 2,4-diaminoquinazoline compounds against Candida species.
Topics: Amphotericin B; Animals; Candida; Drug Resistance, Microbial; Drug Stability; Flucytosine; Mice; Quinazolines | 1979 |
Neonatal osteomyelitis caused by Candida tropicalis. Report of two cases and review of the literature.
Topics: Amphotericin B; Arthritis, Infectious; Bone Development; Candidiasis; Femur; Flucytosine; Follow-Up Studies; Humans; Humerus; Infant, Newborn; Infant, Newborn, Diseases; Knee Joint; Male; Osteomyelitis; Radiography; Shoulder Joint | 1979 |
Localized osseous cryptococcosis.
Topics: Amphotericin B; Cervical Vertebrae; Cryptococcosis; Flucytosine; Humans; Infant; Male; Osteomyelitis | 1979 |
[Candida coxitis (author's transl)].
Topics: Adult; Amphotericin B; Arthritis, Infectious; Candidiasis; Female; Flucytosine; Hip Joint; Humans; Joint Prosthesis; Sepsis | 1979 |
Candida infected ascites caused by perforated ulcer.
Topics: Aged; Amphotericin B; Ascites; Candidiasis; Flucytosine; Humans; Male; Peptic Ulcer Perforation; Stomach Ulcer | 1979 |
[3 cases of pulmonary aspergillosis].
Topics: Amphotericin B; Aspergillosis, Allergic Bronchopulmonary; Cytosine; Female; Flucytosine; Humans; Imidazoles; Male; Miconazole; Middle Aged | 1979 |
Short-term combination chemotherapy for treatment of feline cryptococcosis.
Topics: Administration, Oral; Amphotericin B; Animals; Cat Diseases; Cats; Cryptococcosis; Drug Therapy, Combination; Female; Flucytosine; Injections, Intravenous | 1979 |
[Present state of antimycotic therapy (author's transl)].
Topics: Amphotericin B; Antifungal Agents; Candidiasis; Child; Flucytosine; Griseofulvin; Humans; Imidazoles; Miconazole; Polyenes; Tinea; Tolnaftate | 1979 |
Comparison of microdilution and broth dilution techniques for the susceptibility testing of yeasts to 5-fluorocytosine and amphotericin B.
Topics: Amphotericin B; Culture Media; Cytosine; Flucytosine; Methods; Microbial Sensitivity Tests; Temperature; Time Factors; Yeasts | 1979 |
Candida infections.
Topics: Amphotericin B; Candidiasis; Candidiasis, Cutaneous; Candidiasis, Oral; Candidiasis, Vulvovaginal; Child; Clotrimazole; Complement C5; Female; Flucytosine; Humans; Immunity, Cellular; Immunologic Deficiency Syndromes; Miconazole; Nystatin | 1979 |
Recalcitrant sporotrichosis: a report of a patient treated with various therapies including oral miconazole and 5-fluorocytosine.
Topics: Administration, Oral; Adult; Amphotericin B; Cautery; Cryosurgery; Curettage; Cytosine; Dermatomycoses; Evaluation Studies as Topic; Flucytosine; Griseofulvin; Hand Dermatoses; Humans; Imidazoles; Male; Miconazole; Potassium Iodide; Sporotrichosis | 1979 |
Fungus balls of the urinary tract.
Topics: Adult; Aged; Amphotericin B; Candidiasis; Diabetes Complications; Female; Flucytosine; Humans; Male; Middle Aged; Urinary Tract Infections | 1979 |
[Therapy of opportunistic mycoses].
Topics: Adult; Amphotericin B; Antifungal Agents; Drug Evaluation; Econazole; Flucytosine; Humans; Miconazole; Mycoses; Nystatin | 1979 |
Treatment of cryptococcal meningitis.
Topics: Amphotericin B; Cryptococcosis; Cytosine; Drug Therapy, Combination; Flucytosine; Humans; Meningitis | 1979 |
Treatment of cryptococcal meningitis.
Topics: Amphotericin B; Cryptococcosis; Cytosine; Drug Therapy, Combination; Flucytosine; Humans; Meningitis | 1979 |
Candida parapsilosis endocarditis: medical and surgical cure.
Topics: Adult; Amphotericin B; Aortic Valve; Candidiasis; Endocarditis; Flucytosine; Humans; Male | 1979 |
The role of chemotherapy in the management of fungal endocaridits following homograft valve replacement.
Topics: Amphotericin B; Endocarditis; Flucytosine; Heart Valves; Humans; Mycoses; Postoperative Complications; Transplantation, Homologous | 1979 |
Pharmacokinetics of amphotericin B and flucytosine.
Topics: Amphotericin B; Animals; Cytosine; Drug Administration Schedule; Flucytosine; Half-Life; Humans; Kinetics; Models, Biological; Rabbits; Renal Dialysis | 1979 |
The effect of antifungal agents on pancreatic and gastric secretion in rats.
Topics: Amphotericin B; Animals; Antifungal Agents; Bile; Body Weight; Female; Flucytosine; Gastric Juice; Griseofulvin; Pancreatic Juice; Rats | 1979 |
[Candidiasis of the central nervous system in an infant cured with mycostatic drugs].
Topics: Amphotericin B; Antifungal Agents; Candidiasis; Drug Therapy, Combination; Female; Flucytosine; Humans; Infant; Meningoencephalitis; Nystatin | 1979 |
Clearance of amphotericin B and 5-fluorocytosine by peritoneal dialysis.
Topics: Amphotericin B; Ascitic Fluid; Cryptococcus; Cytosine; Flucytosine; Humans; Kidney Failure, Chronic; Male; Middle Aged; Mycoses; Peritoneal Dialysis; Peritonitis | 1979 |
Torulopsis glabrata fungaemia. A report of two cases.
Topics: Adult; Amphotericin B; Candida; Drug Therapy, Combination; Flucytosine; Humans; Male; Middle Aged; Mycoses; Sepsis | 1977 |
Disk agar diffusion susceptibility testing of yeasts.
Topics: Amphotericin B; Candida; Clotrimazole; Flucytosine; Miconazole; Microbial Sensitivity Tests; Yeasts | 1978 |
Amphotericin B and 5-fluorocytosine penetration into blood and fibrin clots.
Topics: Amphotericin B; Blood; Blood Platelets; Candida; Cytosine; Embolism; Endocarditis, Bacterial; Fibrin; Flucytosine; Humans; Models, Biological | 1979 |
[Iatrogenic mycoses with deep visceral localization caused by opportunistic fungi].
Topics: Amphotericin B; Candida; Candidiasis; Cryptococcosis; Dermatomycoses; Endocarditis; Flucytosine; Humans; Iatrogenic Disease; Imidazoles; Lung Diseases, Fungal; Mycoses; Nystatin; Osteitis; Sepsis; Urinary Tract Infections | 1979 |
Antifungal agents used for deep-seated mycotic infections.
Topics: Amphotericin B; Candidiasis; Cryptococcosis; Cytosine; Flucytosine; Humans; Stilbamidines | 1977 |
The current status of chemotherapeutic agents for the systemic mycoses.
Topics: Amphotericin B; Antifungal Agents; Blastomycosis; Clotrimazole; Flucytosine; Humans; Miconazole; Mycoses; Potassium Iodide; Sporotrichosis; Stilbamidines | 1977 |
Late onset chronic mucocutaneous candidiasis with lymphoma and specific serum inhibitory factor.
Topics: Amphotericin B; Antibodies, Fungal; Antigens, Fungal; Binding, Competitive; Candidiasis, Oral; Female; Flucytosine; Humans; Immunity; Immunosuppression Therapy; In Vitro Techniques; Lymphocyte Activation; Lymphoma, Non-Hodgkin; Middle Aged | 1979 |
Candida meningitis in the newborn.
Topics: Administration, Oral; Amphotericin B; Arthritis, Infectious; Candidiasis; Cytosine; Drug Therapy, Combination; Flucytosine; Humans; Infant, Newborn; Infant, Newborn, Diseases; Infusions, Parenteral; Injections, Spinal; Male; Meningitis | 1979 |
[Microbiological and clinical aspects of antifungal therapy].
Topics: Amphotericin B; Animals; Antifungal Agents; Arthrodermataceae; Dermatomycoses; Drug Resistance, Microbial; Flucytosine; Fungi; Humans; Miconazole; Mycoses | 1977 |
[Critical remarks to the hospital on antifungal chemotherapy].
Topics: Amphotericin B; Antifungal Agents; Drug Therapy, Combination; Flucytosine; Humans; Imidazoles; Mycoses | 1977 |
Cryptococcal meningitis treated with 5-fluorocytosine and amphotericin B.
Topics: Adolescent; Adult; Amphotericin B; Cryptococcosis; Cytosine; Female; Flucytosine; Humans; Male; Meningitis | 1977 |
Stability of four antifungal antimicrobics in vitro.
Topics: Amphotericin B; Antifungal Agents; Culture Media; Drug Stability; Flucytosine; Miconazole; Time Factors | 1978 |
Cryptococcal meningitis. Fatal marrow aplasia from combined therapy.
Topics: Adult; Amphotericin B; Bone Marrow Diseases; Cryptococcosis; Cytosine; Drug Synergism; Drug Therapy, Combination; Flucytosine; Humans; Male; Meningitis | 1978 |
Successful medical therapy for endocarditis due to Candida parapsilosis. A clinical and epidemiologic study.
Topics: Adult; Amphotericin B; Candida; Candidiasis; Endocarditis; Flucytosine; Humans; Male | 1978 |
Cryptococcosis: survival attributed to combination antifungal treatment.
Topics: Adult; Amphotericin B; Cryptococcosis; Cytosine; Drug Therapy, Combination; Flucytosine; Humans; Male | 1978 |
Turbidimetric studies of growth inhibition of yeasts with three drugs: inquiry into inoculum-dependent susceptibility testing, time of onset of drug effect, and implications for current and newer methods.
Topics: Amphotericin B; Cytosine; Flucytosine; Imidazoles; Miconazole; Microbial Sensitivity Tests; Nephelometry and Turbidimetry; Time Factors; Yeasts | 1978 |
Candida meningitis in newborn infants: a review and report of combined amphotericin B--flucytosine therapy.
Topics: Adolescent; Amphotericin B; Candidiasis; Cytosine; Drug Therapy, Combination; Female; Flucytosine; Follow-Up Studies; Humans; Infant, Newborn; Infant, Newborn, Diseases; Infant, Premature, Diseases; Male; Meningitis; Pregnancy; Psychomotor Disorders | 1978 |
[Combination of amphotericin B and 5-fluorocytosine].
Topics: Amphotericin B; Cytosine; Drug Therapy, Combination; Flucytosine; Humans; Mycoses | 1978 |
Drugs for the treatment of systemic fungal infections.
Topics: Amphotericin B; Clotrimazole; Drug Therapy, Combination; Flucytosine; Humans; Kidney Diseases; Meningitis; Miconazole; Mycoses; Rifampin; Thrombophlebitis | 1978 |
Use of antibiotics. Antifungals.
Topics: Administration, Topical; Amphotericin B; Antifungal Agents; Flucytosine; Griseofulvin; Humans; Imidazoles; Infusions, Parenteral; Polyenes | 1978 |
Susceptibility of Aspergillus to 5-fluorocytosine and amphotericin B alone and in combination.
Topics: Amphotericin B; Aspergillus; Culture Media; Cytosine; Drug Interactions; Drug Resistance, Microbial; Flucytosine; Microbial Sensitivity Tests | 1978 |
[Sensitivity of Candida to 5-fluorocytosine and amphotericin B].
Topics: Amphotericin B; Candida; Cytosine; Drug Resistance, Microbial; Flucytosine; Humans | 1978 |
Antifungal therapy for candidal meningitis.
Topics: Adult; Amphotericin B; Antifungal Agents; Candidiasis; Flucytosine; Humans; Male; Meningitis | 1978 |
Amphotericin B and 5-fluorocytosine: in vitro effects on lymphocyte function.
Topics: Amphotericin B; Cytosine; Flucytosine; Humans; In Vitro Techniques; Lymphocytes | 1978 |
Recognition and successful management in pulmonary aspergillosis in leukemia.
Topics: Adult; Aged; Amphotericin B; Aspergillosis; Female; Flucytosine; Humans; Leukemia; Lung Diseases, Fungal; Male; Middle Aged; Nystatin; Sputum | 1978 |
Disseminated Cryptococcus treated with transfer factor.
Topics: Abscess; Aged; Amphotericin B; Cryptococcosis; Flucytosine; Heart; Humans; Lung Abscess; Male; Remission, Spontaneous; Skin Diseases, Infectious; Transfer Factor | 1978 |
Trichosporon cutaneum endocarditis.
Topics: Amphotericin B; Aortic Valve; Cryptococcosis; Cryptococcus; Endocarditis, Subacute Bacterial; Flucytosine; Heart Valve Prosthesis; Humans; Male; Middle Aged | 1978 |
Chromomycosis caused by Philaphora pedrosoi in eastern Nigeria.
Topics: Adult; Amphotericin B; Chromoblastomycosis; Female; Flucytosine; Humans; Male; Middle Aged; Nigeria; Phialophora | 1978 |
[Candidiasis as a cause of systemic infection (author's transl)].
Topics: Amphotericin B; Candidiasis; Drug Therapy, Combination; Flucytosine; Humans; Intestinal Mucosa | 1978 |
[Systemic candidiasis in surgery. Experience with 10 cases (author's transl)].
Topics: Adolescent; Adult; Aged; Amphotericin B; Candidiasis; Drug Therapy, Combination; Female; Flucytosine; Humans; Male; Middle Aged; Postoperative Complications; Sepsis | 1978 |
Case report: immunosuppressive therapy following Cryptococcal meningitis.
Topics: Adult; Amphotericin B; Cryptococcosis; Female; Flucytosine; Humans; Immunosuppression Therapy; Kidney Transplantation; Meningitis; Postoperative Complications; Recurrence; Time Factors; Transplantation, Homologous | 1976 |
Cryptococcosis after renal transplantation: report of ten cases.
Topics: Adult; Amphotericin B; Brain Diseases; Child; Cryptococcosis; Drug Administration Schedule; Female; Flucytosine; Humans; Immunosuppression Therapy; Kidney Transplantation; Lung Diseases, Fungal; Meningitis; Middle Aged; Postoperative Complications; Pseudotumor Cerebri; Transplantation, Homologous | 1976 |
Simple assay for 5-fluorocytosine in the presence of amphotericin B.
Topics: Amphotericin B; Biological Assay; Candida albicans; Candidiasis; Cryptococcosis; Cytosine; Flucytosine; Hot Temperature; Humans; Meningitis; Saccharomyces cerevisiae | 1976 |
Inhibition of potentially pathogenic yeastlike fungi by clotrimazole in combination with 5-fluorocytosine or amphotericin B.
Topics: Amphotericin B; Candida; Candida albicans; Clotrimazole; Cytosine; Drug Combinations; Flucytosine; Imidazoles; Time Factors | 1976 |
Combination amphotericin B-rifampin therapy for pulmonary aspergillosis in a leukemic patient.
Topics: Amphotericin B; Aspergillosis; Aspergillus fumigatus; Drug Synergism; Flucytosine; Humans; In Vitro Techniques; Leukemia, Myeloid, Acute; Lung Diseases, Fungal; Male; Middle Aged; Radiography; Rifampin | 1976 |
Combined treatment with amphotericin B and flucytosine in severe fungal infections.
Topics: Adult; Aged; Amphotericin B; Candida albicans; Candidiasis; Cytosine; Drug Therapy, Combination; Eye Diseases; Female; Flucytosine; Humans; Male; Middle Aged; Mycoses | 1976 |
Pars plana vitrectomy in the management of endogenous Candida endophthalmitis.
Topics: Adult; Amphotericin B; Candida albicans; Candidiasis; Endophthalmitis; Flucytosine; Humans; Male; Microbial Sensitivity Tests; Ophthalmoscopy; Postoperative Care; Substance-Related Disorders; Vitreous Body | 1976 |
Antimicrobial activity of econazole and miconazole in vitro and in experimental candidiasis and aspergillosis.
Topics: Amphotericin B; Animals; Aspergillosis; Bacillus subtilis; Candida; Candidiasis; Corynebacterium diphtheriae; Cryptococcus neoformans; Drug Evaluation, Preclinical; Flucytosine; Fungi; Imidazoles; In Vitro Techniques; Listeria monocytogenes; Male; Mice; Miconazole; Staphylococcus; Streptococcus | 1976 |
Activity of amphotericin B, 5-fluorocytosine, and rifampin against six clinical isolates of Aspergillus.
Topics: Amphotericin B; Aspergillus; Aspergillus flavus; Aspergillus fumigatus; Cytosine; Flucytosine; Microbial Sensitivity Tests; Rifampin; RNA; Uridine | 1976 |
Fungal endocarditis: need for guidelines in evaluating therapy. Experience with two patients previously reported.
Topics: Adult; Amphotericin B; Aortic Valve Stenosis; Candidiasis; Cytosine; Endocarditis; Flucytosine; Heart Valves; Heroin Dependence; Humans; Male; Miconazole; Middle Aged; Prostheses and Implants; Recurrence; Surgical Wound Infection | 1977 |
[Clinical aspects and therapy of candidiasis in pneumological patients].
Topics: Acidosis; Adult; Aged; Amphotericin B; Candidiasis; Drug Synergism; Drug Therapy, Combination; Female; Flucytosine; Humans; Lung Diseases, Fungal; Male; Mannitol; Middle Aged; Respiratory Insufficiency | 1977 |
Cryptococcal meningitis complicating systemic lupus erythematosus: two patients treated with flucytosine and amphotericin B.
Topics: Amphotericin B; Cryptococcosis; Cytosine; Drug Resistance, Microbial; Drug Therapy, Combination; Female; Flucytosine; Humans; Lupus Erythematosus, Systemic; Meningitis; Middle Aged | 1977 |
Quantitation of amphotericin B with use of high-pressure liquid chromatography.
Topics: Amphotericin B; Animals; Anti-Infective Agents; Biological Assay; Chromatography, High Pressure Liquid; Dogs; Evaluation Studies as Topic; Female; Flucytosine; Humans; Rabbits | 1977 |
Two-year cure of Candida infection of prosthetic mitral valve.
Topics: Amphotericin B; Atrial Fibrillation; Candidiasis; Digoxin; Embolism; Endocarditis; Female; Flucytosine; Heart Valve Prosthesis; Humans; Middle Aged; Mitral Valve; Warfarin | 1977 |
Systemic candidiasis following cardiac surgery: an improved outlook.
Topics: Amphotericin B; Candidiasis; Cardiac Surgical Procedures; Child; Child, Preschool; Female; Flucytosine; Humans; Infant; Male; Postoperative Complications; Prognosis | 1977 |
Cryptococcosis.
Topics: Adult; Amphotericin B; Child; Cryptococcosis; Female; Flucytosine; Humans; Lung Diseases, Fungal; Male; Meningitis; Middle Aged | 1977 |
Treatment of candiduria.
Topics: Amphotericin B; Candidiasis; Cytosine; Drug Resistance, Microbial; Flucytosine; Humans; Rifampin; Urinary Tract Infections | 1977 |
[Diagnosis and treatment of indigenous lung mycoses].
Topics: Amphotericin B; Drug Synergism; Flucytosine; Humans; Lung Diseases, Fungal | 1977 |
Amphotericin B: a second look.
Topics: Amphotericin B; Animals; Drug Administration Schedule; Drug Synergism; Drug Therapy, Combination; Flucytosine; Humans; Kidney Diseases; Mice; Mycoses | 1977 |
[Mycotic endocarditis].
Topics: Amphotericin B; Anti-Bacterial Agents; Aspergillosis; Candidiasis; Cardiac Surgical Procedures; Endocarditis, Bacterial; Flucytosine; Humans; Injections; Postoperative Complications; Substance-Related Disorders | 1977 |
[Problems of Candida meningitis in newborn and nursing infants and their treatment with miconazole].
Topics: Administration, Oral; Amphotericin B; Candidiasis; Flucytosine; Humans; Imidazoles; Infant; Infant, Newborn; Infant, Newborn, Diseases; Meningitis; Miconazole | 1977 |
Cryptococcal eye disease.
Topics: Adolescent; Amphotericin B; Cryptococcosis; Eye Diseases; Flucytosine; Humans; Male | 1977 |
Aspergillus oryzae meningitis.
Topics: Adult; Amphotericin B; Antibodies, Fungal; Aspergillus; Aspergillus oryzae; Cerebrospinal Fluid; Female; Flucytosine; Humans; Meningitis | 1976 |
Treatment of Candida endocarditis and arteritis.
Topics: Adult; Amphotericin B; Aneurysm, Infected; Aortography; Arterial Occlusive Diseases; Arteritis; Candidiasis; Drug Therapy, Combination; Endocarditis; Female; Flucytosine; Gangrene; Humans; Mitral Valve Insufficiency | 1976 |
Inhibition of human neutrophil chemotaxis and chemiluminescence by amphotericin B.
Topics: Amphotericin B; Cells, Cultured; Chemotaxis; Flucytosine; Griseofulvin; Humans; Luminescent Measurements; Miconazole; Neutrophils; Nystatin; Phagocytosis; Zymosan | 1976 |
Combination antifungal therapy for cryptococcal meningitis.
Topics: Adult; Aged; Amphotericin B; Cryptococcosis; Cytosine; Drug Therapy, Combination; Flucytosine; Hodgkin Disease; Humans; Male; Meningitis | 1976 |
Cryptococcosis (torulosis, European blastomycosis) of the knee joint. A case report with review of the literature.
Topics: Adult; Amphotericin B; Cryptococcosis; Female; Flucytosine; Humans; Knee Joint; Radiography; Synovial Membrane; Synovitis | 1976 |
Candida sepsis successfully treated by parenteral administration of 5-fluorocytosine.
Topics: Adult; Amphotericin B; Candidiasis; Cytosine; Flucytosine; Humans; Infusions, Parenteral; Male; Sepsis | 1976 |
Pulmonary sporotrichosis: Treatment with miconazole.
Topics: Amphotericin B; Dose-Response Relationship, Drug; Drug Resistance, Microbial; Drug Therapy, Combination; Flucytosine; Humans; Imidazoles; Lung Diseases, Fungal; Male; Miconazole; Middle Aged; Radiography; Recurrence; Sporothrix; Sporotrichosis | 1976 |
Visceral fungal infections due to Petriellidium boydii (allescheria boydii). In vitro drug sensitivity studies.
Topics: Adult; Aged; Amphotericin B; Ascomycota; Disease Susceptibility; Female; Flucytosine; Humans; Male; Miconazole; Microbial Sensitivity Tests; Middle Aged; Mycoses | 1976 |
Susceptibility of Prototheca species to antifungal agents.
Topics: Amphotericin B; Antifungal Agents; Eukaryota; Flucytosine; Griseofulvin; Miconazole; Nystatin | 1976 |
Successful treatment of Candida meningitis with amphotericin B and 5-fluorocytosine in combination.
Topics: Amphotericin B; Candidiasis; Child; Child, Preschool; Cytosine; Drug Administration Schedule; Drug Therapy, Combination; Female; Flucytosine; Humans; Infant; Male; Meningitis; Microbial Sensitivity Tests | 1976 |
[Therapy of generalized juvenile mycoses].
Topics: Amphotericin B; Antifungal Agents; Child; Clotrimazole; Drug Resistance; Flucytosine; Griseofulvin; Humans; Immunologic Deficiency Syndromes; Miconazole; Mycoses; Nystatin | 1976 |
Genitourinary candidiasis: diagnosis and treatment.
Topics: Amphotericin B; Candida; Candidiasis; Flucytosine; Humans; Nystatin; Radiography; Ureter; Ureteral Obstruction; Urinary Tract Infections; Urine | 1976 |
[Systemic candidiasis in the severely burned patient (author's transl)].
Topics: Adolescent; Adult; Amphotericin B; Antifungal Agents; Burns; Candidiasis; Flucytosine; Humans; Injections, Intravenous; Male; Middle Aged | 1976 |
Torulopsis glabrata endocarditis complicating aortic homograft valve treated with 5-fluorocytosine: case report with discussion of antifungal chemotherapy.
Topics: Amphotericin B; Aortic Valve; Aortic Valve Stenosis; Autopsy; Candida; Candidiasis; Cytosine; Endocarditis; Flucytosine; Humans; Male; Middle Aged; Myocardial Infarction; Myocardium; Postoperative Complications; Transplantation, Homologous | 1975 |
Treatment of chronic muco-cutaneous candidiasis by lymphocyte transfer factor.
Topics: Adolescent; Adult; Amphotericin B; Candidiasis, Cutaneous; Child; Child, Preschool; Chronic Disease; Female; Flucytosine; Humans; Infant; Male; Transfer Factor | 1975 |
Candida endophthalmitis.
Topics: Adult; Amphotericin B; Candidiasis; Endophthalmitis; Flucytosine; Heroin Dependence; Humans; Male | 1975 |
Combined activity of amphotericin B and 5-fluorocytosine against Cryptococcus neoformans in vitro and in vivo in mice.
Topics: Amphotericin B; Animals; Cryptococcosis; Cryptococcus; Cryptococcus neoformans; Cytosine; Disease Models, Animal; Drug Interactions; Drug Resistance, Microbial; Drug Therapy, Combination; Flucytosine; Meningitis; Mice | 1975 |
Amphotericin B. Old drug, new therapy.?2110.
Topics: Adjuvants, Immunologic; Amphotericin B; Animals; Candida albicans; Cell Membrane Permeability; Cryptococcus neoformans; Drug Synergism; Flucytosine; Fungi; Immunity; Mice; Mice, Inbred AKR; Mycoses | 1975 |
Immunologic studies in patients with sarcoidosis and cryptococcosis.
Topics: Amphotericin B; Candida; Cell Count; Cryptococcosis; Cryptococcus neoformans; Dinitrochlorobenzene; Female; Fibula; Flucytosine; Humans; Immunity, Cellular; Immunoglobulin A; Immunoglobulin G; Immunoglobulin M; In Vitro Techniques; Middle Aged; Radiography; Sarcoidosis; Skull; T-Lymphocytes | 1975 |
[Cerebromeningeal cryptococcosis. Predisposing role of immunosuppressive therapy in patients with kidney transplants].
Topics: Adult; Amphotericin B; Brain Diseases; Cerebrospinal Fluid; Cryptococcosis; Cryptococcus neoformans; Female; Flucytosine; Humans; Immunosuppressive Agents; Kidney Transplantation; Lymphoma, Non-Hodgkin; Male; Meningitis; Middle Aged; Postoperative Complications; Sarcoidosis; Transplantation, Homologous | 1975 |
Candida endophthalmitis: report of an unusual case with isolation of the etiologic agent by vitreous biopsy.
Topics: Adolescent; Amphotericin B; Biopsy; Candida albicans; Candidiasis; Cataract; Diagnostic Errors; Eye Diseases; Flucytosine; Heroin Dependence; Humans; Male; Visual Acuity; Vitreous Body | 1975 |
Rapid, simple bioassay for 5-fluorocytosine in the presence of amphotericin B.
Topics: Amphotericin B; Biological Assay; Candida albicans; Cytosine; Flucytosine; Methods | 1975 |
Editoral: Treatment of fungal infections.
Topics: Amphotericin B; Aspergillus; Candida; Candida albicans; Cryptococcus neoformans; Cytosine; Drug Therapy, Combination; Flucytosine; Humans; Microbial Sensitivity Tests; Mycoses | 1975 |
Synergism of amphotericin B and 5-fluorocytosine for candida species.
Topics: Amphotericin B; Candida; Candida albicans; Cytosine; Drug Synergism; Flucytosine | 1975 |
Susceptibility of coccidioides immitis, Candida albicans, and Cryptococcus neoformans to amphotericin B, flucytosine, and clotrimazole.
Topics: Adult; Aged; Amphotericin B; Candida albicans; Child; Child, Preschool; Clotrimazole; Coccidioides; Coccidioidomycosis; Cryptococcus; Cryptococcus neoformans; Cytosine; Drug Resistance, Microbial; Female; Flucytosine; Humans; Imidazoles; Lung Diseases; Male; Microbial Sensitivity Tests; Middle Aged; Pregnancy; Pregnancy Complications, Infectious; Spores, Fungal | 1975 |
[Further experimental data on clotrimazole: effectiveness against Cryptococcus neoformans, Sporothrix schenkii and Blastomyces dermatitidis Gilchrist].
Topics: Amphotericin B; Animals; Blastomyces; Clotrimazole; Cryptococcosis; Cryptococcus; Cryptococcus neoformans; Flucytosine; Imidazoles; Male; Mice; Sporothrix; Sporotrichosis | 1975 |
Mucormycosis in a transplant recipient.
Topics: Adult; Aged; Amphotericin B; Azathioprine; Brain Diseases; Drug Resistance, Microbial; Female; Flucytosine; Humans; Kidney Transplantation; Male; Middle Aged; Mucormycosis; Nose Diseases; Postoperative Complications; Prednisone; Transplantation, Homologous | 1975 |
Cryptococcal meningitis: diagnostic value of cryptococcal antigen in cerebrospinal fluid.
Topics: Adult; Amphotericin B; Antigens, Fungal; Autopsy; Cryptococcosis; Cryptococcus neoformans; Flucytosine; Humans; Male; Meningitis; Middle Aged | 1975 |
Fungal infection following renal transplantation.
Topics: Adolescent; Adult; Amphotericin B; Antibodies, Fungal; Aspergillosis; Bacterial Infections; Candidiasis; Cryptococcosis; Female; Flucytosine; Fungi; Histocompatibility Testing; Humans; Immunosuppression Therapy; Kidney Transplantation; Male; Middle Aged; Mycoses; Nocardia Infections; Phialophora; Postoperative Complications; Retrospective Studies | 1975 |
Diagnosis and treatment of cutaneous fungus diseases.
Topics: Actinomycosis; Amphotericin B; Blastomycosis; Candida albicans; Candidiasis, Cutaneous; Chromoblastomycosis; Coccidioidomycosis; Cryptococcosis; Dermatomycoses; Flucytosine; Griseofulvin; Histoplasmosis; Mucormycosis; Mycetoma; Sporotrichosis; Tinea Capitis; Tinea Pedis; Tinea Versicolor | 1975 |
In vitro studies with combinations of 5-fluorocytosine and amphotericin B.
Topics: Amphotericin B; Candida; Candida albicans; Cryptococcus neoformans; Cytosine; Drug Synergism; Flucytosine; Microbial Sensitivity Tests; Yeasts | 1975 |
Letter: Amphotericin B and 5-fluorocytosine.
Topics: Amphotericin B; Animals; Cryptococcosis; Cryptococcus; Cryptococcus neoformans; Cytosine; Drug Synergism; Flucytosine; Humans; Mice | 1975 |
Bilateral renal aspergillosis.
Topics: Adult; Amphotericin B; Aspergillosis; Drug Synergism; Flucytosine; Humans; Kidney Diseases; Male; Rifampin; Therapeutic Irrigation | 1975 |
Letter: Another case of disseminated candidiasis.
Topics: Amphotericin B; Candidiasis; Central Nervous System; Cerebrospinal Fluid Shunts; Cytosine; Female; Flucytosine; Humans; Hydrocephalus; Infant; Knee Joint | 1975 |
[Treatment of respiratory mycoses (author's transl)].
Topics: Amphotericin B; Antifungal Agents; Flucytosine; Humans; Lung Diseases, Fungal; Respiratory Therapy | 1975 |
New antifungal drugs.
Topics: Amphotericin B; Antifungal Agents; Chlorobenzenes; Clotrimazole; Flucytosine; Humans; Imidazoles; Mebendazole; Metronidazole; Miconazole; Mycoses; Thiabendazole; Tinidazole | 1975 |
[Diffuse chronic mucocutaneous candidiasis: Effects of antimycotics in vitro].
Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis, Cutaneous; Candidiasis, Oral; Child; Chronic Disease; Dose-Response Relationship, Drug; Drug Resistance, Microbial; Female; Flucytosine; Fluorouracil; Humans; Hypersensitivity, Delayed; Immunologic Deficiency Syndromes; Immunotherapy; Lymphocyte Activation; Microbial Sensitivity Tests; Nystatin; Skin Diseases; Staphylococcal Infections | 1975 |
Letter: Candida endocarditis.
Topics: Amphotericin B; Candidiasis; Endocarditis; Flucytosine; Humans | 1975 |
Invasive fungal infection in the immunosuppressed host.
Topics: Amphotericin B; Anti-Bacterial Agents; Aspergillosis; Candidiasis; Clotrimazole; Cryptococcosis; Flucytosine; Humans; Immunity, Cellular; Immunosuppression Therapy; Immunosuppressive Agents; Leukocytes; Mucormycosis; Mycoses | 1975 |
Cryptococcal meningitis. Report on case successfully treated with 5-fluorocytosine.
Topics: Administration, Oral; Adult; Amphotericin B; Cryptococcosis; Cytosine; Flucytosine; Humans; Male; Meningitis | 1975 |
Letter: Treatment of fungal infections.
Topics: Amphotericin B; Candidiasis; Cryptococcosis; Cytosine; Drug Therapy, Combination; Flucytosine; Humans | 1975 |
Therapeutic usefulness. 5-Fluorocytosine--a new anti-fungal agent.
Topics: Adult; Aged; Amphotericin B; Candida; Cryptococcosis; Cytosine; Drug Therapy, Combination; Female; Flucytosine; Humans; Lung Diseases, Fungal; Male; Mycoses | 1975 |
Sensitivity of some human pathogenic yeasts and systemic fungi to myxin.
Topics: Amphotericin B; Antifungal Agents; Blastomyces; Candida; Coccidioides; Flucytosine; In Vitro Techniques; Microbial Sensitivity Tests; Spectrophotometry; Sporothrix | 1975 |
Fungal endocarditis: analysis of 24 cases and review of the literature.
Topics: Adolescent; Adult; Aged; Amphotericin B; Aspergillosis; Candida; Candidiasis; Cardiac Surgical Procedures; Endocarditis; Female; Fever; Flucytosine; Heart Valve Prosthesis; Heroin Dependence; Humans; Male; Middle Aged; Mycoses; Postoperative Complications | 1975 |
Actions and uses of antimicrobial agents in the treatment of musculoskeletal infections.
Topics: Aminoglycosides; Amphotericin B; Anti-Bacterial Agents; Bone Diseases; Cephalosporins; Chloramphenicol; Clindamycin; Erythromycin; Flucytosine; Humans; Infections; Lincomycin; Muscular Diseases; Nystatin; Penicillins; Tetracyclines | 1975 |
[Current problems and new developments in therapy of mycoses (author's transl)].
Topics: Amphotericin B; Antifungal Agents; Candidiasis; Clotrimazole; Cryptococcosis; Dermatomycoses; Drug Resistance, Microbial; Flucytosine; Fungi; Griseofulvin; Humans; Miconazole; Mycoses | 1975 |
Therapy of cryptococcosis with a combination of flucytosine and amphotericin B.
Topics: Adult; Aged; Amphotericin B; Cryptococcosis; Cytosine; Drug Therapy, Combination; Female; Flucytosine; Hematologic Diseases; Humans; Kidney; Male; Meningitis; Middle Aged; Prospective Studies | 1975 |
Candida endocarditis treated with a combination of antifungal chemotherapy and aortic valve replacement.
Topics: Amphotericin B; Aortic Valve; Candidiasis; Endocarditis; Flucytosine; Heart Valve Prosthesis; Humans; Male; Middle Aged | 1975 |
Wound infection by Prototheca wickerhamii, a saprophytic alga pathogenic for man.
Topics: Adult; Amphotericin B; Anti-Bacterial Agents; Diabetes Complications; Drug Resistance, Microbial; Dupuytren Contracture; Eukaryota; Fascia; Female; Flucytosine; Hand; Humans; Spores; Surgical Wound Infection | 1975 |
Sensitivity of Scopulariopsis brevicaulis to some antimicrobial agents.
Topics: Amphotericin B; Anti-Infective Agents; Chloramphenicol; Clotrimazole; Drug Resistance, Microbial; Drug Synergism; Flucytosine; Mitosporic Fungi | 1975 |
[Amphotericin-B and 5-fluorocytosine in the treatment of cryptococcosis of the central nervous system].
Topics: Adult; Amphotericin B; Cryptococcosis; Cytosine; Drug Evaluation; Drug Therapy, Combination; Encephalitis; Flucytosine; Humans; Injections, Intravenous; Injections, Spinal; Male | 1975 |
[Therapeutic use of antimycotic substances].
Topics: Amphotericin B; Anti-Bacterial Agents; Antifungal Agents; Burns; Cardiac Surgical Procedures; Catheterization; Clotrimazole; Flucytosine; Humans; Immunologic Deficiency Syndromes; Immunosuppression Therapy; Miconazole; Mycoses | 1976 |
[Identification and special treatment of generalized mycoses].
Topics: Amphotericin B; Clotrimazole; Flucytosine; Humans; Mycoses | 1976 |
Letter: Vaginal candidosis.
Topics: Amphotericin B; Candidiasis, Vulvovaginal; Drug Resistance, Microbial; Female; Flucytosine; Humans | 1976 |
Disseminated candidiasis due to amphotericin B-resistant Candida albicans.
Topics: Abscess; Adult; Amphotericin B; Candida albicans; Candidiasis; Drug Resistance, Microbial; Flucytosine; Humans; Male; Microbial Sensitivity Tests; Pancreatic Diseases | 1992 |
In vitro susceptibility and synergy studies of Aspergillus species to conventional and new agents.
Topics: Amphotericin B; Antifungal Agents; Aspergillus; Azoles; Drug Antagonism; Drug Resistance, Microbial; Drug Synergism; Flucytosine; Itraconazole; Ketoconazole; Miconazole; Microbial Sensitivity Tests | 1992 |
Drugs for treatment of fungal infections.
Topics: Amphotericin B; Antifungal Agents; Drug Interactions; Fluconazole; Flucytosine; Humans; Itraconazole; Ketoconazole; Mycoses; Opportunistic Infections | 1992 |
In vitro antifungal spectrum of itraconazole and treatment of systemic mycoses with old and new antimycotic agents.
Topics: Amphotericin B; Animals; Antifungal Agents; Aspergillosis; Candidiasis; Cryptococcosis; Drug Therapy, Combination; Fluconazole; Flucytosine; Guinea Pigs; Immunocompromised Host; Itraconazole; Ketoconazole; Microbial Sensitivity Tests; Mycoses; Sporotrichosis | 1992 |
Comparative study of six antifungal treatments in an experimental model of murine cryptococcosis.
Topics: Amphotericin B; Animals; Antifungal Agents; Cryptococcosis; Cryptococcus neoformans; Disease Models, Animal; Drug Administration Schedule; Drug Therapy, Combination; Fluconazole; Flucytosine; Itraconazole; Ketoconazole; Mice; Mice, Inbred BALB C; Triazoles | 1992 |
Ventriculitis and hydrocephalus caused by Candida albicans successfully treated by antimycotic therapy and cerebrospinal fluid shunting.
Topics: Adolescent; Amphotericin B; Antifungal Agents; Brain Abscess; Candidiasis; Cerebral Ventricles; Cerebrospinal Fluid; Combined Modality Therapy; Drug Therapy, Combination; Female; Flucytosine; Humans; Hydrocephalus; Itraconazole; Ketoconazole; Ventriculoperitoneal Shunt | 1992 |
In vitro susceptibility of 245 yeast isolates to amphotericin B, 5-fluorocytosine, ketoconazole, fluconazole and itraconazole.
Topics: Amphotericin B; Antifungal Agents; Candida; Fluconazole; Flucytosine; Itraconazole; Ketoconazole; Microbial Sensitivity Tests; Species Specificity | 1992 |
Itraconazole in cryptococcal meningitis in pregnancy: a case report.
Topics: Adult; Amphotericin B; Antifungal Agents; Female; Flucytosine; Humans; Infant, Newborn; Itraconazole; Ketoconazole; Meningitis, Cryptococcal; Pregnancy; Pregnancy Complications, Infectious | 1992 |
Amphotericin B-resistant Candida albicans.
Topics: Amphotericin B; Candida albicans; Candidiasis; Drug Resistance, Microbial; Flucytosine; Humans; Miconazole; Microbial Sensitivity Tests; Treatment Outcome | 1992 |
In vitro activity of cloconazole, sulconazole, butoconazole, isoconazole, fenticonazole, and five other antifungal agents against clinical isolates of Candida albicans and Candida spp.
Topics: Amphotericin B; Antifungal Agents; Candida; Candida albicans; Econazole; Flucytosine; Imidazoles; Ketoconazole; Miconazole; Microbial Sensitivity Tests | 1992 |
Cryptococcal meningitis in systemic lupus erythematosus.
Topics: Adult; Amphotericin B; Cryptococcus; Female; Flucytosine; Humans; Lupus Erythematosus, Systemic; Meningitis, Cryptococcal; Prednisone | 1992 |
Meningitis due to Prototheca wickerhamii in a patient with AIDS.
Topics: Adult; AIDS-Related Opportunistic Infections; Amphotericin B; Cerebrospinal Fluid; Cryptococcosis; Cryptococcus neoformans; Female; Flucytosine; Humans; Meningitis; Meningitis, Fungal; Prototheca | 1992 |
Evaluation of antifungal activity of antimycotics by automatic analyzing system.
Topics: Amphotericin B; Antifungal Agents; Antimycin A; Aspergillus niger; Ciclopirox; Flucytosine; Fungi; Griseofulvin; Image Processing, Computer-Assisted; Ketoconazole; Nystatin; Pyridones; Sodium Chloride | 1992 |
Cryptococcal osteomyelitis and cellular immunodeficiency associated with interleukin-2 deficiency.
Topics: Adolescent; Amphotericin B; Cryptococcosis; Drug Therapy, Combination; Flucytosine; HLA Antigens; Humans; Hypersensitivity, Delayed; Immunity, Cellular; Immunologic Deficiency Syndromes; Interleukin-2; Lymphocyte Activation; Lymphocyte Subsets; Male; Osteomyelitis; Scapula | 1992 |
[Factors affecting prognosis of cryptococcal meningitis].
Topics: Adolescent; Adult; Age Factors; Amphotericin B; Cerebrospinal Fluid Pressure; Child; Child, Preschool; Female; Flucytosine; Humans; Infant; Male; Meningitis, Cryptococcal; Middle Aged; Prognosis | 1992 |
Acute and chronic effects of flucytosine on amphotericin B nephrotoxicity in rats.
Topics: Amphotericin B; Animals; Disease Models, Animal; Drug Combinations; Drug Interactions; Flucytosine; Kidney Diseases; Kidney Function Tests; Male; Rats; Rats, Sprague-Dawley; Renal Circulation | 1992 |
Comparative studies on the postantifungal effect produced by the synergistic interaction of flucytosine and amphotericin B on Candida albicans.
Topics: Amphotericin B; Candida albicans; Drug Synergism; Flucytosine; Microbial Sensitivity Tests; Nephelometry and Turbidimetry; Time Factors | 1992 |
[Comparative study of two systems for the determination of the sensitivity of yeasts to antifungal agents].
Topics: Amphotericin B; Antifungal Agents; Candida; Candida albicans; Flucytosine; In Vitro Techniques; Ketoconazole; Miconazole; Microbial Sensitivity Tests | 1992 |
Treatment of cerebral aspergillosis after liver transplantation.
Topics: Amphotericin B; Aspergillosis; Aspergillus fumigatus; Brain Diseases; Combined Modality Therapy; Flucytosine; Humans; Liver Transplantation; Male; Middle Aged; Opportunistic Infections | 1992 |
Candida albicans purulent pericarditis treated successfully without surgical drainage.
Topics: Amphotericin B; Candidiasis; Drainage; Drug Therapy, Combination; Flucytosine; Humans; Male; Middle Aged; Penicillins; Pericarditis | 1992 |
Systemic candidal infections in neonates.
Topics: Amphotericin B; Candidiasis; Drug Therapy, Combination; Flucytosine; Fungemia; Humans; Infant, Newborn | 1992 |
Isolated ocular cryptococcosis in an immunocompetent patient.
Topics: Amphotericin B; Cryptococcosis; Cryptococcus neoformans; Eye Infections, Fungal; Female; Flucytosine; Fluorescein Angiography; Fundus Oculi; Humans; Immunocompromised Host; Middle Aged; Retinal Diseases; Visual Acuity | 1992 |
[Fluconazole treatment of cryptococcal meningitis associated with HIV infection. Presentation of 4 cases].
Topics: Administration, Oral; Adult; Amphotericin B; Drug Therapy, Combination; Female; Fluconazole; Flucytosine; Follow-Up Studies; HIV Infections; Humans; Length of Stay; Male; Meningitis, Cryptococcal; Time Factors | 1992 |
Effect of cilofungin on phagocytosis and intracellular killing of Candida albicans by human neutrophils.
Topics: Amphotericin B; Antifungal Agents; Candida albicans; Echinocandins; Flucytosine; Humans; Microscopy; Neutrophils; Peptides; Peptides, Cyclic; Phagocytosis | 1992 |
[Cryptococcosis: presentation of 26 cases].
Topics: Acquired Immunodeficiency Syndrome; Adult; Aged; Aged, 80 and over; Amphotericin B; Antigens, Fungal; Cryptococcosis; Cryptococcus; Female; Flucytosine; Humans; Male; Middle Aged; Opportunistic Infections; Retrospective Studies | 1992 |
[Comment on the contribution by A. Krupp and K. G. Ravens: "Foudroyant course of generalized cryptococcosis with no signs of immune compromise"].
Topics: Amphotericin B; Drug Therapy, Combination; Flucytosine; Humans; Immunocompromised Host; Meningitis, Cryptococcal | 1992 |
Raised intracranial pressure and visual complications in AIDS patients with cryptococcal meningitis.
Topics: Acquired Immunodeficiency Syndrome; Adult; Amphotericin B; Blindness; Cranial Nerve Diseases; Cryptococcus neoformans; Female; Flucytosine; Humans; Intracranial Pressure; Male; Meningitis, Cryptococcal; Middle Aged; Papilledema; Uganda | 1992 |
Cryptococcal meningitis: outcome in patients with AIDS and patients with neoplastic disease.
Topics: Acquired Immunodeficiency Syndrome; Adult; Amphotericin B; Antifungal Agents; Drug Therapy, Combination; Female; Flucytosine; Follow-Up Studies; Humans; Male; Meningitis, Cryptococcal; Middle Aged; Neoplasms; Opportunistic Infections; Prognosis; Retrospective Studies; Treatment Outcome | 1992 |
Pancoast's syndrome due to pulmonary infection with Cryptococcus neoformans variety gattii.
Topics: Adult; Amphotericin B; Antigens, Fungal; Cryptococcosis; Cryptococcus neoformans; Drug Therapy, Combination; Flucytosine; Horner Syndrome; Humans; Lung; Lung Diseases, Fungal; Male; Pancoast Syndrome; Serotyping; Tomography, X-Ray Computed | 1992 |
Fluconazole: a position statement by the Society of Infectious Diseases Pharmacists.
Topics: Amphotericin B; Candidiasis; Drug Interactions; Fluconazole; Flucytosine; Humans; Meningitis, Cryptococcal; Societies, Pharmaceutical | 1992 |
[Studies on the effect of combination of amphotericin B and flucytosine on Candida albicans by flow cytometry].
Topics: Amphotericin B; Candida albicans; Drug Therapy, Combination; Flow Cytometry; Flucytosine; Methods | 1992 |
[Cryptococcosis in AIDS patients: a study of 19 cases].
Topics: Acquired Immunodeficiency Syndrome; Adult; Amphotericin B; Cryptococcosis; Cryptococcus neoformans; Drug Therapy, Combination; Female; Fluconazole; Flucytosine; HIV-1; Homosexuality; Humans; Male; Meningitis, Cryptococcal; Middle Aged; Opportunistic Infections; Substance Abuse, Intravenous | 1992 |
Cavitary pulmonary cryptococcosis complicating Churg-Strauss vasculitis.
Topics: Amphotericin B; Churg-Strauss Syndrome; Cryptococcosis; Drug Therapy, Combination; Flucytosine; Humans; Lung; Lung Diseases, Fungal; Male; Middle Aged; Radiography | 1992 |
Suppressive therapy for cryptococcal meningitis.
Topics: Amphotericin B; Drug Therapy, Combination; Fluconazole; Flucytosine; Humans; Meningitis, Cryptococcal; Recurrence | 1992 |
Spectrum of in vitro antifungal activity of ditiocarb sodium.
Topics: Amphotericin B; Antifungal Agents; Arthrodermataceae; Ditiocarb; Drug Synergism; Flucytosine; Fungi; Microbial Sensitivity Tests; Yeasts | 1991 |
In vitro comparison of cilofungin alone and in combination with other antifungal agents against clinical isolates of Candida species.
Topics: Amphotericin B; Antifungal Agents; Candida; Candida albicans; Drug Therapy, Combination; Echinocandins; Flucytosine; Itraconazole; Ketoconazole; Microbial Sensitivity Tests; Peptides; Peptides, Cyclic | 1991 |
Candida zeylanoides: another opportunistic yeast.
Topics: Amphotericin B; Candida; Catheterization, Central Venous; DNA, Fungal; Drug Resistance, Microbial; Electrophoresis, Polyacrylamide Gel; Female; Fluconazole; Flucytosine; Humans; Ketoconazole; Microbial Sensitivity Tests; Middle Aged; Parenteral Nutrition, Total; Polymorphism, Restriction Fragment Length | 1991 |
Cryptococcal meningitis in a child with systemic lupus erythematosus.
Topics: Amphotericin B; Azathioprine; Cerebrospinal Fluid; Child; Cryptococcosis; Diagnosis, Differential; Female; Flucytosine; Humans; Lupus Erythematosus, Systemic; Meningitis; Prednisolone | 1990 |
Fungal keratitis associated with contact lens wear after penetrating keratoplasty.
Topics: Aged; Amphotericin B; Candida; Candidiasis; Contact Lenses; Cornea; Eye Infections, Fungal; Female; Flucytosine; Humans; Keratitis; Keratoplasty, Penetrating; Postoperative Complications | 1991 |
[Cryptococcal meningitis in AIDS: successful long-term prophylaxis with fluconazole].
Topics: Acquired Immunodeficiency Syndrome; Adult; Amphotericin B; Antigens, Bacterial; Cryptococcus; Drug Therapy, Combination; Fluconazole; Flucytosine; Humans; Male; Meningitis, Cryptococcal; Opportunistic Infections; Recurrence; Time Factors; Zidovudine | 1991 |
Noninvasive medical management of fungus ball uropathy in a premature infant.
Topics: Amphotericin B; Candidiasis; Diuresis; Flucytosine; Humans; Hydronephrosis; Infant, Newborn; Infant, Premature, Diseases; Kidney; Male; Ultrasonography; Ureteral Obstruction | 1991 |
[Meningitis caused by Candida albicans in a male patient infected by HIV and failure of treatment with amphotericin B].
Topics: Acquired Immunodeficiency Syndrome; Adult; Amphotericin B; Candidiasis; Drug Therapy, Combination; Flucytosine; Humans; Immunocompromised Host; Ketoconazole; Male; Meningitis, Fungal | 1991 |
[Comparative study of the therapy of Candida esophagitis in HIV-1-infected patients with fluconazole or amphotericin B and flucytosine].
Topics: Amphotericin B; Candidiasis; Drug Therapy, Combination; Esophagitis; Female; Fluconazole; Flucytosine; HIV Infections; HIV-1; Humans; Male | 1991 |
Successful treatment of focal hepatic candidiasis in a patient with acute myeloid leukaemia.
Topics: Adult; Amphotericin B; Candidiasis; Drug Therapy, Combination; Female; Flucytosine; Humans; Leukemia, Myeloid, Acute; Liver Diseases; Remission Induction; Tomography, X-Ray Computed; Ultrasonography | 1991 |
Systemic neonatal candidiasis.
Topics: Amphotericin B; Bacterial Infections; Birth Weight; Candidiasis; Cross Infection; Drug Therapy, Combination; Flucytosine; Humans; Infant, Newborn; Intensive Care Units, Neonatal; Retrospective Studies | 1991 |
Hepatosplenic candidiasis: successful treatment with fluconazole.
Topics: Acute Disease; Adolescent; Adult; Amphotericin B; Candidiasis; Child; Child, Preschool; Fluconazole; Flucytosine; Humans; Leukemia; Liver Diseases; Remission Induction; Splenic Diseases; Tomography, X-Ray Computed | 1991 |
Successful medical treatment of presumed Candida endocarditis in critically ill infants.
Topics: Amphotericin B; Candidiasis; Drug Therapy, Combination; Endocarditis; Female; Flucytosine; Humans; Infant; Male | 1991 |
Cost implications of alternative treatments for AIDS patients with cryptococcal meningitis. Comparison of fluconazole and amphotericin B-based therapies.
Topics: Acquired Immunodeficiency Syndrome; Administration, Oral; Amphotericin B; Costs and Cost Analysis; Cryptococcosis; Delphi Technique; Drug Therapy, Combination; Fluconazole; Flucytosine; Hospitalization; Humans; Infusions, Intravenous; Meningitis; Models, Theoretical; Surveys and Questionnaires | 1991 |
Aspergillus osteomyelitis of the spine.
Topics: Adult; Amphotericin B; Aspergillosis; Aspergillus fumigatus; Flucytosine; Humans; Male; Middle Aged; Osteomyelitis; Radiography; Spinal Diseases | 1991 |
Phaeohyphomycotic brain abscess due to Ochroconis gallopavum in a patient with malignant lymphoma of a large cell type.
Topics: Amphotericin B; Brain; Brain Abscess; Fluconazole; Flucytosine; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Mitosporic Fungi; Mycoses; United States | 1991 |
Treatment of cryptococcal meningitis with five anti-fungal drugs: the role of amphotericin B.
Topics: Amphotericin B; Antifungal Agents; Cryptococcosis; Cryptococcus neoformans; Drug Therapy, Combination; Female; Fluconazole; Flucytosine; Humans; Itraconazole; Ketoconazole; Male; Meningitis; Miconazole; Middle Aged | 1990 |
Chronic Alternaria alternata endophthalmitis following intraocular lens implantation.
Topics: Aged; Alternaria; Amphotericin B; Endophthalmitis; Eye Infections, Fungal; Female; Flucytosine; Humans; Lenses, Intraocular; Retinal Detachment; Visual Acuity; Vitrectomy; Vitreous Body | 1991 |
In vitro susceptibility of 119 yeast isolates to fluconazole, 5-fluorocytosine, amphotericin B and ketoconazole.
Topics: Amphotericin B; Candida; Cryptococcus neoformans; Culture Media; Fluconazole; Flucytosine; Ketoconazole; Microbial Sensitivity Tests; Saccharomyces cerevisiae; Species Specificity; Yeasts | 1991 |
Histoplasma capsulatum infection associated with continuous ambulatory peritoneal dialysis.
Topics: Amphotericin B; Fluconazole; Flucytosine; Histoplasma; Histoplasmosis; Humans; Kidney Failure, Chronic; Male; Middle Aged; Peritoneal Dialysis, Continuous Ambulatory | 1991 |
Successful treatment of Prototheca peritonitis complicating continuous ambulatory peritoneal dialysis.
Topics: Amphotericin B; Diabetes Mellitus, Type 1; Fluconazole; Flucytosine; Humans; Infections; Male; Middle Aged; Peritoneal Dialysis, Continuous Ambulatory; Peritonitis; Prototheca | 1991 |
Candida tropicalis and Candida albicans fungemia in children with leukemia.
Topics: Adolescent; Adult; Amphotericin B; Candida; Candida albicans; Candidiasis; Child; Child, Preschool; Flucytosine; Humans; Infant; Pediatrics; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Rifampin; Risk Factors; Tomography, X-Ray Computed | 1991 |
Combined therapy with fluconazole and flucytosine in murine cryptococcal meningitis.
Topics: Amphotericin B; Animals; Chromatography, Gas; Cryptococcosis; Drug Therapy, Combination; Fluconazole; Flucytosine; Meningitis; Mice; Mice, Inbred BALB C | 1991 |
[Drug therapy of intractable mycoses].
Topics: Administration, Oral; Amphotericin B; Aspergillosis; Candidiasis; Cryptococcosis; Fluconazole; Flucytosine; Humans; Infusions, Intravenous; Lung Diseases, Fungal; Miconazole; Mycoses | 1990 |
Clinical and experimental mycotic keratitis caused by Aspergillus terreus and the effect of subconjunctival oxiconazole treatment in the animal model.
Topics: Amphotericin B; Animals; Antifungal Agents; Aspergillosis; Aspergillus; Corneal Ulcer; Disease Models, Animal; Female; Flucytosine; Humans; Imidazoles; Ketoconazole; Male; Middle Aged; Morpholines; Rabbits | 1990 |
[Pathomorphological estimation of models of mouse Candida infection induced by intravenous or intracerebral contamination].
Topics: Amphotericin B; Animals; Antifungal Agents; Brain; Candidiasis; Colony Count, Microbial; Disease Models, Animal; Flucytosine; Injections; Injections, Intravenous; Mice; Polyenes | 1990 |
[In vitro sensitivity to 5-fluorocytosine and amphotericin B of yeasts of the Candida genus isolated in Barcelona].
Topics: Amphotericin B; Candida; Drug Resistance, Microbial; Flucytosine; Hospitals; Humans; Microbial Sensitivity Tests; Spain | 1990 |
[Fatal catheter septicemia with finding of Candida lusitaniae].
Topics: Aged; Amphotericin B; Candidiasis; Catheterization, Central Venous; Flucytosine; Humans; Male; Parenteral Nutrition, Total; Sepsis | 1990 |
[Endophthalmitis due to Fusarium: an uncommon cause].
Topics: Adult; Amphotericin B; Endophthalmitis; Female; Flucytosine; Fusarium; Humans; Mycoses; Vitrectomy | 1990 |
Effects of preventive, early, and late antifungal chemotherapy with fluconazole in different granulocytopenic models of experimental disseminated candidiasis.
Topics: Acute Disease; Agranulocytosis; Amphotericin B; Animals; Candidiasis; Chronic Disease; Disease Models, Animal; Female; Fluconazole; Flucytosine; Kidney; Liver; Rabbits; Specific Pathogen-Free Organisms | 1990 |
False aneurysm infected by Aspergillus fumigatus: an unusual complication of aortofemoral bypass graft.
Topics: Amphotericin B; Aneurysm, Infected; Antifungal Agents; Aorta, Abdominal; Aspergillosis; Aspergillus fumigatus; Blood Vessel Prosthesis; Femoral Artery; Flucytosine; Humans; Itraconazole; Ketoconazole; Male; Middle Aged | 1990 |
Endogenous Candida endophthalmitis. Management without intravenous amphotericin B.
Topics: Adult; Aged; Amphotericin B; Candida; Candida albicans; Candidiasis; Endophthalmitis; Eye Infections, Fungal; Female; Flucytosine; Humans; Ketoconazole; Male; Middle Aged; Prognosis; Visual Acuity; Vitrectomy; Vitreous Body | 1990 |
[Cryptococcosis in Bujumbura, Burundi. Apropos of 80 observed cases in 42 months].
Topics: Acquired Immunodeficiency Syndrome; Adult; Aged; Amphotericin B; Burundi; Cryptococcosis; Drug Therapy, Combination; Female; Flucytosine; Humans; Male; Middle Aged; Retrospective Studies | 1990 |
[A successfully treated case of infective endocarditis due to Candida tropicalis].
Topics: Adult; Amphotericin B; Candida; Candidiasis; Drug Therapy, Combination; Endocarditis; Flucytosine; Heart Valve Prosthesis; Humans; Male; Mitral Valve | 1990 |
Fatal mucormycosis presenting as an appendiceal mass with metastatic spread to the liver during chemotherapy-induced granulocytopenia.
Topics: Adult; Agranulocytosis; Amphotericin B; Appendix; Cecal Diseases; Female; Flucytosine; Humans; Injections, Intravenous; Liver Diseases; Mucormycosis; Opportunistic Infections; Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1990 |
Effects of incubation temperature, inoculum size, and medium on agreement of macro- and microdilution broth susceptibility test results for yeasts.
Topics: Amphotericin B; Candida; Culture Media; Flucytosine; Ketoconazole; Microbial Sensitivity Tests; Temperature; Triazoles; Yeasts | 1990 |
The value of serum cryptococcal antigen in the diagnosis of cryptococcal infection in patients infected with the human immunodeficiency virus.
Topics: Amphotericin B; Antigens, Fungal; Cryptococcosis; Cryptococcus neoformans; Flucytosine; HIV Infections; Humans; Meningitis; Recurrence | 1990 |
Aspergillus osteomyelitis in a child treated for acute lymphoblastic leukemia.
Topics: Amphotericin B; Aspergillosis; Child; Femur; Flucytosine; Humans; Male; Osteomyelitis; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Rifampin | 1990 |
Treating systemic fungal infections in AIDS patients. Prolonging life against the odds.
Topics: Acquired Immunodeficiency Syndrome; Amphotericin B; Antifungal Agents; Azoles; Candidiasis; Cryptococcosis; Flucytosine; Histoplasmosis; Humans; Meningitis; Mycoses | 1990 |
[Successful drug therapy in Aspergillus endocarditis].
Topics: Aged; Amphotericin B; Amputation, Surgical; Aortic Valve; Aspergillosis; Aspergillus fumigatus; Combined Modality Therapy; Dermatomycoses; Drug Therapy, Combination; Endocarditis; Fingers; Flucytosine; Hand Dermatoses; Heart Valve Diseases; Humans; Male | 1990 |
Is cryptococcal meningoencephalitis in the tropics a distinct entity? A retrospective study from Thailand.
Topics: Adolescent; Adult; Amphotericin B; Cryptococcosis; Cryptococcus neoformans; Female; Flucytosine; Humans; Immune Tolerance; Male; Meningoencephalitis; Middle Aged; Prognosis; Retrospective Studies; Thailand | 1990 |
Fluconazole success after amphotericin B and flucytosine failure in cryptococcal meningitis.
Topics: Adult; Amphotericin B; Cryptococcosis; Fluconazole; Flucytosine; Humans; Male; Meningitis | 1990 |
[Antifungal agents].
Topics: Administration, Oral; Amphotericin B; Fluconazole; Flucytosine; Humans; Infusions, Intravenous; Injections, Intraventricular; Injections, Spinal; Miconazole; Mycoses | 1990 |
Percutaneous nephrostomy drainage in the management of neonatal anuria secondary to renal candidiasis.
Topics: Amphotericin B; Anuria; Bezoars; Candidiasis; Drainage; Flucytosine; Humans; Infant, Newborn; Infant, Premature, Diseases; Kidney Diseases; Male; Nephrostomy, Percutaneous | 1990 |
Renal stone formation following medical treatment of renal candidiasis.
Topics: Amphotericin B; Candidiasis; Female; Flucytosine; Humans; Infant; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Kidney Calculi; Kidney Diseases | 1990 |
In vitro susceptibility testing of Candida isolates from clinical specimens to four antifungal agents.
Topics: Amphotericin B; Candida; Drug Evaluation; Fluconazole; Flucytosine; Miconazole; Microbial Sensitivity Tests; Species Specificity | 1990 |
Chronic mucocutaneous candidiasis in childhood and complications of non-Candida infection: a report of the Pediatric Immunodeficiency Collaborative Study Group.
Topics: Adolescent; Amphotericin B; Autoimmune Diseases; Candidiasis; Candidiasis, Chronic Mucocutaneous; Child; Child, Preschool; Endocrine System Diseases; Family; Female; Flucytosine; Humans; Immunoglobulin A; Immunoglobulin G; Incidence; Infant; Infections; Ketoconazole; Lung Diseases; Male; Survival Rate | 1990 |
Pharmacokinetics, outcome of treatment, and toxic effects of amphotericin B and 5-fluorocytosine in neonates.
Topics: Amphotericin B; Candidiasis; Flucytosine; Gestational Age; Humans; Infant, Low Birth Weight; Infant, Newborn; Infant, Premature; Kidney; Mycoses; Prognosis | 1990 |
First report of chronic meningitis caused by Trichosporon beigelii.
Topics: Adolescent; Amphotericin B; Chronic Disease; Drug Therapy, Combination; Fluconazole; Flucytosine; Humans; Male; Meningitis; Mycoses; Opportunistic Infections; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Trichosporon | 1990 |
Two cases of disseminated Trichosporon beigelii infection treated with combination antifungal therapy.
Topics: Adult; Amphotericin B; Drug Combinations; Flucytosine; Humans; Leukemia, Myeloid, Acute; Lymphoma, Non-Hodgkin; Male; Miconazole; Mycoses; Norfloxacin; Trichosporon | 1990 |
Cryptococcal choroiditis.
Topics: Acquired Immunodeficiency Syndrome; Adult; Amphotericin B; Antigens, Fungal; Choroiditis; Cryptococcosis; Eye Infections, Fungal; Flucytosine; Fluorescein Angiography; Fundus Oculi; Humans; Male; Papilledema; Visual Acuity | 1990 |
Drugs for treatment of fungal infections.
Topics: Amphotericin B; Antifungal Agents; Drug Interactions; Fluconazole; Flucytosine; Humans; Ketoconazole; Mycoses | 1990 |
[Therapeutic drug monitoring of antifungal agents].
Topics: Age Factors; Amphotericin B; Antifungal Agents; Biological Availability; Chromatography, High Pressure Liquid; Dosage Forms; Eating; Flucytosine; Humans; Miconazole; Sex Factors; Smoking | 1990 |
[Therapy of systemic candidiasis].
Topics: Amphotericin B; Candidiasis; Drug Administration Schedule; Drug Therapy, Combination; Flucytosine; Humans | 1990 |
Successful medical treatment of Candida parapsilosis endocarditis in a premature infant.
Topics: Amphotericin B; Candidiasis; Endocarditis; Flucytosine; Humans; Infant, Newborn; Infant, Premature, Diseases; Intensive Care Units, Neonatal; Male | 1990 |
[A case of systemic lupus erythematosus associated with cryptococcal meningitis which was successfully cured by the administration of massive dose of amphotericin B].
Topics: Adult; Amphotericin B; Cryptococcosis; Drug Therapy, Combination; Flucytosine; Humans; Infusions, Intravenous; Lupus Erythematosus, Systemic; Meningitis; Prednisolone | 1990 |
Candida norvegensis peritonitis and invasive disease in a patient on continuous ambulatory peritoneal dialysis.
Topics: Adult; Amphotericin B; Blood; Candida; Candidiasis; Drug Therapy, Combination; Flucytosine; Humans; Immunosuppressive Agents; Kidney Failure, Chronic; Male; Microbial Sensitivity Tests; Peritoneal Dialysis, Continuous Ambulatory; Peritonitis | 1990 |
A case of disseminated phaeohyphomycosis caused by Cladosporium devriesii.
Topics: Adult; Amphotericin B; Cause of Death; Cladosporium; Female; Flucytosine; Humans; Mycoses; Recurrence | 1990 |
Systemic candidiasis and pneumonia in preterm infants.
Topics: Amphotericin B; Candidiasis; Developmental Disabilities; Drug Administration Schedule; Drug Therapy, Combination; Female; Flucytosine; Humans; Infant, Low Birth Weight; Infant, Newborn; Infant, Premature, Diseases; Pneumonia; Pregnancy; Pregnancy Complications, Infectious | 1988 |
Effect of methotrexate alone and in combination with antifungal drugs on the growth of Candida albicans.
Topics: Amphotericin B; Antifungal Agents; Candida albicans; Drug Interactions; Flucytosine; Itraconazole; Ketoconazole; Methotrexate; Microbial Sensitivity Tests; Spores, Fungal; Time Factors | 1989 |
[Treatment of mycoses and new antifungal agents].
Topics: Allylamine; Amphotericin B; Antifungal Agents; Echinocandins; Fluconazole; Flucytosine; Humans; Itraconazole; Ketoconazole; Miconazole; Mycoses; Naphthalenes; Peptides; Peptides, Cyclic; Terbinafine | 1989 |
CNS cryptococcosis: unusual aspects.
Topics: Adult; Aged; Amphotericin B; Central Nervous System Diseases; Cryptococcosis; Female; Fluconazole; Flucytosine; Humans; Male; Middle Aged; Tomography, X-Ray Computed | 1989 |
Serum amphotericin B concentration in a very premature infant with disseminated candidiasis.
Topics: Amphotericin B; Candidiasis; Drug Therapy, Combination; Flucytosine; Humans; Infant, Newborn; Infant, Premature; Liver; Male; Medication Errors | 1989 |
Cryptococcal meningitis: unusual manifestation in a young adult and management.
Topics: Adult; Amphotericin B; Cryptococcosis; Flucytosine; Humans; Male; Meningitis | 1989 |
Cispentacin, a new antifungal antibiotic. II. In vitro and in vivo antifungal activities.
Topics: Amphotericin B; Animals; Antifungal Agents; Candida; Candidiasis; Cycloleucine; Drug Evaluation, Preclinical; Flucytosine; Male; Mice; Mice, Inbred ICR; Microbial Sensitivity Tests | 1989 |
Sensitivity of yeasts to amphotericin B and 5-fluorocytosine.
Topics: Amphotericin B; Candida; Colony Count, Microbial; Drug Resistance, Microbial; Flucytosine; Humans; Microbial Sensitivity Tests | 1989 |
Cryptococcosis complicating continuous ambulatory peritoneal dialysis.
Topics: Amphotericin B; Antibodies, Fungal; Antigens, Fungal; Cryptococcosis; Cryptococcus neoformans; Flucytosine; Humans; Male; Middle Aged; Peritoneal Dialysis, Continuous Ambulatory | 1989 |
Infections with Cryptococcus neoformans in the acquired immunodeficiency syndrome.
Topics: Acquired Immunodeficiency Syndrome; Adult; Aged; Amphotericin B; Cryptococcosis; Cryptococcus neoformans; Drug Therapy, Combination; Female; Flucytosine; Humans; Hyponatremia; Ketoconazole; Male; Meningitis; Middle Aged; Pancytopenia; Prognosis; Recurrence | 1989 |
5-Fluorocytosine resistance in clinical isolates of Cryptococcus neoformans.
Topics: Amphotericin B; Cryptococcosis; Cryptococcus; Cryptococcus neoformans; Drug Resistance, Microbial; Flucytosine; Humans | 1989 |
The effect of cilofungin (LY 121019) in combination with amphotericin B or flucytosine against Candida species.
Topics: Amphotericin B; Antifungal Agents; Candida; Drug Interactions; Echinocandins; Flucytosine; Humans; Microbial Sensitivity Tests; Peptides; Peptides, Cyclic | 1989 |
The effect of cilofungin (LY 121019) in combination with amphotericin B or flucytosine against Candida species.
Topics: Amphotericin B; Antifungal Agents; Candida; Drug Interactions; Echinocandins; Flucytosine; Microbial Sensitivity Tests; Peptides; Peptides, Cyclic | 1989 |
Survival after isolated cerebral mucormycosis.
Topics: Adolescent; Amphotericin B; Brain Diseases; Drug Therapy, Combination; Female; Flucytosine; Humans; Mucormycosis; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Tomography, X-Ray Computed | 1989 |
Endogenous candidal endophthalmitis.
Topics: Aged; Amphotericin B; Candidiasis; Endophthalmitis; Eye Diseases; Female; Flucytosine; Fluorescein Angiography; Fundus Oculi; Humans; Male; Middle Aged; Retinal Diseases; Uveitis; Visual Acuity; Vitreous Body | 1989 |
Fungal peritonitis in children on continuous ambulatory peritoneal dialysis.
Topics: Adolescent; Amphotericin B; Candidiasis; Child; Child, Preschool; Cryptococcosis; Female; Flucytosine; Humans; Kidney Transplantation; Male; Mycoses; Peritoneal Dialysis, Continuous Ambulatory; Peritonitis; Renal Dialysis | 1989 |
Granulocytopenia and thrombocytopenia associated with combination therapy of amphotericin B and low-dose flucytosine in a patient with cryptococcal meningitis.
Topics: Adult; Agranulocytosis; Amphotericin B; Cryptococcosis; Drug Therapy, Combination; Flucytosine; Humans; Male; Meningitis; Thrombocytopenia | 1989 |
Combination therapy of experimental candidiasis, cryptococcosis, aspergillosis and wangiellosis in mice.
Topics: Amphotericin B; Animals; Antifungal Agents; Aspergillosis; Candidiasis; Cryptococcosis; Drug Therapy, Combination; Exophiala; Fluconazole; Flucytosine; Itraconazole; Ketoconazole; Mice; Mycoses; Triazoles | 1987 |
A comparison of the efficacy of itraconazole, amphotericin B and 5-fluorocytosine in the treatment of Aspergillus fumigatus endocarditis in the rabbit.
Topics: Amphotericin B; Animals; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Endocarditis; Flucytosine; Itraconazole; Ketoconazole; Microbial Sensitivity Tests; Rabbits | 1987 |
Infection and colonisation of neonates by Hansenula anomala.
Topics: Amphotericin B; Disease Outbreaks; Drug Therapy, Combination; England; Flucytosine; Gestational Age; Humans; Infant, Newborn; Infant, Premature, Diseases; Mycoses; Pichia; Rectum; Saccharomycetales | 1986 |
Disseminated aspergillosis in a patient with bronchiectasis. A 15-month clinical and immunological follow-up.
Topics: Adult; Amphotericin B; Aspergillosis; Brain Diseases; Bronchiectasis; Ditiocarb; Drug Therapy, Combination; Female; Flucytosine; Humans; Lung Diseases, Fungal; T-Lymphocytes | 1986 |
Antifungal treatment of Candida peritonitis in CAPD patients.
Topics: Amphotericin B; Candidiasis; Flucytosine; Humans; Peritoneal Dialysis, Continuous Ambulatory; Peritonitis | 1987 |
Cryptococcosis in AIDS patients: observations concerning CNS involvement.
Topics: Acquired Immunodeficiency Syndrome; Adult; Amphotericin B; Cryptococcosis; Flucytosine; Humans; Male; Nervous System Diseases; Opportunistic Infections | 1989 |
[Decrease in systemic fungal infections in hematological neoplasms with empirical use of amphotericin B therapy].
Topics: Amphotericin B; Creatinine; Drug Therapy, Combination; Flucytosine; Humans; Leukemia, Myeloid, Acute; Lung Diseases, Fungal; Mycoses; Radiography | 1989 |
Cryptococcal meningoencephalitis presenting transient focal cerebral symptoms.
Topics: Amphotericin B; Cryptococcosis; Flucytosine; Focal Infection; Humans; Ischemic Attack, Transient; Male; Meningoencephalitis; Middle Aged | 1989 |
[Neonatal systemic candidiasis].
Topics: Aminoglycosides; Amphotericin B; Anti-Bacterial Agents; Candidiasis; Cross Infection; Flucytosine; Humans; Infant, Newborn; Infant, Premature; Intensive Care Units, Neonatal; Lactams | 1987 |
[Experimental renal infection with Aspergillus fumigatus in mice: a chemotherapeutic model of an organic mycosis].
Topics: Amphotericin B; Animals; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Disease Models, Animal; Female; Flucytosine; Itraconazole; Ketoconazole; Kidney Diseases; Mice; Mice, Inbred Strains; Miconazole; Triazoles | 1985 |
Effects of imidazole- and triazole-derivative antifungal compounds on the growth and morphological development of Candida albicans hyphae.
Topics: Amphotericin B; Antifungal Agents; Candida albicans; Clotrimazole; Flucytosine; Imidazoles; Itraconazole; Ketoconazole; Miconazole; Triazoles | 1985 |
[Invasive aspergillar pneumopathy during the treatment of microcellular bronchial cancer. Efficacy of early antifungal treatment].
Topics: Amphotericin B; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Aspergillosis; Aspergillus fumigatus; Carcinoma, Small Cell; Drug Therapy, Combination; Flucytosine; Humans; Lung; Lung Diseases, Fungal; Lung Neoplasms; Male; Middle Aged; Radiography; Radioisotope Teletherapy; Sputum | 1985 |
Cryptococcus neoformans: comparisons of in vitro antifungal susceptibilities of serotypes AD and BC.
Topics: Amphotericin B; Antifungal Agents; Cryptococcus; Cryptococcus neoformans; Flucytosine; Itraconazole; Ketoconazole; Miconazole; Microbial Sensitivity Tests; Nystatin; Serotyping; Triazoles | 1986 |
Chronic granulomatous disease of childhood. An unusual case of infection with Aspergillus nidulans var. echinulatus.
Topics: Abscess; Amphotericin B; Aspergillosis; Aspergillus nidulans; Blood Transfusion; Child, Preschool; Flucytosine; Granulomatous Disease, Chronic; Humans; Leukocyte Transfusion; Lung Diseases, Fungal; Male; Spinal Diseases; Thoracic Vertebrae | 1988 |
Survival of a premature neonate with obstructive anuria due to Candida: the role of early sonographic diagnosis and antimycotic treatment.
Topics: Amphotericin B; Anuria; Candidiasis; Drug Therapy, Combination; Flucytosine; Humans; Infant, Newborn; Male; Ultrasonography; Ureteral Obstruction; Urography | 1988 |
[Amphotericin B in the treatment of neurocryptococcosis in patients subjected to renal transplantation].
Topics: Adolescent; Adult; Aged; Amphotericin B; Central Nervous System Diseases; Child; Child, Preschool; Cryptococcosis; Drug Therapy, Combination; Female; Flucytosine; Humans; Kidney; Kidney Transplantation; Male; Middle Aged; Prognosis; Retrospective Studies | 1988 |
Drug resistance in Candida albicans and Candida glabrata.
Topics: Amphotericin B; Antifungal Agents; Azoles; Candida; Candida albicans; Drug Resistance, Microbial; Flucytosine | 1988 |
Enhancement of phagocytosis and intracellular killing of Candida albicans by human neutrophils in the presence of a morpholine antifungal derivative, Ro 14-4767.
Topics: Amphotericin B; Antifungal Agents; Candida albicans; Flucytosine; Humans; In Vitro Techniques; Morpholines; Neutrophils; Phagocytosis | 1988 |
[Amphotericin B and flucytosine therapy of Aspergillus pneumonia and acute renal failure].
Topics: Acute Kidney Injury; Amphotericin B; Aspergillosis; Aspergillus flavus; Aspergillus fumigatus; Combined Modality Therapy; Drug Therapy, Combination; Female; Flucytosine; Humans; Lung Diseases, Fungal; Middle Aged; Renal Dialysis | 1987 |
Renal aspergilloma--a case illustrating the problems of medical therapy.
Topics: Amphotericin B; Aspergillosis; Female; Flucytosine; Humans; Ketoconazole; Kidney Diseases; Middle Aged; Nephrectomy | 1987 |
Systemic and disseminated candidiasis complicating acute renal failure.
Topics: Acute Kidney Injury; Adult; Aged; Amphotericin B; Candidiasis; Catheters, Indwelling; Drainage; Female; Flucytosine; Humans; Male; Peritoneum | 1988 |
[A case of successfully treated cryptococcal meningitis, complicated with aplastic anemia].
Topics: Adult; Amphotericin B; Anemia, Aplastic; Cryptococcosis; Flucytosine; Humans; Male; Meningitis | 1988 |
[Incidence of mycotic infections in children with acute myeloblastic leukemia (AML)].
Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Child; Clotrimazole; Drug Resistance, Microbial; Female; Flucytosine; Humans; Ketoconazole; Leukemia, Myeloid, Acute; Male; Miconazole; Nystatin | 1988 |
An approach to intensive antileukemia therapy in patients with previous invasive aspergillosis.
Topics: Adult; Amphotericin B; Antineoplastic Combined Chemotherapy Protocols; Aspergillosis; Drug Therapy, Combination; Flucytosine; Granulocytes; Humans; Leukemia, Myeloid, Acute; Leukocyte Count; Middle Aged; Recurrence | 1988 |
Intracranial phycomycosis: case reports.
Topics: Adult; Amphotericin B; Biopsy; Brain Diseases; Female; Flucytosine; Humans; Male; Middle Aged; Mycoses; Tomography, X-Ray Computed | 1988 |
Treatment of cryptococcal meningitis with high-dose, long-term combination amphotericin B and flucytosine.
Topics: Administration, Oral; Adolescent; Adult; Amphotericin B; Cryptococcosis; Drug Therapy, Combination; Flucytosine; Humans; Injections, Intravenous; Meningitis; Middle Aged; Recurrence | 1988 |
Cryptococcal meningoencephalitis with parkinsonian features.
Topics: Aged; Aged, 80 and over; Amphotericin B; Basal Ganglia Diseases; Cryptococcosis; Flucytosine; Humans; Male; Meningoencephalitis; Parkinson Disease | 1988 |
Chemotherapy of the pulmonary mycoses. This Official Statement of the American Thoracic Society was adopted by the ATS Board of Directors, November 1987.
Topics: Amphotericin B; Flucytosine; Humans; Imidazoles; Lung Diseases; Mycoses; Triazoles | 1988 |
Parenteral 5-fluorocytosine in the therapy of systemic mycoses.
Topics: Amphotericin B; Candidiasis; Cryptococcosis; Drug Therapy, Combination; Flucytosine; Humans; Infant, Newborn; Infusions, Intravenous; Meningitis; Mycoses | 1988 |
An in vitro comparative study on the effect of amphotericin B, econazole, and 5-fluorocytosine on Naegleria fowleri, Naegleria australiensis, and Naegleria australiensis s.sp. italica.
Topics: Amphotericin B; Animals; Econazole; Flucytosine; Imidazoles; Naegleria | 1988 |
Influence of in vitro susceptibility testing conditions on the anti-candidal activity of LY121019.
Topics: Amphotericin B; Antifungal Agents; Candida; Culture Media; Echinocandins; Flucytosine; Humans; Hydrogen-Ion Concentration; Ketoconazole; Microbial Sensitivity Tests; Peptides; Peptides, Cyclic; Temperature; Time Factors | 1988 |
Cerebral aspergillosis.
Topics: Amphotericin B; Aspergillosis; Aspergillosis, Allergic Bronchopulmonary; Brain Diseases; Diagnosis, Differential; Flucytosine; Humans | 1988 |
Flucytosine interference with serum creatinine determinations.
Topics: Amphotericin B; Child, Preschool; Creatinine; Female; Flucytosine; Humans | 1988 |
Cryptococcal meningitis in AIDS patients. A two-case report.
Topics: Acquired Immunodeficiency Syndrome; Adolescent; Adult; Amphotericin B; Cryptococcosis; Drug Therapy, Combination; Flucytosine; Humans; Opportunistic Infections | 1988 |
[Cryptococcosis in renal transplantation. A report of 4 cases].
Topics: Adolescent; Adult; Amphotericin B; Cryptococcosis; Female; Flucytosine; Humans; Immunosuppression Therapy; Kidney Transplantation; Male; Middle Aged | 1988 |
In vitro susceptibility of Cryptococcus neoformans isolates from patients with acquired immunodeficiency syndrome.
Topics: Acquired Immunodeficiency Syndrome; Amphotericin B; Antifungal Agents; Cryptococcus; Cryptococcus neoformans; Flucytosine; Humans; Ketoconazole; Miconazole; Microbial Sensitivity Tests | 1988 |
[In vitro sensitivity of Aspergillus to terbinafine: comparative study on amphotericin B, 5-fluorocytosine and ketoconazole].
Topics: Amphotericin B; Antifungal Agents; Aspergillus; Flucytosine; Ketoconazole; Microbial Sensitivity Tests; Naphthalenes; Terbinafine | 1988 |
In-vitro activity of antifungal agents in combination with four quinolones.
Topics: 4-Quinolones; Amphotericin B; Anti-Infective Agents; Antifungal Agents; Candida; Candida albicans; Ciprofloxacin; Drug Combinations; Enoxacin; Flucytosine; Mepartricin; Nalidixic Acid; Naphthyridines; Norfloxacin; Quinolines; Saccharomyces cerevisiae | 1988 |
Combined effects of hyperbaric oxygen and antifungal agents on the growth of Candida albicans.
Topics: Amphotericin B; Antifungal Agents; Candida albicans; Clotrimazole; Flucytosine; Hyperbaric Oxygenation; Ketoconazole; Miconazole; Nystatin; Time Factors | 1987 |
Invasive pulmonary aspergillosis diagnosed by blood culture and successfully treated.
Topics: Amphotericin B; Aspergillosis; Aspergillus fumigatus; Blood; Flucytosine; Humans; Lung Diseases, Fungal; Male; Middle Aged; Radiography | 1987 |
[Chromomycosis].
Topics: Amphotericin B; Chromoblastomycosis; Flucytosine; Humans; Ketoconazole; Male; Middle Aged; Mozambique | 1987 |
Treatment of cryptococcal meningitis.
Topics: Amphotericin B; Cryptococcosis; Flucytosine; Humans; Meningitis | 1988 |
Drugs for treatment of deep fungal infection.
Topics: Amphotericin B; Antifungal Agents; Drug Interactions; Flucytosine; Humans; Ketoconazole; Mycoses; Opportunistic Infections | 1988 |
Rhodotorula rubra ventriculitis.
Topics: Adult; Amphotericin B; Cerebral Ventricles; Encephalitis; Female; Flucytosine; Humans; Immune Tolerance; Meningeal Neoplasms; Meningioma; Mycoses; Postoperative Complications; Rhodotorula | 1988 |
Fatal disseminated cryptococcosis following intraocular involvement.
Topics: Adult; Amphotericin B; Cryptococcosis; Flucytosine; Fundus Oculi; Humans; Male; Meningitis; Prednisone; Retina; Retinitis | 1988 |
Isolated Cryptococcus neoformans osteomyelitis in an immunocompetent child.
Topics: Amphotericin B; Child; Cryptococcosis; Drug Therapy, Combination; Female; Flucytosine; Humans; Ilium; Osteomyelitis; Sacroiliac Joint | 1988 |
[Antimycotic agents in generalized fungal infections].
Topics: Amphotericin B; Antifungal Agents; Drug Therapy, Combination; Flucytosine; Humans; Imidazoles; Mycoses; Triazoles | 1988 |
Effect of 5-fluorocytosine in comparison with amphotericin B and/or 5-fluorouracil on the formation of human mature bursts/colonies of haemopoietic progenitor cells.
Topics: Amphotericin B; Cell Division; Cells, Cultured; Drug Interactions; Flucytosine; Fluorouracil; Hematopoietic Stem Cells; Humans | 1988 |
Cryptococcal aortitis.
Topics: Amphotericin B; Aortitis; Cryptococcosis; Drug Therapy, Combination; Flucytosine; Humans; Male; Middle Aged | 1988 |
Evaluation of single-drug and combination antifungal therapy in an experimental model of candidiasis in rabbits with prolonged neutropenia.
Topics: Agranulocytosis; Amphotericin B; Animals; Antifungal Agents; Candidiasis; Cytarabine; Drug Evaluation, Preclinical; Drug Therapy, Combination; Female; Flucytosine; Ketoconazole; Neutropenia; Rabbits; Rifampin | 1988 |
The role of percutaneous nephrostomy in the management of obstructing candidiasis of the urinary tract in infants.
Topics: Amphotericin B; Candidiasis; Combined Modality Therapy; Drug Therapy, Combination; Female; Flucytosine; Humans; Infant; Infant, Newborn; Infant, Premature, Diseases; Male; Nephrostomy, Percutaneous; Urinary Tract Infections | 1988 |
Systemic candidiasis: cutaneous manifestations in low birth weight infants.
Topics: Amphotericin B; Candidiasis; Candidiasis, Cutaneous; Female; Flucytosine; Humans; Infant, Low Birth Weight; Infant, Newborn; Male | 1988 |
[Case of autoimmune hemolytic anemia complicated by cryptococcal meningitis during therapy of neutropenia].
Topics: Agranulocytosis; Amphotericin B; Anemia, Hemolytic, Autoimmune; Cryptococcosis; Female; Flucytosine; Humans; Meningitis; Middle Aged; Neutropenia; Prednisolone; Purpura, Thrombocytopenic | 1988 |
Mycological-diagnostic assessment of the efficacy of amphotericin B + flucytosine to control Cryptococcus neoformans in AIDS patients.
Topics: Acquired Immunodeficiency Syndrome; Adult; Amphotericin B; Cryptococcosis; Dose-Response Relationship, Drug; Drug Therapy, Combination; Flucytosine; Humans; Lung Diseases, Fungal; Male | 1988 |
[Anuria in an infant caused by an intrapyelic mycelial bezoar in a solitary kidney].
Topics: Amphotericin B; Anuria; Bezoars; Candidiasis; Flucytosine; Humans; Infant; Kidney; Kidney Pelvis | 1988 |
[Combined chemotherapy of experimental generalized candidiasis].
Topics: Amphotericin B; Animals; Candidiasis; Drug Evaluation, Preclinical; Drug Therapy, Combination; Flucytosine; Methacycline; Mice; Rifampin | 1987 |
Peripheral eosinophilia in the course of treatment of cryptococcal meningitis.
Topics: Adolescent; Adult; Amphotericin B; Cryptococcosis; Drug Therapy, Combination; Eosinophilia; Female; Flucytosine; Humans; Male; Meningitis; Middle Aged | 1987 |
Successful treatment of disseminated Trichosporon beigelii (cutaneum) infection with associated splenic involvement.
Topics: Adult; Amphotericin B; Combined Modality Therapy; Flucytosine; Humans; Leukemia, Monocytic, Acute; Male; Mycoses; Opportunistic Infections; Splenectomy; Trichosporon | 1986 |
Hepatic candidiasis: an increasing problem in immunocompromised patients.
Topics: Adult; Amphotericin B; Biopsy; Candida; Candidiasis; Drug Therapy, Combination; Female; Flucytosine; Humans; Immunologic Deficiency Syndromes; Ketoconazole; Leukemia, Lymphoid; Leukemia, Myeloid; Leukemia, Myeloid, Acute; Liver; Liver Diseases; Male | 1987 |
An outbreak of Candida parapsilosis endophthalmitis: analysis of strains by enzyme profile and antifungal susceptibility.
Topics: Amphotericin B; Candida; Candidiasis; Disease Outbreaks; Drug Contamination; Endophthalmitis; Flucytosine; Humans; Ketoconazole; Miconazole; Microbial Sensitivity Tests; Postoperative Complications | 1987 |
The place of elective vitrectomy in the management of patients with Candida endophthalmitis.
Topics: Amphotericin B; Candidiasis; Endophthalmitis; Female; Flucytosine; Follow-Up Studies; Humans; Ketoconazole; Male; Visual Acuity; Vitrectomy | 1987 |
[Meningeal cryptococcosis].
Topics: Adult; Amphotericin B; Cryptococcosis; Female; Flucytosine; Humans; Male; Meningitis; Miconazole | 1987 |
Results of a survey of antifungal susceptibility tests in the United States and interlaboratory comparison of broth dilution testing of flucytosine and amphotericin B.
Topics: Amphotericin B; Candida albicans; Cytosine; Drug Resistance, Microbial; Evaluation Studies as Topic; Flucytosine; Microbial Sensitivity Tests; Mycology; Saccharomyces cerevisiae; United States | 1986 |
Diagnosis and treatment of splenic fungal abscesses in the immune-suppressed patient.
Topics: Abscess; Adolescent; Adult; Amphotericin B; Candidiasis; Child, Preschool; Diagnosis, Differential; Female; Flucytosine; Follow-Up Studies; Humans; Immunosuppression Therapy; Liver Abscess; Male; Middle Aged; Splenic Diseases; Tomography, X-Ray Computed; Ultrasonography | 1986 |
Mechanisms of synergistic interactions between amphotericin B and flucytosine.
Topics: Amphotericin B; Candida albicans; Cryptococcus neoformans; Cytosine; Drug Resistance, Microbial; Drug Synergism; Drug Therapy, Combination; Flucytosine; Humans; Meningitis | 1986 |
[A case of cerebral aspergilloma following radical operation of a cerebral aneurysm].
Topics: Amphotericin B; Aspergillosis; Aspergillus fumigatus; Brain Abscess; Circle of Willis; Combined Modality Therapy; Drug Therapy, Combination; Flucytosine; Humans; Intracranial Aneurysm; Male; Middle Aged; Tomography, X-Ray Computed | 1986 |
The influence of antifungal drugs on adherence of Candida albicans to buccal epithelial cells.
Topics: Adhesiveness; Amphotericin B; Antifungal Agents; Candida albicans; Candidiasis; Cheek; Dose-Response Relationship, Drug; Epithelium; Flucytosine; Humans; In Vitro Techniques; Ketoconazole; Miconazole; Microbial Sensitivity Tests; Nystatin; Time Factors | 1986 |
Rapid enzymatic method for measurement of serum flucytosine levels.
Topics: Aminohydrolases; Ammonia; Amphotericin B; Biological Assay; Chromatography, High Pressure Liquid; Creatinine; Cytosine; Drug Therapy, Combination; Flucytosine; Humans; Saccharomyces cerevisiae; Vidarabine | 1986 |
Cryptococcal infections in patients with acquired immune deficiency syndrome.
Topics: Acquired Immunodeficiency Syndrome; Amphotericin B; Antigens, Fungal; Cryptococcosis; Cryptococcus neoformans; Flucytosine; Humans | 1986 |
Effect of medium composition on results of macrobroth dilution antifungal susceptibility testing of yeasts.
Topics: Amphotericin B; Candida; Candida albicans; Cryptococcus neoformans; Culture Media; Flucytosine; Humans; Ketoconazole; Miconazole; Microbial Sensitivity Tests; Yeasts | 1986 |
[Comparative sensitivity of yeasts to antifungal agents using a standardized micromethod].
Topics: Amphotericin B; Antifungal Agents; Candida; Flucytosine; Imidazoles; Microbial Sensitivity Tests; Yeasts | 1986 |
Successful management of primary invasive pulmonary aspergillosis.
Topics: Amphotericin B; Aspergillosis; Aspergillus fumigatus; Drug Therapy, Combination; Flucytosine; Humans; Lung Diseases, Fungal; Male; Middle Aged | 1986 |
Biochemical serogrouping of clinical isolates of Cryptococcus neoformans.
Topics: Amphotericin B; China; Cryptococcus; Cryptococcus neoformans; Culture Media; Flucytosine; Humans; Hydrogen-Ion Concentration; Microbial Sensitivity Tests; Serotyping; United States | 1987 |
Invasive pulmonary aspergillosis in acute leukemia. The contribution of CT to early diagnosis and aggressive management.
Topics: Acute Disease; Adult; Aged; Amphotericin B; Aspergillosis; Female; Flucytosine; Humans; Leukemia; Lung Diseases, Fungal; Male; Middle Aged; Tomography, X-Ray Computed | 1987 |
[Cerebral aspergillosis. Apropos of 4 cases].
Topics: Adult; Amphotericin B; Aspergillosis; Brain Diseases; Combined Modality Therapy; Female; Flucytosine; Humans; Male; Middle Aged | 1987 |
Cerebral phaeohyphomycosis.
Topics: Amphotericin B; Brain Abscess; Cladosporium; Drug Therapy, Combination; Female; Flucytosine; Humans; Ketoconazole; Middle Aged; Mycoses | 1987 |
[Multicenter study of the standardization of sensitivity testing of fungi to 5-fluorocytosine and amphotericin B].
Topics: Amphotericin B; Aspergillus; Candida; Flucytosine; Microbial Sensitivity Tests | 1987 |
The high morbidity of CAPD fungal peritonitis--description of 10 cases and review of treatment strategies.
Topics: Adult; Aged; Amphotericin B; Catheters, Indwelling; Female; Flucytosine; Humans; Kidney Failure, Chronic; Male; Middle Aged; Mycoses; Peritoneal Dialysis, Continuous Ambulatory; Peritoneal Lavage; Peritonitis | 1986 |
[Systemic Candida infections].
Topics: Amphotericin B; Candidiasis; Female; Flucytosine; Humans; Infant, Newborn; Intensive Care Units, Neonatal; Male; Retrospective Studies | 1987 |
Cryptococcal infections of the central nervous system: a ten year experience.
Topics: Adult; Aged; Amphotericin B; Cryptococcosis; Flucytosine; Humans; Meningitis; Middle Aged; Prognosis; Risk Factors; Tomography, X-Ray Computed | 1987 |
High dose ketoconazole in the treatment of cerebral aspergilloma.
Topics: Adult; Amphotericin B; Aspergillosis; Brain Diseases; Drug Therapy, Combination; Female; Flucytosine; Hong Kong; Humans; Ketoconazole; Tomography, X-Ray Computed | 1987 |
Candida infection in massively burned patients.
Topics: Amphotericin B; Anti-Bacterial Agents; Bacterial Infections; Burns; Candidiasis; Child; Flucytosine; Humans; Immune Tolerance; Opportunistic Infections; Retrospective Studies; Wound Infection | 1987 |
[Acute disseminated cryptococcosis disclosing AIDS].
Topics: Acquired Immunodeficiency Syndrome; Acute Disease; Adult; Amphotericin B; Cryptococcosis; Flucytosine; Humans; Male | 1987 |
Comparison of relative susceptibilities of Candida species to three antifungal agents as determined by unstandardized methods.
Topics: Agar; Amphotericin B; Antifungal Agents; Candida; Flucytosine; Ketoconazole; Microbial Sensitivity Tests | 1987 |
Antifungal agents used for deep-seated mycotic infections.
Topics: Amphotericin B; Antifungal Agents; Flucytosine; Humans; Imidazoles; Mycoses; Triazoles | 1987 |
Management of cryptococcosis and toxic epidermal necrolysis in a dog.
Topics: Amphotericin B; Animals; Antifungal Agents; Cryptococcosis; Dog Diseases; Dogs; Drug Therapy, Combination; Female; Flucytosine; Ketoconazole; Stevens-Johnson Syndrome | 1987 |
Influence of six antifungal agents on the chemiluminescence response of mouse spleen cells.
Topics: Amphotericin B; Animals; Antifungal Agents; Female; Flucytosine; Luminescent Measurements; Mice; Miconazole; Oxygen Consumption; Phagocytes; Spleen; Triazoles | 1986 |
[Disseminated cryptococcosis in 2 AIDS patients. A contribution to cryptococcosis diagnosis in AIDS].
Topics: Acquired Immunodeficiency Syndrome; Adult; Amphotericin B; Cryptococcosis; Flucytosine; Humans; Male | 1986 |
Cryptococcal meningoencephalitis. Case report and review of Italian literature.
Topics: Adolescent; Amphotericin B; Cryptococcosis; Flucytosine; Humans; Male; Meningoencephalitis; Tomography, X-Ray Computed | 1986 |
Candida glabrata meningitis.
Topics: Aged; Amphotericin B; Candidiasis; Chronic Disease; Drug Therapy, Combination; Female; Flucytosine; Humans; Meningitis | 1986 |
In vitro evaluation of various antifungal agents alone and in combination by using an automatic turbidimetric system combined with viable count determinations.
Topics: Amphotericin B; Antifungal Agents; Drug Interactions; Flucytosine; Ketoconazole; Microbial Sensitivity Tests; Nephelometry and Turbidimetry | 1986 |
Anuria in a premature infant due to ureteropelvic fungal bezoars.
Topics: Amphotericin B; Anuria; Bezoars; Candidiasis; Female; Flucytosine; Follow-Up Studies; Humans; Infant; Infant, Newborn; Infant, Premature, Diseases; Injections, Intravenous; Kidney Diseases; Radiography; Time Factors; Ureteral Diseases | 1986 |
[A case of systemic lupus erythematosus with cryptococcal meningitis successfully treated with amphotericin B and 5-FC].
Topics: Adult; Amphotericin B; Cryptococcosis; Cytosine; Drug Therapy, Combination; Female; Flucytosine; Humans; Lupus Erythematosus, Systemic; Meningitis | 1986 |
[Antimycotics for systemic use].
Topics: Amphotericin B; Antifungal Agents; Drug Evaluation; Flucytosine; Humans; Imidazoles | 1986 |
Candida albicans arthritis in an infant.
Topics: Amphotericin B; Arthritis, Infectious; Candidiasis; Female; Flucytosine; Humans; Infant; Postoperative Complications; Pulmonary Valve | 1986 |
[Progress in chemotherapeutic agents--antifungal agents].
Topics: Amphotericin B; Antifungal Agents; Flucytosine; Ketoconazole; Nystatin | 1986 |
Microtiter broth dilution method for yeast susceptibility testing with validation by clinical outcome.
Topics: Amphotericin B; Animals; Candida; Candidiasis; Culture Media; Flucytosine; Humans; Ketoconazole; Mice; Miconazole; Microbial Sensitivity Tests | 1986 |
Susceptibility of clinical isolates of yeasts to anti-fungal agents.
Topics: Amphotericin B; Antifungal Agents; Candida; Clotrimazole; Cryptococcus; Flucytosine; Geotrichum; Humans; Miconazole; Microbial Sensitivity Tests; Nystatin; Rhodotorula; Saccharomyces; Trichosporon; Yeasts | 1986 |
Susceptibility testing of medically important fungi.
Topics: Amphotericin B; Antifungal Agents; Drug Synergism; Flucytosine; Fungi; Imidazoles; Microbial Sensitivity Tests | 1986 |
Torulopsis glabrata infection in immunocompromised children.
Topics: Amphotericin B; Candidiasis; Child; Child, Preschool; Drug Therapy, Combination; Female; Flucytosine; Humans; Immune Tolerance; Opportunistic Infections; Urinary Tract Infections | 1987 |
Antifungal treatment of Candida peritonitis in continuous ambulatory peritoneal dialysis patients.
Topics: Aged; Amphotericin B; Antifungal Agents; Candidiasis; Drug Evaluation; Drug Therapy, Combination; Female; Flucytosine; Humans; Infusions, Parenteral; Male; Middle Aged; Peritoneal Dialysis, Continuous Ambulatory; Peritonitis | 1987 |
In-vitro evaluation of antifungal agents in the treatment of yeast peritonitis complicating continuous ambulatory peritoneal dialysis (CAPD).
Topics: Amphotericin B; Antifungal Agents; Azoles; Candida; Candidiasis; Drug Evaluation; Flucytosine; Humans; Kinetics; Mycoses; Peritoneal Dialysis, Continuous Ambulatory; Peritonitis | 1987 |
Cryptococcal infection of the central nervous system.
Topics: Adult; Amphotericin B; Brain; Brain Diseases; Cryptococcosis; Flucytosine; Humans; Lung Diseases, Fungal; Male; Middle Aged; Tomography, X-Ray Computed | 1985 |
[Acute lymphocytic leukemia, complicated with generalized cryptococcosis successfully treated by amphotericin B; a case report].
Topics: Amphotericin B; Cryptococcosis; Female; Flucytosine; Humans; Leukemia, Lymphoid; Middle Aged | 1985 |
Fungal endophthalmitis in narcotic abusers. Medical and surgical therapy in 10 patients.
Topics: Adult; Amphotericin B; Candidiasis; Drug Therapy, Combination; Endophthalmitis; Female; Flucytosine; Heroin; Humans; Male; Miconazole; Mycoses; Substance-Related Disorders; Visual Acuity; Vitrectomy | 1985 |
[Treatment Candida albicans endophthalmitis with ketoconazole].
Topics: Amphotericin B; Candidiasis; Endophthalmitis; Flucytosine; Humans; Ketoconazole | 1985 |
Surgery and granulocyte transfusions for life-threatening infections in chronic granulomatous disease.
Topics: Amphotericin B; Blood Transfusion; Child; Drug Combinations; Flucytosine; Granulocytes; Granulomatous Disease, Chronic; Humans; Liver Abscess; Male; Spondylitis; Staphylococcal Infections; Subphrenic Abscess; Sulfamethoxazole; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination | 1985 |
Cure of cryptococcal infection during continued immunosuppressive therapy.
Topics: Amphotericin B; Cryptococcosis; Flucytosine; Humans; Immunosuppression Therapy; Kidney Transplantation; Prednisone | 1985 |
Cutaneous, ocular, and osteoarticular candidiasis in heroin addicts: new clinical and therapeutic aspects in 38 patients.
Topics: Adult; Aged; Amphotericin B; Bone Diseases; Candida albicans; Candidiasis; Candidiasis, Cutaneous; Eye Diseases; Female; Flucytosine; France; Heroin Dependence; Humans; Joint Diseases; Ketoconazole; Male; Middle Aged; Osteoarthritis; Scalp; Syndrome | 1985 |
Cryptococcosis in the acquired immunodeficiency syndrome.
Topics: Acquired Immunodeficiency Syndrome; Amphotericin B; Antibodies, Fungal; Antigens, Fungal; Cryptococcosis; Cryptococcus neoformans; Drug Therapy, Combination; Encephalitis; Flucytosine; Humans; Meningitis; Retrospective Studies; Serologic Tests | 1985 |
Paraplegia due to aspergillosis. Successful conservative treatment of two cases.
Topics: Amphotericin B; Aspergillosis; Aspergillus fumigatus; Aspergillus niger; Child; Drug Therapy, Combination; Flucytosine; Humans; Male; Paraplegia; Radiography; Spondylitis; Thoracic Vertebrae | 1985 |
[Monitoring of treatment involving 5-fluorocytosine].
Topics: Amphotericin B; Candidiasis; Cytosine; Dose-Response Relationship, Drug; Drug Interactions; Drug Therapy, Combination; Flucytosine; Fluorouracil; Humans; Kinetics | 1985 |
Successful treatment of post-mitral valve annuloplasty Aspergillus flavus endocarditis.
Topics: Amphotericin B; Aspergillosis; Aspergillus flavus; Combined Modality Therapy; Cytosine; Endocarditis; Female; Flucytosine; Heart Valve Prosthesis; Humans; Middle Aged; Mitral Valve; Mitral Valve Prolapse; Postoperative Complications | 1985 |
Cryptococcal disease in patients with the acquired immunodeficiency syndrome. Diagnostic features and outcome of treatment.
Topics: Acquired Immunodeficiency Syndrome; Adult; Amphotericin B; Brain Diseases; Cryptococcosis; Drug Therapy, Combination; Female; Flucytosine; Humans; Injections, Intravenous; Injections, Intraventricular; Male; Meningitis; Middle Aged; Prognosis; Recurrence; Retrospective Studies; Tomography, X-Ray Computed | 1986 |
Exotic infection in the immunocompromised host.
Topics: Aged; Amphotericin B; Cryptococcosis; Flucytosine; Humans; Immunosuppression Therapy; Male; Nephrotic Syndrome; Prednisone | 1986 |
[Cryptococcus neoformans meningoencephalitis in AIDS].
Topics: Acquired Immunodeficiency Syndrome; Adult; Amphotericin B; Cryptococcosis; Drug Therapy, Combination; Flucytosine; Humans; Male; Meningoencephalitis; Risk | 1986 |
Drugs for treatment of systemic fungal infections.
Topics: Amphotericin B; Antifungal Agents; Drug Interactions; Drug Therapy, Combination; Flucytosine; Humans; Ketoconazole; Miconazole; Mycoses | 1986 |
[Cryptococcal meningitis].
Topics: Adult; Amphotericin B; Antifungal Agents; Cryptococcosis; Drug Resistance, Microbial; Drug Therapy, Combination; Flucytosine; Humans; Injections, Intraventricular; Male; Meningitis; Recurrence | 1986 |
Peritonitis in children undergoing continuous ambulatory peritoneal dialysis.
Topics: Adolescent; Adult; Amphotericin B; Anti-Bacterial Agents; Cefazolin; Child; Child, Preschool; Drug Therapy, Combination; Female; Flucytosine; Humans; Infant; Male; Peritoneal Dialysis; Peritoneal Dialysis, Continuous Ambulatory; Peritonitis; Recurrence; Tobramycin | 1985 |
[Candida endophthalmitis: diagnosis, course and therapy in 8 patients].
Topics: Adolescent; Adult; Amphotericin B; Candidiasis; Drug Therapy, Combination; Female; Flucytosine; Heroin Dependence; Humans; Male; Panophthalmitis | 1985 |
Consequences of candidemia for pediatric patients.
Topics: Adolescent; Amphotericin B; Blood; Blood Urea Nitrogen; Candidiasis; Child; Child, Preschool; Creatinine; Drug Therapy, Combination; Female; Flucytosine; Humans; Infant; Infant, Newborn; Infant, Premature, Diseases; Kidney Diseases; Male; Retrospective Studies | 1985 |
Intraocular penetration of systemically administered antifungal agents.
Topics: Amphotericin B; Antifungal Agents; Candidiasis; Cataract Extraction; Drug Contamination; Eye; Flucytosine; Humans; Ketoconazole; Orbital Diseases; Postoperative Complications; Therapeutic Irrigation | 1985 |
Reproducible measurement of amphotericin B in serum by high-performance liquid chromatography in alkaline buffer.
Topics: Amphotericin B; Buffers; Chromatography, High Pressure Liquid; Flucytosine; Humans; Hydrogen-Ion Concentration | 1985 |
Cryptococcal infection of the central nervous system.
Topics: Amphotericin B; Central Nervous System Diseases; Cryptococcosis; Flucytosine; Humans; Meningitis; Prognosis | 1985 |
Spastic paraparesis due to cryptococcal osteomyelitis. A case report.
Topics: Amphotericin B; Combined Modality Therapy; Cryptococcosis; Flucytosine; Humans; Male; Middle Aged; Muscle Spasticity; Osteomyelitis; Paraplegia; Thoracic Vertebrae; Time Factors | 1985 |
Neonatal systemic candidiasis.
Topics: Amphotericin B; Anti-Bacterial Agents; Candidiasis; Critical Care; Drug Therapy, Combination; Flucytosine; Humans; Infant; Infant, Newborn; Infant, Premature, Diseases; Respiration, Artificial | 1985 |
Fungal peritonitis in patients on peritoneal dialysis: incidence, clinical features and prognosis.
Topics: Adult; Aged; Amphotericin B; Catheters, Indwelling; Drug Therapy, Combination; Female; Flucytosine; Humans; Ketoconazole; Male; Miconazole; Middle Aged; Mycoses; Peritoneal Dialysis; Peritonitis; Prognosis | 1985 |
Disseminated candidiasis with extensive folliculitis in abusers of brown Iranian heroin.
Topics: Adult; Amphotericin B; Candidiasis; Conjunctivitis; Female; Flucytosine; Folliculitis; Heroin; Humans; Iran; Ketoconazole; Male; Substance-Related Disorders | 1985 |
Simplified bioassay method for measurement of flucytosine or ketoconazole.
Topics: Amphotericin B; Biological Assay; Candida; Cytosine; Flucytosine; Humans; Ketoconazole | 1985 |
Cryptococcal meningitis.
Topics: Adolescent; Adult; Aged; Amphotericin B; Child; Cryptococcosis; Flucytosine; Follow-Up Studies; Garlic; Humans; Ketoconazole; Meningitis; Miconazole; Middle Aged; Plant Extracts; Plants, Medicinal | 1985 |
Fungal peritonitis in patients on continuous ambulatory peritoneal dialysis. Three recoveries in 5 cases without catheter removal.
Topics: Adult; Aged; Amphotericin B; Catheterization; Drug Therapy, Combination; Female; Flucytosine; Humans; Male; Miconazole; Middle Aged; Mycoses; Peritoneal Dialysis, Continuous Ambulatory; Peritonitis | 1985 |
Cryptococcal meningitis: presentation as sudden deafness.
Topics: Amphotericin B; Audiometry, Evoked Response; Cryptococcosis; Electronystagmography; Evoked Potentials, Auditory; Female; Flucytosine; Hearing Loss, Sudden; Humans; Meningitis; Middle Aged | 1985 |
Candida septic thrombosis of the great central veins associated with central catheters. Clinical features and management.
Topics: Adult; Aged; Amphotericin B; Candidiasis; Catheterization; Cytosine; Female; Flucytosine; Humans; Male; Middle Aged; Sepsis; Surgical Wound Infection; Thrombophlebitis | 1985 |
Aspergillus osteomyelitis. Report of a case and review of the literature.
Topics: Adult; Amphotericin B; Aspergillosis; Drug Therapy, Combination; Flucytosine; Humans; Male; Osteomyelitis | 1985 |
Ocular involvement in the acquired immune deficiency syndrome (AIDS).
Topics: Acquired Immunodeficiency Syndrome; Adult; Amphotericin B; Candidiasis, Oral; Cryptococcosis; Eyelid Neoplasms; Flucytosine; Humans; Male; Sarcoma, Kaposi; Vinblastine | 1985 |
Systemic candidiasis in premature infants experience with drug treatment.
Topics: Amphotericin B; Candidiasis; Cytosine; Drug Therapy, Combination; Flucytosine; Humans; Infant, Newborn; Infant, Premature, Diseases; Ketoconazole; Miconazole | 1985 |
Isolated Candida arthritis: report of a case and definition of a distinct clinical syndrome.
Topics: Amphotericin B; Arthritis, Infectious; Candidiasis; Drug Therapy, Combination; Flucytosine; Humans; Injections, Intra-Articular; Ketoconazole; Knee Joint; Male; Middle Aged | 1985 |
Current concepts in the management of urinary candidosis.
Topics: Administration, Topical; Amphotericin B; Antifungal Agents; Candidiasis; Flucytosine; Humans; Imidazoles; Nystatin; Transfer Factor; Urinary Tract Infections; Urography | 1985 |
Epidemic postsurgical Candida parapsilosis endophthalmitis. Clinical findings and management of 15 consecutive cases.
Topics: Aged; Amphotericin B; Candidiasis; Cataract Extraction; Eye Diseases; Female; Flucytosine; Humans; Ketoconazole; Male; Middle Aged; Ophthalmic Solutions; Therapeutic Irrigation | 1985 |
Deep scopulariopsosis: a case report and sensitivity studies.
Topics: Adult; Amphotericin B; Ankle Joint; Antimony; Chronic Disease; Female; Flucytosine; Granulation Tissue; Griseofulvin; Humans; Microbial Sensitivity Tests; Mitosporic Fungi; Mycoses; Natamycin; Nystatin; Potassium Iodide; Staining and Labeling; Tartrates; Tendinopathy | 1974 |
Human meningoencephalitis caused by the free-living amoebae.
Topics: Amoeba; Amphotericin B; Animals; Flucytosine; Haplorhini; Humans; Meningoencephalitis; Mice | 1973 |
Candida tropicalis and Torulopsis glabrata fungemia in a patient treated with long-term hyperalimentation.
Topics: Amphotericin B; Antifungal Agents; Brain; Candida; Candidiasis; Catheterization; Flucytosine; Humans; Kidney; Lung; Male; Middle Aged; Parenteral Nutrition; Pericardium | 1974 |
[Candida endocarditis in mitral prosthesis (apropos of a case cured by a second operation)].
Topics: Amphotericin B; Candida; Candidiasis; Endocarditis; Female; Flucytosine; Heart Valve Prosthesis; Humans; Middle Aged; Mitral Valve; Statistics as Topic; Surgical Wound Infection; Time Factors | 1973 |
Skin lesions associated with disseminated candidiasis.
Topics: Aged; Amphotericin B; Biopsy; Candida; Candidiasis; Candidiasis, Cutaneous; Child, Preschool; Female; Flucytosine; Humans; Leukemia; Male; Skin | 1974 |
[Generalized primary cryptococcosis. Immunological study and medico-surgical treatment].
Topics: Amphotericin B; Antibodies; Complement System Proteins; Cryptococcosis; Flucytosine; Humans; Immunity, Cellular; Immunoelectrophoresis; Lung Diseases; Male; Middle Aged | 1974 |
Cryptococcal meningitis--treated with 5-fluorocytosine and amphotericin B (a case report).
Topics: Amphotericin B; Cryptococcosis; Cytosine; Female; Flucytosine; Humans; Meningitis; Middle Aged | 1974 |
Current and future chemotherapy of central nervous system fungal infections.
Topics: Administration, Oral; Amphotericin B; Arrhythmias, Cardiac; Brain Diseases; Cytosine; Flucytosine; Gastrointestinal Diseases; Humans; Hypokalemia; Injections, Intravenous; Injections, Spinal; Intestinal Perforation; Kidney Diseases; Meningitis; Mycoses; Paralysis; Radiculopathy; Vision Disorders | 1974 |
Candida endophthalmitis. Successful treatment in a patient with acute leukemia.
Topics: Adult; Amphotericin B; Candidiasis; Candidiasis, Oral; Exudates and Transudates; Flucytosine; Humans; Immunosuppression Therapy; Leukemia, Myeloid, Acute; Male; Retinitis | 1972 |
Editorial: Cryptococcosis and 5-fluorocytosine.
Topics: Amphotericin B; Animals; Cryptococcosis; Cytosine; Drug Resistance, Microbial; Drug Therapy, Combination; Female; Flucytosine; Humans; Male; Meningitis; Pregnancy; Pregnancy Complications, Infectious; Rats | 1974 |
Chemotherapy of the systemic mycoses.
Topics: Amphotericin B; Antifungal Agents; Blastomycosis; Coccidioidomycosis; Cryptococcosis; Flucytosine; Histoplasmosis; Humans; Meningitis; Mycoses; Natamycin; Nocardia Infections; Penicillin G; Potassium Iodide; Sporotrichosis; Stilbamidines; Sulfonamides | 1973 |
Recovery from disseminated candidiasis in a premature neonate.
Topics: Amphotericin B; Antifungal Agents; Arthritis, Infectious; Candidiasis; Cytosine; Drug Resistance, Microbial; Drug Therapy, Combination; Endophthalmitis; Flucytosine; Humans; Infant, Newborn; Infant, Premature, Diseases; Meningitis; Osteomyelitis; Pyelonephritis; Radiography; Recurrence; Sepsis | 1974 |
Physiological properties of mutagen-induced variants of Candida albicans resistant to polyene antibiotics.
Topics: Agglutination Tests; Alkenes; Amphotericin B; Animals; Antifungal Agents; Benzene Derivatives; Candida albicans; Drug Resistance, Microbial; Fatty Acids, Unsaturated; Flucytosine; Genetic Variation; Imidazoles; Lactones; Microbial Sensitivity Tests; Mutagens; Mutation; Nitrobenzenes; Nitrosoguanidines; Nystatin; Pyrroles; Rabbits; Temperature | 1972 |
Assay for two antimicrobials.
Topics: Amphotericin B; Biological Assay; Candida albicans; Culture Media; Cytosine; Flucytosine; Humans; Microbial Sensitivity Tests; Saccharomyces cerevisiae | 1973 |
The combined effect of 5-fluorocytosine and amphotericin B in the therapy of murine cryptococcosis.
Topics: Amphotericin B; Animals; Antifungal Agents; Cryptococcosis; Cryptococcus neoformans; Cytosine; Dose-Response Relationship, Drug; Drug Resistance, Microbial; Drug Synergism; Flucytosine; Injections, Intraperitoneal; Injections, Intravenous; Mice; Microbial Sensitivity Tests | 1973 |
Yeast in the urine.
Topics: Amphotericin B; Candida albicans; Candidiasis; Cystitis; Female; Flucytosine; Humans; Kidney Diseases; Male; Prostatitis; Urinary Catheterization; Urinary Tract Infections | 1973 |
Candida albicans arthritis treated with flucytosine.
Topics: Adult; Amphotericin B; Antifungal Agents; Arthritis, Infectious; Candida albicans; Candidiasis; Catheterization; Cytosine; Female; Flucytosine; Humans; Immunosuppressive Agents; Kidney Transplantation; Osteoarthritis; Transplantation, Homologous | 1973 |
Cryptococcal meningitis in pregnancy.
Topics: Adolescent; Adult; Amphotericin B; Cryptococcosis; Cryptococcus neoformans; Female; Flucytosine; Humans; Meningitis; Pregnancy; Pregnancy Complications, Infectious | 1972 |
Fungemia caused by torulopsis glabrata.
Topics: Amphotericin B; Antibodies, Fungal; Blood; Candida; Candida albicans; Candidiasis; Flucytosine; Humans; Male; Middle Aged; Mitosporic Fungi; Urine | 1973 |
Chemotherapeutic activity of 5-fluorocytosine and amphotericin B against Candida albicans in mice.
Topics: Amphotericin B; Animals; Antifungal Agents; Candida albicans; Candidiasis; Cytosine; Drug Evaluation, Preclinical; Drug Therapy, Combination; Flucytosine; Kidney; Mice | 1973 |
Treatment of mucocutaneous candidasis with transfer factor.
Topics: Amphotericin B; Antigens, Bacterial; Candidiasis, Cutaneous; Child, Preschool; Flucytosine; Humans; Hypersensitivity, Delayed; Immunity, Maternally-Acquired; Immunoglobulin G; Infant; Lectins; Leukocytes; Lymphocytes; Lymphokines; Macrophage Migration-Inhibitory Factors; Male; Peroxidases; Receptors, Drug; Remission, Spontaneous; Time Factors | 1974 |
Systemic mycoses in children. II.
Topics: Actinomycosis; Adult; Amphotericin B; Antifungal Agents; Aspergillosis; Candidiasis; Child; Female; Flucytosine; Fungi; Humans; Infant; Male; Middle Aged; Mycoses; Natamycin; Nocardia asteroides; Nocardia Infections; Potassium Iodide; Sporotrichosis; Stilbamidines; Sulfonamides | 1972 |
Postoperative fungal endocarditis. Fungemia, embolism, and therapy.
Topics: Aged; Amphotericin B; Aortic Valve; Aspergillus; Blood; Candida; Candida albicans; Cryptococcus; Embolism; Endocarditis; Flucytosine; Fungi; Heart Valve Prosthesis; Humans; Male; Middle Aged; Mitral Valve; Mycoses; Postoperative Complications | 1974 |
Effect of 5-fluorocytosine and amphotericin B on Candida albicans infection in mice.
Topics: Amphotericin B; Animals; Antifungal Agents; Candida albicans; Candidiasis; Cytosine; Drug Evaluation; Drug Synergism; Drug Therapy, Combination; Flucytosine; Humans; Kidney; Liver; Male; Mice; Spleen | 1974 |
Nasal cryptococcosis.
Topics: Amphotericin B; Antibodies, Fungal; Biopsy; Cerebrospinal Fluid; Cryptococcosis; Cryptococcus neoformans; Flucytosine; Humans; Male; Middle Aged; Nasal Mucosa; Nose Diseases | 1974 |
Cryptococcal meningitis treated with 5-fluorocytosine and amphotericin B.
Topics: Amphotericin B; Cryptococcosis; Cryptococcus; Cryptococcus neoformans; Cytosine; Drug Resistance, Microbial; Female; Flucytosine; Humans; Injections, Intravenous; Injections, Spinal; Male; Meningitis; Middle Aged | 1974 |
Therapy of deep-seated fungal infections with 5-fluorocytosine.
Topics: Adult; Aged; Amphotericin B; Anterior Chamber; Aspergillosis; Aspergillus fumigatus; Candida albicans; Candidiasis; Cryptococcosis; Cryptococcus neoformans; Cytosine; Drug Resistance, Microbial; Female; Flucytosine; Humans; Keratitis; Kidney Diseases; Kidney Transplantation; Male; Meningitis; Middle Aged; Mycoses; Transplantation, Homologous | 1974 |
Renal candidiasis: diagnosis and management.
Topics: Adult; Amphotericin B; Candidiasis; Female; Flucytosine; Humans; Kidney; Kidney Calculi; Pyelonephritis; Urine | 1973 |
Synergism of amphotericin B with other antimicrobial agents.
Topics: Amphotericin B; Antifungal Agents; Cytosine; Drug Synergism; Flucytosine; Humans; Mycoses; Rifampin | 1973 |
A note on treatment for cryptococcal meningitis.
Topics: Amphotericin B; Cryptococcosis; Flucytosine; Humans; Meningitis | 1973 |
Blood-borne Candida endophthalmitis. A clinical and pathologic study of 21 cases.
Topics: Adolescent; Adult; Amphotericin B; Candidiasis; Catheterization; Chorioretinitis; Choroiditis; Female; Flucytosine; Humans; Macula Lutea; Male; Middle Aged; Ophthalmoscopy; Postoperative Complications; Retinitis; Sepsis | 1973 |
Treatment of systemic mycoses.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Blastomycosis; Candidiasis; Coccidioidomycosis; Cryptococcosis; Flucytosine; Histoplasmosis; Humans; Iodides; Mycoses; Nystatin; Sporotrichosis | 1973 |
The treatment of systemic mycoses.
Topics: Amphotericin B; Antifungal Agents; Flucytosine; Humans; Mycoses; Potassium Iodide; Stilbamidines | 1973 |
Editorial: New drugs for fungal bugs.
Topics: Amphotericin B; Antifungal Agents; Evaluation Studies as Topic; Eye Diseases; Flucytosine; Humans; Imidazoles; Keratitis | 1973 |
Bronchopulmonary geotrichosis.
Topics: Aged; Amphotericin B; Bronchial Diseases; Colistin; Flucytosine; Geotrichosis; Humans; Lung Diseases, Fungal; Male; Microbial Sensitivity Tests; Middle Aged; Mitosporic Fungi; Mycoses; Neomycin; Potassium Iodide; Sulfadiazine | 1973 |
Cure of Aspergillus ustus endocarditis on a prosthetic valve.
Topics: Amphotericin B; Aortic Valve; Aspergillosis; Aspergillus; Drug Therapy, Combination; Endocarditis; Flucytosine; Heart Valve Prosthesis; Humans; Male; Middle Aged; Species Specificity | 1974 |
Candida endophthalmitis.
Topics: Adolescent; Amphotericin B; Candidiasis; Eye; Flucytosine; Humans; Imidazoles; Injections; Injections, Intravenous; Male; Panophthalmitis; Trityl Compounds | 1974 |
Cryptococcal meningitis: a case treated with 5-fluorocytosine.
Topics: Aged; Amphotericin B; Antifungal Agents; Cryptococcosis; Cytosine; Female; Flucytosine; Humans; Meningitis | 1974 |
Flucytosine and amphotericin B: hemodialysis effects on the plasma concentration and clearance. Studies in man.
Topics: Adult; Amphotericin B; Antifungal Agents; Blood Proteins; Cholesterol; Creatinine; Cytosine; Flucytosine; Humans; In Vitro Techniques; Kidney Failure, Chronic; Kidneys, Artificial; Molecular Weight; Mycoses; Protein Binding; Renal Dialysis; Triglycerides | 1974 |
Development of resistance to 5-fluorocytosine in Candida parapsilosis during therapy.
Topics: Adult; Aminohydrolases; Amphotericin B; Antifungal Agents; Candida; Candidiasis; Cell-Free System; Cytosine; Drug Resistance, Microbial; Endocarditis; Female; Flucytosine; Heroin Dependence; Humans; Imidazoles; Recurrence; Trityl Compounds | 1974 |
Cryptococcal hepatitis mimicking primary sclerosing cholangitis. A case report.
Topics: Adult; Amphotericin B; Biopsy; Cholangitis; Cryptococcosis; Diagnostic Errors; Flucytosine; Granuloma; Hepatitis; Humans; Liver; Male; Meningitis; Neurologic Manifestations | 1974 |
Fungal endocarditis secondary to drug addiction. Recent concepts in diagnosis and therapy.
Topics: Adult; Amphotericin B; Aortic Valve Insufficiency; Benzene Derivatives; Candidiasis; Endocarditis; Female; Flucytosine; Follow-Up Studies; Heart Septal Defects, Ventricular; Heart Valve Prosthesis; Heroin; Humans; Imidazoles; Male; Mitral Valve Insufficiency; Oxacillin; Pacemaker, Artificial; Radiography, Thoracic; Substance-Related Disorders; Tricuspid Valve Insufficiency | 1972 |
[Cryptococcus neoformans meningoencephalitis].
Topics: Aged; Amphotericin B; Antifungal Agents; Cryptococcosis; Drug Therapy, Combination; Flucytosine; Humans; Ketoconazole; Male; Meningoencephalitis; Miconazole; Prognosis | 1984 |
Broth dilution and disc diffusion methods in the susceptibility testing of pathogenic Candida albicans against four antimycotics.
Topics: Amphotericin B; Antifungal Agents; Candida albicans; Chlorhexidine; Clotrimazole; Drug Resistance, Microbial; Flucytosine; Humans; Ketoconazole; Microbial Sensitivity Tests; Mouth; Stomatitis | 1984 |
Antimycotic therapy of experimental infections caused by dematiaceous fungi.
Topics: Amphotericin B; Animals; Antifungal Agents; Dose-Response Relationship, Drug; Drug Therapy, Combination; Flucytosine; Fluorouracil; Humans; Ketoconazole; Male; Mice; Mitosporic Fungi; Mycoses; Triazoles | 1984 |
Effective systemic antifungal agents.
Topics: Administration, Oral; Amphotericin B; Cytosine; Drug Evaluation; Drug Resistance, Microbial; Flucytosine; Half-Life; Humans; Infusions, Parenteral; Ketoconazole; Miconazole; Mycoses | 1984 |
[A study on urinary fungal infection].
Topics: Adolescent; Adult; Aged; Amphotericin B; Anti-Bacterial Agents; Bicarbonates; Candida; Candidiasis; Child; Child, Preschool; Female; Flucytosine; Humans; Infant; Male; Middle Aged; Mycoses; Sodium; Sodium Bicarbonate; Urinary Catheterization; Urinary Tract Infections | 1983 |
Treatment of Candida endophthalmitis.
Topics: Amphotericin B; Candidiasis; Cataract Extraction; Endophthalmitis; Eye Infections, Fungal; Fibrosis; Flucytosine; Fungemia; Humans; Male; Middle Aged | 1982 |
Brain abscess caused by a variety of cladosporium trichoides.
Topics: Amphotericin B; Brain Abscess; Cladosporium; Flucytosine; Humans; Male; Middle Aged; Mitosporic Fungi; Mycoses; T-Lymphocytes, Helper-Inducer; T-Lymphocytes, Regulatory | 1983 |
Relapse of Candida parapsilosis endocarditis after long-term suppression with flucytosin: retreatment with valve replacement and ketoconazole.
Topics: Adult; Amphotericin B; Candidiasis; Cytosine; Drug Therapy, Combination; Endocarditis; Female; Flucytosine; Heart Valve Prosthesis; Humans; Imidazoles; Ketoconazole; Mitral Valve; Piperazines; Recurrence | 1980 |
Ocular toxicity of topical antifungal agents.
Topics: Administration, Topical; Amphotericin B; Animals; Antifungal Agents; Cornea; Eye; Flucytosine; Imidazoles; Iritis; Ketoconazole; Miconazole; Piperazines; Rabbits | 1981 |
[Interactions between 5-fluorocytosine and polyene antibiotics, resp. imidazole derivatives (author's transl)].
Topics: Amphotericin B; Antifungal Agents; Candida albicans; Cytosine; Drug Interactions; Econazole; Flucytosine; Imidazoles; Ketoconazole; Nystatin; Piperazines; Saccharomyces cerevisiae | 1981 |
Drugs for treatments of systemic fungal infections.
Topics: Amphotericin B; Antifungal Agents; Flucytosine; Humans; Imidazoles; Ketoconazole; Miconazole; Mycoses; Piperazines | 1982 |
Therapy of superficial fungal infection.
Topics: Administration, Oral; Amphotericin B; Antifungal Agents; Candidiasis; Candidiasis, Oral; Dermatomycoses; Flucytosine; Griseofulvin; Humans; Imidazoles; Injections, Intravenous; Ketoconazole; Miconazole; Piperazines; Tinea; Tinea Versicolor | 1982 |
Treatment of experimental cryptococcal meningitis with amphotericin B, 5-fluorocytosine, and ketoconazole.
Topics: Amphotericin B; Animals; Cryptococcosis; Cryptococcus neoformans; Cytosine; Drug Synergism; Drug Therapy, Combination; Flucytosine; Imidazoles; Ketoconazole; Male; Meningitis; Piperazines; Rabbits | 1982 |
Susceptibility of dermatiaceous fungi to amphotericin B, miconazole, ketoconazole, flucytosine and rifampin alone and in combination.
Topics: Amphotericin B; Antifungal Agents; Cladosporium; Drug Synergism; Flucytosine; Imidazoles; Ketoconazole; Miconazole; Microbial Sensitivity Tests; Mitosporic Fungi; Piperazines; Rifampin | 1982 |
Cutaneous phaeohyphomycosis of the sole caused by Exophiala jeanselmei and its susceptibility to amphotericin B, 5-FC and ketoconazole.
Topics: Amphotericin B; Antifungal Agents; Dermatomycoses; Drug Resistance, Microbial; Female; Flucytosine; Foot Dermatoses; Humans; Imidazoles; Ketoconazole; Middle Aged; Mitosporic Fungi; Piperazines | 1982 |
Interactions among amphotericin B, 5-fluorocytosine, ketoconazole, and miconazole against pathogenic fungi in vitro.
Topics: Amphotericin B; Antifungal Agents; Cytosine; Drug Synergism; Flucytosine; Fungi; Imidazoles; Ketoconazole; Miconazole; Microbial Sensitivity Tests; Piperazines | 1982 |
Combination therapy of experimental candidiasis, cryptococcosis and aspergillosis in mice.
Topics: Amphotericin B; Animals; Antifungal Agents; Aspergillosis; Candidiasis; Cryptococcosis; Drug Synergism; Drug Therapy, Combination; Flucytosine; Imidazoles; Ketoconazole; Male; Mice; Piperazines | 1982 |
Antimicrobial treatment of systemic fungal infections.
Topics: Amphotericin B; Antifungal Agents; Flucytosine; Humans; Imidazoles; Ketoconazole; Miconazole; Mycoses; Piperazines | 1983 |
Hematogenous Candida spondylitis. A case report.
Topics: Amphotericin B; Candidiasis; Clindamycin; Drug Therapy, Combination; Female; Flucytosine; Humans; Ketoconazole; Lumbar Vertebrae; Middle Aged; Osteomyelitis; Spondylitis | 1984 |
Efficacy of antifungal agents in the cornea. II. Influence of corticosteroids.
Topics: Adrenal Cortex Hormones; Amphotericin B; Animals; Antifungal Agents; Candida albicans; Candidiasis; Drug Resistance, Microbial; Drug Therapy, Combination; Flucytosine; Keratitis; Ketoconazole; Miconazole; Natamycin; Rabbits | 1984 |
Drugs for treatment of systemic fungal infections.
Topics: Amphotericin B; Antifungal Agents; Drug Therapy, Combination; Flucytosine; Humans; Ketoconazole; Miconazole; Mycoses | 1984 |
In vitro susceptibilities of sucrose-negative Candida tropicalis, Candida lusitaniae, and Candida norvegensis to amphotericin B, 5-fluorocytosine, miconazole, and ketoconazole.
Topics: Amphotericin B; Candida; Culture Media; Cytosine; Drug Synergism; Flucytosine; Ketoconazole; Miconazole; Microbial Sensitivity Tests; Sucrose | 1984 |
Combination of oral flucytosine and ketoconazole as therapy for experimental cryptococcal meningitis.
Topics: Amphotericin B; Animals; Cryptococcosis; Cryptococcus neoformans; Cytosine; Drug Synergism; Drug Therapy, Combination; Female; Flucytosine; Ketoconazole; Male; Meningitis; Mice; Mice, Inbred BALB C | 1984 |
In vitro susceptibilities of human and wild-type isolates of Basidiobolus and Conidiobolus species.
Topics: Amphotericin B; Antifungal Agents; Culture Media; Flucytosine; Fungi; Humans; Ketoconazole; Miconazole; Microbial Sensitivity Tests; Potassium Iodide | 1984 |
In vitro activities of amphotericin B in combination with four antifungal agents and rifampin against Aspergillus spp.
Topics: Amphotericin B; Antifungal Agents; Aspergillus; Flucytosine; Ketoconazole; Microbial Sensitivity Tests; Rifampin; Triazoles | 1984 |
Influence of the corneal epithelium on the efficacy of topical antifungal agents.
Topics: Administration, Topical; Amphotericin B; Animals; Antifungal Agents; Candidiasis; Cornea; Corneal Diseases; Econazole; Epithelium; Flucytosine; Ketoconazole; Miconazole; Natamycin; Rabbits | 1984 |
Antimycotic activity of BAY N 7133 in animal experiments.
Topics: Administration, Oral; Administration, Topical; Amphotericin B; Animals; Antifungal Agents; Aspergillosis; Candidiasis; Cryptococcosis; Female; Flucytosine; Guinea Pigs; Hair; Infusions, Parenteral; Ketoconazole; Male; Mice; Mycoses; Triazoles | 1984 |
Systemic infection by Rhodotorula spp. in the immunocompromised host.
Topics: Adult; Amphotericin B; Bone Marrow; Flucytosine; Humans; Ketoconazole; Leukemia, Myeloid, Acute; Liver Abscess; Male; Mitosporic Fungi; Mycoses; Rhodotorula | 1984 |
Cryptococcemia.
Topics: Adrenal Cortex Hormones; Adult; Aged; Amphotericin B; Cryptococcosis; Cryptococcus neoformans; Female; Flucytosine; Host-Parasite Interactions; Humans; Lupus Erythematosus, Systemic; Male; Middle Aged; Prognosis | 1983 |
Aspergillus fumigatus endocarditis on a normal heart valve.
Topics: Aged; Amphotericin B; Aspergillosis; Aspergillus fumigatus; Bioprosthesis; Drug Therapy, Combination; Echocardiography; Endocarditis; Flucytosine; Heart Valve Diseases; Heart Valve Prosthesis; Humans; Male; Mitral Valve | 1983 |
[Candida meningitis. Case report].
Topics: Adolescent; Amphotericin B; Antibodies, Fungal; Candida albicans; Candidiasis; Female; Flucytosine; Humans; Meningitis | 1983 |
Esophageal cryptococcosis in a patient with the hyperimmunoglobulin E-recurrent infection (Job's) syndrome.
Topics: Adult; Amphotericin B; Cryptococcosis; Cryptococcus neoformans; Endoscopy; Esophageal Diseases; Flucytosine; Humans; Job Syndrome; Male; Phagocyte Bactericidal Dysfunction | 1984 |
[Pulmonary aspergillosis associated with endocarditis and cerebral embolism in a case of acute myeloblastic leukemia].
Topics: Amphotericin B; Aspergillosis; Aspergillus fumigatus; Endocarditis; Flucytosine; Humans; Intracranial Embolism and Thrombosis; Leukemia, Myeloid; Lung Diseases, Fungal; Male; Middle Aged | 1984 |
[Fungal sepsis and DIC in surgical patients].
Topics: Adult; Aged; Amphotericin B; Disseminated Intravascular Coagulation; Female; Flucytosine; Gabexate; Guanidines; Humans; Male; Middle Aged; Mycoses; Postoperative Complications | 1983 |
Pulmonary mycosis in pregnant women.
Topics: Adult; Amphotericin B; Blastomycosis; Coccidioides; Coccidioidomycosis; Cryptococcosis; Estradiol; Female; Flucytosine; Humans; Lung Diseases, Fungal; Pregnancy; Pregnancy Complications, Infectious; Risk; Stimulation, Chemical; United States | 1984 |
Primary renal candidiasis in two preterm neonates. Report of cases and review of literature on renal candidiasis in infancy.
Topics: Amphotericin B; Candidiasis; Drug Therapy, Combination; Female; Flucytosine; Humans; Hydronephrosis; Hypertension; Infant; Infant, Newborn; Infant, Premature, Diseases; Kidney Diseases; Kidney Pelvis; Male | 1984 |
[Antimycotic chemotherapy in weakened resistance].
Topics: Amphotericin B; Antifungal Agents; Azo Compounds; Disease Susceptibility; Flucytosine; Humans; Immunity, Innate; Mycoses | 1984 |
Laboratory methods for flucytosine (5-fluorocytosine). Report of a Working Group of the British Society for Mycopathology.
Topics: Amphotericin B; Antifungal Agents; Biological Assay; Candida; Culture Media; Cytosine; Drug Resistance, Microbial; Flucytosine; Microbial Sensitivity Tests | 1984 |
Systemic Candida infections in infants in intensive care nurseries: high incidence of central nervous system involvement.
Topics: Amphotericin B; Candidiasis; Central Nervous System Diseases; Female; Flucytosine; Humans; Infant; Infant, Newborn; Intensive Care Units, Neonatal; Male | 1984 |
Exogenous ocular candidiasis associated with intravenous heroin abuse.
Topics: Adult; Amphotericin B; Candidiasis; Eye Diseases; Flucytosine; Heroin; Humans; Male; Substance-Related Disorders | 1984 |
Renal candidiasis in infancy--a case with fungus ball obstruction.
Topics: Amphotericin B; Candidiasis; Flucytosine; Humans; Infant, Newborn; Kidney; Kidney Diseases; Male; Ureteral Obstruction | 1984 |
Trichosporon hepatitis.
Topics: Adult; Amphotericin B; Aspergillosis; Biopsy; Female; Flucytosine; Hepatitis; Humans; Leukemia, Myeloid; Liver; Mitosporic Fungi; Mycoses; Pregnancy; Pregnancy Complications | 1983 |
Trichosporon capitatum: thrush-like oral infection, local invasion, fungaemia and metastatic abscess formation in a leukaemic patient.
Topics: Abscess; Adult; Amphotericin B; Blood; Female; Flucytosine; Humans; Leukemia, Myeloid, Acute; Mitosporic Fungi; Mycoses; Rifampin; Splenic Diseases | 1983 |
Drug therapy of systemic fungal infections, Part II.
Topics: Amphotericin B; Antifungal Agents; Flucytosine; Humans; Miconazole; Mycoses | 1984 |
Exogenous Aspergillus endophthalmitis.
Topics: Amphotericin B; Aspergillosis; Endophthalmitis; Eye Injuries; Flucytosine; Humans; Male; Middle Aged | 1984 |
Candida peritonitis-inefficacy of amphotericin-B and 5-fluorocytosine treatment.
Topics: Amphotericin B; Candidiasis; Catheters, Indwelling; Child, Preschool; Cytosine; Drug Therapy, Combination; Flucytosine; Humans; Male; Peritoneal Dialysis; Peritoneal Dialysis, Continuous Ambulatory; Peritonitis | 1983 |
[Perinatal infections caused by unusual pathogens. 7. Candida-meningitis].
Topics: Amphotericin B; Candidiasis; Flucytosine; Humans; Infant, Newborn; Infant, Premature, Diseases; Male; Meningitis; Miconazole | 1983 |
[Cryptococcus neoformans infection. Illustrated by a case of meningitis].
Topics: Aged; Amphotericin B; Cryptococcosis; Flucytosine; Humans; Male; Meningoencephalitis | 1983 |
[Clinical pharmacology of antifungal agents in deep mycoses].
Topics: Amphotericin B; Cytosine; Dermatomycoses; Drug Interactions; Flucytosine; Humans; Imidazoles; Kidney | 1983 |
[New cases of chromoblastomycosis: importances of anatomo-pathologic examinations].
Topics: Amphotericin B; Chromoblastomycosis; Flucytosine; Humans | 1983 |
Torulopsis infection extensively involving urinary tract.
Topics: Amphotericin B; Biopsy; Candida; Flucytosine; Humans; Male; Middle Aged; Mycoses; Therapeutic Irrigation; Urinary Bladder; Urinary Tract Infections | 1983 |
Candida parapsilosis infection of a total hip-joint replacement: successful reimplantation after treatment with amphotericin B and 5-fluorocytosine. A case report.
Topics: Aged; Amphotericin B; Candidiasis; Cytosine; Drug Therapy, Combination; Female; Flucytosine; Hip Prosthesis; Humans; Reoperation; Surgical Wound Infection | 1984 |
Management of intracardiac fungal masses in premature infants.
Topics: Amphotericin B; Candidiasis; Cardiomyopathies; Female; Flucytosine; Humans; Infant, Newborn; Infant, Premature; Male | 1984 |
Systemic candidiasis in very low-birth-weight infants (less than 1,500 grams).
Topics: Amphotericin B; Candidiasis; Cytosine; Female; Flucytosine; Humans; Infant; Infant, Low Birth Weight; Infant, Newborn; Infant, Premature, Diseases | 1984 |
Disseminated fungal infections in very low-birth-weight infants: therapeutic toxicity.
Topics: Acute Kidney Injury; Amphotericin B; Cytosine; Flucytosine; Humans; Infant; Infant, Low Birth Weight; Infant, Newborn; Infant, Premature, Diseases; Mycoses; Time Factors | 1984 |
Invasive pulmonary aspergillosis in a non-immunosuppressed patient: successful management with systemic amphotericin and flucytosine and inhaled amphotericin.
Topics: Aerosols; Amphotericin B; Aspergillosis; Cytosine; Drug Therapy, Combination; Flucytosine; Humans; Immunocompetence; Lung Diseases, Fungal; Male; Middle Aged | 1984 |
[A case of lymph node aspergillosis].
Topics: Adolescent; Amphotericin B; Aspergillosis; Drug Resistance, Microbial; Female; Flucytosine; Humans; Lymph Nodes; Neck | 1984 |
The effect of Amphotericin-B, 5-fluorocytosine and Nystatin on Histoplasma farciminosum in vitro.
Topics: Amphotericin B; Cytosine; Flucytosine; Histoplasma; Nystatin | 1984 |
Successful treatment of postoperative Candida endophthalmitis in an eye with an intraocular lens implant.
Topics: Aged; Amphotericin B; Candidiasis; Cataract Extraction; Cytosine; Flucytosine; Humans; Lenses, Intraocular; Male; Orbital Diseases; Postoperative Complications | 1984 |
Candida meningitis in two children with severe combined immunodeficiency.
Topics: Amphotericin B; Candidiasis; Flucytosine; Humans; Immunologic Deficiency Syndromes; Infant; Male; Meningitis | 1984 |
Successful treatment of pulmonary and cerebral aspergillosis in an immunosuppressed child.
Topics: Amphotericin B; Aspergillosis; Aspergillus fumigatus; Brain Abscess; Child; Flucytosine; Humans; Immunosuppression Therapy; Leukemia, Lymphoid; Lung Diseases, Fungal; Male; Meningeal Neoplasms | 1982 |
Further evidence for sequential action of amphotericin B and 5-fluorocytosine against Candida albicans.
Topics: Amphotericin B; Candida albicans; Cytosine; Drug Synergism; Flucytosine | 1982 |
[Candida septicemia].
Topics: Amphotericin B; Candidiasis; Flucytosine; Humans; Male; Miconazole; Middle Aged | 1980 |
Disseminate sporotrichosis of skin and bone cured with 5-fluorocytosine: Photosensitivity as a complication.
Topics: Adult; Amphotericin B; Bone Diseases; Cytosine; Drug Therapy, Combination; Flucytosine; Humans; Male; Photosensitivity Disorders; Skin; Skin Diseases, Infectious; Sporotrichosis | 1983 |
Candida meningitis. Course, prognosis and mortality before and after introduction of the new antimycotics.
Topics: Adolescent; Adult; Aged; Amphotericin B; Antifungal Agents; Candidiasis; Child; Child, Preschool; Female; Flucytosine; Humans; Infant; Infant, Newborn; Male; Meningitis; Middle Aged; Prognosis | 1983 |
Neonatal systemic candidiasis.
Topics: Amphotericin B; Candidiasis; Drug Therapy, Combination; Flucytosine; Humans; Infant, Newborn; Infant, Newborn, Diseases | 1983 |
Assessment of antifungal therapy in an 800-gram infant with candidal arthritis and osteomyelitis.
Topics: Amphotericin B; Arthritis, Infectious; Candidiasis; Cytosine; Drug Therapy, Combination; Female; Flucytosine; Humans; Infant, Newborn; Infant, Premature, Diseases; Osteomyelitis; Outcome and Process Assessment, Health Care | 1983 |
[Bronchopulmonary pathology with hypereosinophilia of fungal origin (excluding allergic bronchopulmonary aspergillosis)].
Topics: Adult; Aged; Amphotericin B; Aspergillosis, Allergic Bronchopulmonary; Bronchial Provocation Tests; Candidiasis; Diagnosis, Differential; Female; Flucytosine; Geotrichosis; Helminthosporium; Humans; Lung Diseases, Fungal; Male; Miconazole; Middle Aged; Penicillium; Pulmonary Eosinophilia | 1983 |
[Clinical, diagnostic and therapeutic aspects of cryptococcal infection].
Topics: Amphotericin B; Cryptococcosis; Flucytosine; Humans; Injections, Spinal; Meningitis; Prognosis | 1980 |
Cryptococcal meningitis: complications due to intrathecal treatment.
Topics: Amphotericin B; Catheterization; Cryptococcosis; Drug Therapy, Combination; Female; Flucytosine; Humans; Injections, Intravenous; Injections, Intraventricular; Injections, Spinal; Injections, Subcutaneous; Meningitis; Middle Aged; Recurrence | 1980 |
Intrathecal cryptococcal lesion of the cauda equina successfully treated with intrathecal amphotericin B: A case report.
Topics: Adolescent; Amphotericin B; Cauda Equina; Cryptococcosis; Flucytosine; Granuloma; Humans; Injections, Spinal; Male; Spinal Cord Diseases | 1980 |
Drugs for fungal infections.
Topics: Adult; Amphotericin B; Antifungal Agents; Child; Flucytosine; Griseofulvin; Humans; Miconazole; Mycoses; Nystatin; Potassium Iodide; Stilbamidines; Tolnaftate | 1980 |
Zygomycosis caused by Cunninghamella bertholletiae: mycologic aspects.
Topics: Amphotericin B; Flucytosine; Humans; Lung; Miconazole; Microbial Sensitivity Tests; Mucorales; Mucormycosis; Sputum | 1982 |
Ocular cryptococcosis in New Zealand.
Topics: Adult; Amphotericin B; Cryptococcosis; Eye Diseases; Female; Flucytosine; Humans; Lung Abscess | 1980 |
Vertebral disc space infection and osteomyelitis due to Candida albicans in a patient with acute myelomonocytic leukemia.
Topics: Aged; Amphotericin B; Candidiasis; Flucytosine; Humans; Intervertebral Disc; Leukemia, Myeloid, Acute; Lumbar Vertebrae; Male; Osteomyelitis; Radiography; Spinal Diseases | 1980 |
Disseminated cryptococcosis after transurethral resection of the prostate.
Topics: Amphotericin B; Cryptococcosis; Flucytosine; Humans; Lung Diseases, Fungal; Male; Middle Aged; Prostatectomy; Prostatitis; Transfer Factor; Urethra | 1982 |
Endogenous Candida endophthalmitis in infants.
Topics: Amphotericin B; Candidiasis; Ductus Arteriosus, Patent; Endophthalmitis; Female; Flucytosine; Humans; Infant; Infant, Newborn; Infant, Premature; Intestinal Obstruction; Intestine, Small; Male; Nystatin; Oxygen | 1980 |
[Clinical and therapeutic aspects of Candida endophthalmitis].
Topics: Amphotericin B; Candidiasis; Cytosine; Drug Therapy, Combination; Endophthalmitis; Female; Flucytosine; Humans; Imidazoles; Sepsis | 1980 |
Bilateral endogenous necrotizing scleritis due to Aspergillus oryzae.
Topics: Adolescent; Adult; Amphotericin B; Aspergillosis; Aspergillus oryzae; Child; Cocaine; Eye Diseases; Female; Flucytosine; Heroin; Humans; Inflammation; Injections, Intravenous; Meningitis; Natamycin; Sclera; Substance-Related Disorders | 1982 |
Endogenous Aspergillus endophthalmitis in drug abusers.
Topics: Adult; Amphotericin B; Aspergillosis; Endophthalmitis; Female; Flucytosine; Humans; Microbiological Techniques; Substance-Related Disorders; Visual Acuity; Vitreous Body | 1980 |
Amphotericin B and 5-fluorocytosine: effects on cell-mediated immunity.
Topics: Amphotericin B; Animals; Cytosine; Female; Flucytosine; Guinea Pigs; Immunity, Cellular; Leukocyte Count; Lymphocyte Activation; Macrophage Migration-Inhibitory Factors; Skin Tests; T-Lymphocytes | 1980 |
[Cryptococcal meningoencephalitis functioning as expansive process. Report of a case].
Topics: Adult; Amphotericin B; Biopsy; Cryptococcosis; Cryptococcus neoformans; Drug Therapy, Combination; Flucytosine; Humans; Male; Meningoencephalitis | 1980 |
Peritoneal clearance of amphotericin B and 5-fluorocytosine.
Topics: Amphotericin B; Cryptococcosis; Cytosine; Flucytosine; Humans; Kidney Transplantation; Male; Middle Aged; Peritoneal Dialysis; Transplantation, Homologous | 1980 |
[Treatment of chromoblastomycosis with amphotericin B and 5-fluorocytosine].
Topics: Administration, Oral; Aged; Amphotericin B; Chromoblastomycosis; Cytosine; Drug Therapy, Combination; Flucytosine; Humans; Infusions, Parenteral; Male | 1981 |
Disseminated cutaneous cryptococcosis.
Topics: Aged; Amphotericin B; Cryptococcosis; Cryptococcus neoformans; Dermatomycoses; Female; Flucytosine; Humans | 1981 |
Cryptococcal meningitis. A review of 32 years experience.
Topics: Adolescent; Adult; Aged; Amphotericin B; Antigens, Fungal; Australia; Child; Cryptococcosis; Cryptococcus neoformans; Diagnosis, Differential; Ethnicity; Female; Flucytosine; Follow-Up Studies; Humans; Male; Meningitis; Miconazole; Middle Aged; Tomography, X-Ray Computed | 1982 |
Cerebral abscess caused by Cladosporium bantianum. Case report.
Topics: Amphotericin B; Brain Abscess; Cladosporium; Female; Flucytosine; Humans; Hydrocephalus; Microbiological Techniques; Middle Aged; Mitosporic Fungi; Mycoses; Pulmonary Embolism | 1982 |
Combined in vitro activity of amphotericin B and 5-fluorocytosine against Cryptococcus neoformans and Candida albicans.
Topics: Amphotericin B; Candida albicans; Cryptococcus; Cryptococcus neoformans; Cytosine; Drug Synergism; Flucytosine; Microbial Sensitivity Tests | 1982 |
[Cryptococcosis of the CNS].
Topics: Amphotericin B; Bacteriological Techniques; Cryptococcosis; Diagnosis, Differential; Flucytosine; Humans; Male; Meningitis; Meningoencephalitis; Middle Aged; Myelitis; Prognosis | 1982 |
Cryptococcal osteomyelitis. Report of a case amd a review of the literature.
Topics: Amphotericin B; Child; Cryptococcosis; Female; Flucytosine; Humans; Osteomyelitis | 1982 |
Treatment of systemic fungus infections.
Topics: Amphotericin B; Antifungal Agents; Flucytosine; Humans; Miconazole; Mycoses | 1982 |
Antemortem diagnosis and treatment of cryptococcal meningitis in a horse.
Topics: Amphotericin B; Animals; Cryptococcosis; Cytosine; Drug Therapy, Combination; Flucytosine; Horse Diseases; Horses; Male; Meningitis | 1982 |
Candida lung abscess: successful treatment with amphotericin B and 5-flucytosine.
Topics: Amphotericin B; Candidiasis; Cytosine; Drug Therapy, Combination; Flucytosine; Humans; Lung Abscess; Male; Middle Aged | 1982 |
Ulcerating enteritis associated with flucytosine therapy.
Topics: Aged; Amphotericin B; Biopsy; Cryptococcosis; Cytosine; Diarrhea; Flucytosine; Humans; Ileitis; Ileum; Male; Radiography; Ulcer | 1982 |
Cerebral candidiasis: CT studies in a case of brain abscess and granuloma due to Candida albicans.
Topics: Adult; Amphotericin B; Brain Abscess; Candidiasis; Female; Flucytosine; Granuloma; Humans; Tomography, X-Ray Computed | 1982 |
Success with amphotericin B and 5-fluorocytosine in treating cerebral cryptococcoma accompanying cryptococcal meningitis.
Topics: Adult; Amphotericin B; Brain Diseases; Cryptococcosis; Cytosine; Flucytosine; Humans; Male; Meningitis | 1982 |
[Systemic candidiasis: the clinico-therapeutic picture].
Topics: Amphotericin B; Antifungal Agents; Candidiasis; Flucytosine; Humans | 1982 |
Neonatal systemic candidiasis: a failure to respond to intravenous miconazole in two neonates.
Topics: Amphotericin B; Candidiasis; Drug Therapy, Combination; Flucytosine; Humans; Imidazoles; Infant, Newborn; Infant, Premature, Diseases; Injections, Intravenous; Male; Miconazole | 1982 |
[Antifungal agents in otorhinolaryngology].
Topics: Amphotericin B; Antifungal Agents; Drug Therapy, Combination; Flucytosine; Humans; Imidazoles; Mycoses; Otorhinolaryngologic Diseases | 1982 |
High performance liquid chromatographic (HPLC) and other non-biological methods for quantitation of antifungal drugs.
Topics: Amphotericin B; Antifungal Agents; Body Fluids; Chromatography, High Pressure Liquid; Flucytosine; Griseofulvin; Humans; Miconazole | 1982 |
[Usefulness of computed tomography in the diagnosis of cryptococcal meningoencephalitis--multiple low density lesions in the basal ganglia and corona radiata].
Topics: Adult; Amphotericin B; Basal Ganglia; Cryptococcosis; Female; Flucytosine; Humans; Male; Meningoencephalitis; Tomography, X-Ray Computed | 1982 |
[Candida albicans spondylitis. Review of the literature apropos of a case with study of bone penetration of 5-fluorocytosine].
Topics: Amphotericin B; Candidiasis; Cytosine; Drug Therapy, Combination; Flucytosine; Humans; Intervertebral Disc; Male; Middle Aged; Spondylitis | 1982 |
Cryptococcosis in the United Kingdom and the Irish Republic: an analysis of 69 cases.
Topics: Adolescent; Adrenal Cortex Hormones; Adult; Aged; Amphotericin B; Antigens, Fungal; Child; Collagen Diseases; Cryptococcosis; Female; Flucytosine; Hodgkin Disease; Humans; Ireland; Latex Fixation Tests; Male; Middle Aged; Neoplasms; Sarcoidosis; United Kingdom | 1980 |
Combined action of amphotericin B and 5-fluorocytosine on pathogenic yeasts susceptible to either drug alone.
Topics: Amphotericin B; Candida; Cytosine; Drug Synergism; Flucytosine; Yeasts | 1981 |
Candida endophthalmitis in the premature infant.
Topics: Amphotericin B; Candidiasis; Flucytosine; Humans; Infant, Newborn; Infant, Premature, Diseases; Male; Ophthalmia Neonatorum; Ophthalmoscopy; Prognosis; Prospective Studies | 1981 |
Infectious complications in the child with cancer. II. Management of specific infectious organisms.
Topics: Amphotericin B; Bacterial Infections; Child; Flucytosine; Humans; Infections; Mycoses; Neoplasms; Protozoan Infections; Virus Diseases | 1981 |
Endogenous cryptococcal endophthalmitis.
Topics: Amphotericin B; Cryptococcosis; Eye Diseases; Female; Flucytosine; Humans; Middle Aged | 1981 |
Primary pituitary aspergillosis responding to transsphenoidal surgery and combined therapy with amphotericin-B and 5-fluorocytosine: case report.
Topics: Amphotericin B; Aspergillosis; Brain Abscess; Cytosine; Drug Therapy, Combination; Female; Flucytosine; Humans; Middle Aged; Pituitary Diseases; Postoperative Period | 1981 |
[The treatment of pulmonary fungal infections: the results and the problems (author's transl)].
Topics: Adolescent; Adult; Aged; Amphotericin B; Child; Female; Flucytosine; Humans; Lung Diseases, Fungal; Male; Middle Aged; Prognosis | 1980 |
Recent developments in the therapy of chromoblastomycosis.
Topics: Amphotericin B; Chromoblastomycosis; Cytosine; Drug Resistance, Microbial; Drug Synergism; Flucytosine; Humans | 1981 |
Cryptococcal meningitis in pregnancy.
Topics: Adolescent; Adult; Amphotericin B; Cryptococcosis; Female; Flucytosine; Humans; Meningitis; Pregnancy; Pregnancy Complications, Infectious | 1981 |
[Management of visceral mycoses, with special reference to drug therapy].
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Candidiasis; Flucytosine; Humans; Lung Diseases, Fungal; Mycoses | 1980 |
[Cryptococcus neoformans. An unusual cause of basal meningitis. Case report (author's transl)].
Topics: Adult; Amphotericin B; Cryptococcosis; Diagnosis, Differential; Drug Therapy, Combination; Female; Flucytosine; Humans; Meningitis; Tuberculosis, Meningeal | 1981 |
[Present status and future prospect in the studies of antifungal agents].
Topics: Amphotericin B; Antifungal Agents; Clotrimazole; Flucytosine; Humans; Imidazoles; Mycoses | 1981 |
[Combined Tb and Candida meningitis in an 8-year old boy (author's transl)].
Topics: Amphotericin B; Candidiasis; Child; Ethambutol; Flucytosine; Humans; Isoniazid; Male; Meningitis; Streptomycin; Tuberculosis, Meningeal | 1981 |
[Sensitivity of Candida spp. to 5-fluorocytosine, amphotericin B and imidazoles. Antifongiogram of 120 strains isolated at the Vaudois University Hospital Center during the autumn-winter seasons of 1978 and 1980].
Topics: Amphotericin B; Candidiasis; Cytosine; Flucytosine; Humans; Imidazoles; Microbial Sensitivity Tests; Species Specificity | 1981 |
[New pharmaceuticals in systemic mycoses (author's transl)].
Topics: Amphotericin B; Antifungal Agents; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Flucytosine; Humans; Imidazoles; Miconazole; Mycoses | 1981 |
Practical therapeutics chemotherapy of fungal infections.
Topics: Amphotericin B; Antifungal Agents; Drug Evaluation; Flucytosine; Griseofulvin; Humans; Mycoses | 1981 |
[Microbial sensitivity tests with antifungal agents and their determination in body fluids].
Topics: Amphotericin B; Antifungal Agents; Flucytosine; Fungi; Humans; Microbial Sensitivity Tests; Mycoses | 1981 |
[Urinary tract infections caused by yeasts].
Topics: Amphotericin B; Female; Flucytosine; Humans; Male; Urinary Tract Infections; Yeasts | 1981 |
[Treatment of systemic mycoses].
Topics: Amphotericin B; Cytosine; Flucytosine; Humans; Mycoses | 1981 |
Treating fungal infections.
Topics: Amphotericin B; Drug Therapy, Combination; Flucytosine; Humans; Imidazoles; Mycoses | 1980 |
[Cryptococcosis in the light of three cases (author's transl)].
Topics: Adult; Amphotericin B; Cryptococcosis; Cytosine; Female; Flucytosine; Humans; Male; Meningitis; Middle Aged | 1980 |
Management of central nervous system cryptococcosis.
Topics: Amphotericin B; Brain Diseases; Central Nervous System Diseases; Cryptococcosis; Flucytosine; Humans | 1980 |
Fungal cystitis: awareness, diagnosis and treatment.
Topics: Amphotericin B; Candidiasis; Cystitis; Female; Flucytosine; Humans; Male; Middle Aged; Mycoses | 1980 |
Flucytosine in the management of genitourinary candidiasis: 5 years of experience.
Topics: Agranulocytosis; Amphotericin B; Candidiasis; Cytosine; Female; Flucytosine; Genital Diseases, Female; Genital Diseases, Male; Humans; Male; Urinary Tract Infections | 1980 |
Antifungal antibiotic sensitivity testing: use of Autobac 1 for standardization purposes.
Topics: Amphotericin B; Antifungal Agents; Candida; Clotrimazole; Econazole; Flucytosine; Miconazole; Microbial Sensitivity Tests; Nystatin | 1980 |
Subcutaneous infection with phialophora richardsiae and its susceptibility to 5-fluorocytosine, amphotericin B and miconazole.
Topics: Adult; Aged; Amphotericin B; Cycloheximide; Cytosine; Drug Resistance, Microbial; Flucytosine; Humans; Imidazoles; Male; Miconazole; Mycoses; Phialophora | 1980 |
Cutaneous cryptococcosis.
Topics: Adult; Amphotericin B; Cryptococcosis; Dermatomycoses; Drug Therapy, Combination; Female; Flucytosine; Humans; Skin | 1980 |
[Systemic antifungal treatments].
Topics: Amphotericin B; Antifungal Agents; Flucytosine; Humans; Imidazoles | 1980 |
[Paranasal sinus mycetoma with orbital involvement in a patient with AIDS].
Topics: Abscess; Adult; AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Aspergillosis; Biopsy, Needle; Candidiasis; Diagnosis, Differential; Flucytosine; Humans; Male; Maxillary Sinus; Maxillary Sinusitis; Mycetoma; Orbit; Tomography, X-Ray Computed | 1995 |
Diagnosis of disseminated candidiasis by fine needle aspiration of lymph node and by splenic imprint in a patient with acute promyelocytic leukemia.
Topics: Adult; Amphotericin B; Antifungal Agents; Biopsy, Needle; Candida; Candidiasis; Flucytosine; Humans; Leukemia, Promyelocytic, Acute; Lymph Nodes; Male; Spleen; Tomography, X-Ray Computed | 1995 |
Oral cryptococcosis in a patient with AIDS. A case report.
Topics: AIDS-Related Opportunistic Infections; Amphotericin B; Cryptococcosis; Dental Care for Chronically Ill; Drug Therapy, Combination; Fatal Outcome; Flucytosine; Gingival Diseases; Humans; Male; Middle Aged; Mouth Diseases; Ulcer | 1995 |
Defining conditions for microbroth antifungal susceptibility tests: influence of RPMI and RPMI-2% glucose on the selection of endpoint criteria.
Topics: Amphotericin B; Antifungal Agents; Candida albicans; Culture Media; Flucytosine; Glucose; Ketoconazole; Microbial Sensitivity Tests; Nephelometry and Turbidimetry | 1995 |
Drugs for AIDS and associated infections.
Topics: Acquired Immunodeficiency Syndrome; AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Antiprotozoal Agents; Antiviral Agents; Atovaquone; Candidiasis, Oral; Clindamycin; Clotrimazole; Cryptosporidiosis; Cytomegalovirus Infections; Dapsone; Didanosine; Drug Combinations; Drug Therapy, Combination; Fluconazole; Flucytosine; Folic Acid Antagonists; Foscarnet; Glucuronates; Herpes Simplex; Herpes Zoster; Humans; Isoniazid; Itraconazole; Ketoconazole; Lamivudine; Mycobacterium avium-intracellulare Infection; Naphthoquinones; Nystatin; Pentamidine; Pneumocystis Infections; Pneumonia, Pneumocystis; Prednisone; Primaquine; Reverse Transcriptase Inhibitors; Stavudine; Syphilis; Toxoplasmosis; Trimetrexate; Tuberculosis; Zalcitabine; Zidovudine | 1995 |
Candidal brain abscess associated with vascular invasion: a devastating complication of vascular catheter-related candidemia.
Topics: Amphotericin B; Arterial Occlusive Diseases; Brain; Brain Abscess; Candida albicans; Candidiasis; Carotid Artery Diseases; Carotid Artery, Internal; Catheterization, Central Venous; Cerebral Arteries; Craniotomy; Drug Therapy, Combination; Flucytosine; Fungemia; Humans; Magnetic Resonance Angiography; Male; Middle Aged; Tomography, X-Ray Computed | 1995 |
Comparison of fluconazole, amphotericin B and flucytosine in treatment of a murine model of disseminated infection with Candida glabrata in immunocompromised mice.
Topics: Amphotericin B; Animals; Candidiasis; Colony Count, Microbial; Drug Therapy, Combination; Fluconazole; Flucytosine; Immunosuppression Therapy; Kidney; Male; Mice; Mice, Inbred ICR; Spleen | 1995 |
Candida albicans brain abscesses in a premature infant treated with amphotericin B, flucytosine and fluconazole.
Topics: Amphotericin B; Brain Abscess; Candidiasis; Drug Therapy, Combination; Female; Fluconazole; Flucytosine; Fungemia; Humans; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Tomography, X-Ray Computed | 1995 |
[A case of primary pulmonary cryptococcosis associated with pneumothorax].
Topics: Adult; Amphotericin B; Cryptococcosis; Female; Flucytosine; Humans; Lung Diseases, Fungal; Pneumothorax | 1995 |
Intracatheter amphotericin B retention for fungal peritonitis in continuous ambulatory peritoneal dialysis.
Topics: Administration, Oral; Amphotericin B; Catheters, Indwelling; Drug Therapy, Combination; Female; Flucytosine; Humans; Male; Middle Aged; Mycoses; Peritoneal Dialysis, Continuous Ambulatory; Peritonitis | 1995 |
Quality control guidelines for National Committee for Clinical Laboratory Standards recommended broth macrodilution testing of amphotericin B, fluconazole, and flucytosine.
Topics: Amphotericin B; Candida; Candida albicans; Cryptococcus neoformans; Fluconazole; Flucytosine; Humans; Microbial Sensitivity Tests; Quality Control; Reference Standards; Saccharomyces cerevisiae; Species Specificity; Yeasts | 1995 |
Effect of increasing inoculum sizes of pathogenic filamentous fungi on MICs of antifungal agents by broth microdilution method.
Topics: Amphotericin B; Antifungal Agents; Aspergillus flavus; Aspergillus fumigatus; Colony Count, Microbial; Evaluation Studies as Topic; Flucytosine; Fungi; Fusarium; Humans; Itraconazole; Miconazole; Microbial Sensitivity Tests; Mycoses; Pseudallescheria; Rhizopus; Species Specificity | 1995 |
In vitro activity of amphotericin B, flucytosine and fluconazole against yeasts causing bloodstream infections.
Topics: Amphotericin B; Fluconazole; Flucytosine; Fungemia; Humans; Microbial Sensitivity Tests; Yeasts | 1995 |
Urinary tract candidiasis in neonates and infants.
Topics: Amphotericin B; Candidiasis; Female; Fluconazole; Flucytosine; Humans; Infant; Infant, Newborn; Male; Urinary Tract Infections | 1995 |
In vitro susceptibilities of clinical yeast isolates to three antifungal agents determined by the microdilution method.
Topics: Amphotericin B; Antifungal Agents; Candida; Dose-Response Relationship, Drug; Fluconazole; Flucytosine; Humans; Microbial Sensitivity Tests; Mycoses; Yeasts | 1995 |
Cryptococcal meningitis in children in Papua New Guinea: a reminder.
Topics: Amphotericin B; Child; Drug Therapy, Combination; Flucytosine; Follow-Up Studies; Humans; Male; Meningitis, Cryptococcal; Papua New Guinea | 1994 |
High prevalence of antifungal resistance in Candida spp. from patients with AIDS.
Topics: AIDS-Related Opportunistic Infections; Amphotericin B; Candida; Drug Resistance, Microbial; Fluconazole; Flucytosine; Humans; Microbial Sensitivity Tests | 1994 |
Cryptococcosis after renal transplantation.
Topics: Adult; Amphotericin B; Cryptococcosis; Fluconazole; Flucytosine; Humans; Kidney Transplantation; Male; Middle Aged; Postoperative Complications; Retrospective Studies | 1995 |
Comparative capacity of four antifungal agents to stimulate murine macrophages to produce tumour necrosis factor alpha: an effect that is attenuated by pentoxifylline, liposomal vesicles, and dexamethasone.
Topics: Amphotericin B; Animals; Antifungal Agents; Candida albicans; Cell Death; Dexamethasone; Female; Fluconazole; Flucytosine; Liposomes; Macrophages; Macrophages, Peritoneal; Mice; Pentoxifylline; Tumor Necrosis Factor-alpha | 1994 |
Magnetic resonance image findings of spinal intramedullary abscess caused by Candida albicans: case report.
Topics: Abscess; Amphotericin B; Candidiasis; Flucytosine; Humans; Magnetic Resonance Imaging; Male; Medulla Oblongata; Middle Aged; Spinal Cord Diseases | 1995 |
The effect of antifungal agents on the in vitro susceptibility of Candida albicans to apo-lactoferrin.
Topics: Amphotericin B; Antifungal Agents; Apoproteins; Candida albicans; Cell Death; Cell Wall; Clotrimazole; Drug Resistance, Microbial; Ergosterol; Flucytosine; Lactoferrin; Membrane Glycoproteins; Miconazole; Nystatin; Tunicamycin | 1994 |
Probable disseminated cerebral aspergillosis: recovery with medical treatment.
Topics: Amphotericin B; Aspergillosis; Brain Diseases; Child; Flucytosine; Humans; Immunocompromised Host; Itraconazole; Lung Diseases, Fungal; Male; Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1994 |
Cryptococcosis, AIDS, and clinical trials.
Topics: Acquired Immunodeficiency Syndrome; Amphotericin B; Cryptococcosis; Drug Resistance; Drug Therapy, Combination; Fluconazole; Flucytosine; Humans; Meningitis, Cryptococcal | 1995 |
Variations in DNA subtype, antifungal susceptibility, and slime production among clinical isolates of Candida parapsilosis.
Topics: Amphotericin B; Candida; Candidiasis; Cross Infection; DNA, Fungal; Fluconazole; Flucytosine; Humans; Itraconazole; Karyotyping; Microbial Sensitivity Tests; Molecular Epidemiology | 1995 |
A comparison of susceptibility to five antifungal agents of yeast cultures from burn patients.
Topics: Amphotericin B; Antifungal Agents; Burns; Candida; Drug Resistance, Microbial; Fluconazole; Flucytosine; Humans; Ketoconazole; Miconazole; Microbial Sensitivity Tests; Trichosporon; Yeasts | 1995 |
[Hepatic candidiasis caused by Candida glabrata].
Topics: Aged; Amphotericin B; Candidiasis; Female; Flucytosine; Humans; Liver Abscess; Liver Diseases | 1994 |
Association therapy as a prognostic factor in deep fungal infection complicating oncohaematological diseases.
Topics: Adolescent; Adult; Amphotericin B; Aspergillosis; Aspergillus; Bronchoalveolar Lavage Fluid; Cryptococcus; Drug Therapy, Combination; Female; Flucytosine; Humans; Lung Diseases, Fungal; Lymphoproliferative Disorders; Male; Middle Aged; Mycoses; Prognosis; Retrospective Studies; Risk Factors; Survival Rate | 1994 |
Hepatic involvement culminating in cirrhosis in a child with disseminated cryptococcosis.
Topics: Amphotericin B; Child; Cholestasis, Extrahepatic; Cryptococcosis; Flucytosine; Hepatitis; Humans; Liver; Liver Cirrhosis; Lymphatic Diseases; Male | 1995 |
Selection of candidate quality control isolates and tentative quality control ranges for in vitro susceptibility testing of yeast isolates by National Committee for Clinical Laboratory Standards proposed standard methods.
Topics: Amphotericin B; Antifungal Agents; Candida; Fluconazole; Flucytosine; Microbial Sensitivity Tests; Quality Control; Reference Values; Saccharomyces cerevisiae; Yeasts | 1994 |
Cryptococcosis in renal allograft recipients.
Topics: Amphotericin B; Female; Flucytosine; Graft Rejection; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Meningitis, Cryptococcal; Transplantation, Homologous | 1994 |
Multicenter comparison of a colorimetric microdilution broth method with the reference macrodilution method for in vitro susceptibility testing of yeast isolates.
Topics: Amphotericin B; Antifungal Agents; Colony Count, Microbial; Colorimetry; Fluconazole; Flucytosine; Humans; Microbial Sensitivity Tests; Reference Standards; Reference Values; Yeasts | 1994 |
The postantibiotic effect of antifungal agents against common pathogenic yeasts.
Topics: Amphotericin B; Candida; Cryptococcus neoformans; Flucytosine; Ketoconazole; Miconazole; Microbial Sensitivity Tests | 1994 |
Aspergillus spondylodiscitis: successful conservative treatment in 9 cases.
Topics: Adult; Aged; Amphotericin B; Aspergillosis; Discitis; Drug Therapy, Combination; Female; Flucytosine; Humans; Immunosuppression Therapy; Itraconazole; Lumbar Vertebrae; Magnetic Resonance Imaging; Male; Middle Aged; Myelography; Retrospective Studies; Spondylitis; Thoracic Vertebrae | 1994 |
Comparison of broth dilution and semisolid agar dilution for in vitro susceptibility testing of Cryptococcus neoformans.
Topics: Amphotericin B; Antifungal Agents; Blood; Cerebrospinal Fluid; Cryptococcus neoformans; Fluconazole; Flucytosine; Humans; Itraconazole; Ketoconazole; Miconazole; Microbial Sensitivity Tests; Skin | 1994 |
Comparative in vitro activity of antimycotic agents against pathogenic vaginal yeast isolates.
Topics: Amphotericin B; Antifungal Agents; Azoles; Candida; Candida albicans; Candidiasis, Vulvovaginal; Female; Flucytosine; Humans; Incidence; Microbial Sensitivity Tests; Mycoses; Prevalence; Saccharomyces cerevisiae; Vaginitis | 1994 |
Cryptococcus neoformans vertebral osteomyelitis.
Topics: Aged; Amphotericin B; Antigens, Fungal; Biopsy; Cryptococcosis; Cryptococcus neoformans; Drug Therapy, Combination; Female; Flucytosine; Humans; Osteomyelitis; Spinal Diseases | 1994 |
Latex agglutination test negative cryptococcal meningitis in an immuno-competent individual: a case report.
Topics: Aged; Amphotericin B; Brain; Cryptococcus neoformans; Flucytosine; Humans; Latex Fixation Tests; Male; Meningitis, Cryptococcal | 1994 |
Evaluation of a novel colorimetric broth microdilution method for antifungal susceptibility testing of yeast isolates.
Topics: Amphotericin B; Antifungal Agents; Candida; Colorimetry; Cryptococcus neoformans; Dose-Response Relationship, Drug; Fluconazole; Flucytosine; Microbial Sensitivity Tests; Mycology; Oxidation-Reduction; Yeasts | 1994 |
Management of deep Candida infection in surgical and intensive care unit patients. British Society for Antimicrobial Chemotherapy Working Party.
Topics: Adult; Amphotericin B; Antifungal Agents; Candidiasis; Fluconazole; Flucytosine; Humans; Infant, Newborn; Risk Factors | 1994 |
Correlation between in vitro and in vivo activity of antifungal agents against Candida species.
Topics: Amphotericin B; Animals; Antifungal Agents; Candida; Candida albicans; Candidiasis; Dose-Response Relationship, Drug; Fluconazole; Flucytosine; Male; Mice; Microbial Sensitivity Tests | 1994 |
Cryptococcal meningitis (C. neoformans var. gattii) leading to blindness in previously healthy Melanesian adults in Papua New Guinea.
Topics: Adolescent; Adult; Amphotericin B; Blindness; Child; Cryptococcus neoformans; Female; Flucytosine; Humans; Leukocyte Count; Male; Meningitis, Cryptococcal; Middle Aged; Papua New Guinea; Recurrence; Treatment Outcome | 1994 |
Fungemia and colonization with nystatin-resistant Candida rugosa in a burn unit.
Topics: Amphotericin B; Burn Units; Burns; Candida; Candidiasis; Case-Control Studies; Cross Infection; Fluconazole; Flucytosine; Humans; Ketoconazole; Microbial Sensitivity Tests; Nystatin; Retrospective Studies | 1994 |
Comparative analysis of three antifungal susceptibility test methods against prospectively collected Candida species.
Topics: Amphotericin B; Candida; Candidiasis; Drug Resistance, Microbial; Echinocandins; Esophagitis; Evaluation Studies as Topic; Flucytosine; Fungemia; Humans; Microbial Sensitivity Tests; Peptides, Cyclic; Prospective Studies | 1994 |
Successful treatment of resistant cryptococcal meningitis with amphotericin B lipid emulsion after nephrotoxicity with conventional intravenous amphotericin B.
Topics: Adult; AIDS-Related Opportunistic Infections; Amphotericin B; Drug Resistance, Microbial; Fat Emulsions, Intravenous; Flucytosine; HIV Seropositivity; Humans; Itraconazole; Kidney Diseases; Male; Meningitis, Cryptococcal | 1994 |
Neonatal candidiasis associated with meningitis and endophthalmitis.
Topics: Amphotericin B; Candidiasis; Endophthalmitis; Flucytosine; Humans; Infant; Infant, Newborn; Meningitis, Fungal; Prognosis | 1994 |
Antagonistic effects of fluconazole and 5-fluorocytosine on candidacidal action of amphotericin B in human serum.
Topics: Amphotericin B; Blood Physiological Phenomena; Candida albicans; Flow Cytometry; Fluconazole; Flucytosine; Humans | 1994 |
Disseminated lymphonodular cryptococcosis in a child with X-linked hyper-IgM immunodeficiency.
Topics: Agammaglobulinemia; Amphotericin B; Child, Preschool; Cryptococcosis; Drug Therapy, Combination; Fluconazole; Flucytosine; Genetic Linkage; Humans; Immunoglobulin M; Male; X Chromosome | 1994 |
[In vitro susceptibility to fluconazole of fungal strains freshly isolated from child patients with deep-seated mycoses].
Topics: Amphotericin B; Aspergillus; Candida; Child; Drug Resistance, Microbial; Fluconazole; Flucytosine; Humans; Mycoses | 1993 |
Association of Torulopsis glabrata infections with fluconazole prophylaxis in neutropenic bone marrow transplant patients.
Topics: Amphotericin B; Bacterial Infections; Bone Marrow Transplantation; Candida; Candidiasis; Fluconazole; Flucytosine; Humans; Leukemia; Microbial Sensitivity Tests; Neutropenia | 1993 |
[Unusual course of candidiasis of the central nervous system].
Topics: Adolescent; Amphotericin B; Antitubercular Agents; Brain Diseases; Candida albicans; Candidiasis; Candidiasis, Vulvovaginal; Cerebrospinal Fluid; Diagnosis, Differential; Female; Flucytosine; Humans; Hydrocephalus; Pelvic Inflammatory Disease; Pyelonephritis; Tomography, X-Ray Computed; Tuberculosis, Meningeal | 1994 |
[Congenital candida infections].
Topics: Adult; Amniocentesis; Amphotericin B; Candidiasis; Candidiasis, Cutaneous; Candidiasis, Oral; Candidiasis, Vulvovaginal; Chorioamnionitis; Drug Therapy, Combination; Endophthalmitis; Female; Fetal Membranes, Premature Rupture; Flucytosine; Humans; Infant, Newborn; Infant, Premature, Diseases; Male; Nystatin; Pregnancy | 1993 |
Response to antifungal therapy by human immunodeficiency virus-infected patients with disseminated Penicillium marneffei infections and in vitro susceptibilities of isolates from clinical specimens.
Topics: Acquired Immunodeficiency Syndrome; Amphotericin B; Antifungal Agents; Azoles; Flucytosine; Humans; Microbial Sensitivity Tests; Mycoses; Penicillium | 1993 |
Systemic antifungal drugs.
Topics: Amphotericin B; Antifungal Agents; Drug Interactions; Fluconazole; Flucytosine; Humans; Itraconazole; Ketoconazole; Mycoses | 1994 |
In vitro susceptibility of mycelial and yeast forms of Penicillium marneffei to amphotericin B, fluconazole, 5-fluorocytosine and itraconazole.
Topics: Amphotericin B; Antifungal Agents; Fluconazole; Flucytosine; Itraconazole; Microbial Sensitivity Tests; Microbiological Techniques; Penicillium; Phenotype | 1993 |
[Candida meningitis, in a premature infant, treated with liposomal amphotericin B and flucytosine].
Topics: Amphotericin B; Candidiasis; Drug Carriers; Flucytosine; Humans; Infant, Newborn; Infant, Premature; Liposomes; Meningitis, Fungal | 1993 |
Systemic and gastrointestinal candidiasis of infant mice as model for antifungal therapy.
Topics: Amphotericin B; Animals; Candidiasis; Disease Models, Animal; Fluconazole; Flucytosine; Fungemia; Gastrointestinal Diseases; Mice | 1993 |
Treatment of cryptococcal meningitis with short-course amphotericin B and flucytosine, followed by itraconazole.
Topics: Adult; Amphotericin B; Antifungal Agents; Female; Flucytosine; Humans; Itraconazole; Ketoconazole; Male; Meningitis, Cryptococcal; Middle Aged | 1993 |
Pharmacokinetics of antifungal agents.
Topics: Amphotericin B; Antifungal Agents; Fluconazole; Flucytosine; Humans; Ketoconazole; Mycoses; Peritoneal Dialysis, Continuous Ambulatory; Peritonitis | 1993 |
Efficacy and tolerance of an amphotericin B lipid (Intralipid) emulsion in the treatment of candidaemia in neutropenic patients.
Topics: Adult; Aged; Amphotericin B; Candida; Candidiasis; Fat Emulsions, Intravenous; Female; Flucytosine; Humans; Infusions, Intravenous; Male; Middle Aged; Neutropenia; Species Specificity | 1993 |
Topical treatment of pulmonary aspergilloma by antifungals. Relationship between duration of the disease and efficacy of therapy.
Topics: Aged; Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Aspergillus niger; Female; Fluconazole; Flucytosine; Humans; Instillation, Drug; Lung; Lung Diseases, Fungal; Male; Miconazole; Microbial Sensitivity Tests; Middle Aged; Radiography; Time Factors; Treatment Outcome | 1993 |
Urinary tract infections caused by Candida species.
Topics: Amphotericin B; Azoles; Candidiasis; Flucytosine; Humans; Urinary Tract Infections | 1993 |
Comparative effects of antifungal agents on zidovudine glucuronidation by human liver microsomes.
Topics: Amphotericin B; Antifungal Agents; Antiviral Agents; Chromatography, High Pressure Liquid; Fluconazole; Flucytosine; Glucuronates; Humans; Itraconazole; Ketoconazole; Miconazole; Microsomes, Liver; Zidovudine | 1995 |
Successful treatment of fungal peritonitis with intracatheter antifungal retention.
Topics: Amphotericin B; Antifungal Agents; Candidiasis; Catheters, Indwelling; Female; Fluconazole; Flucytosine; Humans; Male; Middle Aged; Mycoses; Peritoneal Dialysis, Continuous Ambulatory; Peritonitis; Rhodotorula | 1995 |
Systemic antifungal drugs.
Topics: Amphotericin B; Antifungal Agents; Drug Interactions; Fluconazole; Flucytosine; Humans; Itraconazole; Ketoconazole; Mycoses | 1996 |
Cryptococcal meningitis after liver transplantation.
Topics: Adult; Amphotericin B; Antifungal Agents; Female; Flucytosine; Humans; Immunosuppression Therapy; Liver Transplantation; Male; Meningitis, Cryptococcal; Middle Aged | 1996 |
Cutaneous Acanthamoeba infection in the acquired immunodeficiency syndrome: response to multidrug therapy.
Topics: Acanthamoeba; Adult; AIDS-Related Opportunistic Infections; Amebiasis; Amebicides; Amphotericin B; Animals; Anti-Bacterial Agents; Antimetabolites; Antiparasitic Agents; Drug Therapy, Combination; Flucytosine; Humans; Male; Rifampin | 1995 |
Comparative evaluation of macrodilution and alamar colorimetric microdilution broth methods for antifungal susceptibility testing of yeast isolates.
Topics: Amphotericin B; Antifungal Agents; Candida; Colorimetry; Cryptococcus neoformans; Culture Media; Dose-Response Relationship, Drug; Drug Resistance, Microbial; Evaluation Studies as Topic; Fluconazole; Flucytosine; Microbial Sensitivity Tests; Oxidation-Reduction; Species Specificity; Yeasts | 1995 |
In vitro determination of optimal antifungal combinations against Cryptococcus neoformans and Candida albicans.
Topics: Amphotericin B; Antifungal Agents; Candida albicans; Cryptococcus neoformans; Drug Combinations; Fluconazole; Flucytosine; Microbial Sensitivity Tests | 1995 |
Cryptococcal meningitis in pregnancy.
Topics: Adolescent; Amphotericin B; Antifungal Agents; Female; Flucytosine; Humans; Infant, Newborn; Male; Meningitis, Cryptococcal; Pregnancy; Pregnancy Complications, Infectious | 1996 |
Combination chemotherapy of canine and feline cryptococcosis using subcutaneously administered amphotericin B.
Topics: Amphotericin B; Animals; Anti-Bacterial Agents; Antifungal Agents; Cat Diseases; Cats; Cryptococcosis; Dog Diseases; Dogs; Drug Administration Schedule; Drug Therapy, Combination; Flucytosine; Injections, Subcutaneous; Male; Triazoles | 1996 |
[Colorimetric broth microdilution for antifungal susceptibility testing].
Topics: Amphotericin B; Antifungal Agents; Colorimetry; Evaluation Studies as Topic; Fluconazole; Flucytosine; Fungi; Indicator Dilution Techniques; Microbial Sensitivity Tests | 1996 |
In vitro activities of semisynthetic pneumocandin L-733,560 against fluconazole-resistant and -susceptible Candida albicans isolates.
Topics: Amphotericin B; Anti-Bacterial Agents; Antifungal Agents; Candida albicans; Drug Resistance, Microbial; Fluconazole; Flucytosine; Itraconazole; Microbial Sensitivity Tests; Peptides | 1996 |
Cutaneous aspergillosis in a neonate.
Topics: Abscess; Amphotericin B; Antifungal Agents; Aspergillosis; Dermatomycoses; Diagnosis, Differential; Female; Flucytosine; Humans; Infant, Newborn | 1996 |
Cryptococcosis: an unusual cause of endobronchial obstruction.
Topics: Adult; Amphotericin B; Antifungal Agents; Bronchial Diseases; Bronchoscopy; Cryptococcosis; Flucytosine; Humans; Lung Diseases, Obstructive; Male; Radiography | 1996 |
Unusual presentation of cryptococcosis in a patient with AIDS.
Topics: Acquired Immunodeficiency Syndrome; Adult; AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Cryptococcosis; Cryptococcus neoformans; Drug Therapy, Combination; Flucytosine; Humans; Male; Peritonitis | 1996 |
Cryptococcosis as an opportunistic infection in immunodeficiency secondary to paracoccidioidomycosis.
Topics: Adult; Amphotericin B; Antifungal Agents; Cryptococcosis; Flucytosine; Humans; Immunologic Deficiency Syndromes; Male; Middle Aged; Opportunistic Infections; Paracoccidioidomycosis | 1996 |
Aspergillus sinusitis: clinical aspects and treatment outcomes.
Topics: Adolescent; Adult; Aged; Amphotericin B; Antifungal Agents; Aspergillosis; Child; Diabetes Complications; Ethmoid Sinusitis; Female; Flucytosine; Humans; Magnetic Resonance Imaging; Male; Maxillary Sinusitis; Middle Aged; Necrosis; Sinusitis; Sphenoid Sinusitis; Tomography, X-Ray Computed; Treatment Outcome | 1996 |
[Lethal meningeal encephalitis from Cryptococcus neoformans var. neoformans in a girl without serious immunodeficiency].
Topics: Adolescent; Amphotericin B; Antifungal Agents; Antigens, Fungal; Cryptococcosis; Cryptococcus neoformans; Diagnosis, Differential; Drug Therapy, Combination; Encephalitis; Fatal Outcome; Female; Fluconazole; Flucytosine; HIV Seronegativity; Humans; Immunologic Deficiency Syndromes | 1996 |
Multisite reproducibility of the Etest MIC method for antifungal susceptibility testing of yeast isolates.
Topics: Amphotericin B; Antifungal Agents; Candida; Evaluation Studies as Topic; Fluconazole; Flucytosine; Humans; Itraconazole; Ketoconazole; Microbial Sensitivity Tests; Quality Control; Reproducibility of Results | 1996 |
Strain variation among and antifungal susceptibilities of isolates of Candida krusei.
Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Deoxyribonucleases, Type II Site-Specific; DNA, Fungal; Drug Resistance, Microbial; Fluconazole; Flucytosine; Genetic Variation; Humans; Itraconazole; Molecular Epidemiology | 1996 |
[Studies on microtiter broth dilution method for antifungal susceptibility testing of yeast isolates from blood and cerebrospinal fluid].
Topics: Amphotericin B; Antifungal Agents; Candida; Cryptococcus neoformans; Drug Resistance, Microbial; Fluconazole; Flucytosine; Miconazole; Microbial Sensitivity Tests | 1996 |
Invasive candidiasis in infants weighing more than 2500 grams at birth admitted to a neonatal intensive care unit.
Topics: Amphotericin B; Antifungal Agents; Birth Weight; Candidiasis; Congenital Abnormalities; Female; Fluconazole; Flucytosine; Humans; Infant; Infant, Newborn; Intensive Care Units, Neonatal; Male; Retrospective Studies | 1996 |
[Clinical fluconazole and itraconazole resistance of oro-gastrointestinal candidiasis in a patient with AIDS].
Topics: Adult; AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Candida albicans; Candidiasis; Candidiasis, Oral; Drug Resistance, Multiple; Drug Therapy, Combination; Fluconazole; Flucytosine; Gastrointestinal Diseases; Humans; Ketoconazole; Male; Microbial Sensitivity Tests | 1996 |
Comparison of a spectrophotometric microdilution method with RPMI-2% glucose with the National Committee for Clinical Laboratory Standards reference macrodilution method M27-P for in vitro susceptibility testing of amphotericin B, flucytosine, and flucona
Topics: Amphotericin B; Antifungal Agents; Candida albicans; Culture Media; Fluconazole; Flucytosine; Glucose; Humans; Indicator Dilution Techniques; Microbial Sensitivity Tests; Nephelometry and Turbidimetry; Quality Control | 1996 |
Microdilution antifungal susceptibility testing of Candida albicans and Cryptococcus neoformans with and without agitation: an eight-center collaborative study.
Topics: Amphotericin B; Antifungal Agents; Candida albicans; Cryptococcus neoformans; Culture Media; Fluconazole; Flucytosine; Indicator Dilution Techniques; Microbial Sensitivity Tests | 1996 |
Suspected drug eruption in seven dogs during administration of flucytosine.
Topics: Amphotericin B; Animals; Antifungal Agents; Aspergillosis; Cryptococcosis; Dog Diseases; Dogs; Drug Eruptions; Drug Therapy, Combination; Female; Fluconazole; Flucytosine; Itraconazole; Male | 1996 |
Isolation and characterization of fluconazole- and amphotericin B-resistant Candida albicans from blood of two patients with leukemia.
Topics: Adolescent; Adult; Amphotericin B; Animals; Antifungal Agents; Candida albicans; Candidiasis; Drug Resistance, Multiple; Female; Fluconazole; Flucytosine; Fungemia; Humans; Leukemia, Myeloid, Acute; Male; Mice; Microbial Sensitivity Tests; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Virulence | 1997 |
In vitro susceptibility of Trichosporon beigelii to antifungal agents.
Topics: Amphotericin B; Antifungal Agents; Fluconazole; Flucytosine; Itraconazole; Miconazole; Microbial Sensitivity Tests; Trichosporon | 1996 |
Cryptococcal cellulitis in an immunocompetent host.
Topics: Aged; Amphotericin B; Antifungal Agents; Cellulitis; Cryptococcosis; Dermatomycoses; Female; Fluconazole; Flucytosine; Humans; Immunocompetence; Itraconazole; Leg Dermatoses | 1997 |
Rapid susceptibility testing of Candida albicans by flow cytometry.
Topics: Acridine Orange; Amphotericin B; Antifungal Agents; Candida albicans; Flow Cytometry; Flucytosine; Itraconazole; Microbial Sensitivity Tests | 1997 |
Activity of a new triazole, Sch 56592, compared with those of four other antifungal agents tested against clinical isolates of Candida spp. and Saccharomyces cerevisiae.
Topics: Amphotericin B; Antifungal Agents; Candida; Fluconazole; Flucytosine; Humans; Itraconazole; Microbial Sensitivity Tests; Saccharomyces cerevisiae; Triazoles | 1997 |
[Focusing on therapy of systemic mycoses].
Topics: AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Candidiasis; Dose-Response Relationship, Drug; Drug Therapy, Combination; Fluconazole; Flucytosine; HIV Infections; Humans; Meningitis, Cryptococcal; Mycoses | 1995 |
Early surgical management of invasive gingival aspergillosis in a neutropenic patient with leukemia: a case report.
Topics: Adult; Amphotericin B; Antifungal Agents; Aspergillosis; Female; Fluconazole; Flucytosine; Gingival Diseases; Granulocyte Colony-Stimulating Factor; Humans; Immunocompromised Host; Itraconazole; Leukemia, Myeloid, Acute; Neutropenia | 1997 |
[Multisite evaluation of a colorimetric broth microdilution antifungal susceptibility testing].
Topics: Amphotericin B; Antifungal Agents; Candida; Colorimetry; Drug Resistance, Microbial; Evaluation Studies as Topic; Fluconazole; Flucytosine; Indicator Dilution Techniques; Itraconazole; Miconazole; Microbial Sensitivity Tests; Saccharomyces cerevisiae | 1997 |
Effect of pH and buffer system on the in-vitro activity of five antifungals against yeasts.
Topics: Amphotericin B; Antifungal Agents; Buffers; Candida; Culture Media; Fluconazole; Flucytosine; Fungi; Hydrogen-Ion Concentration; Itraconazole; Ketoconazole; Microbial Sensitivity Tests; Reproducibility of Results; Species Specificity; Spectrophotometry | 1997 |
Variations in DNA subtype and antifungal susceptibility among clinical isolates of Candida tropicalis.
Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Cross Infection; DNA, Fungal; Electrophoresis, Gel, Pulsed-Field; Fluconazole; Flucytosine; Humans; Itraconazole; Microbial Sensitivity Tests; Mycological Typing Techniques; Polymorphism, Restriction Fragment Length; Triazoles | 1997 |
Candida norvegensis: a fluconazole-resistant species.
Topics: Adult; Aged; Aged, 80 and over; Amphotericin B; Antifungal Agents; Candida; Candidiasis; Drug Resistance, Microbial; Fluconazole; Flucytosine; Humans; Itraconazole; Microbial Sensitivity Tests; Middle Aged | 1997 |
Rapid high performance liquid chromatographic assay for antifungal agents in human sera.
Topics: Amphotericin B; Antifungal Agents; Chromatography, High Pressure Liquid; Econazole; Fluconazole; Flucytosine; Humans; Itraconazole; Ketoconazole; Miconazole; Spectrophotometry, Ultraviolet | 1996 |
Amphotericin B with or without flucytosine followed by fluconazole as primary therapy for cryptococcal meningitis in patients with AIDS.
Topics: Acquired Immunodeficiency Syndrome; Adult; Amphotericin B; Antifungal Agents; Drug Therapy, Combination; Female; Fluconazole; Flucytosine; Humans; Male; Meningitis, Cryptococcal | 1996 |
Systemic antifungal drugs.
Topics: Amphotericin B; Anorexia; Antifungal Agents; Aspergillosis; Blastomycosis; Candidiasis; Coccidioidomycosis; Cryptococcosis; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme Inhibitors; Dose-Response Relationship, Drug; Drug Interactions; Fluconazole; Flucytosine; Gynecomastia; Histoplasmosis; Humans; Itraconazole; Ketoconazole; Kidney Diseases; Liposomes; Male; Mixed Function Oxygenases; Mucormycosis; Nausea; Paracoccidioidomycosis; Sporotrichosis; Teratogens | 1997 |
Implications of early systemic therapy on the incidence of endogenous fungal endophthalmitis.
Topics: Administration, Oral; Adolescent; Adult; Aged; Amphotericin B; Antifungal Agents; Child; Child, Preschool; Drug Therapy, Combination; Endophthalmitis; Eye Infections, Fungal; Female; Fluconazole; Flucytosine; Fungemia; Humans; Incidence; Infant; Injections, Intravenous; Male; Middle Aged; Retrospective Studies | 1997 |
[In vitro susceptibility to antifungal agents of Candida strains isolated from patients with various diseases of the respiratory tract].
Topics: Adult; Aged; Amphotericin B; Anti-Bacterial Agents; Antifungal Agents; Candida; Candidiasis; Fluconazole; Flucytosine; Humans; Ketoconazole; Microbial Sensitivity Tests; Middle Aged; Nystatin; Respiratory Tract Infections; Species Specificity; Sputum | 1997 |
Treatment of cryptococcal meningitis.
Topics: AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Drug Therapy, Combination; Fluconazole; Flucytosine; Humans; Meningitis, Cryptococcal; Research Design; Selection Bias | 1997 |
Presumed multifocal cryptococcol choroidopathy prior to specific systemic manifestation.
Topics: Acquired Immunodeficiency Syndrome; Adult; Amphotericin B; Antifungal Agents; Choroiditis; Cryptococcosis; Flucytosine; Fluorescein Angiography; Humans; Male | 1997 |
Saccharomyces cerevisiae infections and antifungal susceptibility studies by colorimetric and broth macrodilution methods.
Topics: Amphotericin B; Antifungal Agents; Colorimetry; Fatal Outcome; Female; Fluconazole; Flucytosine; Humans; Infant; Itraconazole; Male; Microbial Sensitivity Tests; Middle Aged; Mycoses; Saccharomyces cerevisiae | 1995 |
[A cured case of primary pulmonary cryptococcosis with cryptococcal meningitis].
Topics: Amphotericin B; Cryptococcosis; Drug Therapy, Combination; Flucytosine; Humans; Lung Diseases, Fungal; Male; Meningitis, Cryptococcal; Middle Aged; Treatment Outcome | 1985 |
In vitro activities of voriconazole (UK-109,496) and four other antifungal agents against 394 clinical isolates of Candida spp.
Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Fluconazole; Flucytosine; Humans; Itraconazole; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole | 1998 |
Hazards of inadequate fluconazole dosage to treat deep-seated or systemic Candida albicans infection.
Topics: Adult; Aged; Amphotericin B; Amputation, Surgical; Antifungal Agents; Arthrodesis; Candidiasis; Diplopia; Fatal Outcome; Female; Fluconazole; Flucytosine; Hemofiltration; Hernia, Inguinal; Humans; Male; Meningococcal Infections; Osteomyelitis; Pulmonary Ventilation; Vitrectomy | 1997 |
Therapy of deep fungal infection in haematological malignancy. Working Party of the British Society for Antimicrobial Chemotherapy.
Topics: Amphotericin B; Antifungal Agents; Flucytosine; Hematologic Neoplasms; Humans; Mycoses | 1997 |
Cryptococcosis at the University Hospital, Kuala Lumpur.
Topics: Adolescent; Adult; Aged; Amphotericin B; Antifungal Agents; Cryptococcosis; Drug Therapy, Combination; Female; Flucytosine; Follow-Up Studies; Humans; Lung Diseases, Fungal; Malaysia; Male; Meningitis, Cryptococcal; Middle Aged | 1998 |
Amphotericin B colloidal dispersion combined with flucytosine with or without fluconazole for treatment of murine cryptococcal meningitis.
Topics: Amphotericin B; Animals; Body Weight; Brain; Drug Therapy, Combination; Fluconazole; Flucytosine; Male; Meningitis, Cryptococcal; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Specific Pathogen-Free Organisms; Survival Analysis | 1998 |
Comparison of the E test with broth microdilution for antifungal susceptibility testing of yeasts.
Topics: Amphotericin B; Antifungal Agents; Colony Count, Microbial; Culture Media; Fluconazole; Flucytosine; Itraconazole; Microbial Sensitivity Tests; Yeasts | 1998 |
Cryptococcosis: an unusual opportunistic infection complicating B cell lymphoproliferative disorders.
Topics: Aged; Amphotericin B; Antifungal Agents; Cryptococcosis; Drug Therapy, Combination; Female; Flucytosine; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Opportunistic Infections; Waldenstrom Macroglobulinemia | 1998 |
Comparison of a 2,3-bis(2-methoxy-4-nitro-5-sulfophenyl)-5-[(phenylamino)carbonyl]-2H-t etrazolium hydroxide (XTT) colorimetric method with the standardized National Committee for Clinical Laboratory Standards method of testing clinical yeast isolates for
Topics: Amphotericin B; Antifungal Agents; Candida; Colorimetry; Cryptococcus; Evaluation Studies as Topic; Fluconazole; Flucytosine; Humans; Itraconazole; Ketoconazole; Microbial Sensitivity Tests | 1998 |
The effect of antifungal drugs in combination on the growth of Candida glabrata in solid and liquid media.
Topics: Agar; Amphotericin B; Antifungal Agents; Candida; Cell Division; Culture Media; Dose-Response Relationship, Drug; Drug Interactions; Flucytosine; Humans; Miconazole; Microbial Sensitivity Tests | 1998 |
Impact of previous aspergillosis on the outcome of bone marrow transplantation.
Topics: Amphotericin B; Anemia, Aplastic; Antifungal Agents; Aspergillosis; Bone Marrow Transplantation; Flucytosine; Humans; Logistic Models; Multivariate Analysis; Neoplasms; Recurrence; Regression Analysis; Retrospective Studies; Risk Factors; Transplantation Conditioning | 1998 |
Successful cure of an extensive burn injury complicated with mucor wound sepsis.
Topics: Administration, Oral; Adult; Amphotericin B; Antifungal Agents; Body Surface Area; Burns; Debridement; Drug Therapy, Combination; Female; Flucytosine; Humans; Immunocompromised Host; Injections, Intravenous; Mucormycosis; Opportunistic Infections; Rhizopus; Wound Infection | 1998 |
The effect of limited exposure to antifungal agents on the germ tube formation of oral Candida albicans.
Topics: Adhesiveness; AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Candida albicans; Candidiasis, Oral; Culture Media; Dose-Response Relationship, Drug; Fluconazole; Flucytosine; HIV Seronegativity; Humans; Ketoconazole; Microscopy, Electron, Scanning; Mouth; Nystatin | 1998 |
Idiopathic CD4+ T-lymphocytopenia in a child with disseminated cryptococcosis.
Topics: Amphotericin B; Antifungal Agents; Antigens, Fungal; Bone Marrow; Child, Preschool; Cryptococcosis; Drug Therapy, Combination; Fatal Outcome; Female; Fluconazole; Flucytosine; Humans; Liver; Lung; Lymph Nodes; T-Lymphocytopenia, Idiopathic CD4-Positive | 1998 |
Clinical evaluation of the ASTY colorimetric microdilution panel for antifungal susceptibility testing.
Topics: Amphotericin B; Antifungal Agents; Candida; Candida albicans; Candidiasis; Colorimetry; Fluconazole; Flucytosine; Humans; Itraconazole; Japan; Laboratories; Microbial Sensitivity Tests; Quality Control; Time Factors | 1998 |
In vitro activity of a new triazole antifungal agent, Sch 56592, against clinical isolates of filamentous fungi.
Topics: Amphotericin B; Antifungal Agents; Flucytosine; Fungi; Humans; Itraconazole; Microbial Sensitivity Tests; Triazoles | 1998 |
[Candida chorioretinitis in drug addicts. Apropos of 2 cases].
Topics: Adult; Amphotericin B; Antifungal Agents; Candidiasis; Chorioretinitis; Cocaine-Related Disorders; Crack Cocaine; Endophthalmitis; Epiretinal Membrane; Eye Infections, Fungal; Flucytosine; Humans; Male; Needle Sharing; Substance Abuse, Intravenous | 1998 |
[Antifungal susceptibility of clinically isolated Candida albicans by broth microdilution method].
Topics: Amphotericin B; Antifungal Agents; Candida albicans; Drug Resistance, Microbial; Flucytosine; Humans; Itraconazole; Miconazole; Microbial Sensitivity Tests | 1998 |
Multi-centre evaluation of the Etest method for antifungal drug susceptibility testing of Candida spp. and Cryptococcus neoformans. BSAC Working Party on Antifungal Chemotherapy.
Topics: Amphotericin B; Antifungal Agents; Candida; Cryptococcus neoformans; Evaluation Studies as Topic; Fluconazole; Flucytosine; Itraconazole; Microbial Sensitivity Tests; Reproducibility of Results | 1998 |
Activity of MK-0991 (L-743,872), a new echinocandin, compared with those of LY303366 and four other antifungal agents tested against blood stream isolates of Candida spp.
Topics: Amphotericin B; Anidulafungin; Anti-Bacterial Agents; Antifungal Agents; Blood; Candida; Caspofungin; Echinocandins; Fluconazole; Flucytosine; Humans; Itraconazole; Lipopeptides; Peptides; Peptides, Cyclic; Sensitivity and Specificity; Serum Bactericidal Test | 1998 |
[Endogenous infectious endophthalmitis].
Topics: Aged; Amphotericin B; Antifungal Agents; Candidiasis; Drug Therapy, Combination; Endophthalmitis; Flucytosine; Humans; Male; Middle Aged; Ofloxacin; Oxacillin; Rifampin; Staphylococcal Infections; Vitrectomy | 1998 |
Study of the susceptibility of yeast isolates of clinical interest to five antifungal agents using the E test.
Topics: Amphotericin B; Antifungal Agents; Candida; Cryptococcus neoformans; Drug Resistance, Microbial; Fluconazole; Flucytosine; Humans; In Vitro Techniques; Itraconazole; Ketoconazole; Microbial Sensitivity Tests; Prototheca | 1998 |
[Study of the in vitro sensitivity of yeasts with the ATB-Fungus system].
Topics: Amphotericin B; Antifungal Agents; Candida; Cryptococcus; Econazole; Flucytosine; Ketoconazole; Miconazole; Nystatin; Saccharomyces cerevisiae; Yeasts | 1998 |
Adhesion of oral Candida albicans isolates to denture acrylic following limited exposure to antifungal agents.
Topics: Adhesiveness; Administration, Topical; Amphotericin B; Analysis of Variance; Antifungal Agents; Candida albicans; Candidiasis, Oral; Denture Bases; Drug Administration Schedule; Fluconazole; Flucytosine; Humans; Image Processing, Computer-Assisted; Ketoconazole; Mouth; Nystatin; Polymethyl Methacrylate; Stomatitis, Denture; Surface Properties; Time Factors | 1998 |
Antifungal susceptibility of Candida isolates at the American University of Beirut Medical Center.
Topics: Amphotericin B; Antifungal Agents; Candida; Candida albicans; Candidiasis; Fluconazole; Flucytosine; Hospitals, University; Humans; Itraconazole; Ketoconazole; Lebanon; Microbial Sensitivity Tests | 1998 |
Multicenter comparison of the sensititre YeastOne Colorimetric Antifungal Panel with the National Committee for Clinical Laboratory standards M27-A reference method for testing clinical isolates of common and emerging Candida spp., Cryptococcus spp., and
Topics: Amphotericin B; Antifungal Agents; Candida; Colorimetry; Cryptococcus; Fluconazole; Flucytosine; Guidelines as Topic; Itraconazole; Ketoconazole; Laboratories; Microbial Sensitivity Tests; Quality Assurance, Health Care; Reference Standards; Yeasts | 1999 |
In vitro susceptibilities of Candida dubliniensis isolates tested against the new triazole and echinocandin antifungal agents.
Topics: AIDS-Related Opportunistic Infections; Amphotericin B; Anti-Bacterial Agents; Antifungal Agents; Candida; Candidiasis; Caspofungin; Echinocandins; Fluconazole; Flucytosine; Humans; Itraconazole; Lipopeptides; Microbial Sensitivity Tests; Peptides; Peptides, Cyclic; Pyrimidines; Thiazoles; Triazoles; Voriconazole | 1999 |
Early mycological treatment failure in AIDS-associated cryptococcal meningitis.
Topics: Adult; AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Cerebrospinal Fluid; Cryptococcus; Drug Therapy, Combination; Flucytosine; Humans; Logistic Models; Meningitis, Cryptococcal; Multivariate Analysis; Serum Albumin; Time Factors; Treatment Failure | 1999 |
Eyelid nodule: a sentinel lesion of disseminated cryptococcosis in a patient with acquired immunodeficiency syndrome.
Topics: Adult; AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Cryptococcosis; Cryptococcus neoformans; Eye Infections, Fungal; Eyelid Diseases; Flucytosine; Humans; Male; Skin Diseases, Bacterial | 1999 |
Antifungal susceptibility of Aspergillus species isolated from invasive oral infection in neutropenic patients with hematologic malignancies.
Topics: Adult; Aged; Amphotericin B; Antifungal Agents; Antineoplastic Agents; Aspergillosis; Aspergillus; Drug Combinations; Drug Evaluation; Female; Fluconazole; Flucytosine; Humans; Immunocompromised Host; Itraconazole; Leukemia; Lymphoma; Male; Miconazole; Microbial Sensitivity Tests; Middle Aged; Mouth Diseases; Neutropenia | 1999 |
First report of Cryptococcus laurentii meningitis and a fatal case of Cryptococcus albidus cryptococcaemia in AIDS patients.
Topics: Adult; AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Cryptococcosis; Cryptococcus; Drug Therapy, Combination; Fatal Outcome; Female; Flucytosine; Humans; Male; Meningitis; Microbial Sensitivity Tests; Middle Aged | 1998 |
Treatment of hydrocephalus secondary to cryptococcal meningitis by use of shunting.
Topics: Adolescent; Adult; Amphotericin B; Antifungal Agents; Cerebrospinal Fluid Shunts; Female; Flucytosine; Humans; Hydrocephalus; Male; Meningitis, Cryptococcal; Middle Aged; Radiography; Treatment Outcome; Ventriculoperitoneal Shunt | 1999 |
The postantifungal effect (PAFE) of antimycotics on oral C. albicans isolates and its impact on candidal adhesion.
Topics: Acrylic Resins; Amphotericin B; Analysis of Variance; Antifungal Agents; Candida albicans; Cell Adhesion; Denture Bases; Fluconazole; Flucytosine; Ketoconazole; Microbial Sensitivity Tests; Nystatin | 1998 |
Antifungal activity of a new triazole, voriconazole (UK-109,496), compared with three other antifungal agents tested against clinical isolates of filamentous fungi.
Topics: Amphotericin B; Antifungal Agents; Flucytosine; Fungi; Humans; Itraconazole; Microbial Sensitivity Tests; Mycoses; Pyrimidines; Triazoles; Voriconazole | 1998 |
In vitro and in vivo experimental activities of antifungal agents against Fusarium solani.
Topics: Amphotericin B; Animals; Antibiotics, Antitubercular; Antifungal Agents; Drug Therapy, Combination; Flucytosine; Fusarium; Male; Mice; Mycoses; Rifampin | 1999 |
[Disseminated cryptococcosis in patients with AIDS. Prognostic factors of poor outcome].
Topics: Acute Disease; Adolescent; Adult; Aged; AIDS-Related Opportunistic Infections; Amphotericin B; Analysis of Variance; Antifungal Agents; Cohort Studies; Cryptococcosis; Data Interpretation, Statistical; Female; Fluconazole; Flucytosine; Humans; Male; Middle Aged; Multivariate Analysis; Prognosis; Recurrence; Spain; Treatment Outcome | 1999 |
Candida parapsilosis: an unusual organism causing prosthetic heart valve infective endocarditis.
Topics: Aged; Amphotericin B; Antifungal Agents; Aortic Valve; C-Reactive Protein; Candida; Candidiasis; Drug Therapy, Combination; Echocardiography; Endocarditis; Flucytosine; Heart Valve Prosthesis; Heart Valve Prosthesis Implantation; Humans; Male; Pacemaker, Artificial | 1999 |
[Meningitis by Cryptococcus neoformans in patients with HIV infection].
Topics: Adult; Amphotericin B; Antifungal Agents; Cryptococcosis; Cryptococcus neoformans; Drug Therapy, Combination; Female; Flucytosine; HIV Seropositivity; Humans; Male; Meningitis, Bacterial; Middle Aged; Retrospective Studies | 1999 |
Saccharomyces keratitis and endophthalmitis.
Topics: Aged; Amphotericin B; Anterior Chamber; Antifungal Agents; Cornea; Endophthalmitis; Eye Infections, Fungal; Female; Flucytosine; Graft Rejection; Humans; Iris; Keratitis; Keratoplasty, Penetrating; Recurrence; Reoperation; Saccharomyces; Vitrectomy; Vitreous Body | 1999 |
Comparative evaluation of Fungitest-, Neo-Sensitabs- and M27T-NCCLS broth microdilution methods for antifungal drug susceptibility testing of Candida species and Cryptococcus neoformans.
Topics: Amphotericin B; Antifungal Agents; Candida; Cryptococcus neoformans; Fluconazole; Flucytosine; Humans; Itraconazole; Ketoconazole; Miconazole; Microbial Sensitivity Tests; Reagent Kits, Diagnostic | 1999 |
[A multicenter study on fungemia caused by yeasts in Spain (April-June, 1997). A Work Group to Study Fungemia)].
Topics: Adult; Age Factors; Aged; Amphotericin B; Antifungal Agents; Candida; Candidiasis; Cross-Sectional Studies; Drug Resistance, Microbial; Female; Fluconazole; Flucytosine; Fungemia; Humans; Itraconazole; Male; Middle Aged; Mycoses; Sex Factors; Spain; Yeasts | 1999 |
The prognostic factors of cryptococcal meningitis in HIV-negative patients.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amphotericin B; Antifungal Agents; Drug Therapy, Combination; Female; Fluconazole; Flucytosine; HIV Seronegativity; Humans; Male; Meningitis, Cryptococcal; Middle Aged; Prognosis; Taiwan; Treatment Outcome | 1999 |
Massive pleural effusions in cryptococcal meningitis.
Topics: Adult; Amphotericin B; Antifungal Agents; Cryptococcosis; Female; Flucytosine; Humans; Meningitis, Cryptococcal; Pleural Effusion | 1999 |
Synergistic fungistatic effects of lactoferrin in combination with antifungal drugs against clinical Candida isolates.
Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Culture Media; Drug Synergism; Fluconazole; Flucytosine; Humans; Lactoferrin; Microbial Sensitivity Tests | 1999 |
[Neonatal candidiasis and liposomal amphotericin B treatment: our experience].
Topics: Age Factors; Amphotericin B; Anti-Bacterial Agents; Antifungal Agents; Body Weight; Candidiasis; Cross Infection; Drug Carriers; Drug Therapy, Combination; Flucytosine; Gestational Age; Humans; Infant, Newborn; Liposomes; Risk Factors; Time Factors | 1999 |
Efficacies of high-dose fluconazole plus amphotericin B and high-dose fluconazole plus 5-fluorocytosine versus amphotericin B, fluconazole, and 5-fluorocytosine monotherapies in treatment of experimental endocarditis, endophthalmitis, and pyelonephritis d
Topics: Amphotericin B; Animals; Antifungal Agents; Candida albicans; Candidiasis; Creatinine; Endocarditis; Endophthalmitis; Fluconazole; Flucytosine; Kidney; Male; Microbial Sensitivity Tests; Myocardium; Pyelonephritis; Rabbits; Survival Analysis; Time Factors; Vitreous Body | 1999 |
Fluconazole-resistant Cryptococcus neoformans isolated from an immunocompetent patient without prior exposure to fluconazole.
Topics: Adult; Amphotericin B; Antifungal Agents; Cryptococcosis; Cryptococcus neoformans; Drug Resistance, Microbial; Drug Therapy, Combination; Fluconazole; Flucytosine; Humans; Immunocompetence; Male; Meningitis | 1999 |
In vitro susceptibility studies of Cryptococcus neoformans isolated from patients with no clinical response to amphotericin B therapy.
Topics: Acquired Immunodeficiency Syndrome; Amphotericin B; Antifungal Agents; Cryptococcosis; Cryptococcus neoformans; Drug Interactions; Drug Resistance, Microbial; Fluconazole; Flucytosine; Humans; Leprostatic Agents; Rifampin; Time Factors | 2000 |
Evaluation of a capacitance method for direct antifungal susceptibility testing of yeasts in positive blood cultures.
Topics: Amphotericin B; Antifungal Agents; Blood; Candida; Candida albicans; Culture Media; Drug Resistance, Microbial; Fluconazole; Flucytosine; Humans; Ketoconazole; Microbial Sensitivity Tests; Reproducibility of Results | 2000 |
Antifungal drug combinations for Cryptococcus neoformans and Prototheca spp.
Topics: Amphotericin B; Antifungal Agents; Cryptococcus neoformans; Drug Therapy, Combination; Flucytosine; Humans; Microbial Sensitivity Tests; Prototheca; Sensitivity and Specificity | 2000 |
Clinical features and in vitro susceptibilities of two varieties of Cryptococcus neoformans in Taiwan.
Topics: Adolescent; Adult; Aged; AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Cryptococcosis; Cryptococcus neoformans; Female; Fluconazole; Flucytosine; Humans; Immunocompromised Host; Male; Microbial Sensitivity Tests; Middle Aged; Retrospective Studies; Seasons; Taiwan | 2000 |
Comparison of a new colorimetric assay with the NCCLS broth microdilution method (M-27A) for antifungal drug MIC determination.
Topics: Amphotericin B; Antifungal Agents; Colorimetry; Dose-Response Relationship, Drug; Fluconazole; Flucytosine; Itraconazole; Microbial Sensitivity Tests | 2000 |
[Establishment and evaluation of microdilution assays for the in vitro sensitivity testing of Aspergillus fumigatus].
Topics: Amphotericin B; Antifungal Agents; Aspergillus fumigatus; Culture Media; Flucytosine; Indicator Dilution Techniques; Microbial Sensitivity Tests | 2000 |
Disseminated Penicillium marneffei infection in an HIV-positive female from Thailand in Germany.
Topics: Adult; Amphotericin B; Anti-HIV Agents; Antifungal Agents; CD4 Lymphocyte Count; Cross Reactions; Drug Therapy, Combination; Female; Fluconazole; Flucytosine; Germany; HIV Seropositivity; Humans; Itraconazole; Mycoses; Penicillium; Thailand; Travel | 1999 |
Cryptococcal osteomyelitis of the spine.
Topics: Administration, Oral; Adult; AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Bone Transplantation; Child; Combined Modality Therapy; Cryptococcosis; Decompression, Surgical; Diagnosis, Differential; Female; Flucytosine; Humans; Ketoconazole; Male; Spondylitis | 1999 |
[Two cases of pulmonary aspergillosis successfully treated with multidrug therapy].
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Drug Therapy, Combination; Fluconazole; Flucytosine; Humans; Itraconazole; Lung Diseases, Fungal; Male; Middle Aged; Radiography; Treatment Outcome | 2000 |
Phenotypic variation and antifungal susceptibility patterns of Candida albicans strains isolated from neutropenic patients.
Topics: Amphotericin B; Antifungal Agents; Candida albicans; Candidiasis; Digestive System; Fluconazole; Flucytosine; Humans; Microbial Sensitivity Tests; Neutropenia; Oropharynx; Phenotype; Urogenital System | 2000 |
Successful treatment of aspergillus brain abscess in a child with acute lymphoblastic leukemia.
Topics: Amphotericin B; Antifungal Agents; Antineoplastic Agents; Aspergillosis; Aspergillus fumigatus; Brain Abscess; Cerebral Cortex; Child, Preschool; Female; Flucytosine; Humans; Immunosuppression Therapy; Precursor Cell Lymphoblastic Leukemia-Lymphoma | 2000 |
Susceptibility testing of Candida species: comparison of NCCLS microdilution method with Fungitest.
Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Drug Resistance, Microbial; Fluconazole; Flucytosine; Itraconazole; Ketoconazole; Miconazole; Microbial Sensitivity Tests | 2000 |
Aspergillus vertebral osteomyelitis in a child with a primary monocyte killing defect: response to GM-CSF therapy.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus; Biopsy, Needle; Child, Preschool; Flucytosine; Granulocyte-Macrophage Colony-Stimulating Factor; Histocytochemistry; Humans; Immunocompromised Host; Itraconazole; Leukocyte Count; Magnetic Resonance Imaging; Male; Monocytes; Osteomyelitis; Radiography, Thoracic; Spinal Diseases; Spine; Tomography, X-Ray Computed | 2000 |
Antimicrobial susceptibility testing of dematiaceous filamentous fungi: effect of medium composition at different temperatures and times of reading.
Topics: Amphotericin B; Antifungal Agents; Colony Count, Microbial; Culture Media; Flucytosine; Fungi; Hot Temperature; Humans; Ketoconazole; Multivariate Analysis; Mycoses; Reproducibility of Results; Statistics, Nonparametric; Time Factors | 1999 |
Successful treatment of invasive aspergillosis in chronic granulomatous disease by granulocyte transfusions followed by peripheral blood stem cell transplantation.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Child, Preschool; Combined Modality Therapy; Drug Resistance, Microbial; Flucytosine; Granulocyte Colony-Stimulating Factor; Granulocytes; Granulomatous Disease, Chronic; Hematopoietic Stem Cell Transplantation; Humans; Immunocompromised Host; Itraconazole; Leukocyte Transfusion; Lung Diseases, Fungal; Male; Neutrophils; Osteomyelitis; Pyrimidines; Respiratory Burst; Ribs; Triazoles; Voriconazole | 2000 |
Comparison of the Etest and microdilution method for antifungal susceptibility testing of Cryptococcus neoformans to four antifungal agents.
Topics: Amphotericin B; Antifungal Agents; Cryptococcus neoformans; Fluconazole; Flucytosine; Itraconazole; Microbial Sensitivity Tests; Retrospective Studies | 2000 |
In vitro susceptibility of Candida albicans isolates from apical and marginal periodontitis to common antifungal agents.
Topics: Amphotericin B; Antifungal Agents; Candida albicans; Clotrimazole; Fluconazole; Flucytosine; Humans; Miconazole; Microbial Sensitivity Tests; Periapical Periodontitis; Periodontitis | 2000 |
Cutaneous fungal infection caused by Fusarium solani.
Topics: Amphotericin B; Animals; Antifungal Agents; Dermatomycoses; Female; Flucytosine; Fusarium; Guinea Pigs; Humans; Male; Middle Aged | 1998 |
Influence of pH and concentration on the postantifungal effect and on the effects of sub-MIC concentrations of 4 antifungal agents on previously treated Candida spp.
Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Drug Resistance, Fungal; Fluconazole; Flucytosine; Hydrogen-Ion Concentration; Ketoconazole; Microbial Sensitivity Tests; Time Factors | 2000 |
Synergistic effects of low doses of histatin 5 and its analogues on amphotericin B anti-mycotic activity.
Topics: Amphotericin B; Antifungal Agents; Antimicrobial Cationic Peptides; Aspergillus; Candida; Cryptococcus; Drug Resistance, Microbial; Drug Synergism; Fluconazole; Flucytosine; Fungi; Histatins; Humans; Magainins; Microbial Sensitivity Tests; Salivary Proteins and Peptides; Xenopus Proteins | 2000 |
Prevalence and antifungal susceptibility of 442 Candida isolates from blood and other normally sterile sites: results of a 2-year (1996 to 1998) multicenter surveillance study in Quebec, Canada.
Topics: Amphotericin B; Antifungal Agents; Blood; Candida; Candidiasis; Cross Infection; Flucytosine; Humans; Microbial Sensitivity Tests; Population Surveillance; Prevalence; Quebec | 2001 |
Candida glabrata infection after total hip arthroplasty.
Topics: Aged; Amphotericin B; Antifungal Agents; Arthroplasty, Replacement, Hip; Candida; Candidiasis; Drug Synergism; Drug Therapy, Combination; Female; Flucytosine; Humans; Prosthesis-Related Infections | 2001 |
In-vitro activity of five antifungal agents against uncommon clinical isolates of Candida spp.
Topics: Amphotericin B; Antifungal Agents; Candida; Fluconazole; Flucytosine; Itraconazole; Ketoconazole; Microbial Sensitivity Tests | 1999 |
Phaeohyphomycosis due to Cladosporium cladosporioides.
Topics: Adult; Amphotericin B; Antifungal Agents; Cladosporium; Dermatomycoses; Flucytosine; Humans; Itraconazole; Male | 2001 |
In vitro activity of a new echinocandin, LY303366, and comparison with fluconazole, flucytosine and amphotericin B against Candida species.
Topics: Amphotericin B; Anidulafungin; Antifungal Agents; Candida; Candidiasis; Culture Media; Echinocandins; Fluconazole; Flucytosine; Humans; Microbial Sensitivity Tests; Peptides, Cyclic; Reproducibility of Results | 2001 |
[Invasive aspergillosis on a surgical intensive care unit].
Topics: Adult; Aged; Aged, 80 and over; Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Drug Therapy, Combination; Fatal Outcome; Female; Flucytosine; Humans; Intensive Care Units; Itraconazole; Male; Middle Aged; Pyrimidines; Risk Factors; Triazoles; Voriconazole | 2000 |
[Antifungal susceptibility testing in chronically recurrent vaginal candidosis as basis for effective therapy].
Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Chronic Disease; Ciclopirox; Female; Fluconazole; Flucytosine; Humans; Itraconazole; Microbial Sensitivity Tests; Naphthalenes; Pyridones; Pyrimidines; Terbinafine; Triazoles; Vaginitis; Voriconazole | 2000 |
[Candida antigen and antibody kinetics during antifungal therapy in non-neutropenic intensive care patients].
Topics: Amphotericin B; Antibodies, Fungal; Antifungal Agents; Antigens, Fungal; Candida; Candidiasis; Fluconazole; Flucytosine; Humans; Intensive Care Units; Neutrophils | 2000 |
Fungaemia in elderly patients.
Topics: Aged; Aged, 80 and over; Amphotericin B; Antifungal Agents; Candidiasis; Cross Infection; Female; Fluconazole; Flucytosine; Fungemia; Humans; Male; Postoperative Complications; Risk Factors; Slovakia; Survival Rate | 2001 |
[Visceral mycotic infections. In clinical practice].
Topics: Amphotericin B; Antifungal Agents; Candidiasis; Cryptococcosis; Fluconazole; Flucytosine; Histoplasmosis; Humans; Immunosuppression Therapy; Mycology; Mycoses; Neutropenia; Prognosis; Risk Factors; Travel | 2001 |
[Fungal infections in intensive care units: a cross-survey].
Topics: Amphotericin B; Antifungal Agents; Candidiasis; Cross Infection; Data Collection; Fluconazole; Flucytosine; France; Humans; Intensive Care Units; Mycoses; Surveys and Questionnaires | 2001 |
Combined topical flucytosine and amphotericin B for refractory vaginal Candida glabrata infections.
Topics: Adult; Amphotericin B; Antifungal Agents; Candidiasis, Vulvovaginal; Drug Combinations; Female; Flucytosine; Humans; Middle Aged | 2001 |
Antifungal susceptibility testing and the correlation with clinical outcome in neonatal candidemia.
Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Female; Fluconazole; Flucytosine; Humans; Infant, Newborn; Male; Microbial Sensitivity Tests | 2001 |
Sinocranial aspergillosis: a form of central nervous system aspergillosis in south India.
Topics: Adolescent; Adult; Aged; Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus; Biopsy; Brain Diseases; Central Nervous System Fungal Infections; Climate; Female; Flucytosine; Granuloma; Humans; India; Male; Middle Aged; Occupational Diseases; Orbital Diseases; Risk Factors; Sinusitis; Tomography, X-Ray Computed | 2001 |
[A case of SLE presenting the features of antiphospholipid antibody syndrome during a treatment for complicated cryptococcal meningitis].
Topics: Adult; Amphotericin B; Antifungal Agents; Antiphospholipid Syndrome; Female; Flucytosine; Humans; Immunosuppressive Agents; Lupus Erythematosus, Systemic; Meningitis, Cryptococcal; Methotrexate; Prednisolone; Thrombocytopenia; Thrombophlebitis | 2001 |
Post-antifungal effect of polyene, azole and DNA-analogue agents against oral Candida albicans and Candida tropicalis isolates in HIV disease.
Topics: AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Candida; Candida albicans; Candidiasis, Oral; Fluconazole; Flucytosine; HIV Infections; Humans; Ketoconazole; Microbial Sensitivity Tests; Nystatin; Oropharynx; Pharyngeal Diseases; Statistics as Topic; Time Factors; Virulence | 2001 |
Development of azole resistance during fluconazole maintenance therapy for AIDS-associated cryptococcal disease.
Topics: Adult; AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Chorioretinitis; Cryptococcosis; Cryptococcus neoformans; Drug Resistance, Multiple, Fungal; Fluconazole; Flucytosine; Humans; Itraconazole; Meningitis, Cryptococcal; Pneumonia; Prednisolone; Pyrimidines; Triazoles; Voriconazole | 2001 |
[In vitro antifungal susceptibility of dematiaceous filamentous fungi using the E-test].
Topics: Agar; Amphotericin B; Antifungal Agents; Colony Count, Microbial; Culture Media; Diffusion; Drug Resistance, Fungal; Fluconazole; Flucytosine; Itraconazole; Ketoconazole; Microbial Sensitivity Tests; Mitosporic Fungi | 2001 |
In vitro susceptibility of clinical isolates of Zygomycota to amphotericin B, flucytosine, itraconazole and voriconazole.
Topics: Amphotericin B; Antifungal Agents; Flucytosine; Fungi; Humans; Itraconazole; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole | 2001 |
Evaluation of amphotericin B and flucytosine in combination against Candida albicans and Cryptococcus neoformans using time-kill methodology.
Topics: Amphotericin B; Anti-Bacterial Agents; Candida albicans; Cryptococcus neoformans; Drug Synergism; Flucytosine; Humans; Microbial Sensitivity Tests; Time Factors | 2001 |
Rates and extents of antifungal activities of amphotericin B, flucytosine, fluconazole, and voriconazole against Candida lusitaniae determined by microdilution, Etest, and time-kill methods.
Topics: Amphotericin B; Antifungal Agents; Candida; Fluconazole; Flucytosine; Humans; Microbial Sensitivity Tests; Pyrimidines; Time Factors; Triazoles; Voriconazole | 2002 |
Itraconazole prophylaxis for invasive gingival aspergillosis in neutropenic patients with acute leukemia.
Topics: Administration, Oral; Amphotericin B; Antifungal Agents; Aspergillosis; Candidiasis, Oral; Capsules; Chi-Square Distribution; Chromatography, High Pressure Liquid; Cohort Studies; Fluconazole; Flucytosine; Gingival Diseases; Humans; Immunocompromised Host; Itraconazole; Leukemia, Myeloid, Acute; Leukocyte Count; Neutropenia; Neutrophils; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Retrospective Studies; Risk Factors; Treatment Outcome | 2002 |
Comparison of the Sensititre YeastOne colorimetric microdilution panel and the NCCLS broth microdilution method for antifungal susceptibility testing against Candida species.
Topics: Amphotericin B; Antifungal Agents; Candida; Colorimetry; Fluconazole; Flucytosine; Humans; Itraconazole; Microbial Sensitivity Tests | 2002 |
SDT1/SSM1, a multicopy suppressor of S-II null mutant, encodes a novel pyrimidine 5'-nucleotidase.
Topics: 5'-Nucleotidase; Amphotericin B; Antifungal Agents; Dose-Response Relationship, Drug; Escherichia coli; Fluconazole; Flucytosine; Fluorouracil; Fungal Proteins; Molecular Sequence Data; Nucleotidases; Phosphorylation; Protein Binding; Recombinant Proteins; Ribosomal Proteins; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Substrate Specificity | 2002 |
Intramedullary abscess resulting from disseminated cryptococcosis despite immune restoration in a patient with AIDS.
Topics: Acquired Immunodeficiency Syndrome; Adult; AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Brain Abscess; Cryptococcosis; Cryptococcus neoformans; Fluconazole; Flucytosine; Humans; Male | 2002 |
Candida parapsilosis: two cases of endocarditis in association with the Toronto stentless porcine valve.
Topics: Aged; Aged, 80 and over; Amphotericin B; Animals; Antifungal Agents; Candida; Candidiasis; Endocarditis; Fluconazole; Flucytosine; Heart Valve Prosthesis; Humans; Male; Middle Aged; Swine | 2002 |
In vitro interaction of terbinafine with itraconazole, fluconazole, amphotericin B and 5-flucytosine against Aspergillus spp.
Topics: Amphotericin B; Antifungal Agents; Aspergillus; Drug Interactions; Drug Synergism; Drug Therapy, Combination; Fluconazole; Flucytosine; Humans; Itraconazole; Microbial Sensitivity Tests; Naphthalenes; Terbinafine | 2002 |
In vitro interaction of flucytosine combined with amphotericin B or fluconazole against thirty-five yeast isolates determined by both the fractional inhibitory concentration index and the response surface approach.
Topics: Algorithms; Amphotericin B; Antifungal Agents; Candida; Drug Interactions; Fluconazole; Flucytosine; Microbial Sensitivity Tests; Models, Biological | 2002 |
Cryptococcus neoformans infection.
Topics: Amphotericin B; Antifungal Agents; Cryptococcosis; Deoxycholic Acid; Drug Combinations; Drug Therapy, Combination; Fluconazole; Flucytosine; Humans; Immunosuppressive Agents; Organ Transplantation | 2002 |
[Candida albicans prosthetic valve endocarditis. Two cases].
Topics: Amphotericin B; Antifungal Agents; Candida albicans; Candidiasis; Drug Therapy, Combination; Endocarditis; Fatal Outcome; Female; Flucytosine; Heart Valve Prosthesis Implantation; Humans; Male; Middle Aged; Prosthesis-Related Infections | 2002 |
Has antifungal susceptibility testing come of age?
Topics: Amphotericin B; Antifungal Agents; Azoles; Candida; Clinical Trials as Topic; Flucytosine; Humans; Microbial Sensitivity Tests; Statistics as Topic | 2002 |
In vitro analysis of antifungal impregnated polymethylmethacrylate bone cement.
Topics: Amphotericin B; Antifungal Agents; Arthroplasty, Replacement; Bone Cements; Candida; Colony Count, Microbial; Fluconazole; Flucytosine; Humans; In Vitro Techniques; Microbial Sensitivity Tests; Mycoses; Polymethyl Methacrylate; Postoperative Complications | 2002 |
Cryptococcal meningitis in a patient with systemic immunosuppression 13 years after liver transplantation.
Topics: Adult; Amphotericin B; Antifungal Agents; Drug Therapy, Combination; Fluconazole; Flucytosine; Germany; Humans; Immunocompromised Host; Liver Transplantation; Male; Meningitis, Cryptococcal | 2002 |
Histone deacetylase inhibitors enhance Candida albicans sensitivity to azoles and related antifungals: correlation with reduction in CDR and ERG upregulation.
Topics: Amphotericin B; Antifungal Agents; ATP-Binding Cassette Transporters; Azoles; Candida albicans; DNA-Binding Proteins; Enzyme Inhibitors; Flucytosine; Fungal Proteins; Gene Expression Regulation, Fungal; Histone Deacetylase Inhibitors; Hydroxamic Acids; Itraconazole; Membrane Transport Proteins; Microbial Sensitivity Tests; Naphthalenes; Sterols; Terbinafine; Transcription Factors; Up-Regulation | 2002 |
Antifungal resistance in pathogenic fungi.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Candida; Candidiasis; Drug Resistance, Fungal; Flucytosine; Forecasting; Humans; Immunocompromised Host; Microbial Sensitivity Tests; Prevalence; Treatment Outcome | 2002 |
Candida (amphotericin-sensitive) lens abscess associated with decreasing arterial blood flow in a very low birth weight preterm infant.
Topics: Abscess; Amphotericin B; Antifungal Agents; Candida albicans; Candidiasis; Cataract Extraction; Endophthalmitis; Eye Infections, Fungal; Female; Flucytosine; Gestational Age; Humans; Infant; Infant, Newborn; Infant, Premature; Infant, Very Low Birth Weight; Lens Diseases; Lens, Crystalline; Ophthalmic Artery | 2002 |
Effects of fluconazole singly and in combination with 5-fluorocytosine or amphotericin B in the treatment of cryptococcal meningoencephalitis in an intracranial murine model.
Topics: Amphotericin B; Animals; Antifungal Agents; Brain; Cryptococcus neoformans; Disease Models, Animal; Drug Therapy, Combination; Fluconazole; Flucytosine; Meningitis, Cryptococcal; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Survival Rate | 2002 |
[A clinical study of 26 cases of cryptococcal meningitis].
Topics: Acquired Immunodeficiency Syndrome; Adolescent; Adult; Amphotericin B; Child; Cryptococcus; Drainage; Drug Therapy, Combination; Female; Fluconazole; Flucytosine; Humans; Lupus Erythematosus, Systemic; Male; Meningitis, Cryptococcal; Middle Aged; Retrospective Studies; Survival Rate; Treatment Outcome | 2002 |
Cryptococcal infection in sarcoidosis.
Topics: Amphotericin B; Antifungal Agents; Cryptococcosis; Cryptococcus neoformans; Flucytosine; Humans; Male; Middle Aged; Opportunistic Infections; Sarcoidosis | 2002 |
A flucytosine-resistant Cryptococcus neoformans (serotype D) strain isolated in turkey from cutaneous lesions.
Topics: Adult; Amphotericin B; Cryptococcosis; Cryptococcus neoformans; Dermatomycoses; Drug Resistance, Fungal; Flucytosine; Humans; Male; Purpura, Thrombotic Thrombocytopenic; Skin | 2002 |
Nosocomial transmission of Saccharomyces cerevisiae in bone marrow transplant patients.
Topics: Adult; Amphotericin B; Antifungal Agents; Bone Marrow Transplantation; Carrier State; Cross Infection; DNA, Fungal; Drug Therapy, Combination; Fatal Outcome; Feces; Female; Flucytosine; Genotype; Humans; Immunocompromised Host; Infection Control; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Mass Screening; Multiple Organ Failure; Mycoses; Pharynx; Saccharomyces cerevisiae | 2002 |
[Pseudozyma sp.: colonizer of the respiratory tract in critical patients].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amphotericin B; Antifungal Agents; Critical Care; Female; Fluconazole; Flucytosine; Fungi; Humans; Itraconazole; Lung Diseases, Fungal; Male; Microbial Sensitivity Tests; Middle Aged; Respiratory Tract Infections; Spain; Trichosporon | 2003 |
Phenotyping of Cryptococcus neoformans strains in Bergamo, Italy (1985-2000).
Topics: Adult; Agglutination Tests; Amphotericin B; Antifungal Agents; Azoles; Cell Adhesion; Cryptococcosis; Cryptococcus neoformans; Endopeptidases; Female; Flucytosine; Humans; Italy; Male; Microbial Sensitivity Tests; Middle Aged; Monophenol Monooxygenase; Phenotype; Urease | 2003 |
In vitro activity of amphotericin B and itraconazole in combination with flucytosine, sulfadiazine and quinolones against Exophiala spinifera.
Topics: Amphotericin B; Anti-Infective Agents; Antifungal Agents; Drug Combinations; Exophiala; Flucytosine; Itraconazole; Microbial Sensitivity Tests; Quinolones; Sulfadiazine | 2003 |
Cryptococcal meningitis in pediatric AIDS.
Topics: AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Child; Drug Therapy, Combination; Flucytosine; Humans; Male; Meningitis, Cryptococcal | 2003 |
Longitudinal study of cryptococcosis in adult solid-organ transplant recipients.
Topics: Adult; Aged; Amphotericin B; Antifungal Agents; Cryptococcosis; Drug Therapy, Combination; Female; Flucytosine; Humans; Immunosuppressive Agents; Incidence; Longitudinal Studies; Male; Middle Aged; Transplants | 2003 |
Treatment of Candida glabrata using topical amphotericin B and flucytosine.
Topics: Administration, Intravaginal; Adult; Amphotericin B; Antifungal Agents; Candidiasis, Vulvovaginal; Drug Therapy, Combination; Female; Flucytosine; Humans; Ointments; Recurrence | 2003 |
Antifungal susceptibility of clinical and environmental isolates of Cryptococcus neoformans to four antifungal drugs determined by two techniques.
Topics: Amphotericin B; Antifungal Agents; Brazil; Cryptococcus neoformans; Drug Resistance, Fungal; Environmental Microbiology; Fluconazole; Flucytosine; Humans; Itraconazole; Microbial Sensitivity Tests; Time Factors | 2003 |
Scopulariopsis brevicaulis, a fungal pathogen resistant to broad-spectrum antifungal agents.
Topics: Amphotericin B; Antifungal Agents; Drug Resistance, Fungal; Flucytosine; Humans; Itraconazole; Microbial Sensitivity Tests; Mitosporic Fungi; Naphthalenes; Pyrimidines; Terbinafine; Triazoles; Voriconazole | 2003 |
A very low birth weight infant with Candida nephritis with fungus balls. Full recovery after pyelotomy and antifungal combination therapy.
Topics: Amphotericin B; Antifungal Agents; Candidiasis; Combined Modality Therapy; Fluconazole; Flucytosine; Humans; Infant, Newborn; Infant, Very Low Birth Weight; Kidney; Male; Nephritis; Urologic Surgical Procedures | 2003 |
Antimycotic activity of Melaleuca alternifolia essential oil and its major components.
Topics: Amphotericin B; Antifungal Agents; Candida; Flucytosine; Fungi; Melaleuca; Microbial Sensitivity Tests; Saccharomycetales; Tea Tree Oil; Terpenes | 2003 |
Right ventricular inflow obstruction from massive fungal vegetation presenting as neonatal circulatory collapse.
Topics: Amphotericin B; Antifungal Agents; Candidiasis; Cardiopulmonary Bypass; Ductus Arteriosus, Patent; Echocardiography, Transesophageal; Female; Flucytosine; Humans; Infant, Newborn; Shock, Cardiogenic; Tricuspid Valve; Ventricular Outflow Obstruction | 2003 |
Persistent cellulitis in a patient receiving renal dialysis.
Topics: Adult; Amphotericin B; Antifungal Agents; Cellulitis; Cryptococcosis; Cryptococcus neoformans; Diagnosis, Differential; Female; Flucytosine; Humans; Renal Dialysis | 2003 |
Bilateral Candida parapsilosis interface keratitis after laser in situ keratomileusis.
Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Cornea; Drug Therapy, Combination; Eye Infections, Fungal; Flucytosine; Humans; Keratitis; Keratomileusis, Laser In Situ; Male; Microscopy, Confocal; Middle Aged | 2003 |
Experimental evaluation of antifungal and antiseptic agents against Rhodotorula spp.
Topics: Amphotericin B; Anti-Infective Agents, Local; Antifungal Agents; Drug Resistance, Fungal; Econazole; Fluconazole; Flucytosine; Humans; Itraconazole; Ketoconazole; Miconazole; Microbial Sensitivity Tests; Nystatin; Rhodotorula | 2003 |
National surveillance of species distribution in blood isolates of Candida species in Japan and their susceptibility to six antifungal agents including voriconazole and micafungin.
Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Echinocandins; Flucytosine; Humans; Itraconazole; Japan; Lipopeptides; Lipoproteins; Micafungin; Microbial Sensitivity Tests; Peptides, Cyclic; Pyrimidines; Triazoles; Voriconazole | 2004 |
Candida tropicalis meningitis in a young infant.
Topics: Amphotericin B; Antifungal Agents; Candida tropicalis; Candidiasis; Cross Infection; Drug Therapy, Combination; Flucytosine; Humans; Infant, Newborn; Intensive Care Units, Neonatal; Male; Meningitis, Fungal | 2003 |
In vitro susceptibilities of rare Candida bloodstream isolates to ravuconazole and three comparative antifungal agents.
Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Drug Resistance, Fungal; Fluconazole; Flucytosine; Fungemia; Humans; Microbial Sensitivity Tests; Thiazoles; Triazoles | 2004 |
Amphotericin B and fluconazole, a potent combination therapy for cryptococcal meningitis.
Topics: Amphotericin B; Animals; Antifungal Agents; Body Weight; Brain; Colony Count, Microbial; Cryptococcus neoformans; Dose-Response Relationship, Drug; Drug Combinations; Fluconazole; Flucytosine; Male; Meningitis, Cryptococcal; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Survival Analysis | 2004 |
Caspofungin in a pediatric patient with persistent candidemia.
Topics: Amphotericin B; Antifungal Agents; Candidiasis; Caspofungin; Child, Preschool; Drug Therapy, Combination; Echinocandins; Endocarditis; Female; Flucytosine; Fungemia; Humans; Lipopeptides; Peptides; Peptides, Cyclic | 2004 |
[In vitro activity of a new semisynthetic echinocandin, micafungin, against clinical isolates of Candida species isolated in Tenri Hospital].
Topics: Amphotericin B; Antifungal Agents; Candida; DNA Fingerprinting; Drug Resistance, Fungal; Echinocandins; Fluconazole; Flucytosine; Hospitals; Humans; Itraconazole; Japan; Lipopeptides; Lipoproteins; Micafungin; Mycoses; Peptides, Cyclic; Random Amplified Polymorphic DNA Technique; Time Factors | 2003 |
Prevalence of Candida dubliniensis among germ tube-positive yeasts recovered from the respiratory specimens in HIV-negative patients.
Topics: Adult; Aged; Amphotericin B; Candida; Drug Resistance, Fungal; Fluconazole; Flucytosine; Humans; Itraconazole; Ketoconazole; Male; Microbial Sensitivity Tests; Middle Aged; Mycological Typing Techniques; Respiratory System; Saudi Arabia; Serotyping | 2004 |
In vitro interactions between amphotericin B, itraconazole, and flucytosine against 21 clinical Aspergillus isolates determined by two drug interaction models.
Topics: Algorithms; Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus; Drug Interactions; Flucytosine; Humans; Itraconazole; Microbial Sensitivity Tests; Models, Biological | 2004 |
[Usefulness of the E-test and its assay conditions in the study of the interaction of antifungal agents. A pilot study].
Topics: Amphotericin B; Antifungal Agents; Azoles; Drug Interactions; Flucytosine; Microbial Sensitivity Tests; Naphthalenes; Pilot Projects; Reproducibility of Results; Terbinafine | 2004 |
Effect of pH on the in vitro activities of amphotericin B, itraconazole, and flucytosine against Aspergillus isolates.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus; Candida; Flucytosine; Humans; Hydrogen-Ion Concentration; Itraconazole; Microbial Sensitivity Tests | 2004 |
In vitro susceptibility of Candida species isolated from cancer patients to some antifungal agents.
Topics: Amphotericin B; Antifungal Agents; Candida; Disease Susceptibility; Fluconazole; Flucytosine; Humans; Ketoconazole; Microbial Sensitivity Tests; Mycoses; Neoplasms; Oropharynx | 2004 |
Steroid responsive late deterioration in Cryptococcus neoformans variety gattii meningitis.
Topics: Acetazolamide; Adult; Amphotericin B; Antifungal Agents; Arachnoiditis; Cerebral Infarction; Dexamethasone; Disease Progression; Drug Therapy, Combination; Fluconazole; Flucytosine; Headache; Humans; Hydrocephalus; Immunocompetence; Male; Meningitis, Cryptococcal; Prednisone; Ventriculoperitoneal Shunt | 2004 |
Penetration of Candida biofilms by antifungal agents.
Topics: Amphotericin B; Antifungal Agents; Biofilms; Candida albicans; Colony Count, Microbial; Culture Media; Diffusion; Fluconazole; Flucytosine; Microscopy, Electron, Scanning; Mutation; Pyrimidines; Staphylococcus epidermidis; Triazoles; Voriconazole | 2004 |
In vitro activities of voriconazole in combination with three other antifungal agents against Candida glabrata.
Topics: Amphotericin B; Antifungal Agents; Candida glabrata; Drug Combinations; Drug Synergism; Flucytosine; Kinetics; Microbial Sensitivity Tests; Naphthalenes; Pyrimidines; Terbinafine; Triazoles; Voriconazole | 2004 |
Balamuthia mandrillaris from soil samples.
Topics: Amphotericin B; Animals; Antibodies, Protozoan; Antiprotozoal Agents; Azithromycin; DNA, Mitochondrial; DNA, Protozoan; DNA, Ribosomal; Fluconazole; Flucytosine; Fluorescent Antibody Technique, Indirect; Genes, rRNA; Lobosea; Microscopy; Molecular Sequence Data; Parasitic Sensitivity Tests; Pentamidine; Phylogeny; RNA, Ribosomal, 16S; Sequence Analysis, DNA; Soil; Sulfadiazine | 2004 |
In vitro method to study antifungal perfusion in Candida biofilms.
Topics: Amphotericin B; Antifungal Agents; Biofilms; Biological Assay; Candida; Candida albicans; Drug Resistance, Fungal; Fluconazole; Flucytosine; Humans; Microbial Sensitivity Tests; Micropore Filters; Microscopy, Electron, Scanning | 2005 |
Risk factors for Candida infections in a neonatal intensive care unit in Costa Rica.
Topics: Amphotericin B; Antifungal Agents; Candidiasis; Costa Rica; Fluconazole; Flucytosine; Humans; Infant, Newborn; Intensive Care Units, Neonatal; Retrospective Studies; Risk Factors | 2005 |
Episodic third nerve palsy with cryptococcal meningitis.
Topics: Abducens Nerve; Adult; AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Fatal Outcome; Flucytosine; Humans; Ischemia; Male; Meningitis, Cryptococcal; Oculomotor Nerve; Oculomotor Nerve Diseases; Pulmonary Embolism; Vasculitis | 2005 |
A case of chromoblastomycosis with an unusual clinical manifestation caused by Phialophora verrucosa on an unexposed area: treatment with a combination of amphotericin B and 5-flucytosine.
Topics: Adult; Amphotericin B; Antifungal Agents; Breast Diseases; Chromoblastomycosis; Dermatomycoses; Drug Therapy, Combination; Female; Flucytosine; Humans; Phialophora | 2005 |
[Meningeal cryptococcosis as a sign of immune reconstitution syndrome].
Topics: Adult; AIDS-Related Opportunistic Infections; Amphotericin B; Anti-HIV Agents; Antifungal Agents; Antiretroviral Therapy, Highly Active; CD4-Positive T-Lymphocytes; Fluconazole; Flucytosine; HIV Infections; Humans; Immunologic Memory; Lamivudine; Lopinavir; Male; Meningitis, Cryptococcal; Pyrimidinones; Recurrence; Ritonavir; Syndrome; T-Lymphocyte Subsets; Zidovudine | 2005 |
5-fluorocytosine and amphotericin B in bronchial secretions.
Topics: Amphotericin B; Animals; Antifungal Agents; Bronchi; Dogs; Flucytosine | 1974 |
Efficacy of amphotericin B and flucytosine against fluconazole-resistant Candida inconspicua clinical isolates.
Topics: Amphotericin B; Antifungal Agents; Candida; Drug Resistance, Fungal; Fluconazole; Flucytosine; Humans | 2005 |
Genome-wide expression profiling of the response to azole, polyene, echinocandin, and pyrimidine antifungal agents in Candida albicans.
Topics: Amphotericin B; Antifungal Agents; Azoles; Candida albicans; Caspofungin; Echinocandins; Flucytosine; Fungal Proteins; Gene Expression Profiling; Gene Expression Regulation, Bacterial; Genome, Fungal; Humans; Ketoconazole; Lipopeptides; Microbial Sensitivity Tests; Oligonucleotide Array Sequence Analysis; Peptides, Cyclic; Polyenes; Pyrimidines | 2005 |
The use of ventriculoperitoneal shunts for uncontrollable intracranial hypertension without ventriculomegally secondary to HIV-associated cryptococcal meningitis.
Topics: Acquired Immunodeficiency Syndrome; Adult; AIDS-Related Opportunistic Infections; Amphotericin B; Drug Therapy, Combination; Female; Fluconazole; Flucytosine; Humans; Immunocompromised Host; Intracranial Hypertension; Lateral Ventricles; Meningitis, Cryptococcal; Middle Aged; Neurosurgical Procedures; Tomography, X-Ray Computed; Treatment Outcome; Ventriculoperitoneal Shunt | 2005 |
Management of cryptococcosis in non-HIV-related patients.
Topics: Administration, Oral; Adolescent; Adult; Amphotericin B; Antifungal Agents; Central Nervous System Fungal Infections; Child; Child, Preschool; China; Cryptococcosis; Drug Therapy, Combination; Female; Flucytosine; Humans; Injections, Intravenous; Injections, Spinal; Itraconazole; Lung Diseases, Fungal; Male; Middle Aged; Retrospective Studies; Skin Diseases; Treatment Outcome; Triazoles | 2005 |
Surface response modeling to examine the combination of amphotericin B deoxycholate and 5-fluorocytosine for treatment of invasive candidiasis.
Topics: Amphotericin B; Animals; Antifungal Agents; Candidiasis; Deoxycholic Acid; Dose-Response Relationship, Drug; Drug Combinations; Drug Synergism; Drug Therapy, Combination; Flucytosine; Male; Mice; Microbial Sensitivity Tests; Models, Biological | 2005 |
Relationship between in vitro activities of amphotericin B and flucytosine and pH for clinical yeast and mold isolates.
Topics: Amphotericin B; Antifungal Agents; Aspergillus fumigatus; Buffers; Candida; Cryptococcus neoformans; Culture Media; Flucytosine; Fungi; Hydrogen-Ion Concentration; Microbial Sensitivity Tests; Rhizopus; Scedosporium | 2005 |
Antiretroviral roll-out, antifungal roll-back: access to treatment for cryptococcal meningitis.
Topics: AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Disease Susceptibility; Flucytosine; HIV Infections; Humans; Meningitis, Cryptococcal; Treatment Outcome | 2005 |
Experience with caspofungin in the treatment of persistent fungemia in neonates.
Topics: Amphotericin B; Antifungal Agents; Candidiasis; Caspofungin; Drug Therapy, Combination; Echinocandins; Female; Fluconazole; Flucytosine; Fungemia; Gestational Age; Humans; Infant, Newborn; Infant, Premature, Diseases; Infant, Very Low Birth Weight; Intensive Care, Neonatal; Lipopeptides; Male; Peptides, Cyclic; Retrospective Studies | 2005 |
Successful treatment of Acanthamoeba rhinosinusitis in a patient with AIDS.
Topics: Acanthamoeba; Adult; AIDS-Related Opportunistic Infections; Amebiasis; Amebicides; Amphotericin B; Animals; Flucytosine; HIV Infections; Humans; Male; Rhinitis; Sinusitis; Treatment Outcome | 2005 |
[Systemic Candida albicans infection with neuromeningeal complication in a premature infant].
Topics: Amphotericin B; Antifungal Agents; Candida albicans; Candidiasis; Drug Therapy, Combination; Flucytosine; Humans; Hydrocephalus; Infant, Newborn; Infant, Premature; Magnetic Resonance Imaging; Male; Meningitis, Bacterial; Radiography | 2005 |
Activities of flucytosine, fluconazole, amphotericin B, and micafungin in a murine model of disseminated infection by Candida glabrata.
Topics: Amphotericin B; Animals; Antifungal Agents; Candida glabrata; Candidiasis; Echinocandins; Fluconazole; Flucytosine; Lipopeptides; Lipoproteins; Male; Micafungin; Mice; Microbial Sensitivity Tests; Peptides, Cyclic | 2005 |
Antimycotic combination therapy in patients with acute myeloblastic leukemia.
Topics: Adolescent; Adult; Aged; Amphotericin B; Antifungal Agents; Drug Administration Schedule; Drug Therapy, Combination; Flucytosine; Humans; Leukemia, Myeloid, Acute; Middle Aged; Mycoses; Tobramycin; Vancomycin | 1989 |
Efficacy of amphotericin B in combination with flucytosine against flucytosine-susceptible or flucytosine-resistant isolates of Cryptococcus neoformans during disseminated murine cryptococcosis.
Topics: Amphotericin B; Animals; Antifungal Agents; Brain; Cryptococcosis; Cryptococcus neoformans; Disease Models, Animal; Drug Combinations; Drug Therapy, Combination; Flucytosine; Lung | 2006 |
Modification of the fluorescein diacetate assay for screening of antifungal agents against Candida albicans: comparison with the NCCLS methods.
Topics: Amphotericin B; Antifungal Agents; Candida albicans; Culture Media; Fluconazole; Flucytosine; Fluoresceins; Fluorometry; Miconazole; Microbial Sensitivity Tests | 2006 |
In vitro interactions of anidulafungin with azole antifungals, amphotericin B and 5-fluorocytosine against Candida species.
Topics: Amphotericin B; Anidulafungin; Animals; Antifungal Agents; Candida; Candida albicans; Candida glabrata; Candida tropicalis; Candidiasis; Drug Interactions; Echinocandins; Flucytosine; Humans; In Vitro Techniques; Microbial Sensitivity Tests; Peptides, Cyclic | 2006 |
[Cryptococcal meningitis disclosed by visual loss in HIV negative patient with ventriculo-atrial shunting].
Topics: Amphotericin B; Anti-Inflammatory Agents; Antifungal Agents; Blindness; Cerebrospinal Fluid Shunts; Diagnosis, Differential; Drug Therapy, Combination; Eye Infections, Fungal; Fluconazole; Flucytosine; Fludrocortisone; Follow-Up Studies; HIV Seronegativity; Humans; Hydrocephalus; Hydrocortisone; Male; Meningitis, Cryptococcal; Middle Aged; Prednisolone; Sarcoidosis; Time Factors; Treatment Outcome | 2006 |
Head-to-head comparison of the activities of currently available antifungal agents against 3,378 Spanish clinical isolates of yeasts and filamentous fungi.
Topics: Amphotericin B; Antifungal Agents; Caspofungin; Echinocandins; Fluconazole; Flucytosine; Fungi; Humans; Itraconazole; Lipopeptides; Microbial Sensitivity Tests; Mycoses; Peptides, Cyclic; Pyrimidines; Spain; Triazoles; Voriconazole; Yeasts | 2006 |
[Cryptococcal meningo-encephalitis in an apparently immunocompetent patient].
Topics: Amphotericin B; Antifungal Agents; Antigens, Fungal; Brain; CD4 Lymphocyte Count; Cerebrospinal Fluid; Cryptococcus neoformans; Drug Therapy, Combination; Encephalitis; Flucytosine; Humans; Immunocompetence; Magnetic Resonance Imaging; Male; Meningitis, Cryptococcal; Middle Aged; Treatment Outcome | 2006 |
[Antifungal susceptibility among the isolates of yeast from the University Hospital of the Ryukyus].
Topics: Amphotericin B; Antifungal Agents; Candida; Candida albicans; Candida glabrata; Candida tropicalis; Drug Resistance, Fungal; Echinocandins; Fluconazole; Flucytosine; Japan; Lipopeptides; Lipoproteins; Micafungin; Miconazole; Minimally Invasive Surgical Procedures; Peptides, Cyclic | 2005 |
Successful treatment of Trichosporon mucoides infection with lipid complex amphotericin B and 5-fluorocytosine.
Topics: Adolescent; Amphotericin B; Antifungal Agents; Drug Therapy, Combination; Flucytosine; Humans; Male; Mycoses; Opportunistic Infections; Trichosporon | 2006 |
Antifungal treatment for cryptococcal meningitis.
Topics: AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Drug Administration Schedule; Flucytosine; Humans; Immunocompromised Host; Meningitis, Cryptococcal | 2006 |
In vitro susceptibilities of Malaysian clinical isolates of Cryptococcus neoformans var. grubii and Cryptococcus gattii to five antifungal drugs.
Topics: Amphotericin B; Antifungal Agents; Cryptococcus; Cryptococcus neoformans; Drug Resistance, Fungal; Fluconazole; Flucytosine; Humans; Itraconazole; Ketoconazole; Microbial Sensitivity Tests | 2006 |
Results obtained with various antifungal susceptibility testing methods do not predict early clinical outcome in patients with cryptococcosis.
Topics: AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Cryptococcosis; Cryptococcus neoformans; Female; Fluconazole; Flucytosine; HIV Infections; Humans; Male; Microbial Sensitivity Tests; Predictive Value of Tests; Prognosis; Treatment Outcome | 2006 |
Antifungal susceptibility of epigallocatechin 3-O-gallate (EGCg) on clinical isolates of pathogenic yeasts.
Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Catechin; Dose-Response Relationship, Drug; Echinocandins; Fluconazole; Flucytosine; Humans; Itraconazole; Lipopeptides; Lipoproteins; Micafungin; Miconazole; Microbial Sensitivity Tests; Peptides, Cyclic; Species Specificity | 2006 |
In vitro susceptibility to antifungal agents of environmental Cryptococcus spp. isolated in the city of Ribeirão Preto, São Paulo, Brazil.
Topics: Amphotericin B; Antifungal Agents; Brazil; Cryptococcus; Drug Resistance, Fungal; Environmental Microbiology; Fluconazole; Flucytosine; Itraconazole; Microbial Sensitivity Tests | 2006 |
[Mycotic complications of shunt infection in children with primary hydrocephalus].
Topics: Amphotericin B; Antifungal Agents; Candidiasis; Cerebrospinal Fluid; Child, Preschool; Female; Fluconazole; Flucytosine; Humans; Hydrocephalus; Infant; Injections, Intravenous; Injections, Intraventricular; Male; Ventriculoperitoneal Shunt | 2002 |
Epidemiology of candidemia in a Turkish tertiary care hospital.
Topics: Amphotericin B; Antifungal Agents; Blotting, Southern; Candida; Candidiasis; Cross Infection; DNA Fingerprinting; Drug Resistance, Fungal; Fluconazole; Flucytosine; Fungemia; Hospital Units; Humans; Microbial Sensitivity Tests; Turkey | 2006 |
Combined antifungal therapy in a murine infection by Candida glabrata.
Topics: Amphotericin B; Animals; Antifungal Agents; Candida glabrata; Candidiasis; Colony Count, Microbial; Disease Models, Animal; Drug Synergism; Drug Therapy, Combination; Echinocandins; Fluconazole; Flucytosine; Immunocompromised Host; Kidney; Lipopeptides; Lipoproteins; Micafungin; Mice; Peptides, Cyclic; Spleen; Survival Analysis | 2006 |
Antifungal susceptibilities of the species of the Pseudallescheria boydii complex.
Topics: Amphotericin B; Antifungal Agents; Candida; Drug Resistance, Fungal; Echinocandins; Fluconazole; Flucytosine; Humans; Itraconazole; Ketoconazole; Lipopeptides; Lipoproteins; Micafungin; Microbial Sensitivity Tests; Naphthalenes; Peptides, Cyclic; Pseudallescheria; Pyrimidines; Quality Control; Quinazolines; Scedosporium; Terbinafine; Thiazoles; Triazoles; Voriconazole | 2006 |
Molluscum or a mimic?
Topics: Adult; AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Antiretroviral Therapy, Highly Active; Cryptococcosis; Diagnosis, Differential; Fluconazole; Flucytosine; HIV Seropositivity; Humans; Male; Molluscum Contagiosum | 2006 |
Effect of neutropenia and treatment delay on the response to antifungal agents in experimental disseminated candidiasis.
Topics: Amphotericin B; Animals; Antifungal Agents; Candida albicans; Candidiasis; Disease Models, Animal; Dose-Response Relationship, Drug; Echinocandins; Flucytosine; Kidney; Lipopeptides; Lipoproteins; Male; Micafungin; Mice; Microbial Sensitivity Tests; Neutropenia; Neutrophils; Peptides, Cyclic; Time Factors | 2007 |
Effect of antifungal treatment in a murine model of blastoschizomycosis.
Topics: Amphotericin B; Animals; Antifungal Agents; Disease Models, Animal; Dose-Response Relationship, Drug; Fluconazole; Flucytosine; Geotrichosis; Geotrichum; Immunocompromised Host; Immunosuppressive Agents; Kidney; Liver; Male; Mice; Microbial Sensitivity Tests; Pyrimidines; Spleen; Survival Analysis; Treatment Outcome; Triazoles; Voriconazole | 2007 |
A novel dodecapeptide from a combinatorial synthetic library exhibits potent antifungal activity and synergy with standard antimycotic agents.
Topics: Amino Acid Sequence; Amphotericin B; Animals; Antifungal Agents; Aspergillus fumigatus; Candida albicans; Combinatorial Chemistry Techniques; Cryptococcus neoformans; Drug Synergism; Erythrocytes; Fluconazole; Flucytosine; Fungi; Hemolysis; Inhibitory Concentration 50; Microbial Sensitivity Tests; Oligopeptides; Rabbits | 2007 |
Temporal bone histopathology case of the month: acute hearing loss due to cryptococcal meningitis in a patient with acquired immunodeficiency syndrome.
Topics: Acquired Immunodeficiency Syndrome; Adult; Amphotericin B; Anti-Bacterial Agents; Cochlear Nerve; Cryptococcus neoformans; Drug Therapy, Combination; Flucytosine; Headache; Hearing Loss, Bilateral; Humans; Male; Meningitis, Cryptococcal; Reflex, Acoustic; Temporal Bone | 2007 |
Images in HIV/AIDS. Pruritic cryptococcal skin lesions in an HIV-positive person.
Topics: Adult; AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Cryptococcosis; Diagnosis, Differential; Drug Therapy, Combination; Facial Dermatoses; Female; Flucytosine; HIV Infections; Humans; Pruritus; Radiography | 2006 |
Colonic cryptococcus infection.
Topics: Adult; Amphotericin B; Antifungal Agents; Biopsy; Colitis; Colonoscopy; Cryptococcosis; Cryptococcus neoformans; Diagnosis, Differential; Drug Therapy, Combination; Flucytosine; Humans; Injections, Intravenous; Intestinal Mucosa; Male | 2007 |
Determinants of disease presentation and outcome during cryptococcosis: the CryptoA/D study.
Topics: Adult; AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Cryptococcosis; Cryptococcus neoformans; Female; Flucytosine; France; Humans; Male; Meningoencephalitis; Prospective Studies; Severity of Illness Index; Treatment Outcome | 2007 |
Subcutaneous cryptococcosis due to Cryptococcus diffluens in a patient with sporotrichoid lesions case report, features of the case isolate and in vitro antifungal susceptibilities.
Topics: Adolescent; Amphotericin B; Antifungal Agents; Base Sequence; Cryptococcosis; Cryptococcus; Diagnosis, Differential; DNA, Fungal; DNA, Ribosomal; DNA, Ribosomal Spacer; Drug Resistance, Fungal; Flucytosine; Humans; Male; Microbial Sensitivity Tests; Molecular Sequence Data; RNA, Ribosomal, 28S; Sequence Analysis, DNA; Sporotrichosis | 2007 |
Serum and intraperitoneal levels of amphotericin B and flucytosine during intravenous treatment of critically ill patients with Candida peritonitis.
Topics: Aged; Amphotericin B; Ascitic Fluid; Candidiasis; Critical Care; Female; Flucytosine; Fungemia; Humans; Male; Middle Aged; Peritonitis; Prospective Studies | 2007 |
Endophthalmitis due to Trichosporon beigelii in acute leukemia.
Topics: Acute Disease; Adult; Amphotericin B; Antifungal Agents; Drug Resistance, Fungal; Endophthalmitis; Female; Fluconazole; Flucytosine; Humans; Leukemia, Myeloid; Male; Middle Aged; Mycoses; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Trichosporon | 2007 |
Meningitis caused by Rhodotorula rubra in an human immunodeficiency virus infected patient.
Topics: Adult; AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Cerebrospinal Fluid; False Positive Reactions; Fatal Outcome; Flucytosine; HIV Infections; Humans; Latex Fixation Tests; Male; Meningitis, Fungal; Rhodotorula | 2007 |
Multicenter comparison of the VITEK 2 antifungal susceptibility test with the CLSI broth microdilution reference method for testing amphotericin B, flucytosine, and voriconazole against Candida spp.
Topics: Amphotericin B; Antifungal Agents; Candida; Culture Media; Flucytosine; Humans; Microbial Sensitivity Tests; Pyrimidines; Reference Standards; Time Factors; Triazoles; Voriconazole | 2007 |
Antifungal susceptibility of bloodstream yeasts isolated at a public children's hospital in Brazil: comparison of the Etest and the AFST-EUCAST microdilution method.
Topics: Amphotericin B; Antifungal Agents; Blood; Brazil; Candida; Child; Child, Preschool; Fluconazole; Flucytosine; Hospitals, Public; Humans; Infant; Infant, Newborn; Itraconazole; Microbial Sensitivity Tests; Pyrimidines; Reproducibility of Results; Sensitivity and Specificity; Triazoles; Voriconazole | 2007 |
Granulomatous prostatitis due to Cryptococcus neoformans: diagnostic usefulness of special stains and molecular analysis of 18S rDNA.
Topics: Abscess; Amphotericin B; Antifungal Agents; Carmine; Coloring Agents; Cryptococcosis; Cryptococcus neoformans; DNA, Fungal; DNA, Ribosomal; Drug Therapy, Combination; Flucytosine; Granuloma; Humans; Lung Diseases, Fungal; Male; Meningitis, Cryptococcal; Methenamine; Middle Aged; Periodic Acid-Schiff Reaction; Prostatitis; Ribotyping; RNA, Fungal; RNA, Ribosomal, 18S; Silver Nitrate; Staining and Labeling | 2008 |
Comparative evaluation of ATB Fungus 2 and Sensititre YeastOne panels for testing in vitro Candida antifungal susceptibility.
Topics: Amphotericin B; Antifungal Agents; Candida; Colony Count, Microbial; False Positive Reactions; Fluconazole; Flucytosine; Itraconazole; Microbial Sensitivity Tests; Reagent Strips; Reproducibility of Results | 2008 |
In vitro interactions of approved and experimental drugs against Candida drugs against Candida spp.
Topics: Amphotericin B; Antifungal Agents; Aspergillus; Benzene Derivatives; Candida albicans; Drug Interactions; Drug Therapy, Combination; Ethylenes; Flucytosine; Humans; In Vitro Techniques; Microbial Sensitivity Tests; Oligopeptides | 2008 |
Current approaches to management of cerebral fungal infection in pediatric patients with hematologic disorders.
Topics: Adolescent; Amphotericin B; Anti-Bacterial Agents; Antifungal Agents; Aspergillosis; Central Nervous System Fungal Infections; Child; Drug Combinations; Echinocandins; Fatal Outcome; Female; Flucytosine; Follow-Up Studies; Graft Rejection; Hematologic Diseases; Humans; Leukemia, Myeloid, Acute; Lipopeptides; Lipoproteins; Magnetic Resonance Imaging; Male; Micafungin; Mucormycosis; Peripheral Blood Stem Cell Transplantation; Remission Induction; Treatment Outcome | 2008 |
Sarcoidosis as risk factor for cryptococcal meningitis in an apparently immunocompetent patient.
Topics: Adult; Amphotericin B; Antifungal Agents; Cryptococcus neoformans; Fatal Outcome; Flucytosine; Humans; Male; Meningitis, Cryptococcal; Opportunistic Infections; Risk Factors; Sarcoidosis, Pulmonary | 2008 |
Cryptococcal meningitis in patients with glioma: a report of two cases.
Topics: Adult; Aged; Amphotericin B; Anti-Inflammatory Agents; Antifungal Agents; Antineoplastic Agents, Alkylating; Brain Neoplasms; Cerebrospinal Fluid; Cryptococcus neoformans; Dacarbazine; Dexamethasone; Fatal Outcome; Fluconazole; Flucytosine; Glioma; Humans; Immunosuppression Therapy; Lomustine; Male; Meningitis, Cryptococcal; Opportunistic Infections; Temozolomide; Treatment Outcome | 2008 |
Combination antifungal therapy involving amphotericin B, rapamycin and 5-fluorocytosine using PEG-phospholipid micelles.
Topics: Amphotericin B; Antifungal Agents; Candida albicans; Chemistry, Pharmaceutical; Drug Carriers; Drug Combinations; Drug Stability; Drug Synergism; Flucytosine; Micelles; Microbial Sensitivity Tests; Phosphatidylethanolamines; Polyethylene Glycols; Sirolimus; Solubility; Technology, Pharmaceutical | 2008 |
Reversible cardiomyopathy following treatment with amphotericin B and flucytosine.
Topics: Amphotericin B; Antifungal Agents; Blood Pressure; Cardiomyopathies; Cryptococcosis; Drug Carriers; Electrocardiography; Female; Flucytosine; Heart; Heart Function Tests; Heart Rate; Humans; Liposomes; Middle Aged; Radionuclide Imaging | 2008 |
Cryptococcosis and deficiency of interleukin12r.
Topics: Amphotericin B; Antifungal Agents; Bone Marrow; Candida albicans; Child, Preschool; Cryptococcosis; Cryptococcus neoformans; Flucytosine; Humans; Interferon-gamma; Male; Receptors, Interleukin-12 | 2008 |
In vitro susceptibility of Cryptococcus gattii clinical isolates.
Topics: Amphotericin B; Antifungal Agents; Cryptococcus; Cryptococcus neoformans; Drug Resistance, Fungal; Fluconazole; Flucytosine; Humans; Microbial Sensitivity Tests; Triazoles | 2008 |
Susceptibility testing of Cryptococcus diffluens against amphotericin B, flucytosine, fluconazole, itraconazole, voriconazole and posaconazole.
Topics: Amphotericin B; Antifungal Agents; Azoles; Cryptococcus; Culture Media; Drug Resistance, Fungal; Fluconazole; Flucytosine; Humans; Itraconazole; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole | 2009 |
Major role for amphotericin B-flucytosine combination in severe cryptococcosis.
Topics: Adult; Amphotericin B; Antifungal Agents; Cryptococcosis; Cryptococcus neoformans; Drug Therapy, Combination; Female; Flucytosine; HIV Seropositivity; Humans; Male; Societies, Medical; Treatment Outcome; United States | 2008 |
Disseminated cryptococcal infection with eosinophilia in a healthy person.
Topics: Adult; Amphotericin B; Antifungal Agents; Cryptococcosis; Drug Therapy, Combination; Eosinophilia; Flucytosine; Humans; Lung Diseases, Fungal; Lymph Nodes; Male; Radiography | 2008 |
Cryptococcal meningitis in an immunocompetent adolescent.
Topics: Adolescent; Amphotericin B; Antifungal Agents; Drug Therapy, Combination; Female; Flucytosine; Humans; Immunocompetence; Magnetic Resonance Imaging; Meningitis, Cryptococcal; Tomography, X-Ray Computed | 2008 |
Five-year retrospective review of guideline-based management of fungal endophthalmitis.
Topics: Adolescent; Adult; Aged; Amphotericin B; Antifungal Agents; Drug Costs; Endophthalmitis; Eye Infections, Fungal; Female; Fluconazole; Flucytosine; Guideline Adherence; Health Care Costs; Humans; Male; Medical Audit; Middle Aged; Mycoses; Practice Guidelines as Topic; Pyrimidines; Retrospective Studies; Treatment Outcome; Triazoles; Visual Acuity; Voriconazole | 2008 |
Fatal cerebral abscess caused by Cladophialophora bantiana.
Topics: Adult; Amphotericin B; Antifungal Agents; Ascomycota; Brain Abscess; Central Nervous System Fungal Infections; Cladosporium; Craniotomy; Drug Therapy, Combination; Fatal Outcome; Flucytosine; Humans; Itraconazole; Male | 2008 |
Molecular identification and susceptibility testing of Trichosporon isolates from a Brazilian hospital.
Topics: Amphotericin B; Antifungal Agents; Brazil; Cross Infection; Dermatomycoses; Drug Resistance, Fungal; Echinocandins; Female; Flucytosine; Fungemia; Hospitals, University; Humans; Mycological Typing Techniques; Mycoses; Onychomycosis; Opportunistic Infections; Organ Specificity; Triazoles; Trichosporon; Urine; Vaginitis | 2008 |
Cerebral infection caused by Cryptococcus gattii: a case report and antifungal susceptibility testing.
Topics: Amphotericin B; Antifungal Agents; Child; Cryptococcus; Drug Resistance, Multiple, Fungal; Drug Synergism; Fluconazole; Flucytosine; Humans; Immunocompetence; Intracranial Hypertension; Itraconazole; Male; Meningitis, Cryptococcal; Microbial Sensitivity Tests; Spinal Puncture; Ventriculoperitoneal Shunt | 2008 |
Combined antifungal therapy in a murine model of disseminated infection by Cladophialophora bantiana.
Topics: Amphotericin B; Animals; Antifungal Agents; Ascomycota; Disease Models, Animal; Drug Therapy, Combination; Echinocandins; Flucytosine; Humans; Lipopeptides; Male; Micafungin; Mice; Mycoses; Treatment Outcome; Triazoles | 2009 |
Successful treatment of invasive sphenoidal, pulmonary and intracerebral aspergillosis after multivisceral transplantation.
Topics: Adult; Amphotericin B; Aspergillosis; Cerebrum; Female; Flucytosine; Humans; Immunocompromised Host; Intestines; Kidney Transplantation; Lung Diseases, Fungal; Neuroaspergillosis; Pyrimidines; Sphenoid Sinus; Triazoles; Voriconazole | 2009 |
Pulmonary cryptococcosis in non-AIDS patients.
Topics: Adolescent; Adult; Amphotericin B; Antifungal Agents; Cryptococcosis; Drug Therapy, Combination; Female; Fluconazole; Flucytosine; HIV Seronegativity; Humans; Lung Diseases, Fungal; Male; Middle Aged; Prognosis; Retrospective Studies; Tomography, X-Ray Computed | 2009 |
Hepatic involvement in a liver transplant recipient with disseminated cryptococcosis.
Topics: Amphotericin B; Antifungal Agents; Cryptococcosis; Fatal Outcome; Flucytosine; Humans; Immunosuppressive Agents; Liver Diseases; Liver Transplantation; Male; Middle Aged; Postoperative Complications | 2009 |
In vitro antifungal combination effects of micafungin with fluconazole, voriconazole, amphotericin B, and flucytosine against clinical isolates of Candida species.
Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Drug Synergism; Echinocandins; Fluconazole; Flucytosine; Humans; Lipopeptides; Micafungin; Pyrimidines; Triazoles; Voriconazole | 2009 |
Antifungal combinations against simulated Candida albicans endocardial vegetations.
Topics: Amphotericin B; Antifungal Agents; Biofilms; Candida albicans; Drug Combinations; Echinocandins; Endocarditis; Flucytosine; Humans; Lipopeptides; Micafungin | 2009 |
Preterm neonates with candidal brain microabscesses: a case series.
Topics: Amphotericin B; Antifungal Agents; Brain; Brain Abscess; Candidiasis; Deoxycholic Acid; Drug Combinations; Drug Therapy, Combination; Echoencephalography; Female; Flucytosine; Follow-Up Studies; Fungemia; Humans; Infant; Infant, Extremely Low Birth Weight; Infant, Newborn; Infant, Premature, Diseases; Magnetic Resonance Imaging | 2009 |
[In vitro activity of voriconazole and other antifungal agents against clinical isolates of 138 Candida spp].
Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Drug Resistance, Fungal; Drug Resistance, Multiple, Fungal; Fluconazole; Flucytosine; Humans; Itraconazole; Microbial Sensitivity Tests; Pyrimidines; Species Specificity; Triazoles; Voriconazole | 2009 |
Cryptococcus gattii meningoencephalitis in an immunocompetent person 13 months after exposure.
Topics: Amphotericin B; Antifungal Agents; Cerebrospinal Fluid; Cryptococcosis; Cryptococcus; Culture Media; DNA, Fungal; DNA, Ribosomal Spacer; Drainage; Female; Fluconazole; Flucytosine; Humans; Meningoencephalitis; Middle Aged; Molecular Sequence Data; Phylogeny; Sequence Analysis, DNA; Switzerland; Travel | 2009 |
Uncommon presentation of intracranial cryptococcal infection mimicking tuberculous infection in two immunocompetent patients.
Topics: Amphotericin B; Antifungal Agents; Cerebellar Diseases; Cryptococcus neoformans; Diagnosis, Differential; Diffusion Magnetic Resonance Imaging; Female; Flucytosine; Humans; Immunocompetence; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Male; Meninges; Meningitis, Cryptococcal; Middle Aged; Tomography, X-Ray Computed; Tuberculosis, Meningeal; Young Adult | 2009 |
Intraocular cryptococcoma.
Topics: Aged; Amphotericin B; Antifungal Agents; Cryptococcosis; Cryptococcus neoformans; Drug Therapy, Combination; Eye Diseases; Eye Infections, Fungal; Fluconazole; Flucytosine; Humans; Male; Middle Aged; Ultrasonography; Vitrectomy; Vitreous Body | 2009 |
Direct antifungal susceptibility testing of positive Candida blood cultures by sensititre YeastOne.
Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Drug Resistance, Fungal; Fluconazole; Flucytosine; Humans; Itraconazole; Ketoconazole; Microbial Sensitivity Tests; Pyrimidines; Reagent Kits, Diagnostic; Sensitivity and Specificity; Time Factors; Triazoles; Voriconazole | 2009 |
Disseminated Cryptococcus neoformans: case report and review of the literature.
Topics: Amphotericin B; Antifungal Agents; Cryptococcosis; Cryptococcus neoformans; Flucytosine; Humans; Liver Transplantation; Male; Middle Aged; Treatment Outcome | 2009 |
Comparison of antifungal MICs for yeasts obtained using the EUCAST method in a reference laboratory and the Etest in nine different hospital laboratories.
Topics: Amphotericin B; Antifungal Agents; Candida; Caspofungin; Cryptococcus neoformans; Drug Resistance, Fungal; Echinocandins; Fluconazole; Flucytosine; Fungemia; Itraconazole; Laboratories, Hospital; Lipopeptides; Microbial Sensitivity Tests; Pyrimidines; Reference Values; Triazoles; Voriconazole; Yeasts | 2010 |
The role of an Ommaya reservoir in the management of children with cryptococcal meningitis.
Topics: Amphotericin B; Antifungal Agents; Child; Cryptococcus neoformans; Drug Delivery Systems; Female; Fluconazole; Flucytosine; Humans; Intracranial Hypertension; Male; Meningitis, Cryptococcal | 2010 |
Candida parapsilosis meningitis associated with shunt infection in an adult male.
Topics: Amphotericin B; Antifungal Agents; Brain Abscess; Candida; Candidiasis; Drainage; Fluconazole; Flucytosine; Follow-Up Studies; Humans; Injections, Intravenous; Male; Meningitis, Bacterial; Middle Aged; Recurrence; Treatment Outcome; Ventriculoperitoneal Shunt | 2010 |
The post-antifungal effect (PAFE) of amphotericin B, nystatin, ketoconazole and 5-fluorocytosine and its impact on the colonization traits of Candida glabrata.
Topics: Amphotericin B; Antifungal Agents; Biofilms; Biomass; Candida glabrata; Candidiasis; Cell Adhesion; Cell Wall; Epithelial Cells; Flucytosine; Humans; Hydrophobic and Hydrophilic Interactions; Ketoconazole; Nephelometry and Turbidimetry; Nystatin | 2010 |
Continuous infusion of amphotericin B deoxycholate in the treatment of cryptococcal meningoencephalitis: analysis of safety and fungicidal activity.
Topics: Adult; Amphotericin B; Antifungal Agents; Cerebrospinal Fluid; Colony Count, Microbial; Cryptococcus; Deoxycholic Acid; Drug Combinations; Female; Flucytosine; HIV Infections; Humans; Infusions, Intravenous; Male; Meningitis, Cryptococcal; Microbial Viability; Middle Aged; Treatment Outcome; Young Adult | 2010 |
Prevalence and management of non-albicans vaginal candidiasis.
Topics: Administration, Intravaginal; Amphotericin B; Antifungal Agents; Candidiasis, Vulvovaginal; Drug Therapy, Combination; Female; Flucytosine; Humans; Ointments; Prevalence; Retrospective Studies | 2010 |
Identification of Paecilomyces variotii in clinical samples and settings.
Topics: Amphotericin B; Antifungal Agents; DNA, Fungal; DNA, Ribosomal; DNA, Ribosomal Spacer; Flucytosine; Fungal Proteins; Genes, rRNA; Humans; Microbial Sensitivity Tests; Molecular Sequence Data; Mycoses; Paecilomyces; Pyrimidines; RNA, Fungal; RNA, Ribosomal, 5.8S; Sequence Analysis, DNA; Triazoles; Tubulin; Voriconazole | 2010 |
JAAD grand rounds quiz*: Renal transplant patient with vegetative plaque on the cheek.
Topics: Amphotericin B; Cheek; Cryptococcosis; Cryptococcus neoformans; Facial Dermatoses; Flucytosine; Humans; Kidney Transplantation; Male; Middle Aged; Postoperative Complications | 2010 |
A prospective descriptive study of cryptococcal meningitis in HIV uninfected patients in Vietnam - high prevalence of Cryptococcus neoformans var grubii in the absence of underlying disease.
Topics: Adolescent; Adult; Aged; Amphotericin B; Antifungal Agents; Cryptococcus gattii; Cryptococcus neoformans; Female; Flucytosine; HIV Infections; Humans; Male; Meningitis, Cryptococcal; Microbial Sensitivity Tests; Middle Aged; Prevalence; Prospective Studies; Treatment Outcome; Vietnam; Young Adult | 2010 |
Drug susceptibility of 64 strains of Rhodotorula sp.
Topics: Amphotericin B; Antifungal Agents; Feces; Female; Fluconazole; Flucytosine; Humans; Itraconazole; Microbial Sensitivity Tests; Nails; Rhodotorula; Skin; Species Specificity; Vagina | 2010 |
In vitro antifungal susceptibilities and amplified fragment length polymorphism genotyping of a worldwide collection of 350 clinical, veterinary, and environmental Cryptococcus gattii isolates.
Topics: Amphotericin B; Amplified Fragment Length Polymorphism Analysis; Animals; Antifungal Agents; Cryptococcus gattii; Environmental Microbiology; Fluconazole; Flucytosine; Genotype; Humans; Microbial Sensitivity Tests; Nitriles; Pyridines; Pyrimidines; Triazoles; Voriconazole | 2010 |
Cryptococcosis in sarcoidosis.
Topics: Adult; Amphotericin B; Antifungal Agents; Cryptococcosis; Drug Therapy, Combination; Flucytosine; Humans; Kidney Diseases; Male; Sarcoidosis; Sarcoidosis, Pulmonary; Treatment Outcome | 2010 |
Disseminated cryptococcosis in a non-Hodgkin's lymphoma patient with late-onset neutropenia following rituximab-CHOP chemotherapy: a case report and literature review.
Topics: Aged; Amphotericin B; Antibodies, Monoclonal, Murine-Derived; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Cryptococcosis; Cryptococcus neoformans; Cyclophosphamide; Doxorubicin; Female; Fluconazole; Flucytosine; Humans; Immunologic Factors; Lymphoma, Non-Hodgkin; Neutropenia; Prednisolone; Rituximab; Treatment Outcome; Vincristine | 2011 |
Candida urinary tract infections--treatment.
Topics: Algorithms; Amphotericin B; Antifungal Agents; Azoles; Candida; Candidiasis; Candidiasis, Invasive; Causality; Echinocandins; Fluconazole; Flucytosine; Humans; Urinary Tract Infections | 2011 |
Oral Candida isolates among HIV-infected subjects in Nigeria.
Topics: Adult; Aged; AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Candida; Candidiasis, Oral; Drug Resistance, Fungal; Female; Fluconazole; Flucytosine; HIV Infections; Humans; Itraconazole; Male; Microbial Sensitivity Tests; Middle Aged; Mycological Typing Techniques; Nigeria; Pyrimidines; Triazoles; Voriconazole | 2011 |
Osteoarticular infection by Candida albicans in an infant with cystic fibrosis.
Topics: Amphotericin B; Antifungal Agents; Candida albicans; Candidemia; Candidiasis, Invasive; Cystic Fibrosis; Female; Fluconazole; Flucytosine; Humans; Infant; Osteoarthritis; Treatment Outcome | 2011 |
Antifungal susceptibility and virulence attributes of bloodstream isolates of Candida from Hong Kong and Finland.
Topics: Amphotericin B; Antifungal Agents; Candida; Candidemia; Caspofungin; Drug Resistance, Fungal; Echinocandins; Finland; Fluconazole; Flucytosine; Hemolysin Proteins; Hong Kong; Humans; Itraconazole; Ketoconazole; Lipopeptides; Microbial Sensitivity Tests; Peptide Hydrolases; Pyrimidines; Triazoles; Virulence Factors; Voriconazole | 2011 |
Cryptococcal meningitis in immunocompetent children.
Topics: Adolescent; Amphotericin B; Antifungal Agents; Antigens, Fungal; Child; Child, Preschool; Cryptococcus neoformans; Drug Administration Schedule; Female; Fluconazole; Flucytosine; Humans; Immunocompetence; Itraconazole; Male; Meningitis, Cryptococcal; Retrospective Studies; Treatment Outcome | 2012 |
74-year-old man from the pacific northwest with fever and a lung mass.
Topics: Aged; Amphotericin B; Antifungal Agents; British Columbia; Bromhexine; Cryptococcosis; Cryptococcus gattii; Flucytosine; Humans; Lung Diseases, Fungal; Male; Microbial Sensitivity Tests; Radiography; Triazoles | 2011 |
Recurrent Saccharomyces cerevisiae fungemia in an otherwise healthy patient.
Topics: Abdominal Pain; Adult; Amphotericin B; Antifungal Agents; Chills; Diagnosis, Differential; Female; Fever; Fluconazole; Flucytosine; Fungemia; Headache; Humans; Nausea; Pyrimidines; Recurrence; Saccharomyces cerevisiae; Triazoles; Voriconazole | 2011 |
[Skin lesions and fever in an VIH-infected patient].
Topics: Adult; Amphotericin B; Antifungal Agents; Cryptococcosis; Cryptococcus neoformans; Dermatomycoses; Fatal Outcome; Fever; Flucytosine; HIV Infections; Humans; Male; Multiple Organ Failure; Respiratory Distress Syndrome | 2012 |
Quantitative and qualitative analyses of the cell death process in Candida albicans treated by antifungal agents.
Topics: Amphotericin B; Antifungal Agents; Biophysical Phenomena; Candida albicans; Cell Death; Flucytosine; Microbial Viability; Microscopy, Atomic Force; Time Factors | 2011 |
Species and susceptibility distribution of 1062 clinical yeast isolates to azoles, echinocandins, flucytosine and amphotericin B from a multi-centre study.
Topics: Amphotericin B; Antifungal Agents; Azoles; Candida; Candidiasis; Echinocandins; Female; Flucytosine; Humans; Male; Microbial Sensitivity Tests | 2012 |
Cryptococcus neoformans: the model organism for yeast antifungal drug susceptibility testing.
Topics: Amphotericin B; Antifungal Agents; Cryptococcus neoformans; Culture Media; Drug Combinations; Fluconazole; Flucytosine; Humans; Microbial Sensitivity Tests | 2012 |
Treatment of cryptococcal meningitis with low-dose amphotericin B and flucytosine.
Topics: Adolescent; Adult; Aged; Amphotericin B; Antifungal Agents; Female; Flucytosine; Humans; Male; Meningitis, Cryptococcal; Middle Aged; Retrospective Studies; Young Adult | 2012 |
Cryptococcus neoformans-Cryptococcus gattii species complex: an international study of wild-type susceptibility endpoint distributions and epidemiological cutoff values for amphotericin B and flucytosine.
Topics: Amphotericin B; Anti-Bacterial Agents; Cryptococcus gattii; Cryptococcus neoformans; Flucytosine; Microbial Sensitivity Tests | 2012 |
Cryptococcal osteomyelitis of the scapula and rib in an immunocompetent patient.
Topics: Amphotericin B; Antifungal Agents; Cryptococcosis; Cryptococcus neoformans; Deoxycholic Acid; Drug Combinations; Female; Flucytosine; Humans; Middle Aged; Osteomyelitis; Ribs; Scapula; Time Factors; Treatment Outcome | 2012 |
Disseminated Cryptococcus with ocular cryptococcoma in a human immunodeficiency virus-negative patient.
Topics: Amphotericin B; Anemia, Hemolytic, Autoimmune; Antifungal Agents; Cryptococcosis; Cryptococcus; Drug Therapy, Combination; Eye Infections, Fungal; Fluconazole; Flucytosine; HIV Seronegativity; Humans; Lung Diseases, Fungal; Magnetic Resonance Imaging; Male; Meningitis, Fungal; Middle Aged; Recurrence; Retinal Diseases; Tomography, X-Ray Computed; Vitreous Body | 2012 |
Wild-type MIC distributions and epidemiological cutoff values for amphotericin B, flucytosine, and itraconazole and Candida spp. as determined by CLSI broth microdilution.
Topics: Amphotericin B; Antifungal Agents; Brazil; Canada; Candida; Candidiasis; Europe; Flucytosine; Humans; Itraconazole; Microbial Sensitivity Tests; United States | 2012 |
Responding to the evidence for improved treatment for cryptococcal meningitis in resource-limited settings.
Topics: Africa South of the Sahara; AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Developing Countries; Fluconazole; Flucytosine; Humans; Meningitis, Cryptococcal; Practice Guidelines as Topic | 2012 |
[Study on in vitro susceptibility of Candida spp. isolated from blood culture].
Topics: Amphotericin B; Antifungal Agents; Blood; Candida; Candidiasis; Caspofungin; Drug Resistance, Fungal; Echinocandins; Fluconazole; Flucytosine; Hospitals; Humans; In Vitro Techniques; Itraconazole; Lipopeptides; Microbial Sensitivity Tests; Pyrimidines; Reproducibility of Results; Risk Factors; Triazoles; Voriconazole | 2012 |
In vitro synergy testing of anidulafungin with fluconazole, tioconazole, 5-flucytosine and amphotericin B against some Candida spp.
Topics: Amphotericin B; Anidulafungin; Antifungal Agents; Candida; Drug Synergism; Echinocandins; Fluconazole; Flucytosine; Imidazoles | 2012 |
The first Korean case of candidemia due to Candida dubliniensis.
Topics: Amphotericin B; Antifungal Agents; Candida; Candidemia; Catheterization, Central Venous; Female; Fluconazole; Flucytosine; Humans; Microbial Sensitivity Tests; Middle Aged; Pyrimidines; Triazoles; Voriconazole | 2012 |
Different presentations and outcomes between HIV-infected and HIV-uninfected patients with Cryptococcal meningitis.
Topics: Adult; Aged; AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Antigens, Fungal; CD4 Lymphocyte Count; Cryptococcus; Female; Flucytosine; Follow-Up Studies; HIV; HIV Infections; Humans; Hydrocephalus; Intracranial Hypertension; Male; Meningitis, Cryptococcal; Retrospective Studies; Spinal Puncture; Taiwan; Treatment Outcome | 2012 |
A case series of the management of symptomatic azole-resistant candida.
Topics: Adolescent; Adult; Aged; Amphotericin B; Antifungal Agents; Azoles; Candida albicans; Candidiasis, Vulvovaginal; Drug Resistance, Fungal; Female; Flucytosine; Humans; Middle Aged; Treatment Outcome; Vaginal Creams, Foams, and Jellies; Young Adult | 2012 |
Quantitative and qualitative analysis of the antifungal activity of allicin alone and in combination with antifungal drugs.
Topics: Amphotericin B; Antifungal Agents; Candida albicans; Disulfides; Drug Synergism; Flucytosine; Microbial Sensitivity Tests; Microscopy, Atomic Force; Microscopy, Electron, Scanning; Sulfinic Acids | 2012 |
Disseminated cryptococcosis revealed by vertebral osteomyelitis in an immunocompetent patient.
Topics: Adult; Amphotericin B; Antifungal Agents; Biopsy; Cryptococcosis; Cryptococcus neoformans; Flucytosine; Humans; Immunocompetence; Magnetic Resonance Imaging; Male; Osteomyelitis; Sacrum; Treatment Outcome | 2012 |
Species level identification and antifungal susceptibility of yeasts isolated from various clinical specimens and evaluation of Integral System Yeasts Plus.
Topics: Amphotericin B; Candida; Colorimetry; Drug Resistance, Multiple, Fungal; Fluconazole; Flucytosine; Humans; Itraconazole; Microbial Sensitivity Tests; Pyrimidines; Reagent Kits, Diagnostic; Reproducibility of Results; ROC Curve; Sensitivity and Specificity; Triazoles; Voriconazole | 2012 |
Early cryptococcal meningitis following treatment with rituximab, fludarabine and cyclophosphamide in a patient with chronic lymphocytic leukemia.
Topics: Aged; Amphotericin B; Antibodies, Monoclonal, Murine-Derived; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Cryptococcus neoformans; Cyclophosphamide; Drug Therapy, Combination; Fatal Outcome; Flucytosine; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Meningitis, Cryptococcal; Rituximab; Time Factors; Vidarabine | 2013 |
Trichosporon asahii causing nosocomial urinary tract infections in intensive care unit patients: genotypes, virulence factors and antifungal susceptibility testing.
Topics: Aged; Aged, 80 and over; Amphotericin B; Antifungal Agents; Cross Infection; DNA, Fungal; DNA, Intergenic; Drug Resistance, Multiple, Fungal; Female; Flucytosine; Genetic Variation; Genotype; Hemolysin Proteins; Humans; Intensive Care Units; Male; Microbial Sensitivity Tests; Peptide Hydrolases; Phospholipases; Pyrimidines; Triazoles; Trichosporon; Trichosporonosis; Urinary Tract Infections; Virulence Factors; Voriconazole | 2012 |
Comparison of three statistical methods for establishing tentative wild-type population and epidemiological cutoff values for echinocandins, amphotericin B, flucytosine, and six Candida species as determined by the colorimetric Sensititre YeastOne method.
Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Echinocandins; Flucytosine; Humans; Microbial Sensitivity Tests; Models, Statistical; Mycology | 2012 |
Cryptococcal meningitis treatment strategies in resource-limited settings: a cost-effectiveness analysis.
Topics: Africa; Amphotericin B; Antifungal Agents; Cost-Benefit Analysis; Fluconazole; Flucytosine; Humans; Meningitis, Cryptococcal | 2012 |
Photo quiz: a 38-year-old male with a 3-month history of abdominal pain, constipation, and headache.
Topics: Abdominal Pain; Acquired Immunodeficiency Syndrome; Adult; Amphotericin B; Antifungal Agents; CD4 Lymphocyte Count; Cerebrospinal Fluid; Constipation; Cryptococcosis; Cryptococcus neoformans; Flucytosine; Headache; Humans; Male; Microscopy; Viral Load | 2012 |
Antifungal susceptibility to amphotericin B, fluconazole, voriconazole, and flucytosine in Candida bloodstream isolates from 15 tertiary hospitals in Korea.
Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Fluconazole; Flucytosine; Humans; Microbial Sensitivity Tests; Pyrimidines; Republic of Korea; Tertiary Care Centers; Triazoles; Voriconazole | 2012 |
Comparison of four reading methods of broth microdilution based on the clinical and laboratory standards institute M27-A3 method for Candida spp.
Topics: Amphotericin B; Antifungal Agents; Candida; Drug Resistance, Fungal; Echinocandins; Fluconazole; Flucytosine; Itraconazole; Lipopeptides; Micafungin; Miconazole; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole | 2012 |
Non-albicans Candida species in blood stream infections in a tertiary care hospital at New Delhi, India.
Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Cross Infection; Fluconazole; Flucytosine; Humans; Incidence; India; Itraconazole; Microbial Sensitivity Tests; Pyrimidines; Retrospective Studies; Tertiary Care Centers; Triazoles; Voriconazole | 2012 |
[Cryptococcal meningitis in a patient with a ventriculoperitoneal shunt and monitoring for pulmonary sarcoidosis].
Topics: Amphotericin B; Antifungal Agents; Arachnoiditis; Carbon; Cerebrospinal Fluid; Coloring Agents; Confusion; Cryptococcus neoformans; Disease Susceptibility; Drug Therapy, Combination; Flucytosine; Humans; Magnetic Resonance Imaging; Male; Meningitis, Cryptococcal; Middle Aged; Prosthesis-Related Infections; Psychomotor Agitation; Sarcoidosis, Pulmonary; Staining and Labeling; Ventriculoperitoneal Shunt | 2013 |
Approaches to antifungal therapies and their effectiveness among patients with cryptococcosis.
Topics: Adult; AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Cryptococcosis; Drug Administration Schedule; Female; Fluconazole; Flucytosine; HIV Infections; Humans; Incidence; Male; Practice Guidelines as Topic; Risk Factors; Severity of Illness Index; Survival Rate; Treatment Outcome | 2013 |
In vitro antifungal activities of amphotericin B, 5-fluorocytosine, fluconazole and itraconazole against Cryptococcus neoformans isolated from cerebrospinal fluid and blood from patients in Serbia.
Topics: AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Cerebrospinal Fluid; Cross Infection; Cryptococcosis; Cryptococcus neoformans; Drug Resistance, Multiple, Fungal; Fluconazole; Flucytosine; Fungemia; Humans; Itraconazole; Kidney Transplantation; Lymphoma; Meningitis, Cryptococcal; Microbial Sensitivity Tests; Postoperative Complications; Serbia | 2012 |
[Comment on this case report].
Topics: Adult; Amphotericin B; Antifungal Agents; Buprenorphine; Candidiasis; Endocarditis; Endophthalmitis; Eye Infections, Fungal; Fatal Outcome; Flucytosine; Hepatitis C, Chronic; Heroin Dependence; Humans; Male; Mycoses; Pneumonia, Staphylococcal; Recurrence; Shock, Cardiogenic; Substance Abuse, Intravenous; Tricuspid Valve; Ultrasonography | 2012 |
Efficiently killing a sugar-coated yeast.
Topics: Amphotericin B; Antifungal Agents; Female; Flucytosine; Humans; Male; Meningitis, Cryptococcal | 2013 |
Treating cryptococcal meningitis in people with HIV.
Topics: AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Drug Therapy, Combination; Fluconazole; Flucytosine; HIV Infections; Humans; Meningitis, Cryptococcal | 2013 |
Pharmacodynamics of liposomal amphotericin B and flucytosine for cryptococcal meningoencephalitis: safe and effective regimens for immunocompromised patients.
Topics: Amphotericin B; Animals; Antifungal Agents; Brain; Cryptococcus neoformans; Drug Therapy, Combination; Flucytosine; Humans; Immunocompromised Host; Male; Meningitis, Cryptococcal; Meningoencephalitis; Mice; Microbial Sensitivity Tests; Models, Biological | 2013 |
Antifungal therapy and management of complications of cryptococcosis due to Cryptococcus gattii.
Topics: Adult; Amphotericin B; Antifungal Agents; Australia; Cryptococcosis; Cryptococcus gattii; Female; Fluconazole; Flucytosine; Follow-Up Studies; Humans; Male; Time Factors; Treatment Outcome | 2013 |
Combination antifungal therapy for cryptococcal meningitis.
Topics: Amphotericin B; Antifungal Agents; Female; Flucytosine; Humans; Male; Meningitis, Cryptococcal | 2013 |
Combination antifungal therapy for cryptococcal meningitis.
Topics: Amphotericin B; Antifungal Agents; Female; Flucytosine; Humans; Male; Meningitis, Cryptococcal | 2013 |
Use of isothermal microcalorimetry to quantify the influence of glucose and antifungals on the growth of Candida albicans in urine.
Topics: Amphotericin B; Antifungal Agents; Calorimetry; Candida albicans; Fluconazole; Flucytosine; Glucose; Humans; Imidazoles; Microbial Sensitivity Tests; Urinary Tract Infections; Urine | 2013 |
Chromosome 5 monosomy of Candida albicans controls susceptibility to various toxic agents, including major antifungals.
Topics: Amphotericin B; Antifungal Agents; Candida albicans; Caspofungin; Chromosomes, Fungal; Echinocandins; Fluconazole; Flucytosine; Lipopeptides | 2013 |
Using Galleria mellonella-Candida albicans infection model to evaluate antifungal agents.
Topics: Amphotericin B; Animals; Antifungal Agents; Candida albicans; Disease Models, Animal; Fluconazole; Flucytosine; Larva; Moths | 2013 |
Pulmonary cryptococcosis and cryptococcal osteomyelitis mimicking primary and metastatic lung cancer in (18)F-FDG PET/CT.
Topics: Adult; Amphotericin B; Cryptococcosis; Cryptococcus neoformans; Female; Flucytosine; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Osteomyelitis; Positron-Emission Tomography | 2014 |
Comparisons of presentations and outcomes of cryptococcal meningitis between patients with and without hepatitis B virus infection.
Topics: Adolescent; Adult; Aged; Amphotericin B; Anti-Infective Agents; Child; Cryptococcus; Female; Fluconazole; Flucytosine; Hepatitis B; Hepatitis B virus; Humans; Liver Cirrhosis; Meningitis, Cryptococcal; Middle Aged; Multivariate Analysis; Retrospective Studies; Treatment Outcome; Young Adult | 2014 |
Inhibition of nucleotide biosynthesis potentiates the antifungal activity of amphotericin B.
Topics: Amphotericin B; Antifungal Agents; Aspergillus fumigatus; Candida albicans; Cryptococcosis; Cryptococcus neoformans; Flucytosine; HIV Infections; Humans; Microbial Sensitivity Tests; Mycophenolic Acid; Nucleotides | 2014 |
Frequency of clinically isolated strains of oral Candida species at Kagoshima University Hospital, Japan, and their susceptibility to antifungal drugs in 2006-2007 and 2012-2013.
Topics: Adult; Aged; Aged, 80 and over; Amphotericin B; Antifungal Agents; Autoimmune Diseases; Bacterial Load; Candida; Candida albicans; Candida glabrata; Candidiasis, Oral; Coinfection; Drug Resistance, Fungal; Echinocandins; Female; Fluconazole; Flucytosine; Humans; Itraconazole; Japan; Lipopeptides; Male; Micafungin; Miconazole; Microbial Sensitivity Tests; Middle Aged; Xerostomia | 2014 |
Fulminant atypical Cryptococcus neoformans pneumonia confirmed by PLEX-ID.
Topics: Amphotericin B; Anti-Bacterial Agents; Antifungal Agents; Bronchoalveolar Lavage Fluid; Coinfection; Cryptococcosis; Cryptococcus neoformans; Fatal Outcome; Female; Flucytosine; HIV Infections; Humans; Male; Middle Aged; Nucleic Acid Amplification Techniques; Pneumonia | 2014 |
Miliary pattern on chest imaging in an immunocompetent child.
Topics: Amphotericin B; Antifungal Agents; Child, Preschool; Cryptococcosis; Drug Therapy, Combination; Female; Flucytosine; Humans; Lung Diseases, Fungal | 2014 |
Antifungal susceptibility of Candida isolates at one institution.
Topics: Amphotericin B; Antifungal Agents; Candida; Candida albicans; Candida glabrata; Candida tropicalis; Candidemia; Drug Resistance, Fungal; Echinocandins; Fluconazole; Flucytosine; Health Facilities; Humans; Itraconazole; Japan; Lipopeptides; Micafungin; Time Factors; Voriconazole | 2014 |
A rapid microplate method for the proliferation assay of fungi and the antifungal susceptibility testing using the colorimetric microbial viability assay.
Topics: Amphotericin B; Antifungal Agents; Candida; Chromogenic Compounds; Colorimetry; Cryptococcus; Flucytosine; Itraconazole; Microbial Sensitivity Tests; Microbial Viability; Oxidation-Reduction; Tetrazolium Salts; Yeasts | 2014 |
Cryptococcal meningitis post autologous stem cell transplantation.
Topics: Adult; Amphotericin B; Antifungal Agents; Fluconazole; Flucytosine; Humans; Immunosuppressive Agents; Male; Meningitis, Cryptococcal; Stem Cell Transplantation; Transplantation, Autologous | 2014 |
Evaluation of possibilities in identification and susceptibility testing for Candida glabrata clinical isolates with the Integral System Yeast Plus (ISYP).
Topics: Amphotericin B; Antifungal Agents; Candida glabrata; Candidiasis; Fluconazole; Flucytosine; Humans; Itraconazole; Microbial Sensitivity Tests; Mycological Typing Techniques; Polymerase Chain Reaction; Sensitivity and Specificity | 2014 |
Cryptococcal meningitis in patients with autoimmune hemolytic anemia.
Topics: Adolescent; Adult; Aged; Amphotericin B; Anemia, Hemolytic, Autoimmune; Antifungal Agents; Cryptococcus neoformans; Female; Flucytosine; Genotype; Humans; Male; Meningitis, Cryptococcal; Middle Aged; Serogroup; Young Adult | 2014 |
Comparison of Etests and Vitek 2 ® to broth microdilution for the susceptibility testing of Cryptococcus neoformans.
Topics: AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Cryptococcosis; Cryptococcus neoformans; Disk Diffusion Antimicrobial Tests; Fluconazole; Flucytosine; Humans; South Africa; Voriconazole | 2014 |
Neuro-ophthalmic presentations and treatment of Cryptococcal meningitis-related increased intracranial pressure.
Topics: Amphotericin B; Antibodies, Fungal; Antifungal Agents; Antigens, Fungal; Cryptococcosis; Cryptococcus gattii; Cryptococcus neoformans; Drug Therapy, Combination; Eye Infections, Fungal; Female; Flucytosine; Humans; Intracranial Hypertension; Intracranial Pressure; Male; Meningitis, Cryptococcal; Optic Neuritis; Papilledema | 2014 |
Pulmonary cryptococcosis with endobronchial lesions and meningitis.
Topics: Amphotericin B; Animals; Bronchi; Bronchoscopy; Columbidae; Cryptococcosis; Cryptococcus neoformans; Drug Therapy, Combination; Fluconazole; Flucytosine; Humans; Lung; Male; Meningitis, Cryptococcal; Middle Aged; Treatment Outcome | 2014 |
Surveillance of antifungal susceptibilities in clinical isolates of Candida species at 36 hospitals in China from 2009 to 2013.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amphotericin B; Antifungal Agents; Candida; Candida albicans; Child; Child, Preschool; China; Drug Resistance, Fungal; Fluconazole; Flucytosine; Hospitals; Humans; Infant; Itraconazole; Middle Aged; Voriconazole; Young Adult | 2015 |
Inhibition of nucleic acid biosynthesis makes little difference to formation of amphotericin B-tolerant persisters in Candida albicans biofilm.
Topics: Amphotericin B; Antifungal Agents; Biofilms; Candida albicans; Candidiasis; Flucytosine; Microbial Sensitivity Tests; Nucleic Acids | 2015 |
Hidden in a headache: cryptococcal meningitis in a septuagenarian.
Topics: Aged; Amphotericin B; Antifungal Agents; Diagnosis, Differential; Drug Therapy, Combination; Female; Fluconazole; Flucytosine; Headache; Humans; Meningitis, Cryptococcal | 2015 |
In vitro antifungal susceptibilities of isolates of Candida spp. and Aspergillus spp. from China to nine systemically active antifungal agents: data from the SENTRY antifungal surveillance program, 2010 through 2012.
Topics: Amphotericin B; Antifungal Agents; Aspergillus; Azoles; Candida; China; Drug Resistance, Fungal; Drug Resistance, Multiple, Fungal; Echinocandins; Fluconazole; Flucytosine; Humans; Microbial Sensitivity Tests; Mutation; Rhodotorula; Sequence Analysis, DNA; Triazoles; Trichosporon; Voriconazole | 2015 |
[Genotypes and in vitro antifungal susceptibility of Cryptococcus isolates in Sichuan Province].
Topics: Amphotericin B; Antifungal Agents; China; Cryptococcus; Fluconazole; Flucytosine; Genotype; Humans; Itraconazole; Microbial Sensitivity Tests; Polymorphism, Restriction Fragment Length; Voriconazole | 2015 |
In vitro activities of a wide panel of antifungal drugs against various Scopulariopsis and Microascus species.
Topics: Amphotericin B; Antifungal Agents; Ascomycota; Caspofungin; Drug Resistance, Fungal; Echinocandins; Fluconazole; Flucytosine; Itraconazole; Ketoconazole; Lipopeptides; Microbial Sensitivity Tests; Scopulariopsis; Triazoles; Voriconazole | 2015 |
Evaluation of virulence factors and antifungal susceptibility patterns of different Candida species isolated from the female camel (Camelus dromedarius) genital tract.
Topics: Amphotericin B; Animals; Antifungal Agents; Camelus; Candida; Candida albicans; Candidiasis; Female; Flucytosine; Fungal Proteins; Hemolysin Proteins; Microbial Sensitivity Tests; Nystatin; Peptide Hydrolases; Phospholipases; Reproductive Tract Infections; Virulence Factors | 2015 |
Management of cryptococcal meningitis in a district hospital in KwaZulu-Natal: a clinical audit.
Topics: Adult; Amphotericin B; Antifungal Agents; Female; Fluconazole; Flucytosine; Hospitals, Urban; Humans; Male; Medical Audit; Meningitis, Cryptococcal; Retrospective Studies; South Africa; Treatment Outcome | 2014 |
Strong correlation between the antifungal effect of amphotericin B and its inhibitory action on germ-tube formation in a Candida albicans URA⁺ strain.
Topics: Amphotericin B; Antifungal Agents; Candida albicans; Drug Resistance, Fungal; Flucytosine; Humans; Microbial Sensitivity Tests | 2015 |
Comparison of two antifungal susceptibility testing of Candida sp. isolates using agar diffusion method: Neo-sensitabs® tablets and Bio-rad® disks.
Topics: Amphotericin B; Antifungal Agents; Candida; Fluconazole; Flucytosine; Humans; Immunodiffusion; Microbial Sensitivity Tests; Prospective Studies; Tablets; Voriconazole | 2016 |
Candida growth in urine cultures: a contemporary analysis of species and antifungal susceptibility profiles.
Topics: Adult; Amphotericin B; Antifungal Agents; Candida; Candidiasis; Drug Resistance, Fungal; Fluconazole; Flucytosine; Humans; Microbial Sensitivity Tests; Species Specificity; United Kingdom; Urinary Tract Infections | 2016 |
Cryptococcal eosinophilic meningitis in a patient with sarcoidosis.
Topics: Amphotericin B; Antifungal Agents; Eosinophilia; Flucytosine; Humans; Male; Meningitis, Cryptococcal; Middle Aged; Muscle Rigidity; Sarcoidosis; Spinal Puncture | 2015 |
Combination of Amphotericin B and Flucytosine against Neurotropic Species of Melanized Fungi Causing Primary Cerebral Phaeohyphomycosis.
Topics: Amphotericin B; Antifungal Agents; Cerebral Phaeohyphomycosis; Culture Media; Drug Combinations; Drug Synergism; Exophiala; Factor Analysis, Statistical; Flucytosine; Humans; Microbial Sensitivity Tests; Saccharomycetales | 2016 |
Susceptibility profile and epidemiological cut-off values of Cryptococcus neoformans species complex from Argentina.
Topics: AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Argentina; Cryptococcosis; Cryptococcus neoformans; Drug Resistance, Fungal; Epidemiologic Methods; Fluconazole; Flucytosine; HIV Infections; Humans; Itraconazole; Meningitis, Cryptococcal; Microbial Sensitivity Tests; Triazoles; Voriconazole | 2016 |
Evaluation of Hepatotoxicity with Treatment Doses of Flucytosine and Amphotericin B for Invasive Fungal Infections.
Topics: Amphotericin B; Animals; Antifungal Agents; Chemical and Drug Induced Liver Injury; Flucytosine; Fungi; Humans; Infections; Inflammation; Interleukin-6; Liver; Mice; NF-kappa B; Tumor Necrosis Factor-alpha | 2016 |
Cryptococcal Meningitis Treatment Strategies Affected by the Explosive Cost of Flucytosine in the United States: A Cost-effectiveness Analysis.
Topics: AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Cost-Benefit Analysis; Deoxycholic Acid; Drug Combinations; Fluconazole; Flucytosine; Humans; Meningitis, Cryptococcal; United States | 2016 |
Editorial Commentary: Life-saving Antimicrobial Drugs: What Are We Doing to Pricing and Availability?
Topics: Amphotericin B; Anti-Infective Agents; Costs and Cost Analysis; Cryptococcosis; Drug Therapy, Combination; Flucytosine; Health Expenditures; Humans | 2016 |
Evaluation of antifungal combination against Cryptococcus spp.
Topics: Amphotericin B; Antifungal Agents; Brazil; Cryptococcosis; Cryptococcus; Cryptococcus neoformans; Drug Combinations; Drug Synergism; Fluconazole; Flucytosine; Genotype; Humans; Itraconazole; Microbial Sensitivity Tests; Molecular Typing; Naphthalenes; Polymorphism, Restriction Fragment Length; Terbinafine; Voriconazole | 2016 |
Cryptococcal cellulitis on the shin of an immunosuppressed patient.
Topics: Amphotericin B; Antifungal Agents; Cellulitis; Cryptococcosis; Cryptococcus neoformans; Cyclosporine; Fluconazole; Flucytosine; Fungemia; Glomerulosclerosis, Focal Segmental; Humans; Immunocompromised Host; Immunosuppressive Agents; Leg Dermatoses; Male; Middle Aged; Prednisone; Skin | 2016 |
Primary cutaneous cryptococcosis successfully managed by surgical debridement and liposomal amphotericin B/flucytosine therapy.
Topics: Aged; Amphotericin B; Antifungal Agents; Cryptococcosis; Debridement; Dermatomycoses; Female; Flucytosine; Humans | 2017 |
Mutations and/or Overexpressions of ERG4 and ERG11 Genes in Clinical Azoles-Resistant Isolates of Candida albicans.
Topics: Amphotericin B; Antifungal Agents; Candida albicans; Candidiasis; Cytochrome P-450 Enzyme System; Drug Resistance, Fungal; Fluconazole; Flucytosine; Fungal Proteins; Gene Expression; Humans; Itraconazole; Microbial Sensitivity Tests; Mutation; Oxidoreductases; RNA, Messenger; Sequence Analysis, DNA; Voriconazole | 2017 |
[Peristomal cellulitis due to Magnusiomyces capitatus in a woman carrying percutaneous gastrostomy tube].
Topics: Aged, 80 and over; Amphotericin B; Antifungal Agents; Aspirin; Cellulitis; Dermatomycoses; Drug Combinations; Female; Flucytosine; Gastrostomy; Geotrichosis; Geotrichum; Humans; Magnesium Oxide; Microbial Sensitivity Tests; Surgical Wound Infection | 2017 |
Cryptococcal Infection of the Ventriculoperitoneal Shunt in an HIV-Infected Patient with an Excellent Immunovirologic Status.
Topics: Abdominal Abscess; Adult; Amphotericin B; Antifungal Agents; Antiretroviral Therapy, Highly Active; Catheter-Related Infections; Device Removal; Flucytosine; HIV Infections; Humans; Male; Meningitis, Cryptococcal; Ventriculoperitoneal Shunt | 2017 |
Utilizing online-dual-SPE-LC with HRMS for the simultaneous quantification of amphotericin B, fluconazole, and fluorocytosine in human plasma and cerebrospinal fluid.
Topics: Amphotericin B; Antifungal Agents; Chromatography, Liquid; Drug Monitoring; Fluconazole; Flucytosine; Humans; Online Systems; Solid Phase Extraction; Tandem Mass Spectrometry | 2017 |
Antifungal Efficacy of an Intravenous Formulation Containing Monomeric Amphotericin B, 5-Fluorocytosine, and Saline for Sodium Supplementation.
Topics: Amphotericin B; Animals; Antifungal Agents; Candida albicans; Candidiasis; Chemistry, Pharmaceutical; Deoxycholic Acid; Drug Carriers; Female; Flucytosine; Mice; Mice, Inbred ICR; Micelles; Particle Size; Phosphatidylethanolamines; Polyethylene Glycols; Sodium; Sodium Chloride | 2017 |
Nursing Management of Lumbar Drainage in Cryptococcal Meningitis: A Case Report.
Topics: Amphotericin B; Antifungal Agents; Cerebrospinal Fluid Pressure; Drainage; Female; Flucytosine; Hearing Loss; Humans; Intracranial Pressure; Meningitis, Cryptococcal; Middle Aged; Neuroscience Nursing; Nurse's Role; Spinal Puncture; Treatment Outcome | 2017 |
Cryptococcal antigen negative meningoencephalitis in HIV/AIDS.
Topics: Acquired Immunodeficiency Syndrome; Adult; Amphotericin B; Antifungal Agents; Antigens, Fungal; Cryptococcus neoformans; Flucytosine; Fungal Capsules; Fungal Polysaccharides; Humans; Male; Meningitis, Cryptococcal; Meningoencephalitis | 2017 |
Isolation of Rhodotorula mucilaginosa from blood cultures in a tertiary care hospital.
Topics: Aged; Aged, 80 and over; Amphotericin B; Antifungal Agents; Azoles; Blood Culture; Child, Preschool; Echinocandins; Female; Flucytosine; Fungemia; Humans; Immunocompromised Host; Infant; Male; Microbial Sensitivity Tests; Middle Aged; Retrospective Studies; Rhodotorula; Spain; Tertiary Care Centers | 2018 |
Necrotic ulcer on the thigh.
Topics: Adult; Amphotericin B; Antifungal Agents; Cryptococcus neoformans; Diagnosis, Differential; Fluconazole; Flucytosine; Humans; Male; Meningitis, Cryptococcal; Necrosis; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Skin Ulcer; Thigh | 2017 |
Relationship between intracranial pressure and antifungal agents levels in the CSF of patients with cryptococcal meningitis.
Topics: Adult; Aged; AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Brazil; Child; Cryptococcus; Drug Therapy, Combination; Female; Fluconazole; Flucytosine; Follow-Up Studies; Humans; Intracranial Pressure; Male; Meningitis, Cryptococcal; Microbial Sensitivity Tests; Middle Aged; Tertiary Care Centers; Treatment Outcome; Voriconazole | 2018 |
Comparative typing analyses of clinical and environmental strains of the Cryptococcus neoformans/Cryptococcus gattii species complex from Ivory Coast.
Topics: Adult; Amphotericin B; Antifungal Agents; Chloramphenicol; Cote d'Ivoire; Cryptococcosis; Cryptococcus gattii; Cryptococcus neoformans; DNA, Fungal; Environmental Microbiology; Female; Fluconazole; Flucytosine; Genotype; HIV Infections; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Molecular Typing; Mycological Typing Techniques; Prospective Studies; Serotyping; Young Adult | 2018 |
A Rare Presentation of Cryptococcal Meningitis and Cerebellitis in an Asplenic Patient, Seronegative for Human Immunodeficiency Virus (HIV).
Topics: Aged; Amphotericin B; Antifungal Agents; Cerebellar Diseases; Cryptococcus neoformans; Diagnosis, Differential; Drug Therapy, Combination; Fluconazole; Flucytosine; Follow-Up Studies; HIV Seronegativity; Humans; Infusions, Intravenous; Magnetic Resonance Imaging; Male; Meningitis, Cryptococcal; Rare Diseases; Risk Assessment; Severity of Illness Index; Splenectomy; Treatment Outcome | 2018 |
Triple therapy versus amphotericin B plus flucytosine for the treatment of non-HIV- and non-transplant-associated cryptococcal meningitis: retrospective cohort study.
Topics: Adult; Amphotericin B; Antifungal Agents; Drug Therapy, Combination; Female; Fluconazole; Flucytosine; Follow-Up Studies; Humans; Male; Meningitis, Cryptococcal; Middle Aged; Retrospective Studies; Treatment Outcome | 2018 |
Bilateral Asymptomatic Cryptococcal Retinitis without Choroiditis or Vitritis.
Topics: Administration, Oral; Adult; Amphotericin B; Antifungal Agents; Choroiditis; Cryptococcosis; Cryptococcus gattii; Drug Therapy, Combination; Eye Diseases; Eye Infections, Fungal; Fluconazole; Flucytosine; HIV Infections; Humans; Infusions, Intravenous; Male; Meningitis, Cryptococcal; Retinitis; Tomography, Optical Coherence; Vitreous Body | 2018 |
Isolated Pulmonary Valve Fungal Endocarditis with Candida parapsilosis: Management Considerations of a Rare Case.
Topics: Administration, Intravenous; Adult; Amphotericin B; Antifungal Agents; Candida parapsilosis; Candidiasis, Invasive; Echocardiography, Transesophageal; Endocarditis; Flucytosine; Humans; Male; Pulmonary Valve; Treatment Outcome | 2017 |
Retrograde Ureteral Catheterization: A Possible New Treatment for Renal Fungal Balls in Very Low Birth Weight Infants.
Topics: Amphotericin B; Antifungal Agents; Anuria; Candidiasis; Caspofungin; Female; Flucytosine; Humans; Infant; Infant, Very Low Birth Weight; Kidney Diseases; Therapeutic Irrigation; Ultrasonography; Ureteral Obstruction; Urinary Catheterization | 2018 |
Case 4: Weakness and Headaches in a 14-year-old Boy.
Topics: Adolescent; Amphotericin B; Antifungal Agents; Cryptococcus neoformans; Diagnosis, Differential; Flucytosine; Headache; Humans; Male; Meningitis, Cryptococcal; Muscle Weakness | 2018 |
Not All It's CrAged Up to Be: Disseminated Cryptococcosis.
Topics: Amphotericin B; Antifungal Agents; Antigens, Fungal; Bias; Flucytosine; Humans; Male; Meningitis, Cryptococcal; Middle Aged | 2018 |
Synergistic Antifungal Activity of Isoquercitrin: Apoptosis and Membrane Permeabilization Related to Reactive Oxygen Species in Candida albicans.
Topics: Amphotericin B; Antifungal Agents; Apoptosis; Candida albicans; Caspases; Catalase; Cell Membrane; Cell Membrane Permeability; Drug Combinations; Drug Synergism; Enzyme Activation; Fluconazole; Flucytosine; Free Radical Scavengers; Microbial Sensitivity Tests; Oxidative Stress; Quercetin; Reactive Oxygen Species; Superoxide Dismutase | 2019 |
Updating guidance for preventing and treating cryptococcal disease: how evidence and decisions interface.
Topics: Adolescent; Adrenal Cortex Hormones; Adult; Amphotericin B; Anti-HIV Agents; Antifungal Agents; Antigens, Fungal; Child; Cryptococcus; Deoxycholic Acid; Drug Combinations; Fluconazole; Flucytosine; HIV Infections; Humans; Maintenance Chemotherapy; Meningitis, Cryptococcal; Practice Guidelines as Topic; World Health Organization | 2018 |
High dose fluconazole in salvage therapy for HIV-uninfected cryptococcal meningitis.
Topics: Adolescent; Adult; Aged; Amphotericin B; Antifungal Agents; China; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Fluconazole; Flucytosine; Humans; Male; Meningitis, Cryptococcal; Middle Aged; Patient Compliance; Retrospective Studies; Salvage Therapy; Young Adult | 2018 |
Comparative antifungal susceptibility analyses of Cryptococcus neoformans VNI and Cryptococcus gattii VGII from the Brazilian Amazon Region by the Etest, Vitek 2, and the Clinical and Laboratory Standards Institute broth microdilution methods.
Topics: Amphotericin B; Antifungal Agents; Brazil; Clinical Laboratory Techniques; Cryptococcosis; Cryptococcus gattii; Cryptococcus neoformans; Disk Diffusion Antimicrobial Tests; Drug Resistance, Fungal; Flucytosine; Humans; Microbial Sensitivity Tests; Voriconazole | 2019 |
In vitro combination between antifungals and diphenyl diselenide against Cryptococcus species.
Topics: Amphotericin B; Antifungal Agents; Benzene Derivatives; Cryptococcosis; Cryptococcus; Drug Synergism; Fluconazole; Flucytosine; Humans; Microbial Sensitivity Tests; Organoselenium Compounds | 2019 |
Multifocal muscle candidiasis of the legs in a patient with acute myeloid leukemia: A case report.
Topics: Abscess; Amphotericin B; Antifungal Agents; Antineoplastic Agents; Candida tropicalis; Candidiasis; Caspofungin; Flucytosine; Humans; Immunocompromised Host; Leg; Leukemia, Myeloid, Acute; Magnetic Resonance Imaging; Male; Middle Aged; Muscle, Skeletal; Muscular Diseases; Opportunistic Infections; Tomography, X-Ray Computed | 2019 |
Species distribution and antifungal drug susceptibilities of yeasts isolated from the blood samples of patients with candidemia.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amphotericin B; Anidulafungin; Antifungal Agents; Candida; Candida albicans; Candida glabrata; Candida parapsilosis; Candidemia; Caspofungin; Child; Child, Preschool; Female; Fluconazole; Flucytosine; Humans; Itraconazole; Male; Micafungin; Microbial Sensitivity Tests; Middle Aged; Triazoles; Voriconazole; Young Adult | 2019 |
Disseminated
Topics: Amphotericin B; Anti-Bacterial Agents; Antifungal Agents; Ciprofloxacin; Cryptococcosis; Cryptococcus neoformans; Extracorporeal Membrane Oxygenation; Fluconazole; Flucytosine; Heart-Assist Devices; Humans; Immunocompetence; Intra-Aortic Balloon Pumping; Male; Middle Aged; Shock, Septic; ST Elevation Myocardial Infarction | 2019 |
Deceptively asymptomatic cryptococcaemia in a renal transplant recipient: the lull before a storm.
Topics: Aged; Amphotericin B; Antifungal Agents; Asymptomatic Diseases; Cerebral Infarction; Cryptococcus neoformans; Flucytosine; Humans; Immunocompetence; Kidney Transplantation; Magnetic Resonance Imaging; Male; Meningitis, Cryptococcal; Transplant Recipients | 2019 |
Clinical Reasoning: A 71-year-old man receiving treatment for cryptococcal meningitis, developing new-onset lethargy.
Topics: Aged; Amphotericin B; Antifungal Agents; Brain Infarction; Flucytosine; Humans; Lethargy; Male; Meningitis, Cryptococcal; Thalamus | 2019 |
Cryptococcal meningitis initially presenting with ST elevations and elevated cardiac biomarkers.
Topics: Amphotericin B; Antifungal Agents; Biomarkers; Cryptococcus neoformans; Delayed Diagnosis; Drug Therapy; Flucytosine; Humans; Male; Meningitis, Cryptococcal; Mental Disorders; Middle Aged; Pharyngeal Neoplasms; Spinal Puncture; ST Elevation Myocardial Infarction; Treatment Outcome | 2019 |
Fluconazole plus flucytosine is a good alternative therapy for non-HIV and non-transplant-associated cryptococcal meningitis: A retrospective cohort study.
Topics: Adult; Amphotericin B; Antifungal Agents; Cryptococcus; Deoxycholic Acid; Drug Combinations; Drug Therapy, Combination; Female; Fluconazole; Flucytosine; HIV Infections; Humans; Immunocompetence; Male; Meningitis, Cryptococcal; Middle Aged; Organ Transplantation; Retrospective Studies; Treatment Outcome | 2019 |
A Novel Role of Fungal Type I Myosin in Regulating Membrane Properties and Its Association with d-Amino Acid Utilization in Cryptococcus gattii.
Topics: Actins; Amino Acids; Amphotericin B; Antifungal Agents; Cell Membrane; Cell Membrane Permeability; Cryptococcosis; Cryptococcus gattii; Endocytosis; Flucytosine; Fungal Proteins; Humans; Mutation; Myosin Type I; Phenotype | 2019 |
Cryptococcus genetic diversity and mixed infections in Ivorian HIV patients: A follow up study.
Topics: Adult; Amphotericin B; Antifungal Agents; Coinfection; Cryptococcosis; Cryptococcus; Cryptococcus neoformans; Female; Fluconazole; Flucytosine; Follow-Up Studies; Genetic Variation; HIV Infections; Humans; Male; Meningitis, Cryptococcal; Microbial Sensitivity Tests; Middle Aged; Multilocus Sequence Typing; Mycological Typing Techniques | 2019 |
5-fluorocytosine resistance is associated with hypermutation and alterations in capsule biosynthesis in Cryptococcus.
Topics: Amphotericin B; Antifungal Agents; Cryptococcus; Drug Resistance, Fungal; Flucytosine; Fungal Proteins; Humans; Microbial Sensitivity Tests; Mutation; Polysaccharides | 2020 |
Identification of Off-Patent Drugs That Show Synergism with Amphotericin B or That Present Antifungal Action against Cryptococcus neoformans and
Topics: Amphotericin B; Animals; Antifungal Agents; Auranofin; Candida albicans; Candidiasis; Cell Line; Ciclopirox; Cryptococcosis; Cryptococcus neoformans; Drug Evaluation, Preclinical; Drug Repositioning; Drug Synergism; Erythromycin; Flucytosine; Humans; Mice; Microbial Sensitivity Tests; Opportunistic Infections; RAW 264.7 Cells; Zebrafish | 2020 |
MIC distributions for amphotericin B, fluconazole, itraconazole, voriconazole, flucytosine and anidulafungin and 35 uncommon pathogenic yeast species from the UK determined using the CLSI broth microdilution method.
Topics: Amphotericin B; Anidulafungin; Antifungal Agents; Fluconazole; Flucytosine; Humans; Itraconazole; Microbial Sensitivity Tests; Phylogeny; United Kingdom; Voriconazole | 2020 |
Case Report: A Case of Severe Cryptococcal Immune Reconstitution Inflammatory Syndrome Presenting with Brain and Intradural Abscesses in an HIV Patient.
Topics: Acquired Immunodeficiency Syndrome; Amphotericin B; Anti-Inflammatory Agents; Anti-Retroviral Agents; Antifungal Agents; Arachnoid; Arachnoiditis; Biopsy; Brain; Brain Abscess; Brain Edema; Cerebellar Diseases; Empyema, Subdural; Fluconazole; Flucytosine; HIV Infections; Humans; Immune Reconstitution Inflammatory Syndrome; Magnetic Resonance Imaging; Male; Meningitis, Cryptococcal; Middle Aged; Prednisone; Recurrence | 2020 |
Cryptococcal meningitis in an immunocompetent patient.
Topics: Adult; Amphotericin B; Antifungal Agents; Culture Techniques; Delayed Diagnosis; Fluconazole; Flucytosine; Fungemia; Headache; Humans; Immune Reconstitution Inflammatory Syndrome; Immunocompetence; Intensive Care Units; Intracranial Hypertension; Male; Meningitis, Cryptococcal; Papilledema; Respiratory Insufficiency; Spinal Puncture; Ventriculoperitoneal Shunt | 2020 |
An Elderly Patient with Pulmonary Cryptococcosis with Mediastinal Lymphadenopathy Who Was Successfully Treated with Amphotericin B and Flucytosine.
Topics: Aged, 80 and over; Amphotericin B; Antifungal Agents; Cryptococcosis; Drug Therapy, Combination; Drug Tolerance; Flucytosine; Humans; Lymphadenopathy; Male; Respiratory Tract Infections | 2020 |
Case Report: Cryptococcal meningitis in Hodgkin's Lymphoma patient receiving brentuximab-vedotin therapy.
Topics: Amphotericin B; Antifungal Agents; Brentuximab Vedotin; Cryptococcus neoformans; Dexamethasone; Flucytosine; Hodgkin Disease; Humans; Male; Meningitis, Cryptococcal; Middle Aged; Opportunistic Infections | 2020 |
Treatment and mortality outcomes in patients with other extrapulmonary cryptococcal disease compared with central nervous system disease.
Topics: Adult; Aged; Amphotericin B; Antifungal Agents; Central Nervous System Diseases; Cryptococcosis; Cryptococcus; Drug Therapy, Combination; Female; Fluconazole; Flucytosine; Humans; Male; Meningitis, Cryptococcal; Middle Aged; Missouri; Treatment Outcome | 2021 |
Triple therapy combined with ventriculoperitoneal shunts can improve neurological function and shorten hospitalization time in non-HIV cryptococcal meningitis patients with increased intracranial pressure.
Topics: Adult; Amphotericin B; Antifungal Agents; Cryptococcus neoformans; Drug Therapy, Combination; Female; Fluconazole; Flucytosine; Follow-Up Studies; Humans; Intracranial Hypertension; Length of Stay; Male; Meningitis, Cryptococcal; Middle Aged; Retrospective Studies; Spinal Puncture; Treatment Outcome; Ventriculoperitoneal Shunt | 2020 |
HIV-Associated Cryptococcal Meningitis Patients Treated with Amphotericin B Deoxycholate Plus Flucytosine under Routine Care Conditions in a Referral Center in São Paulo, Brazil.
Topics: Adult; Amphotericin B; Antifungal Agents; Brazil; Deoxycholic Acid; Drug Combinations; Drug Therapy, Combination; Fluconazole; Flucytosine; HIV Infections; Humans; Male; Meningitis, Cryptococcal; Referral and Consultation; Retrospective Studies | 2021 |
Ending deaths from HIV-related cryptococcal meningitis by 2030.
Topics: Adult; Aged; Aged, 80 and over; AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Female; Flucytosine; Global Health; HIV Infections; Humans; Male; Meningitis, Cryptococcal; Middle Aged | 2021 |
Crazy-paving patterns as rare radiological manifestations of pulmonary cryptococcosis: a case report.
Topics: Amphotericin B; Antifungal Agents; Bronchoscopy; Cryptococcosis; Flucytosine; Humans; Lung Diseases, Fungal; Male; Middle Aged; Tomography, X-Ray Computed; Voriconazole | 2021 |
Topics: Amphotericin B; Anti-Bacterial Agents; Brain; Cryptococcus neoformans; Female; Flucytosine; Humans; Kidney Transplantation; Magnetic Resonance Imaging; Meningitis, Cryptococcal; Middle Aged; Piperacillin, Tazobactam Drug Combination; Pneumonia; Polycystic Kidney Diseases; Treatment Outcome | 2021 |
Genotypic diversity of Iranian Cryptococcus neoformans using multilocus sequence typing (MLST) and susceptibility to antifungals.
Topics: Amphotericin B; Antifungal Agents; Cryptococcus neoformans; Fluconazole; Flucytosine; Genetic Loci; Genetic Variation; Genotype; Imidazoles; Iran; Itraconazole; Microbial Sensitivity Tests; Multilocus Sequence Typing; Mycological Typing Techniques; Voriconazole | 2021 |
Species identification, antifungal susceptibility profiles and biofilm formation attributes of Rhodotorula isolates from ocular infections.
Topics: Amphotericin B; Antifungal Agents; Biofilms; Eye Infections; Flucytosine; Humans; Microbial Sensitivity Tests; Natamycin; Prospective Studies; Rhodotorula | 2021 |
Adaptation to Fluconazole via Aneuploidy Enables Cross-Adaptation to Amphotericin B and Flucytosine in Cryptococcus neoformans.
Topics: Adaptation, Physiological; Amphotericin B; Aneuploidy; Antifungal Agents; Cryptococcosis; Cryptococcus gattii; Cryptococcus neoformans; Drug Resistance, Fungal; Fluconazole; Flucytosine; Humans; Microbial Sensitivity Tests; Serogroup | 2021 |
The gut commensal fungus, Candida parapsilosis, promotes high fat-diet induced obesity in mice.
Topics: Amphotericin B; Animals; Antifungal Agents; Candida parapsilosis; Diet, High-Fat; Fluconazole; Flucytosine; Male; Mice; Mice, Inbred C57BL; Obesity; Symbiosis | 2021 |
Intracranial Epstein-Barr virus-associated smooth muscle tumor with superimposed cryptococcal infection: A case report.
Topics: Adult; Amphotericin B; Antiretroviral Therapy, Highly Active; Cryptococcus neoformans; Epstein-Barr Virus Infections; Flucytosine; Herpesvirus 4, Human; HIV Infections; Humans; Immunocompromised Host; Magnetic Resonance Imaging; Methicillin-Resistant Staphylococcus aureus; Opportunistic Infections; Smooth Muscle Tumor; Superinfection; Temporal Lobe | 2022 |
Surveillance Study of Epidemiology, Antifungal Susceptibility and Risk Factors of Invasive Candidiasis in Critically ill Patients.
Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Candidiasis, Invasive; Critical Illness; Drug Resistance, Fungal; Fluconazole; Flucytosine; Humans; Itraconazole; Microbial Sensitivity Tests; Risk Factors; Voriconazole | 2022 |
Comparison of liposomal amphotericin B alone and in combination with flucytosine in the treatment of non-HIV Cryptococcal meningitis: A nationwide observational study.
Topics: Amphotericin B; Antifungal Agents; Drug Therapy, Combination; Flucytosine; Humans; Meningitis, Cryptococcal; Retrospective Studies; Treatment Outcome | 2022 |
Amphotericin B plus fluorocytosine combined with voriconazole for the treatment of non-HIV and non-transplant-associated cryptococcal meningitis: a retrospective study.
Topics: Amphotericin B; Antifungal Agents; Drug Therapy, Combination; Fluconazole; Flucytosine; Humans; Hypokalemia; Meningitis, Cryptococcal; Retrospective Studies; Treatment Outcome; Voriconazole | 2022 |
Single-Dose Amphotericin B for Cryptococcal Meningitis.
Topics: Amphotericin B; Fluconazole; Flucytosine; Humans; Meningitis, Cryptococcal | 2022 |
Single-Dose Amphotericin B for Cryptococcal Meningitis. Reply.
Topics: Amphotericin B; Fluconazole; Flucytosine; Humans; Meningitis, Cryptococcal | 2022 |
Comparison of amphotericin B deoxycholate in combination with either flucytosine or fluconazole, and voriconazole plus flucytosine for the treatment of HIV-associated cryptococcal meningitis: a prospective multicenter study in China.
Topics: Amphotericin B; Antifungal Agents; Cohort Studies; Deoxycholic Acid; Drug Combinations; Drug Therapy, Combination; Fluconazole; Flucytosine; HIV Infections; Humans; Infertility; Meningitis, Cryptococcal; Prospective Studies; Voriconazole | 2022 |
Cryptococcus neoformans Presenting as a Lung Mass in an Immunocompromised Patient.
Topics: Amphotericin B; Anti-Bacterial Agents; Antifungal Agents; Cryptococcosis; Cryptococcus neoformans; Female; Fluconazole; Flucytosine; Headache; Humans; Immunocompromised Host; Lung; Middle Aged | 2022 |
The acceptability of the AMBITION-cm treatment regimen for HIV-associated cryptococcal meningitis: Findings from a qualitative methods study of participants and researchers in Botswana and Uganda.
Topics: Antifungal Agents; Botswana; Drug Therapy, Combination; Fluconazole; Flucytosine; HIV Infections; Humans; Meningitis, Cryptococcal; Uganda | 2022 |
Systemic lupus erythematosus complicated with cryptococcal meningitis: A case report.
Topics: Adult; Amphotericin B; Antifungal Agents; Cryptococcus neoformans; Female; Flucytosine; Humans; Lupus Erythematosus, Systemic; Meningitis, Cryptococcal | 2023 |
Prevalence and Antifungal Susceptibility of Sporothrix species in Guangzhou, Southern China.
Topics: Amphotericin B; Animals; Antifungal Agents; China; Flucytosine; Humans; Itraconazole; Microbial Sensitivity Tests; Prevalence; Sporothrix; Sporotrichosis; Terbinafine | 2023 |
Epidemiology, antifungal susceptibility, risk factors, and mortality of persistent candidemia in adult patients in China: a 6-year multicenter retrospective study.
Topics: Adult; Amphotericin B; Antifungal Agents; Candida; Candida parapsilosis; Candida tropicalis; Candidemia; China; Female; Flucytosine; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Retrospective Studies; Risk Factors | 2023 |
Correlation of antifungal susceptibility and sequence types within Cryptococcus neoformans VNI from HIV patients, and ERG11 gene polymorphism.
Topics: Amphotericin B; Antifungal Agents; Cryptococcosis; Cryptococcus neoformans; Democratic Republic of the Congo; Drug Resistance, Fungal; Fluconazole; Flucytosine; Fluorouracil; HIV Infections; Humans; Microbial Sensitivity Tests; Polymorphism, Genetic | 2023 |
Palmitoylethanolamide shows limited efficacy in controlling cerebral cryptococcosis
Topics: Amphotericin B; Animals; Antifungal Agents; Cryptococcosis; Cryptococcus neoformans; Flucytosine; Humans; Meningitis, Cryptococcal; Meningoencephalitis; Mice | 2023 |
Synergistic effect of the verapamil and amphotericin B against Cryptococcus neoformans.
Topics: Amphotericin B; Antifungal Agents; Cryptococcosis; Cryptococcus neoformans; Flucytosine; Microbial Sensitivity Tests | 2023 |